Query 020132
Match_columns 330
No_of_seqs 201 out of 1966
Neff 7.2
Searched_HMMs 46136
Date Fri Mar 29 07:16:08 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/020132.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/020132hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 COG0527 LysC Aspartokinases [A 100.0 6.5E-60 1.4E-64 465.9 17.0 272 29-309 104-375 (447)
2 PLN02551 aspartokinase 100.0 8.3E-60 1.8E-64 473.7 14.1 287 18-306 142-509 (521)
3 PRK09084 aspartate kinase III; 100.0 1.6E-55 3.4E-60 437.8 15.8 288 15-306 85-447 (448)
4 PRK09034 aspartate kinase; Rev 100.0 8.3E-55 1.8E-59 433.4 16.0 278 20-309 97-375 (454)
5 PRK06291 aspartate kinase; Pro 100.0 1.2E-54 2.6E-59 433.7 16.8 280 18-306 99-386 (465)
6 PRK09436 thrA bifunctional asp 100.0 1.7E-54 3.7E-59 456.6 17.9 294 14-316 92-390 (819)
7 PRK09181 aspartate kinase; Val 100.0 3.8E-55 8.2E-60 436.0 11.6 276 17-306 114-466 (475)
8 PRK09466 metL bifunctional asp 100.0 4.3E-53 9.3E-58 443.6 16.5 278 16-303 102-379 (810)
9 KOG0456 Aspartate kinase [Amin 100.0 1.3E-53 2.8E-58 400.4 10.4 293 15-309 166-539 (559)
10 PRK05925 aspartate kinase; Pro 100.0 1E-52 2.3E-57 415.3 16.6 273 29-306 95-434 (440)
11 TIGR00656 asp_kin_monofn aspar 100.0 3.6E-51 7.9E-56 402.0 16.8 263 32-305 62-324 (401)
12 PRK08841 aspartate kinase; Val 100.0 5.6E-51 1.2E-55 398.4 13.0 267 32-307 62-379 (392)
13 TIGR00657 asp_kinases aspartat 100.0 3.1E-50 6.7E-55 399.9 18.1 261 33-302 102-362 (441)
14 PRK08961 bifunctional aspartat 100.0 1.9E-48 4E-53 414.0 17.0 302 15-322 93-474 (861)
15 PRK06635 aspartate kinase; Rev 100.0 2.2E-46 4.8E-51 368.4 15.8 266 32-309 62-330 (404)
16 PRK08210 aspartate kinase I; R 100.0 9.5E-46 2.1E-50 363.9 15.5 262 32-302 67-328 (403)
17 PRK07431 aspartate kinase; Pro 100.0 5.4E-46 1.2E-50 381.4 13.7 279 32-316 62-421 (587)
18 cd04245 AAK_AKiii-YclM-BS AAK_ 100.0 1.2E-45 2.6E-50 346.6 8.1 193 19-215 96-288 (288)
19 cd04257 AAK_AK-HSDH AAK_AK-HSD 100.0 5.6E-45 1.2E-49 343.5 8.5 198 16-215 92-294 (294)
20 cd04258 AAK_AKiii-LysC-EC AAK_ 100.0 5.9E-45 1.3E-49 342.5 8.5 199 16-215 88-292 (292)
21 PRK08373 aspartate kinase; Val 100.0 5.1E-44 1.1E-48 342.0 14.2 240 32-305 98-340 (341)
22 cd04243 AAK_AK-HSDH-like AAK_A 100.0 9.2E-45 2E-49 341.9 8.8 198 16-215 91-293 (293)
23 cd04247 AAK_AK-Hom3 AAK_AK-Hom 100.0 2E-44 4.4E-49 340.4 7.6 200 16-216 100-305 (306)
24 cd04244 AAK_AK-LysC-like AAK_A 100.0 4.8E-44 1E-48 338.1 8.2 199 15-215 92-298 (298)
25 cd04259 AAK_AK-DapDC AAK_AK-Da 100.0 8.3E-44 1.8E-48 335.5 6.8 198 16-215 86-295 (295)
26 cd04248 AAK_AK-Ectoine AAK_AK- 100.0 3.3E-41 7.1E-46 315.4 6.5 177 29-215 126-304 (304)
27 TIGR02078 AspKin_pair Pyrococc 100.0 2.5E-40 5.5E-45 314.9 10.2 230 32-304 93-326 (327)
28 cd04261 AAK_AKii-LysC-BS AAK_A 100.0 1.4E-36 2.9E-41 279.2 7.4 180 32-215 60-239 (239)
29 cd04234 AAK_AK AAK_AK: Amino A 100.0 1.4E-36 2.9E-41 277.2 7.3 175 38-215 52-227 (227)
30 cd04260 AAK_AKi-DapG-BS AAK_AK 100.0 3.8E-36 8.3E-41 277.1 7.0 181 31-215 64-244 (244)
31 cd04246 AAK_AK-DapG-like AAK_A 100.0 4.7E-36 1E-40 275.6 7.6 180 32-215 60-239 (239)
32 cd02115 AAK Amino Acid Kinases 100.0 5.4E-29 1.2E-33 228.8 6.8 179 32-214 62-248 (248)
33 PRK14558 pyrH uridylate kinase 99.9 4.6E-25 9.9E-30 201.8 6.3 159 34-216 63-230 (231)
34 PF00696 AA_kinase: Amino acid 99.9 6.1E-25 1.3E-29 201.2 -0.4 148 37-203 89-242 (242)
35 cd04242 AAK_G5K_ProB AAK_G5K_P 99.9 7.9E-24 1.7E-28 195.9 5.3 165 35-214 66-250 (251)
36 cd04239 AAK_UMPK-like AAK_UMPK 99.9 9.4E-24 2E-28 192.9 4.8 150 34-207 63-212 (229)
37 PRK00358 pyrH uridylate kinase 99.9 1.5E-23 3.2E-28 191.7 5.5 156 35-214 66-230 (231)
38 PRK12314 gamma-glutamyl kinase 99.9 9.8E-23 2.1E-27 190.1 6.8 168 35-217 76-265 (266)
39 PRK14557 pyrH uridylate kinase 99.9 1.1E-22 2.4E-27 187.6 5.8 162 33-217 68-239 (247)
40 cd04254 AAK_UMPK-PyrH-Ec UMP k 99.9 1.1E-22 2.3E-27 186.2 4.5 154 37-214 68-230 (231)
41 TIGR02075 pyrH_bact uridylate 99.9 3.2E-22 7E-27 183.2 5.5 156 36-215 68-233 (233)
42 PRK13402 gamma-glutamyl kinase 99.8 3.2E-21 6.9E-26 187.0 6.5 169 35-218 71-259 (368)
43 COG0528 PyrH Uridylate kinase 99.8 5E-21 1.1E-25 171.9 7.0 181 11-215 25-237 (238)
44 PRK14556 pyrH uridylate kinase 99.8 1.2E-20 2.7E-25 173.0 5.0 157 35-215 82-247 (249)
45 cd04253 AAK_UMPK-PyrH-Pf AAK_U 99.8 3.7E-20 8.1E-25 168.3 6.1 112 90-214 94-220 (221)
46 PRK05429 gamma-glutamyl kinase 99.8 4.9E-20 1.1E-24 179.5 5.6 169 36-218 76-263 (372)
47 cd04241 AAK_FomA-like AAK_FomA 99.8 1.1E-19 2.3E-24 168.3 6.8 145 49-207 83-236 (252)
48 TIGR01027 proB glutamate 5-kin 99.8 9.6E-20 2.1E-24 176.9 6.0 168 36-217 68-254 (363)
49 PRK14058 acetylglutamate/acety 99.8 2.5E-19 5.4E-24 167.4 6.6 163 39-216 75-267 (268)
50 TIGR02076 pyrH_arch uridylate 99.8 1.6E-19 3.4E-24 164.1 4.3 137 36-207 62-204 (221)
51 cd04250 AAK_NAGK-C AAK_NAGK-C: 99.7 9.5E-19 2.1E-23 164.4 5.9 151 43-208 93-263 (279)
52 TIGR00761 argB acetylglutamate 99.7 1.1E-18 2.4E-23 159.5 4.9 140 43-198 75-227 (231)
53 cd04249 AAK_NAGK-NC AAK_NAGK-N 99.7 1.8E-18 4E-23 160.2 5.2 147 43-207 77-236 (252)
54 PRK00942 acetylglutamate kinas 99.7 5.1E-18 1.1E-22 159.7 6.6 156 43-216 102-282 (283)
55 cd04238 AAK_NAGK-like AAK_NAGK 99.7 1.1E-17 2.4E-22 155.3 5.6 147 43-207 77-239 (256)
56 PLN02512 acetylglutamate kinas 99.7 4.1E-17 8.8E-22 155.4 8.1 155 48-215 129-308 (309)
57 cd04251 AAK_NAGK-UC AAK_NAGK-U 99.7 1.8E-17 3.8E-22 154.1 4.1 153 37-207 68-243 (257)
58 CHL00202 argB acetylglutamate 99.7 7.2E-17 1.6E-21 152.1 8.3 156 43-215 102-283 (284)
59 cd04255 AAK_UMPK-MosAB AAK_UMP 99.7 6.9E-17 1.5E-21 150.3 5.7 182 13-207 47-245 (262)
60 cd04256 AAK_P5CS_ProBA AAK_P5C 99.7 1.3E-16 2.8E-21 150.2 6.7 167 37-214 95-283 (284)
61 PTZ00489 glutamate 5-kinase; P 99.6 3.1E-16 6.8E-21 146.0 8.5 164 41-217 77-260 (264)
62 PLN02418 delta-1-pyrroline-5-c 99.6 1.8E-16 3.8E-21 166.1 7.4 168 38-217 95-284 (718)
63 COG0263 ProB Glutamate 5-kinas 99.6 4.1E-16 8.9E-21 147.3 7.8 167 37-218 75-261 (369)
64 COG1608 Predicted archaeal kin 99.6 2.6E-15 5.6E-20 135.2 8.5 155 48-215 83-251 (252)
65 COG0548 ArgB Acetylglutamate k 99.5 6.9E-15 1.5E-19 135.8 6.9 150 42-207 80-246 (265)
66 cd04915 ACT_AK-Ectoine_2 ACT d 99.5 4.6E-14 1E-18 104.3 6.0 64 241-305 2-65 (66)
67 cd04236 AAK_NAGS-Urea AAK_NAGS 99.5 8.2E-14 1.8E-18 130.0 8.1 140 48-203 100-253 (271)
68 TIGR01092 P5CS delta l-pyrroli 99.4 5.8E-14 1.3E-18 147.4 5.6 144 63-217 107-276 (715)
69 cd04918 ACT_AK1-AT_2 ACT domai 99.4 1.8E-13 4E-18 100.6 6.4 63 242-305 2-64 (65)
70 cd04252 AAK_NAGK-fArgBP AAK_NA 99.4 2.9E-13 6.2E-18 125.3 8.3 140 48-204 77-231 (248)
71 cd04919 ACT_AK-Hom3_2 ACT doma 99.4 3.4E-13 7.4E-18 98.8 6.3 65 241-305 1-65 (66)
72 cd04235 AAK_CK AAK_CK: Carbama 99.4 5.9E-13 1.3E-17 126.1 9.4 120 90-214 172-307 (308)
73 PRK12353 putative amino acid k 99.4 7.9E-13 1.7E-17 126.2 8.8 121 90-215 176-313 (314)
74 cd04922 ACT_AKi-HSDH-ThrA_2 AC 99.4 9.1E-13 2E-17 96.3 6.6 65 241-305 1-65 (66)
75 cd04937 ACT_AKi-DapG-BS_2 ACT 99.4 1.2E-12 2.5E-17 96.0 6.2 63 241-305 1-63 (64)
76 cd04920 ACT_AKiii-DAPDC_2 ACT 99.3 1.3E-12 2.8E-17 95.6 5.5 62 242-305 1-62 (63)
77 cd04921 ACT_AKi-HSDH-ThrA-like 99.3 2.4E-12 5.3E-17 98.0 7.2 78 241-318 1-78 (80)
78 cd04237 AAK_NAGS-ABP AAK_NAGS- 99.3 1.1E-12 2.4E-17 123.5 6.2 147 42-207 94-263 (280)
79 PRK05279 N-acetylglutamate syn 99.3 1.8E-12 4E-17 129.2 8.2 153 48-217 105-292 (441)
80 cd04917 ACT_AKiii-LysC-EC_2 AC 99.3 2.7E-12 5.8E-17 93.9 6.4 63 241-305 1-63 (64)
81 TIGR00746 arcC carbamate kinas 99.3 8E-12 1.7E-16 118.8 9.4 175 36-215 74-309 (310)
82 cd04916 ACT_AKiii-YclM-BS_2 AC 99.3 5.8E-12 1.3E-16 92.0 6.6 65 241-305 1-65 (66)
83 cd04924 ACT_AK-Arch_2 ACT doma 99.3 9.3E-12 2E-16 90.8 6.6 64 241-304 1-64 (66)
84 TIGR01890 N-Ac-Glu-synth amino 99.3 8.4E-12 1.8E-16 124.2 7.9 116 90-217 151-280 (429)
85 PRK12686 carbamate kinase; Rev 99.2 6.6E-12 1.4E-16 119.1 5.8 122 90-215 174-311 (312)
86 cd04240 AAK_UC AAK_UC: Unchara 99.2 9.2E-12 2E-16 111.9 5.0 148 34-207 25-186 (203)
87 PRK12454 carbamate kinase-like 99.2 2E-11 4.3E-16 115.7 5.8 122 90-215 176-312 (313)
88 PRK06291 aspartate kinase; Pro 99.2 3.6E-11 7.7E-16 120.8 7.4 118 187-306 340-463 (465)
89 COG0527 LysC Aspartokinases [A 99.2 4.3E-11 9.4E-16 119.1 6.7 71 234-306 376-446 (447)
90 PF13840 ACT_7: ACT domain ; P 99.1 4.5E-11 9.8E-16 88.0 4.5 63 237-302 2-65 (65)
91 PRK09034 aspartate kinase; Rev 99.1 1E-10 2.2E-15 117.1 7.5 76 232-307 376-451 (454)
92 PRK12354 carbamate kinase; Rev 99.1 1.6E-10 3.5E-15 109.3 7.8 123 90-217 166-301 (307)
93 PRK09436 thrA bifunctional asp 99.1 1.3E-10 2.9E-15 123.8 7.6 120 187-308 334-463 (819)
94 KOG1154 Gamma-glutamyl kinase 99.1 7.7E-11 1.7E-15 105.8 4.2 156 39-210 92-260 (285)
95 PRK09411 carbamate kinase; Rev 99.1 3.1E-10 6.6E-15 106.7 8.2 118 90-215 167-296 (297)
96 PRK12352 putative carbamate ki 99.0 3.3E-10 7.2E-15 108.0 5.6 122 90-216 177-315 (316)
97 cd04892 ACT_AK-like_2 ACT doma 99.0 1.1E-09 2.3E-14 78.6 6.5 64 242-305 1-64 (65)
98 cd04936 ACT_AKii-LysC-BS-like_ 99.0 1.3E-09 2.8E-14 78.4 6.0 62 242-305 1-62 (63)
99 cd04923 ACT_AK-LysC-DapG-like_ 99.0 1.6E-09 3.6E-14 77.8 6.1 62 242-305 1-62 (63)
100 TIGR00656 asp_kin_monofn aspar 98.9 2.3E-09 5E-14 105.7 6.9 116 187-306 279-400 (401)
101 PRK04531 acetylglutamate kinas 98.9 3.3E-09 7.1E-14 104.4 7.8 84 92-187 122-208 (398)
102 PRK07431 aspartate kinase; Pro 98.9 2.8E-09 6.1E-14 110.1 6.5 71 233-305 511-581 (587)
103 COG2054 Uncharacterized archae 98.8 2.7E-09 5.8E-14 92.5 4.5 83 126-216 118-210 (212)
104 PLN02825 amino-acid N-acetyltr 98.8 2.8E-09 6.1E-14 107.7 5.3 108 54-178 112-235 (515)
105 TIGR00657 asp_kinases aspartat 98.8 6.6E-09 1.4E-13 103.8 6.9 116 187-305 320-440 (441)
106 cd04868 ACT_AK-like ACT domain 98.8 1.2E-08 2.5E-13 71.7 5.2 60 242-301 1-60 (60)
107 PRK09466 metL bifunctional asp 98.7 1.2E-08 2.7E-13 108.4 6.6 118 187-307 336-455 (810)
108 PRK08210 aspartate kinase I; R 98.7 1.8E-08 3.9E-13 99.5 6.9 114 187-305 288-401 (403)
109 cd04912 ACT_AKiii-LysC-EC-like 98.6 6.3E-08 1.4E-12 73.1 6.1 64 241-306 1-67 (75)
110 cd04933 ACT_AK1-AT_1 ACT domai 98.6 7.9E-08 1.7E-12 73.3 6.4 63 241-305 1-69 (78)
111 PRK06635 aspartate kinase; Rev 98.6 5.8E-08 1.2E-12 95.9 6.9 117 187-305 279-402 (404)
112 cd04932 ACT_AKiii-LysC-EC_1 AC 98.5 1.7E-07 3.7E-12 70.9 5.7 62 241-304 1-65 (75)
113 cd04934 ACT_AK-Hom3_1 CT domai 98.5 2.4E-07 5.1E-12 69.8 5.6 64 241-306 1-65 (73)
114 cd04913 ACT_AKii-LysC-BS-like_ 98.5 4.2E-07 9.1E-12 67.1 6.4 61 241-303 1-64 (75)
115 cd04891 ACT_AK-LysC-DapG-like_ 98.5 3.3E-07 7.1E-12 64.8 5.5 57 242-300 1-60 (61)
116 cd04935 ACT_AKiii-DAPDC_1 ACT 98.4 4.3E-07 9.3E-12 68.7 5.7 64 241-306 1-67 (75)
117 cd04890 ACT_AK-like_1 ACT doma 98.4 6.1E-07 1.3E-11 64.7 5.7 60 243-304 2-61 (62)
118 COG0549 ArcC Carbamate kinase 98.2 2E-06 4.3E-11 79.9 6.1 122 90-215 175-311 (312)
119 cd04914 ACT_AKi-DapG-BS_1 ACT 98.2 4.5E-06 9.8E-11 61.6 5.8 57 242-302 2-58 (67)
120 PRK09084 aspartate kinase III; 98.1 6.1E-06 1.3E-10 82.8 6.8 77 231-309 296-373 (448)
121 PLN02551 aspartokinase 98.0 9E-06 1.9E-10 82.9 6.8 64 230-295 355-418 (521)
122 PRK09181 aspartate kinase; Val 97.9 1.9E-05 4.2E-10 79.6 6.2 72 231-304 319-392 (475)
123 PRK08961 bifunctional aspartat 97.7 6.7E-05 1.4E-09 81.1 6.6 73 230-304 311-386 (861)
124 cd04910 ACT_AK-Ectoine_1 ACT d 97.3 0.00062 1.3E-08 50.9 5.5 64 242-305 2-65 (71)
125 PF01842 ACT: ACT domain; Int 97.0 0.00095 2.1E-08 47.8 3.8 54 250-303 6-64 (66)
126 PRK05925 aspartate kinase; Pro 96.9 0.0019 4.1E-08 64.7 6.2 70 230-303 289-359 (440)
127 cd04911 ACT_AKiii-YclM-BS_1 AC 96.7 0.0022 4.7E-08 48.6 3.9 70 242-313 2-72 (76)
128 COG3830 ACT domain-containing 96.6 0.0034 7.4E-08 48.7 4.3 67 240-309 2-70 (90)
129 KOG2436 Acetylglutamate kinase 95.7 0.0088 1.9E-07 59.8 3.6 119 41-177 170-302 (520)
130 cd04888 ACT_PheB-BS C-terminal 95.5 0.026 5.6E-07 41.7 4.7 54 251-304 7-63 (76)
131 PRK08841 aspartate kinase; Val 95.1 0.031 6.7E-07 55.3 5.1 58 230-296 247-304 (392)
132 COG3603 Uncharacterized conser 94.9 0.079 1.7E-06 43.2 5.9 69 232-303 54-122 (128)
133 cd04908 ACT_Bt0572_1 N-termina 94.0 0.12 2.6E-06 37.4 4.8 52 251-302 8-59 (66)
134 PRK13562 acetolactate synthase 94.0 0.13 2.8E-06 39.7 5.1 52 251-302 9-67 (84)
135 cd02116 ACT ACT domains are co 93.9 0.093 2E-06 34.5 3.8 48 253-300 7-59 (60)
136 PRK04435 hypothetical protein; 93.3 0.21 4.6E-06 42.5 5.8 63 239-304 67-132 (147)
137 KOG0456 Aspartate kinase [Amin 92.2 0.16 3.4E-06 49.7 3.9 74 229-304 381-457 (559)
138 cd04870 ACT_PSP_1 CT domains f 91.8 0.3 6.4E-06 36.3 4.3 57 243-302 1-62 (75)
139 PF13740 ACT_6: ACT domain; PD 91.7 0.3 6.5E-06 36.5 4.3 58 241-301 2-63 (76)
140 PRK06737 acetolactate synthase 91.7 0.39 8.6E-06 36.3 4.8 52 251-302 9-66 (76)
141 PRK08178 acetolactate synthase 91.1 0.41 8.8E-06 37.9 4.5 58 242-302 9-71 (96)
142 cd04882 ACT_Bt0572_2 C-termina 90.1 0.33 7.2E-06 34.3 3.1 51 250-302 5-59 (65)
143 cd04872 ACT_1ZPV ACT domain pr 89.2 0.27 5.9E-06 37.7 2.1 36 242-280 2-37 (88)
144 CHL00100 ilvH acetohydroxyacid 88.8 1.1 2.4E-05 39.4 5.9 57 243-302 4-66 (174)
145 cd04875 ACT_F4HF-DF N-terminal 88.8 1.1 2.3E-05 33.1 5.1 33 243-278 1-33 (74)
146 PRK11152 ilvM acetolactate syn 88.7 0.84 1.8E-05 34.5 4.4 52 251-302 10-66 (76)
147 cd04883 ACT_AcuB C-terminal AC 88.7 1.2 2.6E-05 32.2 5.2 53 250-302 7-63 (72)
148 COG4747 ACT domain-containing 87.7 1 2.2E-05 37.0 4.6 58 246-303 71-129 (142)
149 cd04886 ACT_ThrD-II-like C-ter 87.6 1.3 2.9E-05 31.4 4.9 28 251-278 5-32 (73)
150 PRK00194 hypothetical protein; 87.4 0.56 1.2E-05 36.0 2.9 36 241-279 3-38 (90)
151 cd04909 ACT_PDH-BS C-terminal 87.3 1.1 2.3E-05 32.3 4.2 52 251-302 8-64 (69)
152 PRK11895 ilvH acetolactate syn 87.2 1.3 2.8E-05 38.5 5.3 53 251-303 9-67 (161)
153 cd04869 ACT_GcvR_2 ACT domains 87.0 1.9 4E-05 32.1 5.5 56 244-302 2-68 (81)
154 cd04889 ACT_PDH-BS-like C-term 86.8 0.95 2.1E-05 31.3 3.6 50 251-300 5-55 (56)
155 cd04880 ACT_AAAH-PDT-like ACT 85.3 1.6 3.4E-05 32.2 4.3 51 251-302 6-66 (75)
156 cd04893 ACT_GcvR_1 ACT domains 84.6 1.8 4E-05 32.3 4.4 35 242-279 2-36 (77)
157 TIGR00119 acolac_sm acetolacta 84.4 2.1 4.5E-05 37.0 5.2 53 251-305 8-64 (157)
158 cd04903 ACT_LSD C-terminal ACT 81.5 1.8 4E-05 30.5 3.2 52 251-302 6-61 (71)
159 PRK13010 purU formyltetrahydro 81.0 3.6 7.8E-05 39.1 5.8 35 241-278 9-43 (289)
160 COG0440 IlvH Acetolactate synt 80.6 2.8 6E-05 36.4 4.4 53 251-303 11-69 (163)
161 cd04874 ACT_Af1403 N-terminal 77.8 4 8.7E-05 28.8 4.0 41 251-291 7-50 (72)
162 TIGR00655 PurU formyltetrahydr 77.6 2.5 5.5E-05 39.9 3.7 34 243-279 2-35 (280)
163 COG1058 CinA Predicted nucleot 77.6 7.6 0.00016 36.2 6.7 68 47-140 22-89 (255)
164 cd04881 ACT_HSDH-Hom ACT_HSDH_ 77.4 4.8 0.0001 28.9 4.5 52 251-302 7-65 (79)
165 cd04878 ACT_AHAS N-terminal AC 75.9 4.9 0.00011 28.2 4.1 50 251-300 7-62 (72)
166 PRK13011 formyltetrahydrofolat 75.0 8 0.00017 36.6 6.3 62 241-305 7-78 (286)
167 PF13291 ACT_4: ACT domain; PD 74.5 7 0.00015 29.0 4.7 58 242-302 7-68 (80)
168 cd04905 ACT_CM-PDT C-terminal 74.4 6.3 0.00014 29.3 4.5 52 251-302 8-68 (80)
169 cd04879 ACT_3PGDH-like ACT_3PG 74.3 4.3 9.4E-05 28.4 3.4 51 251-301 6-60 (71)
170 cd04929 ACT_TPH ACT domain of 74.0 8.7 0.00019 28.7 5.1 51 252-302 8-65 (74)
171 PF13710 ACT_5: ACT domain; PD 73.9 3.2 7E-05 29.9 2.6 50 253-302 1-56 (63)
172 PRK06027 purU formyltetrahydro 73.1 7.5 0.00016 36.8 5.6 36 241-279 6-41 (286)
173 cd04884 ACT_CBS C-terminal ACT 72.7 5.8 0.00013 28.8 3.8 29 251-279 6-34 (72)
174 cd04904 ACT_AAAH ACT domain of 72.0 10 0.00022 28.0 5.0 52 251-302 7-65 (74)
175 PRK11589 gcvR glycine cleavage 70.5 5.7 0.00012 35.3 3.9 61 239-304 6-68 (190)
176 cd04877 ACT_TyrR N-terminal AC 70.1 7.8 0.00017 28.4 4.0 46 252-298 8-53 (74)
177 cd04900 ACT_UUR-like_1 ACT dom 69.2 16 0.00035 26.6 5.6 30 243-275 3-32 (73)
178 cd04901 ACT_3PGDH C-terminal A 69.0 1.9 4.1E-05 30.8 0.4 52 251-302 6-59 (69)
179 PRK08577 hypothetical protein; 68.6 12 0.00026 31.1 5.3 36 239-277 54-89 (136)
180 cd04876 ACT_RelA-SpoT ACT dom 66.5 10 0.00023 25.5 3.9 29 251-279 5-33 (71)
181 cd04931 ACT_PAH ACT domain of 66.4 13 0.00028 28.9 4.7 52 251-302 21-80 (90)
182 cd04887 ACT_MalLac-Enz ACT_Mal 66.0 11 0.00024 27.1 4.1 52 251-302 6-60 (74)
183 PF11760 CbiG_N: Cobalamin syn 65.3 8.4 0.00018 29.7 3.4 32 111-142 43-78 (84)
184 cd04925 ACT_ACR_2 ACT domain-c 64.2 18 0.00038 26.6 4.9 45 243-290 2-48 (74)
185 cd04902 ACT_3PGDH-xct C-termin 64.1 6.1 0.00013 28.3 2.4 51 251-301 6-60 (73)
186 cd04906 ACT_ThrD-I_1 First of 62.9 18 0.00038 27.4 4.8 52 249-302 6-64 (85)
187 COG4492 PheB ACT domain-contai 62.5 12 0.00026 31.4 3.9 52 251-302 79-137 (150)
188 PRK08198 threonine dehydratase 62.4 16 0.00036 36.0 5.8 59 239-300 325-393 (404)
189 cd04873 ACT_UUR-ACR-like ACT d 62.1 17 0.00038 25.4 4.5 45 244-291 3-49 (70)
190 PRK03670 competence damage-ind 60.9 31 0.00067 32.1 7.0 70 46-140 20-89 (252)
191 PRK11589 gcvR glycine cleavage 60.0 12 0.00025 33.4 3.8 63 242-307 96-172 (190)
192 cd04885 ACT_ThrD-I Tandem C-te 59.5 25 0.00054 25.3 4.9 50 251-301 5-60 (68)
193 cd00885 cinA Competence-damage 59.4 42 0.00092 29.1 7.2 70 45-140 18-87 (170)
194 COG0855 Ppk Polyphosphate kina 59.3 26 0.00055 36.9 6.5 77 90-169 416-496 (696)
195 cd04927 ACT_ACR-like_2 Second 57.0 26 0.00057 25.9 4.8 30 243-275 2-31 (76)
196 PRK03673 hypothetical protein; 56.5 35 0.00077 33.9 6.9 68 46-139 21-88 (396)
197 cd04871 ACT_PSP_2 ACT domains 55.6 5.1 0.00011 30.6 0.7 34 243-278 1-34 (84)
198 TIGR00177 molyb_syn molybdenum 54.3 78 0.0017 26.4 7.8 66 46-137 27-92 (144)
199 COG4747 ACT domain-containing 53.9 40 0.00088 27.8 5.6 56 243-303 5-62 (142)
200 cd04930 ACT_TH ACT domain of t 52.2 31 0.00067 28.1 4.8 27 251-277 48-74 (115)
201 cd04926 ACT_ACR_4 C-terminal 50.9 16 0.00034 26.7 2.7 40 251-290 8-49 (72)
202 PRK01215 competence damage-ind 50.7 57 0.0012 30.5 7.0 70 45-140 22-91 (264)
203 PF00994 MoCF_biosynth: Probab 50.6 63 0.0014 26.8 6.7 68 45-138 16-83 (144)
204 COG0499 SAM1 S-adenosylhomocys 47.7 20 0.00044 35.2 3.5 77 53-149 161-241 (420)
205 smart00852 MoCF_biosynth Proba 47.6 79 0.0017 25.8 6.7 70 44-139 16-85 (135)
206 PRK06349 homoserine dehydrogen 47.6 26 0.00057 35.0 4.5 52 250-301 354-411 (426)
207 PF02254 TrkA_N: TrkA-N domain 45.3 46 0.00099 26.0 4.8 70 38-147 2-71 (116)
208 PRK00549 competence damage-ind 44.1 75 0.0016 31.7 7.1 70 45-140 19-88 (414)
209 cd04899 ACT_ACR-UUR-like_2 C-t 43.9 22 0.00048 25.1 2.5 32 243-277 2-33 (70)
210 PF09413 DUF2007: Domain of un 43.8 35 0.00076 24.3 3.6 44 259-302 13-64 (67)
211 TIGR01127 ilvA_1Cterm threonin 42.7 60 0.0013 31.7 6.1 58 240-300 304-371 (380)
212 PRK07334 threonine dehydratase 42.4 53 0.0012 32.4 5.7 58 242-302 327-394 (403)
213 cd04896 ACT_ACR-like_3 ACT dom 41.2 62 0.0013 24.3 4.6 25 252-276 8-32 (75)
214 cd04895 ACT_ACR_1 ACT domain-c 39.6 28 0.0006 25.9 2.4 47 243-292 3-51 (72)
215 PRK06382 threonine dehydratase 39.4 75 0.0016 31.4 6.3 62 238-302 327-398 (406)
216 TIGR02667 moaB_proteo molybden 38.4 1.3E+02 0.0028 25.8 6.8 71 44-138 20-90 (163)
217 COG0462 PrsA Phosphoribosylpyr 38.0 57 0.0012 31.4 4.9 96 35-147 97-195 (314)
218 PRK05788 cobalamin biosynthesi 36.1 24 0.00052 33.9 2.1 45 111-155 83-132 (315)
219 cd04928 ACT_TyrKc Uncharacteri 35.1 87 0.0019 23.0 4.5 28 244-274 4-31 (68)
220 TIGR00200 cinA_nterm competenc 33.3 1.6E+02 0.0034 29.5 7.4 68 47-140 21-88 (413)
221 cd00758 MoCF_BD MoCF_BD: molyb 30.4 2E+02 0.0044 23.4 6.5 66 46-137 19-84 (133)
222 PF13511 DUF4124: Domain of un 28.5 64 0.0014 22.4 2.8 29 130-158 3-33 (60)
223 cd00886 MogA_MoaB MogA_MoaB fa 28.2 2.5E+02 0.0055 23.5 6.9 68 47-138 21-88 (152)
224 COG1104 NifS Cysteine sulfinat 28.1 2.4E+02 0.0052 28.0 7.5 94 34-153 90-183 (386)
225 smart00460 TGc Transglutaminas 27.6 45 0.00097 23.3 1.9 25 41-67 8-32 (68)
226 COG1778 Low specificity phosph 27.3 16 0.00035 31.6 -0.6 52 144-207 11-62 (170)
227 cd04897 ACT_ACR_3 ACT domain-c 25.8 1.8E+02 0.004 21.7 4.9 47 242-291 2-50 (75)
228 COG0303 MoeA Molybdopterin bio 25.8 1.9E+02 0.0042 28.8 6.5 72 47-146 204-275 (404)
229 COG0329 DapA Dihydrodipicolina 25.7 1.3E+02 0.0028 28.6 5.1 80 47-145 26-106 (299)
230 COG2150 Predicted regulator of 25.2 91 0.002 27.1 3.5 59 241-300 93-155 (167)
231 cd05402 NT_PAP_TUTase Nucleoti 24.7 96 0.0021 24.3 3.5 43 280-322 37-81 (114)
232 PTZ00445 p36-lilke protein; Pr 24.6 2.8E+02 0.0061 25.3 6.7 27 46-72 29-55 (219)
233 PF12122 DUF3582: Protein of u 24.3 91 0.002 24.8 3.2 51 253-305 8-58 (101)
234 PF01841 Transglut_core: Trans 22.6 47 0.001 25.7 1.3 29 40-70 52-80 (113)
235 cd00952 CHBPH_aldolase Trans-o 22.5 1.8E+02 0.004 27.6 5.5 80 48-146 31-111 (309)
236 PF09186 DUF1949: Domain of un 22.5 1.8E+02 0.0038 19.4 4.1 45 258-303 8-52 (56)
237 PRK06545 prephenate dehydrogen 21.5 1.3E+02 0.0027 29.3 4.2 59 240-302 289-353 (359)
238 PF11713 Peptidase_C80: Peptid 20.7 75 0.0016 27.3 2.2 37 242-278 104-143 (157)
239 PF11823 DUF3343: Protein of u 20.2 1.9E+02 0.004 21.1 4.0 46 258-303 14-62 (73)
240 PRK14324 glmM phosphoglucosami 20.1 6.5E+02 0.014 25.1 9.1 53 15-67 155-207 (446)
No 1
>COG0527 LysC Aspartokinases [Amino acid transport and metabolism]
Probab=100.00 E-value=6.5e-60 Score=465.88 Aligned_cols=272 Identities=40% Similarity=0.617 Sum_probs=253.8
Q ss_pred CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEee
Q 020132 29 GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATG 108 (330)
Q Consensus 29 ~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G 108 (330)
++.+++.+|+++|+||++|+++|+.+|+++|++|++++++++++.+++.++++.+....++..+..+++ .+.|||++|
T Consensus 104 ~~~~~~~~D~ilS~GE~~Sa~lla~~L~~~Gv~A~~~~~~~~~i~t~~~~~~a~i~~~~~~~~l~~~~~--~~~v~Vv~G 181 (447)
T COG0527 104 GEVSPRERDELLSLGERLSAALLAAALNALGVDARSLDGRQAGIATDSNHGNARILDEDSERRLLRLLE--EGKVPVVAG 181 (447)
T ss_pred cCCCHHHHHHHHhhchHHHHHHHHHHHHhCCCceEEEchHHceeeecCcccccccchhhhhhhHHHHhc--CCcEEEecC
Confidence 567899999999999999999999999999999999999999999988888877766555443666776 889999999
Q ss_pred eeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccc
Q 020132 109 FIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRT 188 (330)
Q Consensus 109 ~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a 188 (330)
|+|.+++|+++|||||||||+|++||++|+|+++.||||||||||+|||++|+|++|++|||+||.||+++|++|+||+|
T Consensus 182 F~G~~~~G~~tTLGRGGSD~SA~~laa~l~Ad~~~I~TDVdGI~TaDPRiVp~Ar~i~~isyeEa~ELA~~GAkVLHpra 261 (447)
T COG0527 182 FQGINEDGETTTLGRGGSDYSAAALAAALGADEVEIWTDVDGVYTADPRIVPDARLLPEISYEEALELAYLGAKVLHPRA 261 (447)
T ss_pred ceeecCCCCEEEeCCCcHHHHHHHHHHHcCCCEEEEEECCCCCccCCCCCCCcceEcCccCHHHHHHHHHCCchhcCHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceeeecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecceeEEeeecccccCCCCchhhhhhhhccc
Q 020132 189 IIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDV 268 (330)
Q Consensus 189 ~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~ 268 (330)
++||++++||++|+|+++|+.+||+|.+...+. ...+++|+..+|+++|++.|..|...+|+.+++|..|+++
T Consensus 262 v~pa~~~~Ip~~i~~t~~p~~~GTlI~~~~~~~-------~~~v~gIa~~~~~~~i~v~~~~~~~~~g~~a~vf~~l~~~ 334 (447)
T COG0527 262 VEPAMRSGIPLRIKNTFNPDAPGTLITAETESD-------EPVVKGIALDDNVALITVSGPGMNGMVGFAARVFGILAEA 334 (447)
T ss_pred HHHHHhcCCcEEEEecCCCCCCceEEecCCcCC-------CCceEEEEeCCCeEEEEEEccCccccccHHHHHHHHHHHc
Confidence 999999999999999999999999998875432 1568899999999999999999999999999999999999
Q ss_pred CccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHHHhc
Q 020132 269 GANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALN 309 (330)
Q Consensus 269 gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~~~~ 309 (330)
||+++||.|+.++.+++|++++.+.+++.+.||+.+.....
T Consensus 335 ~i~v~~I~q~~~~~~i~~~v~~~~~~~a~~~l~~~~~~~~~ 375 (447)
T COG0527 335 GINVDLITQSISEVSISFTVPESDAPRALRALLEEKLELLA 375 (447)
T ss_pred CCcEEEEEeccCCCeEEEEEchhhHHHHHHHHHHHHhhhcc
Confidence 99999999999999999999999999999999999875553
No 2
>PLN02551 aspartokinase
Probab=100.00 E-value=8.3e-60 Score=473.67 Aligned_cols=287 Identities=26% Similarity=0.434 Sum_probs=247.7
Q ss_pred hhhcccccCCC-----CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHH
Q 020132 18 STYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRL 92 (330)
Q Consensus 18 ~~~~~l~~~~~-----~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i 92 (330)
..++.|++++. ++.+++.+|.++|+||+||+++|+.+|+++|++|.+++++++++++++.+++++++ +.+.+.+
T Consensus 142 ~~~~~l~~ll~~i~~~~~~~~~~~d~ils~GE~lSa~lla~~L~~~Gi~a~~lda~~~gi~t~~~~~~a~i~-~~~~~~l 220 (521)
T PLN02551 142 KLLDELEQLLKGIAMMKELTPRTRDYLVSFGERMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADIL-EATYPAV 220 (521)
T ss_pred HHHHHHHHHHHhhhhhcccchHHHHHHHhHHHHHHHHHHHHHHHHCCCCcEEechHHcceEecCCCCccchh-hhhHHHH
Confidence 33444554443 46788899999999999999999999999999999999999988888888887765 3444555
Q ss_pred HHhhcc---CCCccEEEeeeeecC-CCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhh
Q 020132 93 EKWFSQ---SPSNTIIATGFIAST-PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTL 168 (330)
Q Consensus 93 ~~~l~~---~~~~VpVv~G~i~~~-~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~i 168 (330)
++.+.. ..+.|||++||+|.+ .+|.++||||||||++|+++|++|+|+++.||||||||||+||+.+|+|+++++|
T Consensus 221 ~~~l~~~~~~~~~v~Vv~GFig~~~~~G~~ttLGRGGSD~sA~~la~~L~A~~v~I~tDV~Gi~taDPr~v~~A~~l~~l 300 (521)
T PLN02551 221 AKRLHGDWIDDPAVPVVTGFLGKGWKTGAITTLGRGGSDLTATTIGKALGLREIQVWKDVDGVLTCDPRIYPNAVPVPYL 300 (521)
T ss_pred HHHHHhhhccCCeEEEEcCccccCCCCCcEEecCCChHHHHHHHHHHHcCCCEEEEEeCCCceeCCCCCCCCCceEeccc
Confidence 555421 245899999999999 8999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEeeCCCC-C----------C---------Ccc----
Q 020132 169 SYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPV-D----------E---------NED---- 224 (330)
Q Consensus 169 s~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~-~----------~---------~~~---- 224 (330)
||+||.||+++|++||||+|++||++++||++|+|+++|+.+||+|..... + . ..|
T Consensus 301 sy~Ea~elA~~GakVlhp~ai~pa~~~~Ipi~vknt~~p~~~GT~I~~~~~~~~~~v~~It~~~~v~li~i~~~~m~~~~ 380 (521)
T PLN02551 301 TFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPTAPGTLITKTRDMSKAVLTSIVLKRNVTMLDIVSTRMLGQY 380 (521)
T ss_pred CHHHHHHHHhCCCcccCHHHHHHHHHCCceEEEEecCCCCCCCcEEecccccCCCcccceecCCCeEEEEEecCCCCCcc
Confidence 999999999999999999999999999999999999999999999964321 0 0 000
Q ss_pred ------------------------------c---c--c-------c------cCCcccceeecceeEEeeecccccCCCC
Q 020132 225 ------------------------------E---Q--I-------I------DSPVKGFATIDNLALVNVEGTGMAGVPG 256 (330)
Q Consensus 225 ------------------------------~---~--~-------~------~~~~~~i~~~~nia~IsvvG~~~~~~~g 256 (330)
. . . . -..+..+.+.+++++|++||. |..++|
T Consensus 381 g~~arvf~~l~~~~I~Vd~IssSe~sIs~~v~~~~~~~~~~i~~~l~~l~~el~~~~~V~v~~~vAiISvVG~-~~~~~g 459 (521)
T PLN02551 381 GFLAKVFSTFEDLGISVDVVATSEVSISLTLDPSKLWSRELIQQELDHLVEELEKIAVVNLLQGRSIISLIGN-VQRSSL 459 (521)
T ss_pred cHHHHHHHHHHHcCCcEEEEeccCCEEEEEEehhHhhhhhhHHHHHHHHHHHhhcCCeEEEeCCEEEEEEEcc-CCCCcc
Confidence 0 0 0 0 011345777899999999998 788999
Q ss_pred chhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHH
Q 020132 257 TANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (330)
Q Consensus 257 v~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~ 306 (330)
+++++|++|+++||||.||+|++|+++|||+|+++|.++++++||+.|+.
T Consensus 460 vaariF~aLa~~gInV~mIsqgaSeinIS~vV~~~d~~~Av~aLH~~Ff~ 509 (521)
T PLN02551 460 ILEKVFRVLRTNGVNVQMISQGASKVNISLIVNDDEAEQCVRALHSAFFE 509 (521)
T ss_pred HHHHHHHHHHHCCCCeEEEEecCCCcEEEEEEeHHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999999999999999975
No 3
>PRK09084 aspartate kinase III; Validated
Probab=100.00 E-value=1.6e-55 Score=437.75 Aligned_cols=288 Identities=31% Similarity=0.542 Sum_probs=248.6
Q ss_pred HHHhhhcccccCCCC---CccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHH
Q 020132 15 FIRSTYNFLSNVDSG---HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKR 91 (330)
Q Consensus 15 ~i~~~~~~l~~~~~~---~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~ 91 (330)
.++..++.|++++.+ +.+++.+|.++|+||+|||++++.+|+++|++|.++++++++ .+++.++++++++..+...
T Consensus 85 ~i~~~~~~l~~l~~~~~~~~~~~~~d~i~s~GE~lSa~l~~~~L~~~Gi~a~~l~~~~~i-~t~~~~~~~~~~~~~~~~~ 163 (448)
T PRK09084 85 EIERLLENITVLAEAASLATSPALTDELVSHGELMSTLLFVELLRERGVQAEWFDVRKVM-RTDDRFGRAEPDVAALAEL 163 (448)
T ss_pred HHHHHHHHHHHHHHhhhhcCChhhhhhhhhHHHHHHHHHHHHHHHhCCCCcEEEchHHeE-EecCCCCcccccHHHHHHH
Confidence 355566777776654 467789999999999999999999999999999999999995 4667788888888777655
Q ss_pred HHHhhcc--CCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhh
Q 020132 92 LEKWFSQ--SPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLS 169 (330)
Q Consensus 92 i~~~l~~--~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is 169 (330)
+.+.+.. ..+ |||++||+|.+.+|.++||||||||++|+++|++|+|+++++|||||||||+||+++|+|+++++|+
T Consensus 164 ~~~~~~~~~~~~-v~Vv~Gf~g~~~~G~~ttLgRggSD~~a~~~a~~l~a~~~~i~tdv~Gi~t~dP~~~~~a~~i~~is 242 (448)
T PRK09084 164 AQEQLLPLLAEG-VVVTQGFIGSDEKGRTTTLGRGGSDYSAALLAEALNASRVEIWTDVPGIYTTDPRIVPAAKRIDEIS 242 (448)
T ss_pred HHHHHHHhhcCC-cEEecCeeecCCCCCEeecCCCchHHHHHHHHHHcCCCEEEEEECCCccccCCCCCCCCCeEcccCC
Confidence 5544432 245 9999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEeeCCCCCC-------------------Ccc------
Q 020132 170 YQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDE-------------------NED------ 224 (330)
Q Consensus 170 ~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~-------------------~~~------ 224 (330)
|+||.+|+++|++++||+++.+|++++||++|+|+++|+.+||+|.+..... ..+
T Consensus 243 ~~ea~ela~~Ga~vlh~~~~~~~~~~~i~i~i~~~~~~~~~GT~I~~~~~~~~~v~~it~~~~i~lItv~~~~~~~~~g~ 322 (448)
T PRK09084 243 FEEAAEMATFGAKVLHPATLLPAVRSNIPVFVGSSKDPEAGGTWICNDTENPPLFRAIALRRNQTLLTLHSLNMLHARGF 322 (448)
T ss_pred HHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEEeCCCCCCCceEEecCCCCCCeeEEEEeeCCEEEEEEecCCCCccccH
Confidence 9999999999999999999999999999999999999998999997542100 000
Q ss_pred ----------------------------cc--c-c--------------cCCcccceeecceeEEeeecccccCCCCchh
Q 020132 225 ----------------------------EQ--I-I--------------DSPVKGFATIDNLALVNVEGTGMAGVPGTAN 259 (330)
Q Consensus 225 ----------------------------~~--~-~--------------~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a 259 (330)
.. . . -+.+..+.+.+|+++|+++|.+|+++||+++
T Consensus 323 ~a~if~~l~~~~I~Vd~I~sse~sIs~~i~~~~~~~~~~~~~~~~l~~el~~~~~i~~~~~va~IsvvG~gm~~~~gv~a 402 (448)
T PRK09084 323 LAEVFGILARHKISVDLITTSEVSVSLTLDTTGSTSTGDTLLTQALLTELSQLCRVEVEEGLALVALIGNNLSKACGVAK 402 (448)
T ss_pred HHHHHHHHHHcCCeEEEEeccCcEEEEEEechhhhhhhhHHHHHHHHHHHhcCCeEEEECCeEEEEEECCCcccCcChHH
Confidence 00 0 0 0113457778999999999999999999999
Q ss_pred hhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHH
Q 020132 260 AIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (330)
Q Consensus 260 ~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~ 306 (330)
|+|++|++ +||.||+|++|+++|||+|+++|.+++++.||++|+.
T Consensus 403 rif~aL~~--~nI~~I~qgsSe~sIS~vV~~~d~~~al~~LH~~f~~ 447 (448)
T PRK09084 403 RVFGVLEP--FNIRMICYGASSHNLCFLVPESDAEQVVQALHQNLFE 447 (448)
T ss_pred HHHHHHHh--CCeEEEEEcCCCCcEEEEEcHHHHHHHHHHHHHHHhc
Confidence 99999986 6899999999999999999999999999999999974
No 4
>PRK09034 aspartate kinase; Reviewed
Probab=100.00 E-value=8.3e-55 Score=433.39 Aligned_cols=278 Identities=26% Similarity=0.417 Sum_probs=245.3
Q ss_pred hcccccCCCCCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccC
Q 020132 20 YNFLSNVDSGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQS 99 (330)
Q Consensus 20 ~~~l~~~~~~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~ 99 (330)
++.|..++. +.+++.+|.++|+||++|+++++.+|+++|+++.++++++++++++++++++.++. .+.+.+..++.
T Consensus 97 l~~l~~~~~-~~~~~~~d~l~s~GE~~S~~l~a~~L~~~g~~a~~~~~~~~~~~t~~~~~~a~i~~-~~~~~~~~~~~-- 172 (454)
T PRK09034 97 LEHLANLAS-RNPDRLLDAFKARGEDLNAKLIAAYLNYEGIPARYVDPKEAGIIVTDEPGNAQVLP-ESYDNLKKLRD-- 172 (454)
T ss_pred HHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCcEEEchHHceEEecCCcCceeEcH-hhHHHHHHHHh--
Confidence 444444433 45778889999999999999999999999999999999999888888888766654 34566666665
Q ss_pred CCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhc
Q 020132 100 PSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYF 179 (330)
Q Consensus 100 ~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~ 179 (330)
.+.|||++||+|.+.+|++++|||||||++|+++|++|+|+++.+|||||||||+||+.+|+|+++++|||+||.+|+++
T Consensus 173 ~~~v~Vv~GFig~~~~g~~ttlgRggSD~tA~~la~~l~A~~~~i~tdV~Gi~taDPr~v~~A~~l~~lsy~Ea~ela~~ 252 (454)
T PRK09034 173 RDEKLVIPGFFGVTKDGQIVTFSRGGSDITGAILARGVKADLYENFTDVDGIYAANPRIVKNPKSIKEITYREMRELSYA 252 (454)
T ss_pred cCCEEEecCccccCCCCCEEecCCCcHHHHHHHHHHHcCCCEEEEEecCCccCcCCCCCCCCCeECCccCHHHHHHHHhC
Confidence 56899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccceeeecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecceeEEeeecccccCCCCchh
Q 020132 180 GANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTAN 259 (330)
Q Consensus 180 g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a 259 (330)
|+++|||+|+.||++++||++|+|+++|+.+||+|....... ....+++|+..+|+++|++.|.+|...+|+++
T Consensus 253 Gakvlhp~ai~~a~~~~Ipi~v~~~~~p~~~GT~I~~~~~~~------~~~~Vk~It~~~~i~~Itv~~~~~~~~~g~~a 326 (454)
T PRK09034 253 GFSVFHDEALIPAYRGGIPINIKNTNNPEDPGTLIVPDRDNK------NKNPITGIAGDKGFTSIYISKYLMNREVGFGR 326 (454)
T ss_pred CcccCCHHHHHHHHHcCCCEEEEcCCCCCCCccEEEeccccC------ccccceEEEecCCEEEEEEccCCCCCCccHHH
Confidence 999999999999999999999999999999999997643211 11469999999999999999988999999999
Q ss_pred hhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHH-HHHHHHHHHHhc
Q 020132 260 AIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVA-EALESKFREALN 309 (330)
Q Consensus 260 ~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av-~~Lh~~f~~~~~ 309 (330)
++|+.|+++||+|+|++ +|+.++||++++++..++. +.+.++|..++.
T Consensus 327 ~if~~la~~~I~Vd~i~--ss~~sis~~v~~~~~~~a~~~~l~~el~~~~~ 375 (454)
T PRK09034 327 KVLQILEDHGISYEHMP--SGIDDLSIIIRERQLTPKKEDEILAEIKQELN 375 (454)
T ss_pred HHHHHHHHcCCeEEEEc--CCCcEEEEEEeHHHhhHHHHHHHHHHHHHhhC
Confidence 99999999999999996 7789999999999987765 666666655553
No 5
>PRK06291 aspartate kinase; Provisional
Probab=100.00 E-value=1.2e-54 Score=433.71 Aligned_cols=280 Identities=42% Similarity=0.645 Sum_probs=251.9
Q ss_pred hhhcccccCCC-----CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCC---chhhH
Q 020132 18 STYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPD---FSESE 89 (330)
Q Consensus 18 ~~~~~l~~~~~-----~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~---~~~~~ 89 (330)
..++.|++++. ++++++.+|.++|+||+|||++++.+|+++|++|.+++++++++++++.++.+.++ +....
T Consensus 99 ~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~~Sa~l~~~~L~~~Gi~a~~l~~~~~~i~t~~~~~~~~~~~~~~~~~~ 178 (465)
T PRK06291 99 SRIEELEKALVGVSYLGELTPRSRDYILSFGERLSAPILSGALRDLGIKSVALTGGEAGIITDSNFGNARPLPKTYERVK 178 (465)
T ss_pred HHHHHHHHHHHHHHHhccCChHHHHHHHhhhHHHHHHHHHHHHHhCCCCeEEEchHHCcEEecCCCCceeechhhHHHHH
Confidence 33455555543 35677889999999999999999999999999999999999877777777765543 34444
Q ss_pred HHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLS 169 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is 169 (330)
+.++.+++ .+.|||++||+|.+.+|.++|+||||||++|+.+|.+|+|+++++||||||||++||+.+|+|+++++++
T Consensus 179 ~~~~~ll~--~~~vpVv~Gfig~~~~g~~~tlgrggsD~~A~~~A~~l~a~~~~i~tdV~Gi~~~dP~~~~~a~~i~~l~ 256 (465)
T PRK06291 179 ERLEPLLK--EGVIPVVTGFIGETEEGIITTLGRGGSDYSAAIIGAALDADEIWIWTDVDGVMTTDPRIVPEARVIPKIS 256 (465)
T ss_pred HHHHHHhh--cCcEEEEeCcEEcCCCCCEEEecCCChHHHHHHHHHhcCCCEEEEEECCCCCCCCCCCCCCCCeEccccC
Confidence 56677776 7899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecceeEEeeecc
Q 020132 170 YQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGT 249 (330)
Q Consensus 170 ~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~nia~IsvvG~ 249 (330)
|+||.+++++|++++||+|+.+|+++|||++|.|+++|+.+||+|.+.... ....+++|+..+|+++|+++|.
T Consensus 257 ~~ea~~l~~~G~~v~~~~a~~~~~~~~i~i~i~~~~~~~~~gt~i~~~~~~-------~~~~V~~It~~~~valIsI~g~ 329 (465)
T PRK06291 257 YIEAMELSYFGAKVLHPRTIEPAMEKGIPVRVKNTFNPEFPGTLITSDSES-------SKRVVKAVTLIKNVALINISGA 329 (465)
T ss_pred HHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEecCCCCCCCceEEEecccc-------cCcccceEEeeCCEEEEEEeCC
Confidence 999999999999999999999999999999999999999999999764321 1246899999999999999999
Q ss_pred cccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHH
Q 020132 250 GMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (330)
Q Consensus 250 ~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~ 306 (330)
+|...+|+++++|+.|+++||+|+||+|++|+.+++|++++++.+++++.||+.|..
T Consensus 330 ~m~~~~g~~arvf~~L~~~gI~V~mIsq~sse~sIsf~V~~~d~~~av~~L~~~~~~ 386 (465)
T PRK06291 330 GMVGVPGTAARIFSALAEEGVNVIMISQGSSESNISLVVDEADLEKALKALRREFGE 386 (465)
T ss_pred CCCCCccHHHHHHHHHHHCCCcEEEEEecCCCceEEEEEeHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999999999999998864
No 6
>PRK09436 thrA bifunctional aspartokinase I/homoserine dehydrogenase I; Provisional
Probab=100.00 E-value=1.7e-54 Score=456.59 Aligned_cols=294 Identities=40% Similarity=0.659 Sum_probs=265.1
Q ss_pred HHHHhhhcccccCCC-----CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhh
Q 020132 14 EFIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSES 88 (330)
Q Consensus 14 ~~i~~~~~~l~~~~~-----~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~ 88 (330)
+.|+..++.|+.++. ++++++.+|+++|+||+||+++++.+|+++|++|++++++++++ +++.++++.++++.+
T Consensus 92 ~~i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~i~-t~~~~~~~~~~~~~~ 170 (819)
T PRK09436 92 AKVDQEFAQLKDILHGISLLGECPDSVNAAIISRGERLSIAIMAAVLEARGHDVTVIDPRELLL-ADGHYLESTVDIAES 170 (819)
T ss_pred HHHHHHHHHHHHHHHHHHhhccCChhhhhheeeHHHHHHHHHHHHHHHhCCCCeEEECHHHeEE-ecCCCCCceechHhh
Confidence 345555666666554 36788899999999999999999999999999999999999865 566777788888788
Q ss_pred HHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhh
Q 020132 89 EKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTL 168 (330)
Q Consensus 89 ~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~i 168 (330)
.+.+++++.. .+.|||++||+|.+.+|.++++||||||++|+++|.+++|+.+++|||||||||+||+.+|+|++++++
T Consensus 171 ~~~i~~~~~~-~~~v~Vv~Gfig~~~~G~~ttlGRgGSD~~A~~~A~~l~A~~~~i~tdVdGvyt~DP~~~~~A~~i~~i 249 (819)
T PRK09436 171 TRRIAASFIP-ADHVILMPGFTAGNEKGELVTLGRNGSDYSAAILAACLDADCCEIWTDVDGVYTADPRVVPDARLLKSL 249 (819)
T ss_pred HHHHHHHHhc-CCcEEEecCcccCCCCCCEEEeCCCCchHHHHHHHHHcCCCEEEEEECCCceECCCCCCCCCCeEeeEe
Confidence 8888888752 478999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecceeEEeeec
Q 020132 169 SYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEG 248 (330)
Q Consensus 169 s~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~nia~IsvvG 248 (330)
+|+|+.+++++|++++||+|+.+|+++|||++|+|+++|+.+||+|..... . ..+.+++|+..+|+++|+++|
T Consensus 250 sy~ea~el~~~G~kvlhp~a~~~a~~~~Ipi~i~n~~~p~~~GT~I~~~~~-~------~~~~Vk~It~~~dvalIsV~G 322 (819)
T PRK09436 250 SYQEAMELSYFGAKVLHPRTIAPIAQFQIPCLIKNTFNPQAPGTLIGAESD-E------DSLPVKGISNLNNMAMFNVSG 322 (819)
T ss_pred cHHHHHHHHhcCCccchHHHHHHHHHCCceEEEccCCCCCCCceEEEecCc-c------cccccceEEEeCCEEEEEEEc
Confidence 999999999999999999999999999999999999999999999976421 1 234699999999999999999
Q ss_pred ccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHHHhccCccccc
Q 020132 249 TGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQH 316 (330)
Q Consensus 249 ~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~~~~~~~i~~~ 316 (330)
.+|...+|+++++|+.|+++||+|+|++|++|+.+|||++++++.+++++.||+.|..++..+.+.++
T Consensus 323 ~gm~~~~G~~arIf~~La~~gI~V~mIsqssSe~sIsf~V~~~d~~~av~~L~~~f~~el~~~~~~~i 390 (819)
T PRK09436 323 PGMKGMVGMASRVFAALSRAGISVVLITQSSSEYSISFCVPQSDAAKAKRALEEEFALELKEGLLEPL 390 (819)
T ss_pred CCCCCCcCHHHHHHHHHHHCCCcEEEEEcCCCCceEEEEEeHHHHHHHHHHHHHHHHHHhccCCcceE
Confidence 99999999999999999999999999999999999999999999999999999999877765554443
No 7
>PRK09181 aspartate kinase; Validated
Probab=100.00 E-value=3.8e-55 Score=435.99 Aligned_cols=276 Identities=21% Similarity=0.344 Sum_probs=231.1
Q ss_pred HhhhcccccCCC------CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHH
Q 020132 17 RSTYNFLSNVDS------GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEK 90 (330)
Q Consensus 17 ~~~~~~l~~~~~------~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~ 90 (330)
+..++.+.+++. ++++++.+|.++|+||+||+++|+.+|+++|++|.++|+..+.. +. ++ .+.+
T Consensus 114 ~~~l~~l~~~l~~~~~~l~e~~~~~~D~l~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~~~--~~-------~~-~~~~ 183 (475)
T PRK09181 114 RACLIDLQRLCAYGHFSLDEHLLTVREMLASIGEAHSAFNTALLLQNRGVNARFVDLTGWDD--DD-------PL-TLDE 183 (475)
T ss_pred HHHHHHHHHHHhcCcchhhccChhHhHHHhhHhHHHHHHHHHHHHHhCCCCeEEeccccccC--Cc-------cc-chHH
Confidence 344455554432 57899999999999999999999999999999999998876532 11 11 1345
Q ss_pred HHHHhhcc--CCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccch--hHhhhhh
Q 020132 91 RLEKWFSQ--SPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKV--SEAVILR 166 (330)
Q Consensus 91 ~i~~~l~~--~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~--~~a~~i~ 166 (330)
++++.+.. ..+.|||++||+ .+.+|.++|||||||||+|+++|++|+|+++.|||||+ |||+|||++ |+|++++
T Consensus 184 ~i~~~l~~~~~~~~v~Vv~GF~-~~~~G~itTLGRGGSDyTAailAa~L~A~~~~IwTDV~-I~taDPriV~~~~A~~i~ 261 (475)
T PRK09181 184 RIKKAFKDIDVTKELPIVTGYA-KCKEGLMRTFDRGYSEMTFSRIAVLTGADEAIIHKEYH-LSSADPKLVGEDKVVPIG 261 (475)
T ss_pred HHHHHHhhhccCCcEEEecCCc-CCCCCCEEecCCChHHHHHHHHHHHcCCCEEEEeCCCc-cccCCCCcCCCCCCeEcC
Confidence 66666652 246899999996 57789999999999999999999999999999999996 999999999 6899999
Q ss_pred hhhhHHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEeeCCCC-C----------C---------Ccc--
Q 020132 167 TLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPV-D----------E---------NED-- 224 (330)
Q Consensus 167 ~is~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~-~----------~---------~~~-- 224 (330)
+|||+||.||+++|++||||+|++||++++||++|+|+++|+.+||+|.+... + . ..+
T Consensus 262 ~lsy~Ea~ELA~~GAkVLHp~ti~pa~~~~Ipi~V~nt~~p~~~GT~I~~~~~~~~~~ik~It~~~~~~~i~i~~~~~~~ 341 (475)
T PRK09181 262 RTNYDVADQLANLGMEAIHPKAAKGLRQAGIPLRIKNTFEPEHPGTLITKDYVSEQPRVEIIAGSDKVFALEVFDQDMVG 341 (475)
T ss_pred ccCHHHHHHHHHcCchhcCHHHHHHHHHcCCeEEEecCCCCCCCCeEEecCcccccccceeEeccCCEEEEEEcCCCCCC
Confidence 99999999999999999999999999999999999999999999999965310 0 0 000
Q ss_pred --------------------------------cc-c----------ccCCc--ccceeecceeEEeeecccccCCCCchh
Q 020132 225 --------------------------------EQ-I----------IDSPV--KGFATIDNLALVNVEGTGMAGVPGTAN 259 (330)
Q Consensus 225 --------------------------------~~-~----------~~~~~--~~i~~~~nia~IsvvG~~~~~~~gv~a 259 (330)
.. . ....+ ..+. .+++++|++||.+|. +||+++
T Consensus 342 ~~g~~~~if~~l~~~~i~v~~i~ss~~sis~~v~~~~~~~~~~~~~L~~~~~~~~i~-~~~~a~VsvVG~gm~-~~gv~a 419 (475)
T PRK09181 342 EDGYDLEILEILTRHKVSYISKATNANTITHYLWGSLKTLKRVIAELEKRYPNAEVT-VRKVAIVSAIGSNIA-VPGVLA 419 (475)
T ss_pred cchHHHHHHHHHHHcCCeEEEEEecCcEEEEEEcCChHHHHHHHHHHHHhcCCceEE-ECCceEEEEeCCCCC-cccHHH
Confidence 00 0 00011 2344 389999999999995 899999
Q ss_pred hhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHH
Q 020132 260 AIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (330)
Q Consensus 260 ~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~ 306 (330)
|+|++|++.||||.||+|++|+++|||+|+++|.++|+++||+.|+.
T Consensus 420 k~f~aL~~~~Ini~~i~qg~se~~Is~vV~~~d~~~Av~~lH~~f~~ 466 (475)
T PRK09181 420 KAVQALAEAGINVLALHQSMRQVNMQFVVDEDDYEKAICALHEALVE 466 (475)
T ss_pred HHHHHHHHCCCCeEEEEecCCcceEEEEEeHHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999999999999974
No 8
>PRK09466 metL bifunctional aspartate kinase II/homoserine dehydrogenase II; Provisional
Probab=100.00 E-value=4.3e-53 Score=443.58 Aligned_cols=278 Identities=28% Similarity=0.448 Sum_probs=249.6
Q ss_pred HHhhhcccccCCCCCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHh
Q 020132 16 IRSTYNFLSNVDSGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKW 95 (330)
Q Consensus 16 i~~~~~~l~~~~~~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~ 95 (330)
+...++.|+.++.++++++.+|.++|+||+||+++++.+|+++|++|.++++++++. +++. +.+.+++..+.++++++
T Consensus 102 i~~~~~~l~~~l~~~~~~~~~d~ils~GE~~Sa~lla~~L~~~G~~a~~ld~~~~i~-~~~~-~~~~i~~~~~~~~l~~~ 179 (810)
T PRK09466 102 LISDLERLAALLDGGINDAQYAEVVGHGEVWSARLMAALLNQQGLPAAWLDARSFLR-AERA-AQPQVDEGLSYPLLQQL 179 (810)
T ss_pred HHHHHHHHHHHhhccCCchhhhheecHHHHHHHHHHHHHHHhCCCCcEEEcHHHhee-cCCC-CCcccchhhhHHHHHHH
Confidence 555677778888788899999999999999999999999999999999999999854 4333 24556666677888888
Q ss_pred hccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhh
Q 020132 96 FSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWE 175 (330)
Q Consensus 96 l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~ 175 (330)
+....+.|||++||+|.+.+|.++||||||||++|+.+|++|+|+++.||||||||||+|||++|+|+++++|||+||.|
T Consensus 180 ~~~~~~~v~Vv~GF~g~~~~G~~ttLGRGGSD~tA~~la~~l~A~~v~i~tDV~Gi~taDPr~v~~A~~i~~isy~Ea~e 259 (810)
T PRK09466 180 LAQHPGKRLVVTGFISRNEAGETVLLGRNGSDYSATLIGALAGVERVTIWSDVAGVYSADPRKVKDACLLPLLRLDEASE 259 (810)
T ss_pred HhccCCeEEEeeCccccCCCCCEEEcCCChHHHHHHHHHHHcCCCEEEEEeCCCccccCCcccCCCceEcccCCHHHHHH
Confidence 87445589999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhcccccccccccceeeecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecceeEEeeecccccCCC
Q 020132 176 MSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVP 255 (330)
Q Consensus 176 l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~nia~IsvvG~~~~~~~ 255 (330)
|+++|++||||+|++||++++||++|+|+++|+.+||+|..... ....++.|+..+|+++|++.|.++.+.+
T Consensus 260 la~~GakVlHp~ti~pa~~~~Ipi~V~ntf~p~~~GT~I~~~~~--------~~~~v~~It~~~~v~~i~i~~~~~~g~~ 331 (810)
T PRK09466 260 LARLAAPVLHARTLQPVSGSDIDLQLRCSYQPEQGSTRIERVLA--------SGTGARIVTSLDDVCLIELQVPASHDFK 331 (810)
T ss_pred HHHcCccccCHHHHHHHHHcCCeEEEecCCCCCCCceEEecCcc--------cccceeeeeccCCEEEEEEecCCcCCcc
Confidence 99999999999999999999999999999999999999975321 1234678889999999999998888889
Q ss_pred CchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHH
Q 020132 256 GTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESK 303 (330)
Q Consensus 256 gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~ 303 (330)
|+.+++|+.|+++||+++||+|++++.+++|.++.++.+++.+.|++.
T Consensus 332 g~~~~if~~l~~~~I~v~~i~~~~s~~sis~~i~~~~~~~~~~~l~~~ 379 (810)
T PRK09466 332 LAQKELDQLLKRAQLRPLAVGVHPDRQLLQLAYTSEVADSALKLLDDA 379 (810)
T ss_pred hHHHHHHHHHHHCCCeEEEEEecCCCcEEEEEEeHHHHHHHHHHHHhh
Confidence 999999999999999999999999999999999999999888888774
No 9
>KOG0456 consensus Aspartate kinase [Amino acid transport and metabolism]
Probab=100.00 E-value=1.3e-53 Score=400.37 Aligned_cols=293 Identities=28% Similarity=0.414 Sum_probs=243.6
Q ss_pred HHHhhhcccccCCC-----CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhH
Q 020132 15 FIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESE 89 (330)
Q Consensus 15 ~i~~~~~~l~~~~~-----~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~ 89 (330)
.+..+.+.|+++++ +|.+.+.+|+++|+||.+|+|+|+++|+.+|++|+.+|...++.++.+.+.+.+.- +.+.
T Consensus 166 v~~~~le~leq~Lk~i~mm~Elt~RTrD~lvs~GE~lS~rf~aA~lnd~G~kar~~D~~~I~~~~~d~~t~~d~~-~a~~ 244 (559)
T KOG0456|consen 166 VIAKLLEGLEQLLKGIAMMKELTLRTRDYLVSFGECLSTRFFAAYLNDIGHKARQYDAFEIGFITTDDFTNDDIL-EATY 244 (559)
T ss_pred HHHHHHHHHHHHHHHHHHHHhcchhhhhHhhhhhhHHHHHHHHHHHHhcCccceeechhheeccccccccchhHH-HHHH
Confidence 34444555666665 48899999999999999999999999999999999999999877665444332221 1222
Q ss_pred HHHHHhhc-c--CCCccEEEeeeee-cCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhh
Q 020132 90 KRLEKWFS-Q--SPSNTIIATGFIA-STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (330)
Q Consensus 90 ~~i~~~l~-~--~~~~VpVv~G~i~-~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i 165 (330)
..+-+++. . ....|||++||+| ....|-.+++||||+|.+|+.+|++||++++.+|+|||||+|+||+++|.|+++
T Consensus 245 ~av~k~~~~~~aken~VPVvTGf~Gk~~~tg~lt~lGRG~sDl~At~i~~al~~~EiQVWKdVDGv~T~DP~~~p~Ar~v 324 (559)
T KOG0456|consen 245 PAVSKLLSGDWAKENAVPVVTGFLGKGWPTGALTTLGRGGSDLTATTIGKALGLDEIQVWKDVDGVLTCDPRIYPGARLV 324 (559)
T ss_pred HHHHHhcccccccCCccceEeeccccCccccceecccCCchhhHHHHHHHHcCchhhhhhhhcCceEecCCccCCCcccc
Confidence 22223332 1 3568999999999 567788999999999999999999999999999999999999999999999999
Q ss_pred hhhhhHHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEeeCCCCC--------------------CCcc-
Q 020132 166 RTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVD--------------------ENED- 224 (330)
Q Consensus 166 ~~is~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~--------------------~~~~- 224 (330)
|.++++||.||+|+|+.|+||-+++++++.+||++|+|..+|..+||.|.+...- .+.|
T Consensus 325 p~lT~dEAaELaYfGaqVlHP~sM~~~~~~~IPvRvKN~~NP~~~GTvI~~d~~m~k~~~TsI~lK~nv~mldI~Str~l 404 (559)
T KOG0456|consen 325 PYLTFDEAAELAYFGAQVLHPFSMRPAREGRIPVRVKNSYNPTAPGTVITPDRDMSKAGLTSIVLKRNVTMLDIASTRML 404 (559)
T ss_pred CccCHHHHHHHHhhhhhhccccccchhhccCcceEeecCCCCCCCceEeccchhhhhccceEEEEeccEEEEEecccchh
Confidence 9999999999999999999999999999999999999999999999999876310 0000
Q ss_pred --------------------------------------------cc-------cccCCcccceeecceeEEeeecccccC
Q 020132 225 --------------------------------------------EQ-------IIDSPVKGFATIDNLALVNVEGTGMAG 253 (330)
Q Consensus 225 --------------------------------------------~~-------~~~~~~~~i~~~~nia~IsvvG~~~~~ 253 (330)
.| .+-..+-.+.+.+..++||++|. |++
T Consensus 405 ~q~GFLAkvFti~ek~~isVDvvaTSEV~iSltL~~~~~~sreliq~~l~~a~eeL~ki~~vdll~~~sIiSLiGn-vq~ 483 (559)
T KOG0456|consen 405 GQHGFLAKVFTIFEKLGISVDVVATSEVSISLTLDPSKLDSRELIQGELDQAVEELEKIAVVDLLKGRSIISLIGN-VQN 483 (559)
T ss_pred hhhhHHHHHHHHHHHhCcEEEEEEeeeEEEEEecChhhhhhHHHHHhhHHHHHHHHHHhhhhhhhccchHHhhhhh-hhh
Confidence 00 00011233445568899999997 999
Q ss_pred CCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHHHhc
Q 020132 254 VPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALN 309 (330)
Q Consensus 254 ~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~~~~ 309 (330)
..|++.+.|..|+++||||.|||||+|+++|||+|++++.++++++||+.|++.+.
T Consensus 484 ss~i~~rmF~~l~e~giNvqMISQGAskvNIS~ivne~ea~k~v~~lH~~~~e~~~ 539 (559)
T KOG0456|consen 484 SSGILERMFCVLAENGINVQMISQGASKVNISCIVNEKEAEKCVQALHKAFFETLD 539 (559)
T ss_pred hhHHHHHHHHHHHhcCcceeeeccccccceEEEEEChHHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999999999999999999999999999999987653
No 10
>PRK05925 aspartate kinase; Provisional
Probab=100.00 E-value=1e-52 Score=415.27 Aligned_cols=273 Identities=25% Similarity=0.386 Sum_probs=239.3
Q ss_pred CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEee
Q 020132 29 GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATG 108 (330)
Q Consensus 29 ~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G 108 (330)
++++++.+|.++|+||++||++++.+|+++|++|.++++++++ .++++|+++.++++.+.+.+..+.. ..+.|||++|
T Consensus 95 ~~~~~~~~d~i~s~GE~~Sa~l~a~~L~~~Gi~a~~ld~~~~i-~t~~~~~~a~~~~~~~~~~~~~~~~-~~~~v~Vv~G 172 (440)
T PRK05925 95 EEISSEDQARILAIGEDISASLICAYCCTYVLPLEFLEARQVI-LTDDQYLRAVPDLALMQTAWHELAL-QEDAIYIMQG 172 (440)
T ss_pred CcCCchhhhhheehhHHHHHHHHHHHHHhCCCCeEEEcHHHhE-eecCCccccccCHHHHHHHHHHhhc-cCCcEEEecC
Confidence 5667888999999999999999999999999999999999995 5666788888887777766666543 2568999999
Q ss_pred eeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccc
Q 020132 109 FIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRT 188 (330)
Q Consensus 109 ~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a 188 (330)
|+|.+.+|.+++|||||||++|+++|.+++|+.+++|||||||||+||+.+|+|+++++++|+|+.+++++|++++||++
T Consensus 173 F~g~~~~G~~ttLgrGgsD~~AallA~~l~Ad~~~i~TdVdGvytaDP~~~~~A~~i~~is~~ea~ela~~Ga~vl~~~~ 252 (440)
T PRK05925 173 FIGANSSGKTTVLGRGGSDFSASLIAELCKAREVRIYTDVNGIYTMDPKIIKDAQLIPELSFEEMQNLASFGAKVLHPPM 252 (440)
T ss_pred cceeCCCCCEEEeccCcHHHHHHHHHHHcCCCEEEEEEcCCccCCCCcCCCCCCeEeeEECHHHHHHHHhCCCCcCCHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceeeecccceEEeeeccccCceeEeeCCC---CC----------CC-----------------------------c-cc
Q 020132 189 IIPVMRYDIPIVIRNIFNLSVPGIMICRPP---VD----------EN-----------------------------E-DE 225 (330)
Q Consensus 189 ~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~---~~----------~~-----------------------------~-~~ 225 (330)
+++|+++|||++|.|+++|+.+||+|.+.. .+ .+ . +.
T Consensus 253 ~~~a~~~~Ipi~I~~~~~p~~~GT~i~~~~~~~~~~~~ik~It~~~~~~~i~v~~~~~~~~~~~~if~~l~~~~I~vd~i 332 (440)
T PRK05925 253 LKPCVRAGIPIFVTSTFDVTKGGTWIYASDKEVSYEPRIKALSLKQNQALWSVDYNSLGLVRLEDVLGILRSLGIVPGLV 332 (440)
T ss_pred HHHHHHCCCcEEEecCCCCCCCccEEecCCccccCCCceEEEEEeCCEEEEEEecCCcchhHHHHHHHHHHHcCCcEEEE
Confidence 999999999999999999999999996532 00 00 0 00
Q ss_pred -----------c--cc-----------cCCcccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCc
Q 020132 226 -----------Q--II-----------DSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE 281 (330)
Q Consensus 226 -----------~--~~-----------~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se 281 (330)
. .. .+.+..+.+.+|+++|++||.+|+. +++++++|++|++.||||.|++|+ +
T Consensus 333 ~s~~~sis~~i~~~~~~~~~~~~l~~~l~~~~~i~~~~~~a~VsvVG~gm~~-~~v~~~~~~aL~~~~Ini~~i~~s--~ 409 (440)
T PRK05925 333 MAQNLGVYFTIDDDDISEEYPQHLTDALSAFGTVSCEGPLALITMIGAKLAS-WKVVRTFTEKLRGYQTPVFCWCQS--D 409 (440)
T ss_pred eccCCEEEEEEechhccHHHHHHHHHHhcCCceEEEECCEEEEEEeCCCccc-ccHHHHHHHHHhhCCCCEEEEECC--C
Confidence 0 00 0123457778899999999999997 789999999999999999999874 6
Q ss_pred ceeeeecchhhHHHHHHHHHHHHHH
Q 020132 282 HSVCFAVPEKEVKAVAEALESKFRE 306 (330)
Q Consensus 282 ~sIS~vv~~~d~~~av~~Lh~~f~~ 306 (330)
.+|||+|+++|.+++++.||++|+.
T Consensus 410 ~~is~vV~~~d~~~av~~LH~~f~~ 434 (440)
T PRK05925 410 MALNLVVNEELAVAVTELLHNDYVK 434 (440)
T ss_pred ceEEEEEehHHHHHHHHHHHHHHhc
Confidence 7999999999999999999999975
No 11
>TIGR00656 asp_kin_monofn aspartate kinase, monofunctional class. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. The protein slr0657 from Synechocystis PCC6803 is extended by a duplication of the C-terminal region corresponding to the beta chain. Incorporation of a second copy of the C-terminal domain may be quite common in this subgroup of aspartokinases.
Probab=100.00 E-value=3.6e-51 Score=401.97 Aligned_cols=263 Identities=37% Similarity=0.564 Sum_probs=243.3
Q ss_pred cccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeee
Q 020132 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (330)
Q Consensus 32 ~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~ 111 (330)
++..+|.++++||++|+++++.+|+++|++|.++++.+..+++++++++.+++...+.+.++++++ .+.|||++||+|
T Consensus 62 ~~~~~~~i~~~Ge~~s~~~~~~~l~~~g~~a~~l~~~~~~~~t~~~~~~~~~~~~~~~~~l~~~l~--~~~vpVi~g~~~ 139 (401)
T TIGR00656 62 TPRERDELVSHGERLSSALFSGALRDLGVKAIWLDGGEAGIITDDNFGNAKIDIIATEERLLPLLE--EGIIVVVAGFQG 139 (401)
T ss_pred ChHHHHHHhhHHHHHHHHHHHHHHHhCCCceEEeccccceEEeCCCCCceEeeecchHHHHHHHHh--CCCEEEecCcce
Confidence 456689999999999999999999999999999999988777777776655655556678888888 789999999999
Q ss_pred cCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccce
Q 020132 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIP 191 (330)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~ 191 (330)
.+.+|+++++||||||++|+.+|.+|+|+++++||||||||++||+.+|+++++++++|+||.+|+++|++++||+|+.+
T Consensus 140 ~~~~g~~~~lgrg~sD~~A~~lA~~l~A~~l~i~tdV~Gv~~~DP~~~~~a~~i~~ls~~ea~~l~~~G~~v~~~~a~~~ 219 (401)
T TIGR00656 140 ATEKGYTTTLGRGGSDYTAALLAAALKADRVDIYTDVPGVYTTDPRVVEAAKRIDKISYEEALELATFGAKVLHPRTVEP 219 (401)
T ss_pred eCCCCCEeecCCCcHHHHHHHHHHHcCCCEEEEEECCCCCCcCCCCCCCCcEECCccCHHHHHHHHHcCCcccCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecceeEEeeecccccCCCCchhhhhhhhcccCcc
Q 020132 192 VMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGAN 271 (330)
Q Consensus 192 a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~ 271 (330)
|++++||++|+|+++|+ +||+|.+... ..+.+++++.++|+++|+++|.+|.+.+|+++++|+.|++++|+
T Consensus 220 a~~~~i~i~i~~~~~~~-~gT~I~~~~~--------~~~~v~~I~~~~~va~vsv~g~~~~~~~g~~~~if~~L~~~~I~ 290 (401)
T TIGR00656 220 AMRSGVPIEVRSSFDPE-EGTLITNSME--------NPPLVKGIALRKNVTRVTVHGLGMLGKRGFLARIFGALAERNIN 290 (401)
T ss_pred HHHCCCeEEEEECCCCC-CCeEEEeCcc--------cCCceEEEEEECCEEEEEEecCCCCCCccHHHHHHHHHHHcCCc
Confidence 99999999999999998 8999976421 12368999999999999999999999999999999999999999
Q ss_pred EEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 272 VIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 272 I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
++|++|+.|+.+|+|+++++|.+++++.||+.|.
T Consensus 291 i~~i~~~~s~~~Is~~V~~~d~~~a~~~L~~~~~ 324 (401)
T TIGR00656 291 VDLISQTPSETSISLTVDETDADEAVRALKDQSG 324 (401)
T ss_pred EEEEEcCCCCceEEEEEeHHHHHHHHHHHHHHHH
Confidence 9999999899999999999999999999999773
No 12
>PRK08841 aspartate kinase; Validated
Probab=100.00 E-value=5.6e-51 Score=398.39 Aligned_cols=267 Identities=22% Similarity=0.312 Sum_probs=230.0
Q ss_pred cccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeee
Q 020132 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (330)
Q Consensus 32 ~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~ 111 (330)
+++.+|.++|+||++|+.+++.+|+++|++++++++.+..+++++.+++.+++.. ..+.++++++ .+.|||++||+|
T Consensus 62 ~~~~~d~l~s~GE~~s~~lla~~L~~~Gi~a~~l~~~~~~i~t~~~~~~~~i~~~-~~~~i~~ll~--~~~vpVv~Gf~g 138 (392)
T PRK08841 62 TARELDVLLSAGEQVSMALLAMTLNKLGYAARSLTGAQANIVTDNQHNDATIKHI-DTSTITELLE--QDQIVIVAGFQG 138 (392)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEehhHcCEEecCCCCCceechh-hHHHHHHHHh--CCCEEEEeCCcc
Confidence 3456899999999999999999999999999999999986677666654444332 3478888887 789999999999
Q ss_pred cCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccce
Q 020132 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIP 191 (330)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~ 191 (330)
.+++|.++|+||||||++|+.+|.+|+|+++++||||||||++||+++|+|+++++|+|+||.+|+++|++++||+|+++
T Consensus 139 ~~~~g~~ttlgrggsD~tAa~lA~~L~Ad~l~i~TDVdGVyt~DP~~v~~A~~i~~is~~ea~ela~~Ga~vlhp~ai~~ 218 (392)
T PRK08841 139 RNENGDITTLGRGGSDTTAVALAGALNADECQIFTDVDGVYTCDPRVVKNARKLDVIDFPSMEAMARKGAKVLHLPSVQH 218 (392)
T ss_pred cCCCCCEEEeCCCChHHHHHHHHHHcCCCEEEEEeCCCCCCcCCCCCCCCceEcccccHHHHHHHHhcCccccCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecccceEEeeeccccCceeEeeCCCCC---------CC---------cc----------------------------c
Q 020132 192 VMRYDIPIVIRNIFNLSVPGIMICRPPVD---------EN---------ED----------------------------E 225 (330)
Q Consensus 192 a~~~~i~v~i~~~~~~~~~GT~I~~~~~~---------~~---------~~----------------------------~ 225 (330)
|+++|||++|+|++++ .+||+|...... .+ .+ .
T Consensus 219 a~~~~Ipi~i~n~~~~-~~GT~I~~~~~~~~i~~i~~~~~~~~i~v~~~~~~~i~~~l~~~~i~v~~i~~~~~~~~~~v~ 297 (392)
T PRK08841 219 AWKHSVPLRVLSSFEV-GEGTLIKGEAGTQAVCGIALQRDLALIEVESESLPSLTKQCQMLGIEVWNVIEEADRAQIVIK 297 (392)
T ss_pred HHHCCCeEEEEecCCC-CCCeEEEeccCCCcEEEEEEeCCeEEEEeccchHHHHHHHHHHcCCCEEEEEecCCcEEEEEC
Confidence 9999999999999986 579999643210 00 00 0
Q ss_pred c-----cccCCcccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHH
Q 020132 226 Q-----IIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEAL 300 (330)
Q Consensus 226 ~-----~~~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~L 300 (330)
+ ........+...+|+++|++||.++ ||+++++|++|+++|||+.|++| |+.+|||+|+++|.+++++.|
T Consensus 298 ~~~~~~~~~~~~~~i~~~~~~a~vsvVG~~~---~gv~~~~~~aL~~~~I~i~~i~~--s~~~is~vv~~~~~~~av~~l 372 (392)
T PRK08841 298 QDACAKLKLVFDDKIRNSESVSLLTLVGLEA---NGMVEHACNLLAQNGIDVRQCST--EPQSSMLVLDPANVDRAANIL 372 (392)
T ss_pred HHHHHHHHHhCcccEEEeCCEEEEEEECCCC---hHHHHHHHHHHHhCCCCEEEEEC--CCcEEEEEEeHHHHHHHHHHH
Confidence 0 0000112466778999999999874 99999999999999999999985 689999999999999999999
Q ss_pred HHHHHHH
Q 020132 301 ESKFREA 307 (330)
Q Consensus 301 h~~f~~~ 307 (330)
|++|+..
T Consensus 373 H~~f~~~ 379 (392)
T PRK08841 373 HKTYVTS 379 (392)
T ss_pred HHHHcCC
Confidence 9999754
No 13
>TIGR00657 asp_kinases aspartate kinase. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. This may be a feature of a number of closely related forms, including a paralog from B. subtilis.
Probab=100.00 E-value=3.1e-50 Score=399.92 Aligned_cols=261 Identities=36% Similarity=0.557 Sum_probs=238.8
Q ss_pred ccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeec
Q 020132 33 ESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIAS 112 (330)
Q Consensus 33 ~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~ 112 (330)
++.+|.++|+||++|+++++.+|+++|++++++++.+..+++++++++..+......+.++.+++ .+.|||++||+|.
T Consensus 102 ~~~~d~ils~GE~~s~~l~~~~l~~~Gi~a~~l~~~~~~l~t~~~~~~~~~~~~~~~~~l~~~l~--~~~vpVv~G~~g~ 179 (441)
T TIGR00657 102 PREMDRILSFGERLSAALLSAALEELGVKAVSLLGGEAGILTDSNFGRARVIIEILTERLEPLLE--EGIIPVVAGFQGA 179 (441)
T ss_pred cchHhheecHHHHHHHHHHHHHHHhCCCCCEEEEcCcceEEecCCCCceeecHhhhHHHHHHHHh--cCCEEEEeCcEee
Confidence 56789999999999999999999999999999999998888877776544334455688888887 7899999999999
Q ss_pred CCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhccccccccccccee
Q 020132 113 TPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPV 192 (330)
Q Consensus 113 ~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a 192 (330)
+.+|+++++||||||++|+.+|.+|+|+++++||||||||++||+.+|+++++++++|+|+.+|+++|++++||+|+++|
T Consensus 180 ~~~g~~~~lgrggsD~~A~~lA~~l~a~~l~~~tDV~Gv~~~DP~~~~~a~~i~~is~~ea~el~~~G~~v~~~~a~~~~ 259 (441)
T TIGR00657 180 TEKGETTTLGRGGSDYTAALLAAALKADECEIYTDVDGIYTTDPRIVPDARRIDEISYEEMLELASFGAKVLHPRTLEPA 259 (441)
T ss_pred CCCCCEeecCCCchHHHHHHHHHHcCCCEEEEEECCCCCCcCCCCCCCCCeECCccCHHHHHHHHhcCCcccCHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecceeEEeeecccccCCCCchhhhhhhhcccCccE
Q 020132 193 MRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANV 272 (330)
Q Consensus 193 ~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I 272 (330)
++++||++|+|+++|..+||+|.+..... ....++.++..+|+++|++.|.+|.. +|+++++|+.|+++||+|
T Consensus 260 ~~~~i~i~i~~~~~~~~~GT~I~~~~~~~------~~~~i~~It~~~~v~~Isv~g~~~~~-~g~la~if~~L~~~~I~I 332 (441)
T TIGR00657 260 MRAKIPIVVKSTFNPEAPGTLIVASTKEM------EEPIVKGLSLDRNQARVTVSGLGMKG-PGFLARVFGALAEAGINV 332 (441)
T ss_pred HHcCCeEEEecCCCCCCCceEEEeCCCcc------ccCccceEEEeCCEEEEEEECCCCCC-ccHHHHHHHHHHHcCCeE
Confidence 99999999999999988999998653211 12368999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcceeeeecchhhHHHHHHHHHH
Q 020132 273 IMISQASSEHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 273 ~~Isq~~se~sIS~vv~~~d~~~av~~Lh~ 302 (330)
+|++|++|+.+|+|++++++.+++.+.|..
T Consensus 333 ~~i~q~~se~sIs~~I~~~~~~~a~~~L~~ 362 (441)
T TIGR00657 333 DLITQSSSETSISFTVDKEDADQAKTLLKS 362 (441)
T ss_pred EEEEecCCCceEEEEEEHHHHHHHHHHHHH
Confidence 999999999999999999999999888744
No 14
>PRK08961 bifunctional aspartate kinase/diaminopimelate decarboxylase protein; Provisional
Probab=100.00 E-value=1.9e-48 Score=413.98 Aligned_cols=302 Identities=29% Similarity=0.434 Sum_probs=245.6
Q ss_pred HHHhhhcccccCCC-----CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCC-------CCC
Q 020132 15 FIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSN-------QVD 82 (330)
Q Consensus 15 ~i~~~~~~l~~~~~-----~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g-------~~~ 82 (330)
.+...++.|++++. ++.+++.+|.++|+||++||.+++.+|+++|++|++++++++++++++.++ +..
T Consensus 93 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~~~~~~~~~~~~~~~~~~~~ 172 (861)
T PRK08961 93 VLAERLAALQRLLDGIRALTRASLRWQAEVLGQGELLSTTLGAAYLEASGLDMGWLDAREWLTALPQPNQSEWSQYLSVS 172 (861)
T ss_pred HHHHHHHHHHHHHHHHHHhccCChhhhheEEEehHHHHHHHHHHHHHhCCCCcEEEcHHHhEeecCccccccccccccce
Confidence 34455666666653 466788999999999999999999999999999999999999776652111 112
Q ss_pred CCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHh
Q 020132 83 PDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEA 162 (330)
Q Consensus 83 ~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a 162 (330)
++.......++.++. ..+.|||++||+|.+.+|.++||||||||++|+.+|.+|+|+++++|||||||||+||+.+|+|
T Consensus 173 ~~~~~~~~~~~~~~~-~~~~v~Vv~Gf~g~~~~g~~ttLgrggsD~~A~~iA~~l~a~~~~i~tdv~Gv~t~dP~~~~~a 251 (861)
T PRK08961 173 CQWQSDPALRERFAA-QPAQVLITQGFIARNADGGTALLGRGGSDTSAAYFAAKLGASRVEIWTDVPGMFSANPKEVPDA 251 (861)
T ss_pred ecHhhHHHHHHHHhc-cCCeEEEeCCcceeCCCCCEEEEeCCchHHHHHHHHHHcCCCEEEEEeCCCccccCCCCCCCCc
Confidence 222112234444443 2336999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhhHHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEeeCCCCC----------C---------Cc
Q 020132 163 VILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVD----------E---------NE 223 (330)
Q Consensus 163 ~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~----------~---------~~ 223 (330)
++++++||+|+.+|+++|++++||+|+++|+++|||++|+|+++|+.+||+|.++... . ..
T Consensus 252 ~~i~~ls~~e~~el~~~g~~v~~~~a~~~a~~~~i~i~v~~~~~~~~~gT~I~~~~~~~~~v~~It~~~~v~lItv~~~~ 331 (861)
T PRK08961 252 RLLTRLDYDEAQEIATTGAKVLHPRSIKPCRDAGIPMAILDTERPDLSGTSIDGDAEPVPGVKAISRKNGIVLVSMETIG 331 (861)
T ss_pred eEecccCHHHHHHHHHCCCeEECHHHHHHHHHCCCCEEEEeCCCCCCCccEEeCCCCCCCcceeEEEECCEEEEEEecCC
Confidence 9999999999999999999999999999999999999999999999899999754210 0 00
Q ss_pred c----------------------------------cccc---------------cCCcccceeecceeEEeeecccccCC
Q 020132 224 D----------------------------------EQII---------------DSPVKGFATIDNLALVNVEGTGMAGV 254 (330)
Q Consensus 224 ~----------------------------------~~~~---------------~~~~~~i~~~~nia~IsvvG~~~~~~ 254 (330)
+ .... ...+..+.+.+++++|++||.+|+++
T Consensus 332 ~~~~~g~~a~if~~la~~~I~Vd~I~sse~sis~~i~~~~~~~~~~~~~~l~~~l~~~~~i~~~~~va~ISvVG~gm~~~ 411 (861)
T PRK08961 332 MWQQVGFLADVFTLFKKHGLSVDLISSSETNVTVSLDPSENLVNTDVLAALSADLSQICRVKIIVPCAAVSLVGRGMRSL 411 (861)
T ss_pred ccccccHHHHHHHHHHHcCCeEEEEEcCCCEEEEEEccccccchHHHHHHHHHHHhhcCcEEEeCCeEEEEEeCCCcccC
Confidence 0 0000 00123467778999999999999999
Q ss_pred CCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHHHhccCcccccCCCCCC
Q 020132 255 PGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQHSSSSWP 322 (330)
Q Consensus 255 ~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~~~~~~~i~~~~~~~~~ 322 (330)
+|+++++|++|++. +|.|++|++|+++|||+|+++|.+++++.||+.|+.. .....+.+.+|-
T Consensus 412 ~gv~arif~aL~~~--~I~~i~~gsSe~~Is~vV~~~d~~~av~~LH~~f~~~---~~~~~~~~~~~~ 474 (861)
T PRK08961 412 LHKLGPAWATFGAE--RVHLISQASNDLNLTFVIDESDADGLLPRLHAELIES---GAMPVVFGPRWR 474 (861)
T ss_pred cChHHHHHHHHhhc--CeEEEECCCccccEEEEEeHHHHHHHHHHHHHHHhcC---CCCceeeCccHH
Confidence 99999999999986 5788999999999999999999999999999999754 233446666664
No 15
>PRK06635 aspartate kinase; Reviewed
Probab=100.00 E-value=2.2e-46 Score=368.38 Aligned_cols=266 Identities=31% Similarity=0.493 Sum_probs=235.8
Q ss_pred cccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeee
Q 020132 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (330)
Q Consensus 32 ~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~ 111 (330)
++..++.++++||++|+++++.+|+++|++++++++.++.++++.++++.++.. ...+.++.+++ .+.|||++||+|
T Consensus 62 ~~~~~~~~~~~Ge~~~~~~~~~~l~~~g~~a~~l~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~l~--~~~ipVi~g~~~ 138 (404)
T PRK06635 62 DPRELDMLLSTGEQVSVALLAMALQSLGVKARSFTGWQAGIITDSAHGKARITD-IDPSRIREALD--EGDVVVVAGFQG 138 (404)
T ss_pred CHHHHHHHhhhhHHHHHHHHHHHHHhCCCCeEEeChhhCCEEecCCCCceEeee-cCHHHHHHHHh--CCCEEEecCccE
Confidence 456678999999999999999999999999999999998666666665433321 22478888888 789999999999
Q ss_pred cCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccce
Q 020132 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIP 191 (330)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~ 191 (330)
.+.+|+++++||||||++|+++|.+|+|+++++||||||||++||+.+++++++++++|+|+.+++++|++++||+|+.+
T Consensus 139 ~~~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tDV~Gv~~~dP~~~~~a~~i~~i~~~e~~~l~~~g~~~~~~~a~~~ 218 (404)
T PRK06635 139 VDEDGEITTLGRGGSDTTAVALAAALKADECEIYTDVDGVYTTDPRIVPKARKLDKISYEEMLELASLGAKVLHPRSVEY 218 (404)
T ss_pred eCCCCCEEecCCCChHHHHHHHHHHhCCCEEEEEEcCCCCCcCCCCCCCCceECCccCHHHHHHHHHcCCcccCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecceeEEeeecccccCCCCchhhhhhhhcccCcc
Q 020132 192 VMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGAN 271 (330)
Q Consensus 192 a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~ 271 (330)
+++++||++|.|++++ .+||.|....... .....++.++..+++++|+++| |.+.+|+++++|++|+++||+
T Consensus 219 ~~~~~i~~~i~~~~~~-~~gT~i~~~~~~~-----~~~~~i~~I~~~~~v~~Isv~g--~~~~~g~l~~i~~~L~~~~I~ 290 (404)
T PRK06635 219 AKKYNVPLRVRSSFSD-NPGTLITGEEEEI-----MEQPVVTGIAFDKDEAKVTVVG--VPDKPGIAAQIFGALAEANIN 290 (404)
T ss_pred HHHcCceEEEEcCCCC-CCCCEEeeCCccc-----cccCceEEEEecCCeEEEEECC--CCCCccHHHHHHHHHHHcCCe
Confidence 9999999999999987 5799997653200 0234688899999999999998 889999999999999999999
Q ss_pred EEEEeccCCc---ceeeeecchhhHHHHHHHHHHHHHHHhc
Q 020132 272 VIMISQASSE---HSVCFAVPEKEVKAVAEALESKFREALN 309 (330)
Q Consensus 272 I~~Isq~~se---~sIS~vv~~~d~~~av~~Lh~~f~~~~~ 309 (330)
|++++|+.++ .+++|++++++.+++++.||+ +..+++
T Consensus 291 i~~is~s~~~~~~~~is~~v~~~~~~~a~~~L~~-~~~~~~ 330 (404)
T PRK06635 291 VDMIVQNVSEDGKTDITFTVPRDDLEKALELLEE-VKDEIG 330 (404)
T ss_pred EEEEEecCCCCCceeEEEEEcHHHHHHHHHHHHH-HHHHcC
Confidence 9999998766 899999999999999999999 434443
No 16
>PRK08210 aspartate kinase I; Reviewed
Probab=100.00 E-value=9.5e-46 Score=363.88 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=227.6
Q ss_pred cccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeee
Q 020132 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (330)
Q Consensus 32 ~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~ 111 (330)
+++.++.++++||.+|+++++++|+++|++|.++++.+..+++++.++..++... ..+.++.+++ .+.|||++||+|
T Consensus 67 ~~~~~~~l~~~Ge~~s~~~~~~~l~~~Gi~a~~l~~~~~~~~t~~~~~~~~v~~~-~~~~l~~~l~--~~~vpVi~G~~~ 143 (403)
T PRK08210 67 SKREQDLLMSCGEIISSVVFSNMLNENGIKAVALTGGQAGIITDDNFTNAKIIEV-NPDRILEALE--EGDVVVVAGFQG 143 (403)
T ss_pred ChHHHHHHHhHhHHHHHHHHHHHHHhCCCCeEEechHHccEEccCCCCceeeehh-hHHHHHHHHh--cCCEEEeeCeee
Confidence 4567788999999999999999999999999999999987777766654333221 2377888887 789999999999
Q ss_pred cCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccce
Q 020132 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIP 191 (330)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~ 191 (330)
.+.+|+++++||||||++|+.+|.+|+|++++|||||||||++||+.+|+++++++++|+|+.+|+++|++++||+|+++
T Consensus 144 ~~~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~i~tDV~GV~~~dP~~~~~a~~i~~ls~~ea~~l~~~G~~v~~~~a~~~ 223 (403)
T PRK08210 144 VTENGDITTLGRGGSDTTAAALGVALKAEYVDIYTDVDGIMTADPRIVEDARLLDVVSYNEVFQMAYQGAKVIHPRAVEI 223 (403)
T ss_pred cCCCCCEEEeCCCchHHHHHHHHHHcCCCEEEEEECCCCCCcCCCCcCCCCeECCccCHHHHHHHHHCCccccCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecceeEEeeecccccCCCCchhhhhhhhcccCcc
Q 020132 192 VMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGAN 271 (330)
Q Consensus 192 a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~ 271 (330)
|++++||++|+|++++ .+||+|.+........ +.....+++|+..+|+++|++.+..+ .+|+++++|+.|+++||+
T Consensus 224 ~~~~~i~i~i~~~~~~-~~gT~I~~~~~~~~~~-~~~~~~v~~It~~~~i~~isv~~~~~--~~g~la~If~~L~~~~I~ 299 (403)
T PRK08210 224 AMQANIPLRIRSTYSD-SPGTLITSLGDAKGGI-DVEERLITGIAHVSNVTQIKVKAKEN--AYDLQQEVFKALAEAGIS 299 (403)
T ss_pred HHHCCCeEEEEecCCC-cCCcEEEecCcccccc-ccccCceEEEEEcCCcEEEEEecCCC--cchHHHHHHHHHHHcCCe
Confidence 9999999999999985 3699998753211100 01234699999999999999987554 499999999999999999
Q ss_pred EEEEeccCCcceeeeecchhhHHHHHHHHHH
Q 020132 272 VIMISQASSEHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 272 I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~ 302 (330)
|+|++|+. .+++|+++.++.+++.+.|++
T Consensus 300 i~~i~~~~--~~is~~v~~~~~~~a~~~l~~ 328 (403)
T PRK08210 300 VDFINIFP--TEVVFTVSDEDSEKAKEILEN 328 (403)
T ss_pred EEEEEecC--ceEEEEEcHHHHHHHHHHHHH
Confidence 99999873 479999999999999888777
No 17
>PRK07431 aspartate kinase; Provisional
Probab=100.00 E-value=5.4e-46 Score=381.37 Aligned_cols=279 Identities=28% Similarity=0.428 Sum_probs=240.3
Q ss_pred cccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeee
Q 020132 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (330)
Q Consensus 32 ~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~ 111 (330)
+...++.++++||++|+.+++.+|+++|++|+++++.++++++++.+|..++... ..+.++++++ .+.|||++||+|
T Consensus 62 ~~~~~~~~ls~Ge~~s~~l~~~~l~~~gi~a~~l~~~~~~~~~~~~~~~~~i~~~-~~~~l~~~l~--~g~vpVv~g~~g 138 (587)
T PRK07431 62 PRREMDMLLSTGEQVSIALLSMALHELGQPAISLTGAQVGIVTESEHGRARILEI-KTDRIQRHLD--AGKVVVVAGFQG 138 (587)
T ss_pred CHHHHHHHHHHhHHHHHHHHHHHHHHCCCCeEEechhHcCeEecCCCCceeeeec-cHHHHHHHHh--CCCeEEecCCcC
Confidence 4456788999999999999999999999999999999987777665554333221 2267888887 789999999988
Q ss_pred cCCC--CCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhccccccccccc
Q 020132 112 STPD--NIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTI 189 (330)
Q Consensus 112 ~~~~--g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~ 189 (330)
.+.+ |+++++||||||++|+++|.+|+|+++++||||||||++||+.+|+++++++++|+|+.+|+++|+++|||+|+
T Consensus 139 ~~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~i~TDVdGVyt~DP~~~~~a~~i~~i~~~e~~el~~~G~~v~~~~a~ 218 (587)
T PRK07431 139 ISLSSNLEITTLGRGGSDTSAVALAAALGADACEIYTDVPGVLTTDPRLVPEAQLMDEISCDEMLELASLGASVLHPRAV 218 (587)
T ss_pred CCCCCCCCEeecCCCchHHHHHHHHHHcCCCEEEEEeCCCccCcCCCCCCCCCeECCCcCHHHHHHHHhCCCceEhHHHH
Confidence 7644 88999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeeecccceEEeeeccccCceeEeeCCCCC--------------------------------C----------------
Q 020132 190 IPVMRYDIPIVIRNIFNLSVPGIMICRPPVD--------------------------------E---------------- 221 (330)
Q Consensus 190 ~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~--------------------------------~---------------- 221 (330)
.+|+++|||++|+|++. +.+||+|.+.... .
T Consensus 219 ~~~~~~~i~i~i~~~~~-~~~GT~i~~~~~~~~~~~~~~~~~~i~gi~~~~~~a~itl~~~~~~~g~~a~if~~l~~~~I 297 (587)
T PRK07431 219 EIARNYGVPLVVRSSWS-DAPGTLVTSPPPRPRSLGGLELGKPVDGVELDEDQAKVALLRVPDRPGIAAQLFEELAAQGV 297 (587)
T ss_pred HHHHHcCCcEEEecCCC-CCCCeEEEeCCcccccccchhcccccceEEEecCceEEEEecCCCcccHHHHHHHHHHHcCC
Confidence 99999999999999984 5579999643100 0
Q ss_pred C-cc-cc---------------------------cccCCc--ccceeecceeEEeeecccccCCCCchhhhhhhhcccCc
Q 020132 222 N-ED-EQ---------------------------IIDSPV--KGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGA 270 (330)
Q Consensus 222 ~-~~-~~---------------------------~~~~~~--~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI 270 (330)
+ .+ .| .....+ ..+++.+++++|+++|.+|+..+|+++|+|++|++++|
T Consensus 298 ~v~~i~qs~~~~~~~~isf~i~~~d~~~~~~~l~~l~~~~~~~~i~~~~~~a~IsvvG~gm~~~~gi~~ki~~aL~~~~I 377 (587)
T PRK07431 298 NVDLIIQSIHEGNSNDIAFTVAENELKKAEAVAEAIAPALGGAEVLVETNVAKLSISGAGMMGRPGIAAKMFDTLAEAGI 377 (587)
T ss_pred cEEEEEeccCCCCCccEEEEEeHHHHHHHHHHHHHHHHHcCCCcEEEeCCeEEEEEECCCcccCccHHHHHHHHHHHCCC
Confidence 0 00 00 000011 24777889999999999999999999999999999999
Q ss_pred cEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHHHhccCccccc
Q 020132 271 NVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQH 316 (330)
Q Consensus 271 ~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~~~~~~~i~~~ 316 (330)
+|.||+ +|+.+|||+|+++|.+++++.||++|+.++....|.|+
T Consensus 378 ~i~~i~--sSe~~Is~vv~~~d~~~av~~Lh~~f~~~~~~~~~~~~ 421 (587)
T PRK07431 378 NIRMIS--TSEVKVSCVIDAEDGDKALRAVCEAFELEDSQIEINPT 421 (587)
T ss_pred cEEEEE--cCCCEEEEEEcHHHHHHHHHHHHHHhccCCcccccCcc
Confidence 999998 78999999999999999999999999999999999998
No 18
>cd04245 AAK_AKiii-YclM-BS AAK_AKiii-YclM-BS: Amino Acid Kinase Superfamily (AAK), AKiii-YclM-BS; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. In Bacillus subtilis (BS), YclM is reported to be a single polypeptide of 50 kD. The Bacillus subtilis 168 AKIII is induced by lysine and repressed by threonine, and it is synergistically inhibited by lysine and threonine.
Probab=100.00 E-value=1.2e-45 Score=346.58 Aligned_cols=193 Identities=28% Similarity=0.468 Sum_probs=175.6
Q ss_pred hhcccccCCCCCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhcc
Q 020132 19 TYNFLSNVDSGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQ 98 (330)
Q Consensus 19 ~~~~l~~~~~~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~ 98 (330)
.++.+.+++. .++++.+|.++|+||++|+++++.+|+++|+++.+++++++++.+++.++++.+... +.+.+.++++
T Consensus 96 ~~~~l~~~~~-~~~~~~~d~i~s~GE~lSa~ll~~~L~~~Gi~a~~ld~~~~~i~t~~~~~~a~~~~~-~~~~~~~~~~- 172 (288)
T cd04245 96 ILENLANLDY-ANPDYLLDALKARGEYLNAQLMAAYLNYQGIDARYVIPKDAGLVVTDEPGNAQILPE-SYQKIKKLRD- 172 (288)
T ss_pred HHHHHHHhhc-cCCHHHHHHHHHHhHHHHHHHHHHHHHHCCCCeEEEcHHHCceeecCCccccccchh-hHHHHHHHHh-
Confidence 3444444432 356788999999999999999999999999999999999997777888887776553 6677888887
Q ss_pred CCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhh
Q 020132 99 SPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSY 178 (330)
Q Consensus 99 ~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~ 178 (330)
.+.|||++||+|.+.+|++++|||||||++|+++|.+|+|+++.+|||||||||+||+++|+|+++++|||+||.+|++
T Consensus 173 -~~~v~Vv~Gf~g~~~~G~~ttLgRggSD~tAal~A~~l~A~~v~i~tdVdGvytaDPr~v~~A~~i~~lsy~EA~ela~ 251 (288)
T cd04245 173 -SDEKLVIPGFYGYSKNGDIKTFSRGGSDITGAILARGFQADLYENFTDVDGIYAANPRIVANPKPISEMTYREMRELSY 251 (288)
T ss_pred -CCCEEEEeCccccCCCCCEEEcCCCchHHHHHHHHHHcCCCEEEEEeCCCceECCCCCCCCCCeEeCccCHHHHHHHHH
Confidence 5789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccceeeecccceEEeeeccccCceeEee
Q 020132 179 FGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (330)
Q Consensus 179 ~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~ 215 (330)
+|+++|||+|+.||++++||++|+|+++|+.+||+|.
T Consensus 252 ~GakVlhp~ai~~a~~~~Ipi~v~n~~~p~~~GT~I~ 288 (288)
T cd04245 252 AGFSVFHDEALIPAIEAGIPINIKNTNHPEAPGTLIV 288 (288)
T ss_pred CCCcccCHHHHHHHHHCCCcEEEeeCCCCCCCCceeC
Confidence 9999999999999999999999999999999999984
No 19
>cd04257 AAK_AK-HSDH AAK_AK-HSDH: Amino Acid Kinase Superfamily (AAK), AK-HSDH; this CD includes the N-terminal catalytic domain of aspartokinase (AK) of the bifunctional enzyme AK - homoserine dehydrogenase (HSDH). These aspartokinases are found in bacteria (E. coli AKI-HSDHI, ThrA and E. coli AKII-HSDHII, MetL) and higher plants (Z. mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. ThrA and MetL are involved in threonine and methionine biosynthesis, respectively. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathway end products. Maize AK-HSDH is a Thr-sensitive 180-kD enzyme. Arabidopsis AK-HSDH is an alanine-act
Probab=100.00 E-value=5.6e-45 Score=343.50 Aligned_cols=198 Identities=48% Similarity=0.808 Sum_probs=180.1
Q ss_pred HHhhhcccccCCC-----CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHH
Q 020132 16 IRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEK 90 (330)
Q Consensus 16 i~~~~~~l~~~~~-----~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~ 90 (330)
|...++.|+.++. ++++++.+|.++|+||+||+++++.+|+++|++|.++++++++ .+++.++++.++.+.+.+
T Consensus 92 i~~~~~~l~~~l~~~~~~~~~~~~~~d~ils~GE~lSa~lla~~L~~~Gi~a~~ld~~~~i-~t~~~~~~a~~~~~~~~~ 170 (294)
T cd04257 92 LGNDLEELKDLLEGIYLLGELPDSIRAKVLSFGERLSARLLSALLNQQGLDAAWIDARELI-VTDGGYLNAVVDIELSKE 170 (294)
T ss_pred HHHHHHHHHHHHHHHHhhccCChhHhhhheeHHHHHHHHHHHHHHHhCCCCeEEEchHHee-EecCCCCceEechHhhHH
Confidence 3444555555544 4678899999999999999999999999999999999999975 456667778888777788
Q ss_pred HHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhh
Q 020132 91 RLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY 170 (330)
Q Consensus 91 ~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~ 170 (330)
.+++++... +.|||++||+|.+.+|.++++||||||++|+++|.+|+|+++++||||||||++||+.+|+|+++++++|
T Consensus 171 ~l~~~~~~~-~~v~Vv~Gfig~~~~G~~ttlGRGGSD~~A~~lA~~l~a~~l~i~tdVdGvyt~DP~~~~~A~~i~~is~ 249 (294)
T cd04257 171 RIKAWFSSN-GKVIVVTGFIASNPQGETTTLGRNGSDYSAAILAALLDADQVEIWTDVDGVYSADPRKVKDARLLPSLSY 249 (294)
T ss_pred HHHHHHhcC-CCEEEecCcccCCCCCCEEECCCCchHHHHHHHHHHhCCCEEEEEeCCCccCCCCCCCCCCCeEeceeCH
Confidence 999888732 7899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEee
Q 020132 171 QEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (330)
Q Consensus 171 ~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~ 215 (330)
+|+.+++++|++++||+|+.+|+++|||++|+|+++|+.+||+|+
T Consensus 250 ~ea~~l~~~Gakv~h~~~~~~a~~~~Ipi~i~~~~~p~~~GT~I~ 294 (294)
T cd04257 250 QEAMELSYFGAKVLHPKTIQPVAKKNIPILIKNTFNPEAPGTLIS 294 (294)
T ss_pred HHHHHHHhCCCcccCHHHHHHHHHCCCCEEEeeCCCCCCCCCEeC
Confidence 999999999999999999999999999999999999999999984
No 20
>cd04258 AAK_AKiii-LysC-EC AAK_AKiii-LysC-EC: Amino Acid Kinase Superfamily (AAK), AKiii-LysC-EC: this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive aspartokinase isoenzyme AKIII. AKIII is a monofunctional class enzyme (LysC) found in some bacteria such as E. coli. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. In E. coli, LysC is reported to be a homodimer of 50 kD subunits.
Probab=100.00 E-value=5.9e-45 Score=342.46 Aligned_cols=199 Identities=32% Similarity=0.585 Sum_probs=180.9
Q ss_pred HHhhhcccccCCC-----CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHH
Q 020132 16 IRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEK 90 (330)
Q Consensus 16 i~~~~~~l~~~~~-----~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~ 90 (330)
|...++.|++++. ++++++.+|.++|+||+|||++++.+|+++|++|.++++++++ .+++.+++++++.+.+.+
T Consensus 88 i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~i-~t~~~~~~a~~~~~~~~~ 166 (292)
T cd04258 88 LEELLEELTQLAEGAALLGELSPASRDELLSFGERMSSLLFSEALREQGVPAEWFDVRTVL-RTDSRFGRAAPDLNALAE 166 (292)
T ss_pred HHHHHHHHHHHHhhhccccccChHhHhHhhhHHHHHHHHHHHHHHHhCCCCeEEEchHHeE-EecCCCccccccHHHHHH
Confidence 4455666666664 4668889999999999999999999999999999999999995 466778888898888777
Q ss_pred HHHHhhcc-CCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhh
Q 020132 91 RLEKWFSQ-SPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLS 169 (330)
Q Consensus 91 ~i~~~l~~-~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is 169 (330)
.++.++.. ..+.|||++||+|.+.+|+++||||||||++|+++|.+|+|+++++||||+|||++||+++|+|+++++++
T Consensus 167 ~~~~~~~~~~~~~v~Vv~Gf~g~~~~G~~ttLGrggsD~~a~~~a~~l~a~~~~i~tdv~Gv~~~dP~~~~~a~~i~~is 246 (292)
T cd04258 167 LAAKLLKPLLAGTVVVTQGFIGSTEKGRTTTLGRGGSDYSAALLAEALHAEELQIWTDVAGIYTTDPRICPAARAIKEIS 246 (292)
T ss_pred HHHHHHHHhhcCCEEEECCccccCCCCCEEecCCCchHHHHHHHHHHcCCCEEEEEECCCccCCCCCCCCCCCeEeceeC
Confidence 77776553 25689999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEee
Q 020132 170 YQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (330)
Q Consensus 170 ~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~ 215 (330)
|+||.+|+++|++++||+|+.++++++||++|+|+++|+.+||+|.
T Consensus 247 y~Ea~ela~~Gakvlhp~a~~~~~~~~ipi~i~~~~~p~~~GT~I~ 292 (292)
T cd04258 247 FAEAAEMATFGAKVLHPATLLPAIRKNIPVFVGSSKDPEAGGTLIT 292 (292)
T ss_pred HHHHHHHHHCCCcccCHHHHHHHHHcCCcEEEEeCCCCCCCCceeC
Confidence 9999999999999999999999999999999999999999999984
No 21
>PRK08373 aspartate kinase; Validated
Probab=100.00 E-value=5.1e-44 Score=342.03 Aligned_cols=240 Identities=28% Similarity=0.403 Sum_probs=206.1
Q ss_pred cccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhH---HHHHHhhccCCCccEEEee
Q 020132 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESE---KRLEKWFSQSPSNTIIATG 108 (330)
Q Consensus 32 ~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~---~~i~~~l~~~~~~VpVv~G 108 (330)
+++.+|.++|+||++|+.+++.+|+++|++|.++++++++ .+++.+++++++...+. +.+..+++ .+.|||++|
T Consensus 98 ~~~~~D~ils~GE~lSa~lla~~L~~~Gi~a~~l~~~~~i-~t~~~~~~a~i~~~~s~~~~~~l~~~l~--~g~VpVv~G 174 (341)
T PRK08373 98 SEALRDYILSFGERLSAVLFAEALENEGIKGKVVDPWEIL-EAKGSFGNAFIDIKKSKRNVKILYELLE--RGRVPVVPG 174 (341)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHCCCceEEEeHHHhe-eecCCccceeechhhhhhhHHHHHHHHh--CCcEEEEeC
Confidence 4677899999999999999999999999999999999984 56777777777664443 55666666 789999999
Q ss_pred eeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccc
Q 020132 109 FIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRT 188 (330)
Q Consensus 109 ~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a 188 (330)
|++ +.+|.++++||||||++|+.+|++|+|+++++||||||||++||+.+|+|++++++||+||.+++++|++++||+|
T Consensus 175 f~g-~~~G~~ttLGRGGSD~tA~~lA~~L~A~~v~i~TDVdGVytaDP~~v~~A~~i~~isy~Ea~ela~~Gakvlhp~a 253 (341)
T PRK08373 175 FIG-NLNGFRATLGRGGSDYSAVALGVLLNAKAVLIMSDVEGIYTADPKLVPSARLIPYLSYDEALIAAKLGMKALHWKA 253 (341)
T ss_pred Ccc-CCCCeEEEcCCCchHHHHHHHHHHcCCCEEEEEECCCccCCCCCCCCCCCeEcccCCHHHHHHHHHCcChhhhHHH
Confidence 998 8899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceeeecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecceeEEeeecccccCCCCchhhhhhhhccc
Q 020132 189 IIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDV 268 (330)
Q Consensus 189 ~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~ 268 (330)
+++|++ +||++|+|++++. +||+|.+.... ...++.+ +..|.|.|+++|. .+.+++
T Consensus 254 i~~a~~-~Ipi~v~~t~~~~-~GT~I~~~~~~--------~~~~~~~-~~~~~~~i~~~~~--~~~~~~----------- 309 (341)
T PRK08373 254 IEPVKG-KIPIIFGRTRDWR-MGTLVSNESSG--------MPILVHK-VGEEHAEILVVGV--EEEIGY----------- 309 (341)
T ss_pred HHHHHc-CCcEEEecCCCCC-CCcEEecCCCC--------CceEEEE-ecCCEEEEEEecc--CCCCCC-----------
Confidence 999999 9999999999984 89999765321 1346666 7889999999973 333332
Q ss_pred CccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 269 GANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 269 gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
.+ +. ..+..+++.|++++..++++.+|+..+
T Consensus 310 --~~--~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (341)
T PRK08373 310 --PV--YE--EGEFWFKIKVPKEELIEALREIHRRVF 340 (341)
T ss_pred --Cc--ee--cCCceEEEecCHHHHHHHHHHHHHHhh
Confidence 21 11 236778999999999999999999753
No 22
>cd04243 AAK_AK-HSDH-like AAK_AK-HSDH-like: Amino Acid Kinase Superfamily (AAK), AK-HSDH-like; this family includes the N-terminal catalytic domain of aspartokinase (AK) of the bifunctional enzyme AK- homoserine dehydrogenase (HSDH). These aspartokinases are found in such bacteria as E. coli (AKI-HSDHI, ThrA and AKII-HSDHII, MetL) and in higher plants (Z. mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. ThrA and MetL are involved in threonine and methionine biosynthesis, respectively. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathway end products. Maize AK-HSDH is a Thr-sensitive 180-kD enzyme. Arabidopsis AK-
Probab=100.00 E-value=9.2e-45 Score=341.89 Aligned_cols=198 Identities=43% Similarity=0.751 Sum_probs=180.4
Q ss_pred HHhhhcccccCCC-----CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHH
Q 020132 16 IRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEK 90 (330)
Q Consensus 16 i~~~~~~l~~~~~-----~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~ 90 (330)
+...++.|+.++. ++++++.+|.++|+||+||+++++.+|+++|++|.++++++++. +++.++++.+++..+.+
T Consensus 91 i~~~~~~l~~~l~~~~~~~~~s~~~~d~ils~GE~lSa~lla~~L~~~Gi~a~~ld~~~~i~-t~~~~~~~~~~~~~s~~ 169 (293)
T cd04243 91 LDSLLERLKDLLEGIRLLGELSDKTRAEVLSFGELLSSRLMSAYLQEQGLPAAWLDARELLL-TDDGFLNAVVDLKLSKE 169 (293)
T ss_pred HHHHHHHHHHHHHhhhhhccCCchhhhHheeHHHHHHHHHHHHHHHhCCCCcEEEcHHHeEE-ecCCCCcchhhhHHHHH
Confidence 4445566665553 46788999999999999999999999999999999999999854 55667777888877788
Q ss_pred HHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhh
Q 020132 91 RLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY 170 (330)
Q Consensus 91 ~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~ 170 (330)
.++.++... +.|||++||+|.+.+|+++++||||||++|+++|.+++|+++++||||||||++||+.+|+|+++++++|
T Consensus 170 ~~~~~~~~~-~~v~Vv~Gfig~~~~G~~ttLGRggsD~~A~~~a~~l~a~~~~i~tdvdGiyt~dP~~~~~a~~i~~ls~ 248 (293)
T cd04243 170 RLAQLLAEH-GKVVVTQGFIASNEDGETTTLGRGGSDYSAALLAALLDAEEVEIWTDVDGVYTADPRKVPDARLLKELSY 248 (293)
T ss_pred HHHHHHhcC-CCEEEecCccccCCCCCEEEeCCCCcHHHHHHHHHHcCCCEEEEEeCCCccCCCCCCCCCCCeEeceeCH
Confidence 899888721 7999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEee
Q 020132 171 QEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (330)
Q Consensus 171 ~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~ 215 (330)
+|+.+|+++|++++||+|+.+|+++|||++|+|+++|+.+||+|+
T Consensus 249 ~ea~~l~~~Gakvl~p~ai~~a~~~~i~i~i~~~~~p~~~GT~I~ 293 (293)
T cd04243 249 DEAMELAYFGAKVLHPRTIQPAIRKNIPIFIKNTFNPEAPGTLIS 293 (293)
T ss_pred HHHHHHHhCCCcccCHHHHHHHHHCCCcEEEecCCCCCCCCCEeC
Confidence 999999999999999999999999999999999999999999984
No 23
>cd04247 AAK_AK-Hom3 AAK_AK-Hom3: Amino Acid Kinase Superfamily (AAK), AK-Hom3; this CD includes the N-terminal catalytic domain of the aspartokinase HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae and other related AK domains. Aspartokinase, the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single aspartokinase isoenzyme type, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies show that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydrodynamic size.
Probab=100.00 E-value=2e-44 Score=340.44 Aligned_cols=200 Identities=30% Similarity=0.521 Sum_probs=168.9
Q ss_pred HHhhhcccccCCC-----CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCC-chhhH
Q 020132 16 IRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPD-FSESE 89 (330)
Q Consensus 16 i~~~~~~l~~~~~-----~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~-~~~~~ 89 (330)
++..++.|++++. ++++++.+|.++|+||+||+++++.+|+++|+++.++++++++. ++......... .....
T Consensus 100 i~~~~~~l~~~l~~~~~l~~~~~~~~d~i~s~GE~lSa~l~a~~L~~~Gi~a~~ld~~~~i~-~~~~~~~~~~~~~~~~~ 178 (306)
T cd04247 100 INKECELLRKYLEAAKILSEISPRTKDLVISTGEKLSCRFMAAVLRDRGVDAEYVDLSHIVD-LDFSIEALDQTFYDELA 178 (306)
T ss_pred HHHHHHHHHHHHHHHHhhhhcchHHHHHHhhHHHHHHHHHHHHHHHhCCCCeEEEcHHHhee-cCCCccccccchhHHHH
Confidence 3344555555543 46788899999999999999999999999999999999999864 43321011111 12333
Q ss_pred HHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLS 169 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is 169 (330)
+.+...+....+.|||++||+|.+.+|+++||||||||++|+++|..|+|+++++|||||||||+||+++|+|+++++|+
T Consensus 179 ~~~~~~~~~~~~~v~Vv~GFig~~~~G~~ttLGRgGsD~~A~~la~~l~a~~v~i~tdVdGvyt~DP~~~~~a~~i~~is 258 (306)
T cd04247 179 QVLGEKITACENRVPVVTGFFGNVPGGLLSQIGRGYTDLCAALCAVGLNADELQIWKEVDGIFTADPRKVPTARLLPSIT 258 (306)
T ss_pred HHHHHHhhccCCceEEeeccEecCCCCCeEEeCCCchHHHHHHHHHHcCCCEEEEeecCCeeECCCCCCCCCCeEecccC
Confidence 33444443235689999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEeeC
Q 020132 170 YQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMICR 216 (330)
Q Consensus 170 ~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~ 216 (330)
|+||.+|+++|++|+||+|+.||++++||++|+|+++|+.+||+|.+
T Consensus 259 ~~ea~el~~~GakVlHp~ti~pa~~~~Ipi~i~nt~~P~~~GT~I~~ 305 (306)
T cd04247 259 PEEAAELTYYGSEVIHPFTMEQVIKARIPIRIKNVENPRGEGTVIYP 305 (306)
T ss_pred HHHHHHHHhCcCcccCHHHHHHHHHcCCcEEEecCCCCCCCCcEEcC
Confidence 99999999999999999999999999999999999999999999965
No 24
>cd04244 AAK_AK-LysC-like AAK_AK-LysC-like: Amino Acid Kinase Superfamily (AAK), AK-LysC-like; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive AK isoenzyme found in higher plants. The lysine-sensitive AK isoenzyme is a monofunctional protein. It is involved in the overall regulation of the aspartate pathway and can be synergistically inhibited by S-adenosylmethionine. Also included in this CD is an uncharacterized LysC-like AK found in Euryarchaeota and some bacteria. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP.
Probab=100.00 E-value=4.8e-44 Score=338.09 Aligned_cols=199 Identities=41% Similarity=0.639 Sum_probs=176.4
Q ss_pred HHHhhhcccccCCC-----CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCC---ch
Q 020132 15 FIRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPD---FS 86 (330)
Q Consensus 15 ~i~~~~~~l~~~~~-----~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~---~~ 86 (330)
.|...++.|++++. ++.+++.+|.++|+||+||+++++.+|+++|++|.+++++++++++++.+++..++ ..
T Consensus 92 ~i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~l~~~~~~i~t~~~~~~a~~~~~~~~ 171 (298)
T cd04244 92 IIDSLLEELEKLLYGIAYLGELTPRSRDYIVSFGERLSAPIFSAALRSLGIKARALDGGEAGIITDDNFGNARPLPATYE 171 (298)
T ss_pred HHHHHHHHHHHHHHHHHhhhcCCchHhhHhccHhHHHHHHHHHHHHHhCCCCeEEEcHHHcceeecCcccccccchhHHH
Confidence 44555666666654 35678899999999999999999999999999999999999977777776654443 33
Q ss_pred hhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhh
Q 020132 87 ESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILR 166 (330)
Q Consensus 87 ~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~ 166 (330)
.....+..+++ .+.|||++||+|.+.+|+++++||||||++|+.+|.+|+|+++++||||||||++||+.+|++++++
T Consensus 172 ~i~~~l~~ll~--~~~vpVv~Gfig~~~~g~~ttlgRggsD~~A~~~A~~l~a~~l~i~tdV~Gv~~~dP~~~~~a~~i~ 249 (298)
T cd04244 172 RVRKRLLPMLE--DGKIPVVTGFIGATEDGAITTLGRGGSDYSATIIGAALDADEIWIWKDVDGVMTADPRIVPEARTIP 249 (298)
T ss_pred HHHHHHHHHhh--cCCEEEEeCccccCCCCCEEEecCCChHHHHHHHHHHcCCCEEEEEECCCCCCCCCCCCCCCCeEcC
Confidence 33444555555 6899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhHHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEee
Q 020132 167 TLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (330)
Q Consensus 167 ~is~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~ 215 (330)
+++|+||.+|+++|++++||+|+.+|++++||++|+|+++|+.+||+|.
T Consensus 250 ~lsy~Ea~el~~~Ga~vlhp~ai~~a~~~~Ipi~i~n~~~p~~~GT~I~ 298 (298)
T cd04244 250 RLSYAEAMELAYFGAKVLHPRTVEPAMEKGIPVRVKNTFNPEAPGTLIT 298 (298)
T ss_pred ccCHHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEeeCCCCCCCCCEeC
Confidence 9999999999999999999999999999999999999999999999984
No 25
>cd04259 AAK_AK-DapDC AAK_AK-DapDC: Amino Acid Kinase Superfamily (AAK), AK-DapDC; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the bifunctional enzyme AK - DAP decarboxylase (DapDC) found in some bacteria. Aspartokinase is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. DapDC, which is the lysA gene product, catalyzes the decarboxylation of DAP to lysine.
Probab=100.00 E-value=8.3e-44 Score=335.54 Aligned_cols=198 Identities=34% Similarity=0.530 Sum_probs=175.0
Q ss_pred HHhhhcccccCCC-----CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCC-------CCC
Q 020132 16 IRSTYNFLSNVDS-----GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQ-------VDP 83 (330)
Q Consensus 16 i~~~~~~l~~~~~-----~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~-------~~~ 83 (330)
|...++.|++++. ++++++.+|.++|+||+|||++++.+|++.|++|.+++++++++++ +.+|+ +.+
T Consensus 86 i~~~~~~l~~~l~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~i~~~-~~~~~~~~~~~~a~v 164 (295)
T cd04259 86 LANDLAQLQRWLTGISLLKQASPRTRAEVLALGELMSTRLGAAYLEAQGLKVKWLDARELLTAT-PTLGGETMNYLSARC 164 (295)
T ss_pred HHHHHHHHHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEcHHHheeec-cccccccccccccee
Confidence 4444555555543 4678889999999999999999999999999999999999997654 34443 333
Q ss_pred CchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhh
Q 020132 84 DFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAV 163 (330)
Q Consensus 84 ~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~ 163 (330)
+...+..++++.+.. .+.|||++||+|.+.+|.++||||||||++|+.+|.+|+|+++++||||||||++||+.+|+|+
T Consensus 165 ~~~~~~~~l~~~l~~-~~~v~Vv~GFig~~~~G~~ttLGrggsD~tA~~lA~~l~A~~l~i~TdV~Gvyt~DP~~~~~a~ 243 (295)
T cd04259 165 ESEYADALLQKRLAD-GAQLIITQGFIARNAHGETVLLGRGGSDTSAAYFAAKLQAARCEIWTDVPGLFTANPHEVPHAR 243 (295)
T ss_pred hhhhhHHHHHHHHhc-CCceeEeCCceeeCCCCCEEEECCCChHHHHHHHHHHcCCCEEEEEECCCccccCCCCCCCCCe
Confidence 344566788887762 2579999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhHHhhhhhhcccccccccccceeeecccceEEeeeccccCceeEee
Q 020132 164 ILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (330)
Q Consensus 164 ~i~~is~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~~~~GT~I~ 215 (330)
++++++|+||.+++++|++++||+|+++|++++||++|+|+++|+.+||+|+
T Consensus 244 ~i~~ls~~ea~~l~~~Ga~v~h~~a~~~a~~~~ipi~i~~~~~p~~~GT~I~ 295 (295)
T cd04259 244 LLKRLDYDEAQEIATMGAKVLHPRCIPPARRANIPMVVRSTERPELSGTLIT 295 (295)
T ss_pred EeceeCHHHHHHHHHcCCcccCHHHHHHHHHCCCCEEEEeCCCCCCCCcEeC
Confidence 9999999999999999999999999999999999999999999999999984
No 26
>cd04248 AAK_AK-Ectoine AAK_AK-Ectoine: Amino Acid Kinase Superfamily (AAK), AK-Ectoine; this CD includes the N-terminal catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and other various halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinase and L-aspartate-semialdehyde dehydrogenase. The M. alcaliphilum and the V. cholerae aspartokinases are encoded on the ectABCask operon.
Probab=100.00 E-value=3.3e-41 Score=315.41 Aligned_cols=177 Identities=19% Similarity=0.305 Sum_probs=153.8
Q ss_pred CCccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEee
Q 020132 29 GHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATG 108 (330)
Q Consensus 29 ~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G 108 (330)
++++++.+|.++|+||++||.+++.+|++.|++|+++|+..+.. .+.+ . +...+.+.+..+ + ..+.|||++|
T Consensus 126 ~e~~~~~rd~l~S~GE~~Sa~l~a~~L~~~Gi~A~~vD~~~~~~--~~~~---t-~~~~i~~~~~~~-~-~~~~v~IvtG 197 (304)
T cd04248 126 AEHLLAARELLASLGEAHSAFNTALLLQNRGVNARFVDLSGWRD--SGDM---T-LDERISEAFRDI-D-PRDELPIVTG 197 (304)
T ss_pred hhCCHHHHHHHhhhCHHHHHHHHHHHHHHCCCCeEEECcccccc--cCCC---C-cHHHHHHHHHhh-c-cCCcEEEeCC
Confidence 46788999999999999999999999999999999998876632 1111 1 122333333332 1 2568999999
Q ss_pred eeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccch--hHhhhhhhhhhHHhhhhhhcccccccc
Q 020132 109 FIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKV--SEAVILRTLSYQEAWEMSYFGANVLHP 186 (330)
Q Consensus 109 ~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~--~~a~~i~~is~~e~~~l~~~g~~v~~p 186 (330)
| +.+.+|.++||||||||++|+.+|++|+|++++|||||+ |||+||+++ ++|++++++||+||.||+++|++++||
T Consensus 198 F-~~~~~G~itTLGRGGSDyTAs~iAa~l~A~ev~I~TDV~-i~taDPriV~~~~A~~i~~lsY~EA~ELA~~GakvLHP 275 (304)
T cd04248 198 Y-AKCAEGLMREFDRGYSEMTFSRIAVLTGASEAIIHKEFH-LSSADPKLVGEDKARPIGRTNYDVADQLANLGMEAIHP 275 (304)
T ss_pred c-cCCCCCCEEEcCCCcHHHHHHHHHHHcCCCEEEEECCCc-eecCCCCccCCCCceEeCccCHHHHHHHHHcChhhcCH
Confidence 9 567799999999999999999999999999999999996 999999999 589999999999999999999999999
Q ss_pred cccceeeecccceEEeeeccccCceeEee
Q 020132 187 RTIIPVMRYDIPIVIRNIFNLSVPGIMIC 215 (330)
Q Consensus 187 ~a~~~a~~~~i~v~i~~~~~~~~~GT~I~ 215 (330)
+|++||++++||++|+|+++|+.+||+|+
T Consensus 276 ~ai~pa~~~~IPi~Vkntf~P~~~GTlIt 304 (304)
T cd04248 276 KAAKGLRQAGIPLRVKNTFEPDHPGTLIT 304 (304)
T ss_pred HHHHHHHHcCCeEEEecCCCCCCCCceeC
Confidence 99999999999999999999999999984
No 27
>TIGR02078 AspKin_pair Pyrococcus aspartate kinase subunit, putative. This family consists of proteins restricted to and found as paralogous pairs (typically close together) in species of Pyrococcus, a hyperthermophilic archaeal genus. Members are always found close to other genes of threonine biosynthesis and appear to represent the Pyrococcal form of aspartate kinase. Alignment to aspartokinase III from E. coli shows that 300 N-terminal and 20 C-terminal amino acids are homologous, but the form in Pyrococcus lacks ~ 100 amino acids in between.
Probab=100.00 E-value=2.5e-40 Score=314.93 Aligned_cols=230 Identities=26% Similarity=0.408 Sum_probs=190.5
Q ss_pred cccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHH---HHHHhhccCCCccEEEee
Q 020132 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEK---RLEKWFSQSPSNTIIATG 108 (330)
Q Consensus 32 ~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~---~i~~~l~~~~~~VpVv~G 108 (330)
++..+|+++|+||++|+++++. |+++.++++++++ .+++.++++.+++..+.. .+.++++ .+.|||++|
T Consensus 93 ~~~~~d~I~s~GE~lSa~Lla~-----gi~a~~vd~~~~i-~t~~~~~~a~~~~~~~~~~~~~l~~~l~--~g~IpVv~G 164 (327)
T TIGR02078 93 KEALRDYILSLGERLSAVIFAE-----GINGKVVDPWDIF-FAKGDFGNAFIDIKKSKRNAKILYEVLE--SGKIPVIPG 164 (327)
T ss_pred ChHHHHHHHHHHHHHHHHHHHc-----cCCcEEEcHHHHh-ccCCcCCceeechhhhHhhHHHHHHHHh--CCcEEEEeC
Confidence 4567899999999999999987 8999999999985 466777887788655543 4444555 789999999
Q ss_pred eeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccc
Q 020132 109 FIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRT 188 (330)
Q Consensus 109 ~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a 188 (330)
|++ +.+|.++++||||||++|+++|.+|+|+++++||||||||++||+.+|+|+++++++|+||.+++++|++++||+|
T Consensus 165 f~~-~~~G~~ttlGRGgSD~~Aa~lA~~L~A~~v~i~TDVdGVytaDP~~v~~A~~i~~lsy~Ea~ela~~Gakvlhp~a 243 (327)
T TIGR02078 165 FYG-NLNGYRVTLGRGGSDYSAVALGVLLNSKLVAIMSDVEGIFTADPKLVPSARLIPYLSYEEIKIAAKLGMKALQWKA 243 (327)
T ss_pred Ccc-CCCCeEEEcCCCChHHHHHHHHHhcCCCEEEEEECCCccCCCCCCcCCCceEccccCHHHHHHHHHCCchhhHHHH
Confidence 998 8899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceeeecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecc-eeEEeeecccccCCCCchhhhhhhhcc
Q 020132 189 IIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDN-LALVNVEGTGMAGVPGTANAIFGAVKD 267 (330)
Q Consensus 189 ~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~n-ia~IsvvG~~~~~~~gv~a~if~~L~~ 267 (330)
+++|+++|||++|+|+++|. +||+|+..... .++ +++... ++.|++-
T Consensus 244 ~~~a~~~~Ipi~I~~t~~~~-~GT~I~~~~~~---------~~~--i~~~~~~i~~v~~~-------------------- 291 (327)
T TIGR02078 244 ADLAKEYKIPVLFGRTRDWR-MGTLISNRSSG---------MPL--MVYKDGELLVVNVR-------------------- 291 (327)
T ss_pred HHHHHHCCCeEEEEeCCCcC-CCcEEecCCCC---------CcE--EEEccCcEEEEEEe--------------------
Confidence 99999999999999999986 79999765321 112 444554 5555441
Q ss_pred cCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHH
Q 020132 268 VGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKF 304 (330)
Q Consensus 268 ~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f 304 (330)
..++...+. ..+..+++.|++++..++++.+|+..
T Consensus 292 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (327)
T TIGR02078 292 REISYPVIE--EGEFWKKYKVPKEDGIEIIRELHRKV 326 (327)
T ss_pred ecccccccc--cCCceEEEecCHHHHHHHHHHHHhhh
Confidence 111111222 23667899999999999999999864
No 28
>cd04261 AAK_AKii-LysC-BS AAK_AKii-LysC-BS: Amino Acid Kinase Superfamily (AAK), AKii; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive aspartokinase isoenzymes. The B. subtilis 168 AKII is induced by methionine, and repressed and inhibited by lysine. Although Corynebacterium glutamicum is known to contain a single aspartokinase isoenzyme type, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In this organism and other various Gram-positive bacteria, the DAP-lysine pathway is feedback regulated by the concerted action of lysine and
Probab=100.00 E-value=1.4e-36 Score=279.21 Aligned_cols=180 Identities=33% Similarity=0.481 Sum_probs=163.3
Q ss_pred cccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeee
Q 020132 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (330)
Q Consensus 32 ~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~ 111 (330)
+.+..+.++++||++++.++++.|+++|++++++++.++.+++.++++..++.. ...+.++++++ .+.|||++||++
T Consensus 60 ~~~~~~~i~a~Ge~~~~~l~~~~l~~~g~~a~~l~~~~~~l~~~~~~~~~~i~~-~~~~~l~~ll~--~~~ipVi~G~~~ 136 (239)
T cd04261 60 PARELDVLLSTGEQVSIALLAMALNRLGIKAISLTGWQAGILTDGHHGKARIID-IDPDRIRELLE--EGDVVIVAGFQG 136 (239)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEechhhCCEEecCCCCcceech-hhHHHHHHHHH--cCCeEEEcCccc
Confidence 455678889999999999999999999999999999998666655554333322 12378888888 789999999999
Q ss_pred cCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccce
Q 020132 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIP 191 (330)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~ 191 (330)
.+++|.++++|||++|++|+.+|.+|+|+++++||||||||++||+.+|+++++++++|+|+.+++++|++++||+|+++
T Consensus 137 ~~~~g~~~~l~rg~sD~~A~~lA~~l~A~~lii~tdV~GVy~~dP~~~~~a~~i~~i~~~ea~~l~~~G~~~~~~~a~~~ 216 (239)
T cd04261 137 INEDGDITTLGRGGSDTSAVALAAALGADRCEIYTDVDGVYTADPRIVPKARKLDEISYDEMLEMASLGAKVLHPRSVEL 216 (239)
T ss_pred cCCCCCEEecCCCChHHHHHHHHHHcCCCEEEEEeCCCCCCCCCCCCCCCceEccccCHHHHHHHHhccccccCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecccceEEeeeccccCceeEee
Q 020132 192 VMRYDIPIVIRNIFNLSVPGIMIC 215 (330)
Q Consensus 192 a~~~~i~v~i~~~~~~~~~GT~I~ 215 (330)
|.++|||++|.|+++|+ +||+|.
T Consensus 217 ~~~~~i~i~I~n~~~~~-~gt~i~ 239 (239)
T cd04261 217 AKKYGVPLRVLSSFSEE-PGTLIT 239 (239)
T ss_pred HHHcCCeEEEecCCCCC-CCcEeC
Confidence 99999999999999999 999984
No 29
>cd04234 AAK_AK AAK_AK: Amino Acid Kinase Superfamily (AAK), Aspartokinase (AK); this CD includes the N-terminal catalytic domain of aspartokinase (4-L-aspartate-4-phosphotransferase;). AK is the first enzyme in the biosynthetic pathway of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. It also catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. One mechanism for the regulation of this pathway is by the production of several isoenzymes of aspartokinase with different repressors and allosteric inhibitors. Pairs of ACT domains are proposed to specifically bind amino acids leading to allosteric regulation of the enzyme. In Escherichia coli, three different aspartokinase isoenzymes are regulated specifically by lysine, methionine, and threonine. AK-HSDHI (ThrA) and AK-HSDHII (MetL) are bifunctional enzymes that consist of an N-terminal AK and a C-terminal homoserine dehyd
Probab=100.00 E-value=1.4e-36 Score=277.24 Aligned_cols=175 Identities=42% Similarity=0.698 Sum_probs=160.3
Q ss_pred eeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCC-CccEEEeeeeecCCCC
Q 020132 38 FVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSP-SNTIIATGFIASTPDN 116 (330)
Q Consensus 38 ~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~-~~VpVv~G~i~~~~~g 116 (330)
.++|.||.+|+++++++|+++|+++.++++.++++++++. +..........+.++++++ . +.|||++||++.+++|
T Consensus 52 ~~~s~Ge~~~~~l~~~~l~~~Gi~a~~l~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~--~~~~vpVv~g~i~~~~~g 128 (227)
T cd04234 52 LLLSFGERLSARLLAAALRDRGIKARSLDARQAGITTDDN-HGAARIIEISYERLKELLA--EIGKVPVVTGFIGRNEDG 128 (227)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCCeEEeCHHHCCEEcCCc-cchhhHHHHHHHHHHHHHh--hCCCEEEecCceecCCCC
Confidence 6778999999999999999999999999999988776543 2222334445688888888 7 8999999999999999
Q ss_pred CcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccceeeecc
Q 020132 117 IPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYD 196 (330)
Q Consensus 117 ~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~~~~ 196 (330)
.+++++|||+|++|+.+|.+|+|+++++||||||||++||+.+|+++++++++|+|+.+++..|+++|||+|+++|.+++
T Consensus 129 ~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tdV~Gvy~~dP~~~~~a~~i~~i~~~e~~~l~~~G~~~~~~~a~~~a~~~~ 208 (227)
T cd04234 129 EITTLGRGGSDYSAAALAAALGADEVEIWTDVDGIYTADPRIVPEARLIPEISYDEALELAYFGAKVLHPRAVEPARKAN 208 (227)
T ss_pred CEEEeeCCCcHHHHHHHHHHhCCCEEEEEECCCccCCCCCCCCCCceEcCcCCHHHHHHHHhCCccccCHHHHHHHHHcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceEEeeeccccCceeEee
Q 020132 197 IPIVIRNIFNLSVPGIMIC 215 (330)
Q Consensus 197 i~v~i~~~~~~~~~GT~I~ 215 (330)
||++|+|+++|..+||+|+
T Consensus 209 i~i~i~~~~~~~~~gT~I~ 227 (227)
T cd04234 209 IPIRVKNTFNPEAPGTLIT 227 (227)
T ss_pred CeEEEEeCCCCCCCCCEeC
Confidence 9999999999998999984
No 30
>cd04260 AAK_AKi-DapG-BS AAK_AKi-DapG-BS: Amino Acid Kinase Superfamily (AAK), AKi-DapG; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the diaminopimelate-sensitive aspartokinase isoenzyme AKI (DapG), a monofunctional class enzyme found in Bacilli (Bacillus subtilis 168), Clostridia, and Actinobacteria bacterial species. In Bacillus subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The B. subtilis AKI is tetrameric consisting of two alpha and two bet
Probab=100.00 E-value=3.8e-36 Score=277.07 Aligned_cols=181 Identities=34% Similarity=0.512 Sum_probs=163.3
Q ss_pred ccccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeee
Q 020132 31 ATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFI 110 (330)
Q Consensus 31 ~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i 110 (330)
.++..++.++++||.+++.+++++|+++|++|..+++.++++++.+.++..++... ..+.++++++ .+.|||++||+
T Consensus 64 ~t~~~~~~~~~~Ge~~~~~~~~~~l~~~Gi~a~~l~~~~~~lit~~~~~~~~v~~~-~~~~l~~ll~--~g~VPVv~g~~ 140 (244)
T cd04260 64 ISPRELDLLMSCGEIISAVVLTSTLRAQGLKAVALTGAQAGILTDDNYSNAKIIKV-NPKKILSALK--EGDVVVVAGFQ 140 (244)
T ss_pred CCHHHHHHHHHHhHHHHHHHHHHHHHhCCCCeEEechHHcCEEecCCCCceeeecc-CHHHHHHHHh--CCCEEEecCCc
Confidence 34566788999999999999999999999999999999987777666643332221 1266888887 78999999999
Q ss_pred ecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccc
Q 020132 111 ASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTII 190 (330)
Q Consensus 111 ~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~ 190 (330)
+.+++|++++++|||+|++|+.+|.+|+|+++++||||||||++||+.+++++++++|+++|+.++++.|++++||+|++
T Consensus 141 ~~~~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tDV~GVy~~dP~~~~~a~~i~~i~~~e~~~l~~~g~~v~~~~a~~ 220 (244)
T cd04260 141 GVTEDGEVTTLGRGGSDTTAAALGAALNAEYVEIYTDVDGIMTADPRVVPNARILDVVSYNEVFQMAHQGAKVIHPRAVE 220 (244)
T ss_pred ccCCCCCEEEeCCCchHHHHHHHHHHcCCCEEEEEECCCcCCcCCCCCCCCCeEcccCCHHHHHHHHHcCchhcCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeecccceEEeeeccccCceeEee
Q 020132 191 PVMRYDIPIVIRNIFNLSVPGIMIC 215 (330)
Q Consensus 191 ~a~~~~i~v~i~~~~~~~~~GT~I~ 215 (330)
+|+++++|++|.|+++|+ +||+|+
T Consensus 221 ~~~~~~i~v~I~~~~~~~-~gt~i~ 244 (244)
T cd04260 221 IAMQANIPIRIRSTMSEN-PGTLIT 244 (244)
T ss_pred HHHHcCCeEEEecCCCCC-CCCEeC
Confidence 999999999999999988 899984
No 31
>cd04246 AAK_AK-DapG-like AAK_AK-DapG-like: Amino Acid Kinase Superfamily (AAK), AK-DapG-like; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the diaminopimelate-sensitive aspartokinase isoenzyme AKI (DapG), a monofunctional enzymes found in Bacilli (Bacillus subtilis 168), Clostridia, and Actinobacteria bacterial species, as well as, the catalytic AK domain of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis 168, the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related isoenzymes. In Bacillus subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. The role of the AKI isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulati
Probab=100.00 E-value=4.7e-36 Score=275.58 Aligned_cols=180 Identities=33% Similarity=0.513 Sum_probs=163.1
Q ss_pred cccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeee
Q 020132 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (330)
Q Consensus 32 ~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~ 111 (330)
+...++.+++.||++++.++++.|+++|++|.++++.++.+.+..++++.++.. ...+.++++++ .+.|||++||++
T Consensus 60 ~~~~~~~i~~~Ge~~~~~~~~~~l~~~g~~a~~l~~~~~~l~~~~~~~~~~~~~-~~~~~l~~ll~--~g~ipVi~g~~~ 136 (239)
T cd04246 60 SPRELDMLLSTGEQISAALLAMALNRLGIKAISLTGWQAGILTDDHHGNARIID-IDPKRILEALE--EGDVVVVAGFQG 136 (239)
T ss_pred CHHHHHHHHHHhHHHHHHHHHHHHHhCCCCeEEeccccCCEEecCCCCceeech-hhHHHHHHHHh--cCCEEEEcCccc
Confidence 455678899999999999999999999999999999997666655554433322 23478888888 789999999999
Q ss_pred cCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccce
Q 020132 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIP 191 (330)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~ 191 (330)
.+++|.+++++|||+|++|+.+|.+|+|+++++||||||||++||+.+|+++++++++|+|+.++++.|++++||+|+++
T Consensus 137 ~~~~g~~~~l~~g~~D~~A~~lA~~l~A~~li~~tdV~GVy~~dP~~~~~a~~i~~l~~~e~~~l~~~G~~~~~~~a~~~ 216 (239)
T cd04246 137 VNEDGEITTLGRGGSDTTAVALAAALKADRCEIYTDVDGVYTADPRIVPKARKLDVISYDEMLEMASLGAKVLHPRSVEL 216 (239)
T ss_pred cCCCCCEEecCCCChHHHHHHHHHHcCCCEEEEEECCCCCCCCCCCCCCCCeEcccCCHHHHHHHHhCCCcccCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecccceEEeeeccccCceeEee
Q 020132 192 VMRYDIPIVIRNIFNLSVPGIMIC 215 (330)
Q Consensus 192 a~~~~i~v~i~~~~~~~~~GT~I~ 215 (330)
|+++|||++|+|+++|+ +||+|+
T Consensus 217 a~~~gi~i~i~~~~~~~-~gt~i~ 239 (239)
T cd04246 217 AKKYNVPLRVRSSFSEN-PGTLIT 239 (239)
T ss_pred HHHCCCeEEEecCCCCC-CCcEeC
Confidence 99999999999999998 999984
No 32
>cd02115 AAK Amino Acid Kinases (AAK) superfamily, catalytic domain; present in such enzymes like N-acetylglutamate kinase (NAGK), carbamate kinase (CK), aspartokinase (AK), glutamate-5-kinase (G5K) and UMP kinase (UMPK). The AAK superfamily includes kinases that phosphorylate a variety of amino acid substrates. These kinases catalyze the formation of phosphoric anhydrides, generally with a carboxylate, and use ATP as the source of the phosphoryl group; are involved in amino acid biosynthesis. Some of these kinases control the process via allosteric feed-back inhibition.
Probab=99.95 E-value=5.4e-29 Score=228.81 Aligned_cols=179 Identities=37% Similarity=0.503 Sum_probs=155.0
Q ss_pred cccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeee
Q 020132 32 TESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (330)
Q Consensus 32 ~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~ 111 (330)
+....+.+++.|+.++++++++.|.++|+++.++++.++...+.+ ++..........+.++++++ .+.|||++||.+
T Consensus 62 ~~~~~~~~~~~~~~~~~~~~~~~l~~~gi~a~~~~~~~~~~~~~~-~~~~g~~~~~~~~~l~~~l~--~~~ipVv~g~~~ 138 (248)
T cd02115 62 TDRETDALAAMGEGMSNLLIAAALEQHGIKAVPLDLTQAGFASPN-QGHVGKITKVSTDRLKSLLE--NGILPILSGFGG 138 (248)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEchHHcCeEeCC-CCCcccceeeCHHHHHHHHh--CCcEEEecCeEe
Confidence 455677899999999999999999999999999999998766543 33322222234488888888 789999999988
Q ss_pred cCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccce
Q 020132 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIP 191 (330)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~ 191 (330)
.+.+ ....++|+++|++|+.+|.+|+|++++|||||+|||++||+++++++++++++++|+.+++..|..++||+++.+
T Consensus 139 ~~~~-~~~~~~~~~sD~~A~~lA~~l~A~~li~~tdV~Gv~~~dP~~~~~a~~i~~i~~~e~~~l~~~g~~~~k~~a~~~ 217 (248)
T cd02115 139 TDEK-ETGTLGRGGSDSTAALLAAALKADRLVILTDVDGVYTADPRKVPDAKLLSELTYEEAAELAYAGAMVLKPKAADP 217 (248)
T ss_pred ccCC-ceeeecCCCHHHHHHHHHHHcCCCEEEEEecCCeeecCCCCcCCcCeECCcCCHHHHHHHHHcCCCccCHHHHHH
Confidence 7765 677789999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecccceEEeeecc--------ccCceeEe
Q 020132 192 VMRYDIPIVIRNIFN--------LSVPGIMI 214 (330)
Q Consensus 192 a~~~~i~v~i~~~~~--------~~~~GT~I 214 (330)
+.+++++++|.|+.+ ++..||+|
T Consensus 218 ~~~~~~~v~I~~~~~~~~l~~~~~~~~GT~I 248 (248)
T cd02115 218 AARAGIPVRIANTENPGALALFTPDGGGTLI 248 (248)
T ss_pred HHHcCCcEEEEeCCCcccccccCCCCCCCCC
Confidence 999999999999887 45567654
No 33
>PRK14558 pyrH uridylate kinase; Provisional
Probab=99.91 E-value=4.6e-25 Score=201.80 Aligned_cols=159 Identities=23% Similarity=0.347 Sum_probs=130.5
Q ss_pred cccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecC
Q 020132 34 SFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIAST 113 (330)
Q Consensus 34 ~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~ 113 (330)
...|.+...||+||+.+++.+|.++|++++++++. . .... + .....+.+..+++ .+.|||++|+.+
T Consensus 63 ~~~d~ig~~~~~ln~~~~~~~l~~~gi~a~~~~~~--~--~~~~-----~-~~~~~~~i~~ll~--~g~vpV~~G~~~-- 128 (231)
T PRK14558 63 TRADQIGMLGTVINALYLKDIFEKSGLKAVIVSQI--V--NLPS-----V-EPINYDDIELYFR--AGYIVIFAGGTS-- 128 (231)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHcCCCeEEeccc--c--ccch-----h-hhhhHHHHHHHHH--CCCEEEEECCCC--
Confidence 34566767799999999999999999999999862 1 1111 1 1223478888888 789999999853
Q ss_pred CCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccceee
Q 020132 114 PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVM 193 (330)
Q Consensus 114 ~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~ 193 (330)
... +.+|++|+++|.+++|+.+++||||||||++||+++|+|+++++++++|+.++ |+++|||+|+++|.
T Consensus 129 -~~~------~~~D~~a~~lA~~l~a~~l~~~tdVdGvy~~dP~~~~~a~~i~~i~~~e~~~~---g~~~~d~~a~~~a~ 198 (231)
T PRK14558 129 -NPF------FTTDTAAALRAVEMKADILIKATKVDGIYDKDPKKFPDAKKIDHLTFSEAIKM---GLKVMDTEAFSICK 198 (231)
T ss_pred -CCC------CCcHHHHHHHHHHcCCCEEEEEecCCeeEccCCCCCCCCeEcccccHHHHHHc---CcccccHHHHHHHH
Confidence 111 23599999999999999999999999999999999999999999999998876 78999999999999
Q ss_pred ecccceEEeeecccc---------CceeEeeC
Q 020132 194 RYDIPIVIRNIFNLS---------VPGIMICR 216 (330)
Q Consensus 194 ~~~i~v~i~~~~~~~---------~~GT~I~~ 216 (330)
++|+|++|+|+++|+ ..||+|.+
T Consensus 199 ~~gi~v~I~ng~~~~~l~~~l~g~~~GT~i~~ 230 (231)
T PRK14558 199 KYGITILVINFFEPGNLLKALKGENVGTLVVP 230 (231)
T ss_pred HCCCCEEEEeCCCCCHHHHHHCCCCCcEEeCC
Confidence 999999999987652 45787754
No 34
>PF00696 AA_kinase: Amino acid kinase family Match to Glutamate-5-kinases, C-terminal end of the alignment Match to Aspartate kinases; InterPro: IPR001048 This entry contains proteins with various specificities and includes the aspartate, glutamate and uridylate kinase families. In prokaryotes and plants the synthesis of the essential amino acids lysine and threonine is predominantly regulated by feed-back inhibition of aspartate kinase (AK) and dihydrodipicolinate synthase (DHPS). In Escherichia coli, thrA, metLM, and lysC encode aspartokinase isozymes that show feedback inhibition by threonine, methionine, and lysine, respectively []. The lysine-sensitive isoenzyme of aspartate kinase from spinach leaves has a subunit composition of 4 large and 4 small subunits []. In plants although the control of carbon fixation and nitrogen assimilation has been studied in detail, relatively little is known about the regulation of carbon and nitrogen flow into amino acids. The metabolic regulation of expression of an Arabidopsis thaliana aspartate kinase/homoserine dehydrogenase (AK/HSD) gene, which encodes two linked key enzymes in the biosynthetic pathway of aspartate family amino acids has been studied []. The conversion of aspartate into either the storage amino acid asparagine or aspartate family amino acids may be subject to a coordinated, reciprocal metabolic control, and this biochemical branch point is a part of a larger, coordinated regulatory mechanism of nitrogen and carbon storage and utilization.; GO: 0008652 cellular amino acid biosynthetic process; PDB: 2X2W_B 2WXB_B 1B7B_C 2J4L_F 2J4K_E 2J4J_F 2OGX_B 3QUO_A 3D40_A 3D41_A ....
Probab=99.89 E-value=6.1e-25 Score=201.19 Aligned_cols=148 Identities=32% Similarity=0.451 Sum_probs=123.4
Q ss_pred ceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCC
Q 020132 37 DFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDN 116 (330)
Q Consensus 37 ~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g 116 (330)
+.+++.|+.+++..+...+.+.|+.+...++. ....+.++++++ .+.|||++||.+.+.+|
T Consensus 89 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~i~~~l~--~~~ipVv~g~~~~~~~g 149 (242)
T PF00696_consen 89 DEIVSAGERLGAHAVGLSLSDGGISAAKRDAR-----------------EVDKEAIRELLE--QGIIPVVSGFAGIDDDG 149 (242)
T ss_dssp HHHHHHHHHCTHHEEEHHHTGGTEEEEEEESS-----------------EEHHHHHHHHHH--TTSEEEEESEEEEETTS
T ss_pred HHHHHhhhhhhHHHHhhhhhcccchhhhhhhh-----------------hhHHHHHHHHHH--CCCEEEEeCCcccCCCC
Confidence 34445555555555555555544444333222 123388899998 79999999999899999
Q ss_pred CcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhh------hcccccccccccc
Q 020132 117 IPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMS------YFGANVLHPRTII 190 (330)
Q Consensus 117 ~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~------~~g~~v~~p~a~~ 190 (330)
++++++++++|++|+.||.+|+|++++|||||||||++||+.+|+++++++|+++|+.+++ ..|++++||.|++
T Consensus 150 ~~~~~~~~~sD~~A~~lA~~l~A~~li~~tdV~Gv~~~dP~~~~~~~~i~~l~~~e~~~l~~~~~~~~~gm~~k~~~a~~ 229 (242)
T PF00696_consen 150 EVTTLGNVSSDYIAALLAAALGADKLIFLTDVDGVYTADPRIVPDARLIPELSYDEAEELASKSGDVTGGMKPKHPAALE 229 (242)
T ss_dssp TEEEEEEETHHHHHHHHHHHTTCSEEEEEESSSSEBSSSTTTSTTSEBESEEEHHHHHHHHHHTTSSTTTHHHHHHHHHH
T ss_pred CcccCCCCCHHHHHHHHHHHhCchhhhhhhhcCceeecCCCCCCCCeeeeEeeHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999999999999999999 7899999999999
Q ss_pred eeeecccceEEee
Q 020132 191 PVMRYDIPIVIRN 203 (330)
Q Consensus 191 ~a~~~~i~v~i~~ 203 (330)
+++++++|++|+|
T Consensus 230 ~~~~~~~~v~I~n 242 (242)
T PF00696_consen 230 AAEEGGIPVHIIN 242 (242)
T ss_dssp HHHHTTSEEEEEE
T ss_pred HHHcCCCcEEEeC
Confidence 9999999999986
No 35
>cd04242 AAK_G5K_ProB AAK_G5K_ProB: Glutamate-5-kinase (G5K) catalyzes glutamate-dependent ATP cleavage; G5K transfers the terminal phosphoryl group of ATP to the gamma-carboxyl group of glutamate, in the first and controlling step of proline (and, in mammals, ornithine) biosynthesis. G5K is subject to feedback allosteric inhibition by proline or ornithine. In microorganisms and plants, proline plays an important role as an osmoprotectant and, in mammals, ornithine biosynthesis is crucial for proper ammonia detoxification, since a G5K mutation has been shown to cause human hyperammonaemia. Microbial G5K generally consists of two domains: a catalytic G5K domain and one PUA (pseudo uridine synthases and archaeosine-specific transglycosylases) domain, and some lack the PUA domain. G5K requires free Mg for activity, it is tetrameric, and it aggregates to higher forms in a proline-dependent way. G5K lacking the PUA domain remains tetrameric, active, and proline-inhibitable, but the Mg requir
Probab=99.89 E-value=7.9e-24 Score=195.92 Aligned_cols=165 Identities=18% Similarity=0.287 Sum_probs=133.4
Q ss_pred ccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCC
Q 020132 35 FTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTP 114 (330)
Q Consensus 35 ~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~ 114 (330)
.++.++|+||..+.++++..|++.|+++ .+++ .+++.+++... +....+.++.+++ .|.|||+.+
T Consensus 66 ~~~~~~~~Gq~~l~~~~~~~l~~~Gi~~-----~q~l-~t~~~~~~~~~-~~~~~~~i~~ll~--~g~iPVv~~------ 130 (251)
T cd04242 66 EKQALAAVGQSLLMALYEQLFAQYGIKV-----AQIL-LTRDDFEDRKR-YLNARNTLETLLE--LGVIPIINE------ 130 (251)
T ss_pred HHHHHHHHhHHHHHHHHHHHHHHcCCeE-----EEEE-EehhHhcchHH-HHHHHHHHHHHHH--CCCEEEEcC------
Confidence 4477899999999999999999999996 4443 34444432211 1223467888887 789999964
Q ss_pred CCCccc--ccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhh--hHHhhhhh-----hccccccc
Q 020132 115 DNIPTT--LKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLS--YQEAWEMS-----YFGANVLH 185 (330)
Q Consensus 115 ~g~~~~--lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is--~~e~~~l~-----~~g~~v~~ 185 (330)
++.+++ ++|+++|++|+.+|.+|+|++++|||||||||++||+.+|+++++++++ ++|+.+++ .++.++|+
T Consensus 131 ~d~v~~~~~~~~~~D~~A~~lA~~l~Ad~liilTDVdGvy~~dP~~~~~a~~i~~i~~~~~e~~~~~~~~~~~~~tggm~ 210 (251)
T cd04242 131 NDTVATEEIRFGDNDRLSALVAGLVNADLLILLSDVDGLYDKNPRENPDAKLIPEVEEITDEIEAMAGGSGSSVGTGGMR 210 (251)
T ss_pred CCCeeeeccccCChHHHHHHHHHHcCCCEEEEecCcCEEEeCCCCCCCCCeEEEEecCChHHHHHHhcccCcCcccCCcH
Confidence 233333 6889999999999999999999999999999999999999999999999 99999985 56789999
Q ss_pred c--cccceeeecccceEEeeecccc---------CceeEe
Q 020132 186 P--RTIIPVMRYDIPIVIRNIFNLS---------VPGIMI 214 (330)
Q Consensus 186 p--~a~~~a~~~~i~v~i~~~~~~~---------~~GT~I 214 (330)
| +++..+.++|++++|.|+..|+ ..||.|
T Consensus 211 ~Kl~a~~~a~~~gi~v~I~~g~~~~~i~~~l~g~~~GT~i 250 (251)
T cd04242 211 TKLKAARIATEAGIPVVIANGRKPDVLLDILAGEAVGTLF 250 (251)
T ss_pred HHHHHHHHHHHCCCcEEEEcCCCCCHHHHHHcCCCCCeEe
Confidence 9 6888899999999999987553 457766
No 36
>cd04239 AAK_UMPK-like AAK_UMPK-like: UMP kinase (UMPK)-like, the microbial/chloroplast uridine monophosphate kinase (uridylate kinase) enzyme that catalyzes UMP phosphorylation and plays a key role in pyrimidine nucleotide biosynthesis. Regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinases of E. coli (Ec) and Pyrococcus furiosus (Pf) are known to function as homohexamers, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial UMPKs have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Als
Probab=99.88 E-value=9.4e-24 Score=192.85 Aligned_cols=150 Identities=23% Similarity=0.267 Sum_probs=127.8
Q ss_pred cccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecC
Q 020132 34 SFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIAST 113 (330)
Q Consensus 34 ~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~ 113 (330)
...+.+.+.|+++++++|+..|.++|+++..+++.++...+. ..+. +.+..+++ .+.|||++||.+..
T Consensus 63 ~~~~~~~~~~~~l~~~l~~~~l~~~Gi~a~~~~~~~~~~~~~------~~~~----~~l~~~l~--~g~ipVi~g~~g~~ 130 (229)
T cd04239 63 ATADYIGMLATVMNALALQDALEKLGVKTRVMSAIPMQGVAE------PYIR----RRAIRHLE--KGRIVIFGGGTGNP 130 (229)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHcCCCEEEeCHHHHhhhhc------cccH----HHHHHHHh--CCCEEEEeCccCCC
Confidence 345677788999999999999999999999999987643221 1122 67888887 78999999996321
Q ss_pred CCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccceee
Q 020132 114 PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVM 193 (330)
Q Consensus 114 ~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~ 193 (330)
. +.+|++|+.+|.+|+|+++++||||||||++||+.+|+++++++++++|+.+++. .++||.|++++.
T Consensus 131 -----~----~~sD~~A~~lA~~l~a~~li~~tdVdGvy~~dP~~~~~a~~i~~i~~~e~~~~~~---~~~~~~a~~~~~ 198 (229)
T cd04239 131 -----G----FTTDTAAALRAEEIGADVLLKATNVDGVYDADPKKNPDAKKYDRISYDELLKKGL---KVMDATALTLCR 198 (229)
T ss_pred -----C----CCcHHHHHHHHHHcCCCEEEEEECCCcccCCCCCCCCCCeEEeEEcHHHHHHHhc---CCccHHHHHHHH
Confidence 1 2479999999999999999999999999999999999999999999999988763 889999999999
Q ss_pred ecccceEEeeeccc
Q 020132 194 RYDIPIVIRNIFNL 207 (330)
Q Consensus 194 ~~~i~v~i~~~~~~ 207 (330)
++|+|++|.|+++|
T Consensus 199 ~~~i~v~I~~g~~~ 212 (229)
T cd04239 199 RNKIPIIVFNGLKP 212 (229)
T ss_pred HCCCeEEEECCCCh
Confidence 99999999998765
No 37
>PRK00358 pyrH uridylate kinase; Provisional
Probab=99.88 E-value=1.5e-23 Score=191.73 Aligned_cols=156 Identities=23% Similarity=0.296 Sum_probs=126.3
Q ss_pred ccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCC
Q 020132 35 FTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTP 114 (330)
Q Consensus 35 ~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~ 114 (330)
..+.+.+.++++++++++..|.++|+++..+++..+...+. . ...+.+.++++ .|.|||++|+.+
T Consensus 66 ~~~~~~~~~~~l~~~ll~~~l~~~Gi~a~~~~~~~~~~~~~--------~--~~~~~~~~~l~--~g~vPVv~g~~~--- 130 (231)
T PRK00358 66 TADYMGMLATVMNALALQDALERAGVDTRVQSAIPMPQVAE--------P--YIRRRAIRHLE--KGRVVIFAAGTG--- 130 (231)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHcCCCeEEechhhcccccC--------c--ccHHHHHHHHH--CCCEEEEECCCC---
Confidence 34566678899999999999999999998666544322111 1 12256778887 789999988632
Q ss_pred CCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccceeee
Q 020132 115 DNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMR 194 (330)
Q Consensus 115 ~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~~ 194 (330)
... +.+|++|+++|.+|+|+++++||||||||++||+.+|+|+++++++++|+.++ |++++|+.++++|.+
T Consensus 131 --~~~----~ssD~~A~~lA~~l~A~~li~~tdVdGVy~~dP~~~~~a~~i~~i~~~e~~~~---g~~~~d~~a~~~a~~ 201 (231)
T PRK00358 131 --NPF----FTTDTAAALRAEEIGADVLLKATNVDGVYDADPKKDPDAKKYDRLTYDEVLEK---GLKVMDATAISLARD 201 (231)
T ss_pred --CCC----CCchHHHHHHHHHcCCCEEEEeeCcCceEcCCCCCCCCCEEeeEecHHHHHHc---CCcchhHHHHHHHHH
Confidence 111 34799999999999999999999999999999999999999999999987766 889999999999999
Q ss_pred cccceEEeeecccc---------CceeEe
Q 020132 195 YDIPIVIRNIFNLS---------VPGIMI 214 (330)
Q Consensus 195 ~~i~v~i~~~~~~~---------~~GT~I 214 (330)
++++++|.|+.+|+ ..||+|
T Consensus 202 ~~i~v~I~~g~~~~~l~~~l~g~~~GT~i 230 (231)
T PRK00358 202 NKIPIIVFNMNKPGNLKRVVKGEHIGTLV 230 (231)
T ss_pred cCCcEEEECCCCchHHHHHHCCCCCCEEe
Confidence 99999999987653 357776
No 38
>PRK12314 gamma-glutamyl kinase; Provisional
Probab=99.87 E-value=9.8e-23 Score=190.12 Aligned_cols=168 Identities=17% Similarity=0.226 Sum_probs=129.7
Q ss_pred ccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCC
Q 020132 35 FTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTP 114 (330)
Q Consensus 35 ~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~ 114 (330)
.++.++|+||.++.+++...|+++|+++ .+++ .|.+.|++.+. +....+.++++++ .|.|||+.+
T Consensus 76 ~~~a~aa~Gq~~l~~~~~~~~~~~g~~~-----~q~l-lT~~~~~~~~~-~~~~~~~l~~ll~--~g~IPVv~~------ 140 (266)
T PRK12314 76 EKQALAAVGQPELMSLYSKFFAEYGIVV-----AQIL-LTRDDFDSPKS-RANVKNTFESLLE--LGILPIVNE------ 140 (266)
T ss_pred HHHHHHHHhHHHHHHHHHHHHHHcCCeE-----EEEE-EecccccchHH-HHHHHHHHHHHHH--CCCEEEEcC------
Confidence 4578999999999999999999999974 5664 45555543222 2233578888887 789999964
Q ss_pred CCCccccc----ccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhh--HHhhhhhhc-----cccc
Q 020132 115 DNIPTTLK----RDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY--QEAWEMSYF-----GANV 183 (330)
Q Consensus 115 ~g~~~~lg----rggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~--~e~~~l~~~-----g~~v 183 (330)
++.+++.+ ||++|++|+++|.+++|+.++|||||||||++||+.+|+|+++++|++ .+..+++.. |.++
T Consensus 141 nd~v~~~~~~~~~~~~D~~Aa~lA~~l~Ad~liilTDVdGVy~~dP~~~~~a~~i~~I~~~~~~~~~~~~~~~~~~~tGG 220 (266)
T PRK12314 141 NDAVATDEIDTKFGDNDRLSAIVAKLVKADLLIILSDIDGLYDKNPRINPDAKLRSEVTEITEEILALAGGAGSKFGTGG 220 (266)
T ss_pred CCCeeeccccceecchHHHHHHHHHHhCCCEEEEEeCCCcccCCCCCCCCCCeEEEEecCCCHHHHHHhccCCCCcccCc
Confidence 22233333 788999999999999999999999999999999999999999999986 555555432 4445
Q ss_pred ccc--cccceeeecccceEEeeeccc---------cCceeEeeCC
Q 020132 184 LHP--RTIIPVMRYDIPIVIRNIFNL---------SVPGIMICRP 217 (330)
Q Consensus 184 ~~p--~a~~~a~~~~i~v~i~~~~~~---------~~~GT~I~~~ 217 (330)
|.| +++..|.++|++++|.|+..| +..||+|.+.
T Consensus 221 M~~Kl~aa~~a~~~gv~v~I~~g~~~~~i~~~l~g~~~GT~i~~~ 265 (266)
T PRK12314 221 MVTKLKAAKFLMEAGIKMVLANGFNPSDILDFLEGESIGTLFAPK 265 (266)
T ss_pred hHHHHHHHHHHHHCCCeEEEEcCCCchHHHHHHcCCCCceEEccC
Confidence 655 688999999999999998655 2469998653
No 39
>PRK14557 pyrH uridylate kinase; Provisional
Probab=99.87 E-value=1.1e-22 Score=187.64 Aligned_cols=162 Identities=19% Similarity=0.274 Sum_probs=126.9
Q ss_pred ccccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeec
Q 020132 33 ESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIAS 112 (330)
Q Consensus 33 ~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~ 112 (330)
....|.+.++||++|++++...|++. ++....+.++..++.... +....++...++ .|.|||++||.+.
T Consensus 68 ~~~~D~ig~~g~~lna~ll~~~l~~~-------~~~~~~i~t~~~~~~~~~--~~~~~~~~~~l~--~g~VvV~~G~~g~ 136 (247)
T PRK14557 68 RVEADNIGTLGTIINSLMLRGVLTSK-------TNKEVRVMTSIPFNAVAE--PYIRLRAVHHLD--NGYIVIFGGGNGQ 136 (247)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHhh-------hCCceeEEeccccccccc--hhhHHHHHHHHh--CCCEEEEECCcCC
Confidence 34568999999999999999999984 233333344433332111 122244566676 7789999998663
Q ss_pred CCCCCcccccccCcchhHHHHHHHHhhceeEEEe-ecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccce
Q 020132 113 TPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWT-DVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIP 191 (330)
Q Consensus 113 ~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~t-dv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~ 191 (330)
+.++ +|++|+++|.+++|+.+++|| |||||||+||+.+|+|+++++++|.|+. ..+.++|++.|+++
T Consensus 137 ---~~~s------tD~lAallA~~l~Ad~li~~ttdVdGvY~~DP~~~~~Ak~i~~i~~~e~~---~~~~~~~~~~A~~~ 204 (247)
T PRK14557 137 ---PFVT------TDYPSVQRAIEMNSDAILVAKQGVDGVFTSDPKHNKSAKMYRKLNYNDVV---RQNIQVMDQAALLL 204 (247)
T ss_pred ---CccC------hHHHHHHHHHHhCCCEEEEecCCcCEeECCCCCCCCCCEEeeEEChhhhc---ccCHHHHHHHHHHH
Confidence 3333 599999999999999999995 9999999999999999999999999874 45788999999999
Q ss_pred eeecccceEEeeecccc---------CceeEeeCC
Q 020132 192 VMRYDIPIVIRNIFNLS---------VPGIMICRP 217 (330)
Q Consensus 192 a~~~~i~v~i~~~~~~~---------~~GT~I~~~ 217 (330)
|.++|||++|.|+.+|+ ..||+|.+.
T Consensus 205 a~~~gi~v~I~ng~~~~~l~~~l~g~~~GT~i~~~ 239 (247)
T PRK14557 205 ARDYNLPAHVFNFDEPGVMRRICLGEHVGTLINDD 239 (247)
T ss_pred HHHCCCcEEEEeCCCChHHHHHHcCCCCcEEEecC
Confidence 99999999999987653 469999764
No 40
>cd04254 AAK_UMPK-PyrH-Ec UMP kinase (UMPK)-Ec, the microbial/chloroplast uridine monophosphate kinase (uridylate kinase) enzyme that catalyzes UMP phosphorylation and plays a key role in pyrimidine nucleotide biosynthesis; regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinase of E. coli (Ec) is known to function as a homohexamer, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial and chloroplast UMPKs (this CD) have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Members of this CD be
Probab=99.86 E-value=1.1e-22 Score=186.21 Aligned_cols=154 Identities=24% Similarity=0.278 Sum_probs=128.7
Q ss_pred ceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCC
Q 020132 37 DFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDN 116 (330)
Q Consensus 37 ~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g 116 (330)
|.+.+.|+++++++++..|+++|+++.++++.++.... ...+. +.++++++ .+.|||++|+.+
T Consensus 68 d~~g~~~~~~n~~ll~~~L~~~Gv~a~~l~~~~~~~~~------~~~~~----~~l~~~l~--~g~ipV~~g~~G----- 130 (231)
T cd04254 68 DYMGMLATVINALALQDALESLGVKTRVMSAIPMQGVA------EPYIR----RRAIRHLE--KGRVVIFAGGTG----- 130 (231)
T ss_pred hHHHHHHHHHHHHHHHHHHHHcCCCeEEEcHHHhhhhh------cccCH----HHHHHHHH--CCCEEEEECCcC-----
Confidence 45666799999999999999999999999998862111 12334 78888888 789999998854
Q ss_pred CcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccceeeecc
Q 020132 117 IPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYD 196 (330)
Q Consensus 117 ~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~~~~ 196 (330)
...+ .+|++|+++|.+|+|+++++||||||||++||+.+|+++++++++++|+.+ .|++++|+.++++|.++|
T Consensus 131 ~~~~----~~D~~a~~lA~~l~a~~l~~~tdVdGvy~~dp~~~~~a~~i~~i~~~~~~~---~~~~~~d~~a~~~a~~~g 203 (231)
T cd04254 131 NPFF----TTDTAAALRAIEINADVILKATKVDGVYDADPKKNPNAKRYDHLTYDEVLS---KGLKVMDATAFTLCRDNN 203 (231)
T ss_pred CCCC----CcHHHHHHHHHHcCCCEEEEEeCCCEEEecCCCCCCCcEEeeEecHHHHHh---cchhhhHHHHHHHHHHCC
Confidence 2111 259999999999999999999999999999999999999999999998866 478899999999999999
Q ss_pred cceEEeeecccc---------CceeEe
Q 020132 197 IPIVIRNIFNLS---------VPGIMI 214 (330)
Q Consensus 197 i~v~i~~~~~~~---------~~GT~I 214 (330)
++++|.|+.+|+ ..||+|
T Consensus 204 i~~~I~~g~~~~~l~~~l~g~~~GT~i 230 (231)
T cd04254 204 LPIVVFNINEPGNLLKAVKGEGVGTLI 230 (231)
T ss_pred CeEEEEeCCCccHHHHHHCCCCCCEEe
Confidence 999999987553 457776
No 41
>TIGR02075 pyrH_bact uridylate kinase. This protein, also called UMP kinase, converts UMP to UDP by adding a phosphate from ATP. It is the first step in pyrimidine biosynthesis. GTP is an allosteric activator. In a large fraction of all bacterial genomes, the gene tends to be located immediately downstream of elongation factor Ts and upstream of ribosome recycling factor. A related protein family, believed to be equivalent in function and found in the archaea and in spirochetes, is described by a separate model, TIGR02076.
Probab=99.85 E-value=3.2e-22 Score=183.24 Aligned_cols=156 Identities=22% Similarity=0.268 Sum_probs=129.5
Q ss_pred cceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCC
Q 020132 36 TDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPD 115 (330)
Q Consensus 36 ~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~ 115 (330)
.|.+.+.++++++++|+..|.++|+++.++++.++. ..... ...+.++++++ .|.|||+.|+.+.
T Consensus 68 ~d~~g~~~~~l~~~l~~~~L~~~Gi~a~~l~~~~~~-~~~~~---------~~~~~i~~ll~--~g~VpV~~g~~g~--- 132 (233)
T TIGR02075 68 ADYMGMLATVINGLALRDALEKLGVKTRVLSAISMP-QICES---------YIRRKAIKHLE--KGKVVIFSGGTGN--- 132 (233)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhCCCCcEEeccccCC-CCccc---------cCHHHHHHHHH--CCCEEEEECCCCC---
Confidence 566778899999999999999999999999988764 11111 12377788887 7899999987542
Q ss_pred CCcccccccCcchhHHHHHHHHhhceeEEEee-cccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccceeee
Q 020132 116 NIPTTLKRDGSDFSAAIMGALLRAHQVTIWTD-VDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMR 194 (330)
Q Consensus 116 g~~~~lgrggsD~~A~~lA~~l~A~~l~~~td-v~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~~ 194 (330)
. . ..+|++|+++|..|+|+.+++||| |||||++||+++|+++++++++++|+.++ |++++|+.++++|.+
T Consensus 133 ~---~---~s~D~~a~~lA~~l~a~~li~~td~VdGvy~~dp~~~~~a~~i~~i~~~e~~~~---~~~~~d~~~~~~a~~ 203 (233)
T TIGR02075 133 P---F---FTTDTAAALRAIEINADVILKGTNGVDGVYTADPKKNKDAKKYETITYNEALKK---NLKVMDLTAFALARD 203 (233)
T ss_pred C---C---CCchHHHHHHHHHcCCCEEEEeecccCeEEcCCCCCCCCCeECcEecHHHHHhc---CHHHHHHHHHHHHHH
Confidence 1 1 135999999999999999999999 99999999999999999999999998764 778999999999999
Q ss_pred cccceEEeeecccc---------CceeEee
Q 020132 195 YDIPIVIRNIFNLS---------VPGIMIC 215 (330)
Q Consensus 195 ~~i~v~i~~~~~~~---------~~GT~I~ 215 (330)
+|++++|.|+.+|+ ..||+|+
T Consensus 204 ~~i~v~i~~g~~~~~l~~~l~g~~~GT~i~ 233 (233)
T TIGR02075 204 NNLPIVVFNIDEPGALKKVILGKGIGTLVS 233 (233)
T ss_pred CCCeEEEEeCCCcchHHHHHCCCCCCEEeC
Confidence 99999999987553 4577763
No 42
>PRK13402 gamma-glutamyl kinase; Provisional
Probab=99.83 E-value=3.2e-21 Score=187.00 Aligned_cols=169 Identities=18% Similarity=0.279 Sum_probs=134.1
Q ss_pred ccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCC
Q 020132 35 FTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTP 114 (330)
Q Consensus 35 ~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~ 114 (330)
.++.+.+.|+.++...+...|.++|+++ .++++ +.+.+.+ +-.+...+..++.+++ .+.|||+..
T Consensus 71 ~~qalaavGq~~l~~~~~~~f~~~g~~~-----aqvLl-T~~d~~~-~~~y~n~~~~l~~LL~--~g~IPIine------ 135 (368)
T PRK13402 71 EKQAMAAAGQGLLMATWSKLFLSHGFPA-----AQLLL-THGDLRD-RERYINIRNTINVLLE--RGILPIINE------ 135 (368)
T ss_pred HHHHHHHhhHHHHHHHHHHHHHHCCCeE-----EEEEE-ecchhhh-HHHHHHHHHHHHHHHH--CCcEEEEeC------
Confidence 3456779999999999999999999998 34433 3333321 1113334578888887 789999962
Q ss_pred CCCccc--ccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhh--HHhhhhh-----hccccccc
Q 020132 115 DNIPTT--LKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY--QEAWEMS-----YFGANVLH 185 (330)
Q Consensus 115 ~g~~~~--lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~--~e~~~l~-----~~g~~v~~ 185 (330)
++.+++ ++||++|++|+++|.+++|+.++++|||||||++||+.+|++++|+++++ +|+.+++ ..|.++|+
T Consensus 136 nD~v~~~el~~GdnD~lAa~vA~~l~Ad~LiilTDVdGvy~~dP~~~p~a~~I~~I~~i~~e~~~l~~~~~s~~gtGGM~ 215 (368)
T PRK13402 136 NDAVTTDRLKVGDNDNLSAMVAALADADTLIILSDIDGLYDQNPRTNPDAKLIKQVTEINAEIYAMAGGAGSNVGTGGMR 215 (368)
T ss_pred CCcEeecccccCChHHHHHHHHHHhCCCEEEEEecCCeEEeCCCCCCCCCEEEEEeccCcHHHHHHhcccccCcCcCCch
Confidence 122333 67899999999999999999999999999999999999999999999997 6777766 36789999
Q ss_pred c--cccceeeecccceEEeeeccc---------cCceeEeeCCC
Q 020132 186 P--RTIIPVMRYDIPIVIRNIFNL---------SVPGIMICRPP 218 (330)
Q Consensus 186 p--~a~~~a~~~~i~v~i~~~~~~---------~~~GT~I~~~~ 218 (330)
| .|+..|.++|+|++|.|+..| +..||+|.+..
T Consensus 216 ~Kl~Aa~~a~~~gi~v~I~~g~~~~~l~~~l~g~~~GT~i~~~~ 259 (368)
T PRK13402 216 TKIQAAKIAMSHGIETFIGNGFTADIFNQLLKGQNPGTYFTPEE 259 (368)
T ss_pred HHHHHHHHHHHcCCcEEEEcCCCchHHHHHhcCCCCceEEecCC
Confidence 9 688999999999999998765 34699997653
No 43
>COG0528 PyrH Uridylate kinase [Nucleotide transport and metabolism]
Probab=99.83 E-value=5e-21 Score=171.90 Aligned_cols=181 Identities=22% Similarity=0.288 Sum_probs=138.0
Q ss_pred hhHHHHHhhhcccccCCCC----------------------CccccccceeeeccchhHHHHHHHHHHhcCCccccccce
Q 020132 11 LSYEFIRSTYNFLSNVDSG----------------------HATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTR 68 (330)
Q Consensus 11 ~~~~~i~~~~~~l~~~~~~----------------------~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~ 68 (330)
.+++++..+.+.|+++.+. -.+....|++=....+++|.++...|.+.|++++.+++.
T Consensus 25 id~~~i~~~a~~i~~~~~~g~eV~iVvGGGni~Rg~~~~~~g~~r~~~D~mGmlaTvmNal~L~~aL~~~~~~~~v~sai 104 (238)
T COG0528 25 IDPEVLDRIANEIKELVDLGVEVAVVVGGGNIARGYIGAAAGMDRVTADYMGMLATVMNALALQDALERLGVDTRVQSAI 104 (238)
T ss_pred CCHHHHHHHHHHHHHHHhcCcEEEEEECCCHHHHhHHHHHcCCchhhhhHHHHHHHHHHHHHHHHHHHhcCCcceecccc
Confidence 4677777777777777642 122223444444556677778888899999998888776
Q ss_pred eEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEee-
Q 020132 69 EVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTD- 147 (330)
Q Consensus 69 ~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~td- 147 (330)
.+... ..+.+..+..+.++ .+.|+|..| |...-+++| |++|+++|..++|+-++..|+
T Consensus 105 ~~~~~----------~e~~~~~~A~~~l~--~grVvIf~g--Gtg~P~fTT-------Dt~AALrA~ei~ad~ll~atn~ 163 (238)
T COG0528 105 AMPQV----------AEPYSRREAIRHLE--KGRVVIFGG--GTGNPGFTT-------DTAAALRAEEIEADVLLKATNK 163 (238)
T ss_pred cCccc----------cCccCHHHHHHHHH--cCCEEEEeC--CCCCCCCch-------HHHHHHHHHHhCCcEEEEeccC
Confidence 65311 12234466777777 789999877 222234444 999999999999999999995
Q ss_pred cccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccceeeecccceEEeeeccc---------cCceeEee
Q 020132 148 VDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNL---------SVPGIMIC 215 (330)
Q Consensus 148 v~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~---------~~~GT~I~ 215 (330)
|||||++||+++|+|+++++|||.|+.++ +.++|+|.|+.+|++++||++++|...+ ++.||.|.
T Consensus 164 VDGVY~~DPkk~pdA~~~~~Lty~e~l~~---~l~vmD~tA~~l~~~~~i~i~Vfn~~~~~~l~~~~~ge~~gT~V~ 237 (238)
T COG0528 164 VDGVYDADPKKDPDAKKYDTLTYDEVLKI---GLKVMDPTAFSLARDNGIPIIVFNINKPGNLKRALKGEEVGTIVE 237 (238)
T ss_pred CCceeCCCCCCCCCceecccCCHHHHHHh---cCeeecHHHHHHHHHcCCcEEEEeCCCCccHHHHHcCCCCceEec
Confidence 99999999999999999999999999877 5899999999999999999999997654 35577764
No 44
>PRK14556 pyrH uridylate kinase; Provisional
Probab=99.81 E-value=1.2e-20 Score=173.02 Aligned_cols=157 Identities=20% Similarity=0.258 Sum_probs=127.1
Q ss_pred ccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCC
Q 020132 35 FTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTP 114 (330)
Q Consensus 35 ~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~ 114 (330)
..|++=..+.++.|.++...|.+.|++++.+++-...- + ++ . .+.+++.+.++ .|.|+|+.|+.|
T Consensus 82 ~~D~~GmlaT~iNal~l~~~l~~~~~~~~v~sa~~~~~-----~--~e--~-~~~~~~~~~l~--~g~vvi~~gg~G--- 146 (249)
T PRK14556 82 TADSMGMIATMINALALRDMLISEGVDAEVFSAKGVDG-----L--LK--V-ASAHEFNQELA--KGRVLIFAGGTG--- 146 (249)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHcCCCeEEeeccccCc-----C--CC--C-CCHHHHHHHHh--CCCEEEEECCCC---
Confidence 45666667788889999999999999988877654311 1 11 1 24477777887 788999888754
Q ss_pred CCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccceeee
Q 020132 115 DNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMR 194 (330)
Q Consensus 115 ~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~~ 194 (330)
++..+ +|++|+++|..++|+.+++|||||||||+||+++|+|+++++++|.|+.+. +..+|++.|+++|.+
T Consensus 147 ~p~~S------tD~lAallA~~l~Ad~Lii~TdVDGVYd~DP~~~p~A~~i~~I~~~e~~~~---~l~vmd~~A~~~a~~ 217 (249)
T PRK14556 147 NPFVT------TDTTASLRAVEIGADALLKATTVNGVYDKDPNKYSDAKRFDKVTFSEVVSK---ELNVMDLGAFTQCRD 217 (249)
T ss_pred CCcCC------cHHHHHHHHHHcCCCEEEEEeCCCccCCCCCCCCCCceEeeEEchhhhccc---chHhHHHHHHHHHHH
Confidence 34444 399999999999999999999999999999999999999999999988653 568999999999999
Q ss_pred cccceEEeeeccc---------cCceeEee
Q 020132 195 YDIPIVIRNIFNL---------SVPGIMIC 215 (330)
Q Consensus 195 ~~i~v~i~~~~~~---------~~~GT~I~ 215 (330)
+|||++|+|+.+| +..||+|.
T Consensus 218 ~gIpi~I~ng~~~~~L~~~l~Ge~~GT~i~ 247 (249)
T PRK14556 218 FGIPIYVFDLTQPNALVDAVLDSKYGTWVT 247 (249)
T ss_pred CCCcEEEECCCCchHHHHHHcCCCCceEEE
Confidence 9999999998655 34688874
No 45
>cd04253 AAK_UMPK-PyrH-Pf AAK_UMPK-PyrH-Pf: UMP kinase (UMPK)-Pf, the mostly archaeal uridine monophosphate kinase (uridylate kinase) enzymes that catalyze UMP phosphorylation and play a key role in pyrimidine nucleotide biosynthesis; regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinase of Pyrococcus furiosus (Pf) is known to function as a homohexamer, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial UMPKs have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs (this CD) appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Members of thi
Probab=99.80 E-value=3.7e-20 Score=168.28 Aligned_cols=112 Identities=24% Similarity=0.284 Sum_probs=96.1
Q ss_pred HHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLS 169 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is 169 (330)
+.+.++++ .+.|||++||++ + .+ +|++|+++|.+|+|+++++||||||||++||+..|+++++++++
T Consensus 94 ~~~~~~l~--~g~vpv~~G~~~----~-~s------~D~~a~~lA~~l~a~~li~~tdVdGVy~~dP~~~~~a~~i~~i~ 160 (221)
T cd04253 94 EEALEAMF--TGKIVVMGGTEP----G-QS------TDAVAALLAERLGADLLINATNVDGVYSKDPRKDPDAKKFDRLS 160 (221)
T ss_pred HHHHHHHH--cCCeEEEECCCC----C-Cc------cHHHHHHHHHHcCCCEEEEEeCCCeeECCCCCCCCCCeEeeEeC
Confidence 55667777 789999999964 2 22 49999999999999999999999999999999999999999999
Q ss_pred hHHhhhhhhc-----cc-ccccccccceeeecccceEEeeecccc---------CceeEe
Q 020132 170 YQEAWEMSYF-----GA-NVLHPRTIIPVMRYDIPIVIRNIFNLS---------VPGIMI 214 (330)
Q Consensus 170 ~~e~~~l~~~-----g~-~v~~p~a~~~a~~~~i~v~i~~~~~~~---------~~GT~I 214 (330)
++|+.+++.. |. .++|+.+++++.+++++++|.|+..|+ ..||.|
T Consensus 161 ~~e~~~~~~~~~~~~g~~~~~d~~a~~~~~~~gi~~~I~~g~~p~~l~~~l~g~~~GT~I 220 (221)
T cd04253 161 ADELIDIVGKSSWKAGSNEPFDPLAAKIIERSGIKTIVVDGRDPENLERALKGEFVGTII 220 (221)
T ss_pred HHHHHHHccCCCcCCCCCcchHHHHHHHHHHCCCeEEEECCCCccHHHHHHCCCCCCeEe
Confidence 9999999865 44 578999999999999999999986553 357766
No 46
>PRK05429 gamma-glutamyl kinase; Provisional
Probab=99.79 E-value=4.9e-20 Score=179.54 Aligned_cols=169 Identities=20% Similarity=0.262 Sum_probs=131.1
Q ss_pred cceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEee-eeecCC
Q 020132 36 TDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATG-FIASTP 114 (330)
Q Consensus 36 ~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G-~i~~~~ 114 (330)
.+.+.+.||..+++++...|+++|+++.. +. .+.+.+.. ...+......++.+++ .+.|||+++ +...
T Consensus 76 ~qa~aavGq~~L~~~~~~~l~~~gi~~~q-----il-~t~~d~~~-~~~~ln~~~~i~~Ll~--~g~IPVi~~nd~v~-- 144 (372)
T PRK05429 76 KQAAAAVGQSRLMQAYEELFARYGITVAQ-----IL-LTRDDLED-RERYLNARNTLRTLLE--LGVVPIINENDTVA-- 144 (372)
T ss_pred HHHHHHHhHHHHHHHHHHHHHHCCCCEEE-----EE-eehhHhhh-hhHhhhHHHHHHHHHH--CCCEEEEcCCCccc--
Confidence 45677899999999999999999999654 33 23332311 1112223467788887 789999963 2111
Q ss_pred CCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhh--HHhhhhhh-----cccccccc-
Q 020132 115 DNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY--QEAWEMSY-----FGANVLHP- 186 (330)
Q Consensus 115 ~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~--~e~~~l~~-----~g~~v~~p- 186 (330)
+..+++|++|++|+++|.+++|+.++|+|||||||++||+.+|++++++++++ +|+.+++. .|.++|+|
T Consensus 145 ---~~~l~~gd~D~~Aa~lA~~l~Ad~LiilTDVdGVy~~dP~~~p~a~~I~~i~~~~~e~~~~~~~~~~~~gtGGM~~K 221 (372)
T PRK05429 145 ---TDEIKFGDNDTLSALVANLVEADLLILLTDVDGLYTADPRKNPDAKLIPEVEEITDELEAMAGGAGSGLGTGGMATK 221 (372)
T ss_pred ---eecccccChHHHHHHHHHHcCCCEEEEecCCCeeEcCCCCCCCCceEEEEeccCCHHHHHHhcCCCCCcCcCCcHHH
Confidence 11256789999999999999999999999999999999999999999999998 67878763 57789999
Q ss_pred -cccceeeecccceEEeeeccc---------cCceeEeeCCC
Q 020132 187 -RTIIPVMRYDIPIVIRNIFNL---------SVPGIMICRPP 218 (330)
Q Consensus 187 -~a~~~a~~~~i~v~i~~~~~~---------~~~GT~I~~~~ 218 (330)
.|+..|.++|++++|.|+..| +..||+|.+..
T Consensus 222 l~aa~~a~~~Gi~v~I~~g~~~~~l~~~l~g~~~GT~i~~~~ 263 (372)
T PRK05429 222 LEAARIATRAGIPVVIASGREPDVLLRLLAGEAVGTLFLPQE 263 (372)
T ss_pred HHHHHHHHHCCCeEEEEcCCCccHHHHHhcCCCCCEEEeeCC
Confidence 688889999999999998655 24699998653
No 47
>cd04241 AAK_FomA-like AAK_FomA-like: This CD includes a fosfomycin biosynthetic gene product, FomA, and similar proteins found in a wide range of organisms. Together, the fomA and fomB genes in the fosfomycin biosynthetic gene cluster of Streptomyces wedmorensis confer high-level fosfomycin resistance. FomA and FomB proteins converted fosfomycin to fosfomycin monophosphate and fosfomycin diphosphate in the presence of ATP and a magnesium ion, indicating that FomA and FomB catalyzed phosphorylations of fosfomycin and fosfomycin monophosphate, respectively. FomA and related sequences in this CD are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.79 E-value=1.1e-19 Score=168.27 Aligned_cols=145 Identities=15% Similarity=0.192 Sum_probs=119.7
Q ss_pred HHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcch
Q 020132 49 QMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDF 128 (330)
Q Consensus 49 ~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~ 128 (330)
..+.+.|.++|+++.++++.++.....++. ..++. +.++++++ .|.|||++|+++.+.+|.+.++ ++|+
T Consensus 83 ~~~~~~l~~~g~~a~~l~~~~~~~~~~g~~--~~~~~----~~l~~ll~--~g~iPVi~~~~~~~~~~~~~~~---~~D~ 151 (252)
T cd04241 83 SIVVDALLEAGVPAVSVPPSSFFVTENGRI--VSFDL----EVIKELLD--RGFVPVLHGDVVLDEGGGITIL---SGDD 151 (252)
T ss_pred HHHHHHHHHCCCCeEEEChHHeEEecCCee--eeecH----HHHHHHHh--CCCEEEEcCCeEecCCCCeEEe---ChHH
Confidence 366889999999999999999876543221 23444 88899998 8999999999888888877665 4899
Q ss_pred hHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhc-------cccccccc--ccceeeecccce
Q 020132 129 SAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYF-------GANVLHPR--TIIPVMRYDIPI 199 (330)
Q Consensus 129 ~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~-------g~~v~~p~--a~~~a~~~~i~v 199 (330)
+|+.+|.+|+|++++|+|||||||++|| |+++++++++++++.++... ..++|.++ ++..|.++|+++
T Consensus 152 ~A~~lA~~l~A~~li~ltdv~Gv~~~~P---~~~~~i~~i~~~~~~~~~~~~~~~~~~~tGGm~~Kl~aa~~a~~~Gv~v 228 (252)
T cd04241 152 IVVELAKALKPERVIFLTDVDGVYDKPP---PDAKLIPEIDVGSLEDILAALGSAGTDVTGGMAGKIEELLELARRGIEV 228 (252)
T ss_pred HHHHHHHHcCCCEEEEEeCCCeeECCCC---CCCeEcceeCccchHHHHHhcCcCCccccCCHHHHHHHHHHHHhcCCeE
Confidence 9999999999999999999999999999 88999999999888887642 34688884 666777789999
Q ss_pred EEeeeccc
Q 020132 200 VIRNIFNL 207 (330)
Q Consensus 200 ~i~~~~~~ 207 (330)
+|.|+..+
T Consensus 229 ~I~~g~~~ 236 (252)
T cd04241 229 YIFNGDKP 236 (252)
T ss_pred EEEeCCCH
Confidence 99998754
No 48
>TIGR01027 proB glutamate 5-kinase. Bacterial ProB proteins hit the full length of this model, but the ProB-like domain of delta 1-pyrroline-5-carboxylate synthetase does not hit the C-terminal 100 residues of this model. The noise cutoff is set low enough to hit delta 1-pyrroline-5-carboxylate synthetase and other partial matches to this family.
Probab=99.78 E-value=9.6e-20 Score=176.92 Aligned_cols=168 Identities=17% Similarity=0.268 Sum_probs=130.4
Q ss_pred cceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEe-eeeecCC
Q 020132 36 TDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIAT-GFIASTP 114 (330)
Q Consensus 36 ~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~-G~i~~~~ 114 (330)
++.+.+.|+.++..++...|.++|+++ .++++ +.+.+.+. -.+......+..+++ .+.|||++ ++...
T Consensus 68 ~qa~aa~Gq~~l~~~~~~~l~~~Gi~~-----aqill-t~~d~~~~-~~~lna~~~i~~Ll~--~g~iPVi~end~v~-- 136 (363)
T TIGR01027 68 KQALAAVGQVRLMQLYEQLFSQYGIKV-----AQILL-TRADFSDR-ERYLNARNTLEALLE--LGVVPIINENDTVA-- 136 (363)
T ss_pred HHHHHHhChHHHHHHHHHHHHHcCCeE-----EEEEE-eccchhhH-HHHHHHHHHHHHHHh--CCCEEEEeCCCcee--
Confidence 456788999999999999999999986 34433 43333211 112234477788887 78999996 33111
Q ss_pred CCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhH--Hhhhhh-----hccccccccc
Q 020132 115 DNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQ--EAWEMS-----YFGANVLHPR 187 (330)
Q Consensus 115 ~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~--e~~~l~-----~~g~~v~~p~ 187 (330)
+..+++|++|++|+++|.+++|+.++|+|||||||++||+.+|+|++++++++. +..+++ .+|.++|+|+
T Consensus 137 ---~~~l~~gd~D~lAa~lA~~l~Ad~liilTDVdGVy~~dP~~~p~A~~I~~i~~~~~~~~~i~~~~~~~~gtGGM~~K 213 (363)
T TIGR01027 137 ---TEEIKFGDNDTLSALVAILVGADLLVLLTDVDGLYDADPRTNPDAKLIPVVEEITDLLLGVAGDSGSSVGTGGMRTK 213 (363)
T ss_pred ---eeecCcCChHHHHHHHHHHcCCCEEEEEeCCCcccCCCCCCCCCCeEEEEeccCcHHHHHhhcCCCcCcCcCCchHH
Confidence 133667889999999999999999999999999999999999999999999864 444554 3678899997
Q ss_pred --ccceeeecccceEEeeecccc---------CceeEeeCC
Q 020132 188 --TIIPVMRYDIPIVIRNIFNLS---------VPGIMICRP 217 (330)
Q Consensus 188 --a~~~a~~~~i~v~i~~~~~~~---------~~GT~I~~~ 217 (330)
|+..|.++|++++|.|+..|+ ..||+|.+.
T Consensus 214 l~Aa~~a~~~gi~v~I~~g~~~~~l~~~l~g~~~GT~i~~~ 254 (363)
T TIGR01027 214 LQAADLATRAGVPVIIASGSKPEKIADALEGAPVGTLFHAQ 254 (363)
T ss_pred HHHHHHHHHCCCeEEEEeCCCccHHHHHhcCCCCcEEEeeC
Confidence 889999999999999987652 459999764
No 49
>PRK14058 acetylglutamate/acetylaminoadipate kinase; Provisional
Probab=99.77 E-value=2.5e-19 Score=167.42 Aligned_cols=163 Identities=14% Similarity=0.206 Sum_probs=129.2
Q ss_pred eeeccchhHHHHHHHHHHhcCCccccccceeEEEECC------------------C-CCCC-CCCCchhhHHHHHHhhcc
Q 020132 39 VVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNP------------------T-SSNQ-VDPDFSESEKRLEKWFSQ 98 (330)
Q Consensus 39 v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~------------------~-~~g~-~~~~~~~~~~~i~~~l~~ 98 (330)
..+.| .++..++ +.|.++|++|+++++.++.+++. . ..|. .+++. +.++.+++
T Consensus 75 ~~a~~-~ln~~lv-~~L~~~Gv~a~~l~~~~~~l~~~~~~~~~~~~~~g~~~~~d~g~~g~v~~v~~----~~i~~ll~- 147 (268)
T PRK14058 75 IMAMA-LINKQLV-ERLQSLGVNAVGLSGLDGGLLEGKRKKAVRVVEEGKKKIIRGDYTGKIEEVNT----DLLKLLLK- 147 (268)
T ss_pred HHHHH-HHHHHHH-HHHHhCCCCccccCcccCCEEEEEEecccccccCCcceeccCCceeEEEEECH----HHHHHHHH-
Confidence 44778 7777776 59999999999999998744321 1 1111 23444 88999998
Q ss_pred CCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhh
Q 020132 99 SPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSY 178 (330)
Q Consensus 99 ~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~ 178 (330)
.+.|||++|+ +.+..|+.+++ ++|.+|+.+|.+|+|++++|||||+|||++||. +++++++++++|+.++..
T Consensus 148 -~g~iPVi~~~-~~~~~g~~~~i---~~D~~A~~lA~~l~A~~li~ltdv~Gv~~~~p~---~~~~i~~i~~~e~~~l~~ 219 (268)
T PRK14058 148 -AGYLPVVAPP-ALSEEGEPLNV---DGDRAAAAIAGALKAEALVLLSDVPGLLRDPPD---EGSLIERITPEEAEELSK 219 (268)
T ss_pred -CCCEEEEeCc-eECCCCcEEec---CHHHHHHHHHHHcCCCEEEEEeCChhhccCCCC---CCcCccCcCHHHHHHHhh
Confidence 7899999997 66677887765 589999999999999999999999999999984 378999999999999887
Q ss_pred ccccccccc--ccceeeeccc-ceEEeeecccc-------CceeEeeC
Q 020132 179 FGANVLHPR--TIIPVMRYDI-PIVIRNIFNLS-------VPGIMICR 216 (330)
Q Consensus 179 ~g~~v~~p~--a~~~a~~~~i-~v~i~~~~~~~-------~~GT~I~~ 216 (330)
...++|.|+ ++..+.++|+ +++|.|+..|+ ..||+|.+
T Consensus 220 ~~tGgM~~Kl~aa~~a~~~Gv~~v~I~~g~~~~~l~~~l~G~GT~I~~ 267 (268)
T PRK14058 220 AAGGGMKKKVLMAAEAVEGGVGRVIIADANVDDPISAALAGEGTVIVN 267 (268)
T ss_pred ccCCccHHHHHHHHHHHHcCCCEEEEEcCCCcchHHHHhCCCceEEec
Confidence 777899985 6666677888 69999886553 24898864
No 50
>TIGR02076 pyrH_arch uridylate kinase, putative. This family consists of the archaeal and spirochete proteins most closely related to bacterial uridylate kinases (TIGR02075), an enzyme involved in pyrimidine biosynthesis. Members are likely, but not known, to be functionally equivalent to their bacterial counterparts. However, substantial sequence differences suggest that regulatory mechanisms may be different; the bacterial form is allosterically regulated by GTP.
Probab=99.77 E-value=1.6e-19 Score=164.08 Aligned_cols=137 Identities=23% Similarity=0.225 Sum_probs=106.7
Q ss_pred cceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCC
Q 020132 36 TDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPD 115 (330)
Q Consensus 36 ~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~ 115 (330)
.|.+...+++++++++...|...++++...+ . ....+.+. .+.|||++||++
T Consensus 62 ~~~~g~~~~~ln~~~l~~ll~~~~~~~~~~~------------------~----~~~~~~l~--~g~ipv~~G~~~---- 113 (221)
T TIGR02076 62 LDEIGIDATRLNAMLLIAALGDDAYPKVPEN------------------F----EEALEAMS--LGKIVVMGGTHP---- 113 (221)
T ss_pred HHHhhhHHHHHHHHHHHHHHHhcCCCCcCCC------------------H----HHHHHHHH--cCCEEEEcCCCC----
Confidence 3455556677777776666666666554321 1 22344554 678999999852
Q ss_pred CCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhh---cccc---ccccccc
Q 020132 116 NIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSY---FGAN---VLHPRTI 189 (330)
Q Consensus 116 g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~---~g~~---v~~p~a~ 189 (330)
| .+ +|++|+++|.+++|+.++++|||||||++||+++|+++++++++++|+.+++. +|.+ .+++.|+
T Consensus 114 ~-~s------~D~~A~~lA~~l~A~~li~ltdVdGvy~~dP~~~~~a~~i~~i~~~e~~~~~~~~~~~~g~~~~~~~~a~ 186 (221)
T TIGR02076 114 G-HT------TDAVAALLAEFSKADLLINATNVDGVYDKDPKKDPDAKKFDKLTPEELVEIVGSSSVKAGSNEVVDPLAA 186 (221)
T ss_pred C-CC------cHHHHHHHHHHcCCCEEEEEeCCCcccCCCCCCCCCCeEeeEECHHHHHHHhcCCCccCCCCceeHHHHH
Confidence 2 22 49999999999999999999999999999999999999999999999999876 3333 5688899
Q ss_pred ceeeecccceEEeeeccc
Q 020132 190 IPVMRYDIPIVIRNIFNL 207 (330)
Q Consensus 190 ~~a~~~~i~v~i~~~~~~ 207 (330)
+.+.+.+++++|.|+..|
T Consensus 187 ~~~~~~~i~v~I~~g~~~ 204 (221)
T TIGR02076 187 KIIERSKIRTIVVNGRDP 204 (221)
T ss_pred HHHHHCCCcEEEECCCCc
Confidence 999999999999998765
No 51
>cd04250 AAK_NAGK-C AAK_NAGK-C: N-Acetyl-L-glutamate kinase - cyclic (NAGK-C) catalyzes the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of arginine biosynthesis found in some bacteria and photosynthetic organisms using the non-acetylated, cyclic route of ornithine biosynthesis. In this pathway, glutamate is first N-acetylated and then phosphorylated by NAGK to give phosphoryl NAG, which is converted to NAG-ornithine. There are two variants of this pathway. In one, typified by the pathway in Thermotoga maritima and Pseudomonas aeruginosa, the acetyl group is recycled by reversible transacetylation from acetylornithine to glutamate. The phosphorylation of NAG by NAGK is feedback inhibited by arginine. In photosynthetic organisms, NAGK is the target of the nitrogen-signaling protein PII. Hexameric formation of NAGK domains appears to be essential to both arginine inhibition and NAGK-PII complex formation. NAGK-C are members of the Amino A
Probab=99.75 E-value=9.5e-19 Score=164.40 Aligned_cols=151 Identities=15% Similarity=0.193 Sum_probs=121.0
Q ss_pred cchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCC---------------CCCCchhhHHHHHHhhccCCCccEEEe
Q 020132 43 GELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQ---------------VDPDFSESEKRLEKWFSQSPSNTIIAT 107 (330)
Q Consensus 43 GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~---------------~~~~~~~~~~~i~~~l~~~~~~VpVv~ 107 (330)
| .++.. +++.|.+.|++|+++++.+..+++.++++. ..++. +.++.+++ .+.|||++
T Consensus 93 g-~ln~~-l~~~L~~~Gv~a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~g~i~~i~~----~~i~~ll~--~g~IPVi~ 164 (279)
T cd04250 93 G-KVNKE-IVSLINRAGGKAVGLSGKDGNLIKAKKKDATVIEEIIDLGFVGEVTEVNP----ELLETLLE--AGYIPVIA 164 (279)
T ss_pred C-chHHH-HHHHHHHcCCCcceeecCCCCEEEEEECcccccCCCcccCcccceEEEcH----HHHHHHHH--CCCeEEEc
Confidence 6 45555 499999999999999999875565444331 12333 78888888 78999999
Q ss_pred eeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhc--cccccc
Q 020132 108 GFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYF--GANVLH 185 (330)
Q Consensus 108 G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~--g~~v~~ 185 (330)
| ++.+..|++++++ +|.+|+.+|.+|+|+++++||||+|||++||. .++++++++++|+.+++.. ..++|.
T Consensus 165 ~-~~~~~~g~~~~~~---~D~~A~~lA~~l~A~~li~ltdv~Gv~~~~p~---~~~~i~~i~~~e~~~l~~~~~~tGgm~ 237 (279)
T cd04250 165 P-VGVGEDGETYNIN---ADTAAGAIAAALKAEKLILLTDVAGVLDDPND---PGSLISEISLKEAEELIADGIISGGMI 237 (279)
T ss_pred C-CccCCCCcEEEeC---HHHHHHHHHHHhCCCEEEEEECCcccccCCCC---CccccccCCHHHHHHHHHcCCCCCchH
Confidence 9 5888888888774 89999999999999999999999999999885 3799999999999999854 357888
Q ss_pred cc--ccceeeecccc-eEEeeecccc
Q 020132 186 PR--TIIPVMRYDIP-IVIRNIFNLS 208 (330)
Q Consensus 186 p~--a~~~a~~~~i~-v~i~~~~~~~ 208 (330)
++ ++..+.++|++ ++|.|+..|+
T Consensus 238 ~Kl~~a~~a~~~g~~~v~I~~g~~~~ 263 (279)
T cd04250 238 PKVEACIEALEGGVKAAHIIDGRVPH 263 (279)
T ss_pred HHHHHHHHHHHhCCCEEEEeCCCCCc
Confidence 84 55666677876 9999886653
No 52
>TIGR00761 argB acetylglutamate kinase. This model describes N-acetylglutamate kinases (ArgB) of many prokaryotes and the N-acetylglutamate kinase domains of multifunctional proteins from yeasts. This enzyme is the second step in the "acetylated" ornithine biosynthesis pathway. A related group of enzymes representing the first step of the pathway contain a homologous domain and are excluded from this model.
Probab=99.74 E-value=1.1e-18 Score=159.47 Aligned_cols=140 Identities=16% Similarity=0.252 Sum_probs=111.8
Q ss_pred cchhHHHHHHHHHHhcCCccccccceeEEEECCCCC--------CC-CCCCchhhHHHHHHhhccCCCccEEEeeeeecC
Q 020132 43 GELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSS--------NQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIAST 113 (330)
Q Consensus 43 GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~--------g~-~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~ 113 (330)
++.++..+ .+.|.++|++++++++.+..+++...+ |. ..++. +.++.+++ .+.|||++|+ +.+
T Consensus 75 ~g~~~~~i-~~~L~~~G~~a~~l~~~~~~~it~~~~~~~~~~~~g~i~~i~~----~~i~~~l~--~g~IPVi~~~-~~~ 146 (231)
T TIGR00761 75 IGQVNKEL-VALLNKHGINAIGLTGGDGQLFTARSLDKEDLGYVGEIKKVNK----ALLEALLK--AGYIPVISSL-ALT 146 (231)
T ss_pred hcchHHHH-HHHHHhCCCCcccccCCCCCEEEEEECCCccCCcccceEEEcH----HHHHHHHH--CCCeEEECCC-ccC
Confidence 44666555 559999999999999998644433222 11 12333 88899998 7899999995 888
Q ss_pred CCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcc--ccccccc--cc
Q 020132 114 PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG--ANVLHPR--TI 189 (330)
Q Consensus 114 ~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g--~~v~~p~--a~ 189 (330)
.+|++++++ +|++|+.||.+|+|++++|||||||||++||+ +++++++++|+.+++..| .++|.|+ ++
T Consensus 147 ~~g~~~~l~---sD~~A~~lA~~l~A~~li~ltdv~Gv~~~d~~-----~~i~~i~~~e~~~l~~~~~~tggm~~Kl~~a 218 (231)
T TIGR00761 147 AEGQALNVN---ADTAAGALAAALGAEKLVLLTDVPGILNGDGQ-----SLISEIPLEEIEQLIEQGIITGGMIPKVNAA 218 (231)
T ss_pred CCCcEEEeC---HHHHHHHHHHHcCCCEEEEEECCCCeecCCCC-----eeccccCHHHHHHHHHcCCCCCchHHHHHHH
Confidence 889998884 89999999999999999999999999999874 689999999999999766 5788884 56
Q ss_pred ceeeecccc
Q 020132 190 IPVMRYDIP 198 (330)
Q Consensus 190 ~~a~~~~i~ 198 (330)
..|.++|++
T Consensus 219 ~~a~~~gv~ 227 (231)
T TIGR00761 219 LEALRGGVK 227 (231)
T ss_pred HHHHHcCCC
Confidence 666667776
No 53
>cd04249 AAK_NAGK-NC AAK_NAGK-NC: N-Acetyl-L-glutamate kinase - noncyclic (NAGK-NC) catalyzes the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of microbial arginine biosynthesis using the acetylated, noncyclic route of ornithine biosynthesis. There are two variants of this pathway. In one, typified by the pathway in Escherichia coli, glutamate is acetylated by acetyl-CoA and acetylornithine is deacylated hydrolytically. In this pathway, feedback inhibition by arginine occurs at the initial acetylation of glutamate and not at the phosphorylation of NAG by NAGK. Homodimeric NAGK-NC are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.73 E-value=1.8e-18 Score=160.15 Aligned_cols=147 Identities=17% Similarity=0.170 Sum_probs=116.1
Q ss_pred cchhHHHHHHHHHHhcCCccccccceeEEEECCCCCC-------C-CCCCchhhHHHHHHhhccCCCccEEEeeeeecCC
Q 020132 43 GELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSN-------Q-VDPDFSESEKRLEKWFSQSPSNTIIATGFIASTP 114 (330)
Q Consensus 43 GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g-------~-~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~ 114 (330)
++.++.++++..+ ++|++|+++++.+..+++..+++ . .+++. +.++.+++ .|.|||++|+ +.+.
T Consensus 77 ~~~~n~~lv~~l~-~~Gv~a~~l~~~~~~~~~~~~~~~~~~~~G~v~~i~~----~~l~~ll~--~g~ipVi~~~-g~~~ 148 (252)
T cd04249 77 AGTANKQLMAQAI-KAGLKPVGLSLADGGMTAVTQLDPELGAVGKATANDP----SLLNDLLK--AGFLPIISSI-GADD 148 (252)
T ss_pred cCcccHHHHHHHH-hCCCCceeeeccCCCEEEEEEcCCCCCcccceEEEcH----HHHHHHHH--CCCEEEECCC-EECC
Confidence 6677777777665 89999999999987656543222 1 12344 88898998 8899999985 8888
Q ss_pred CCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcc--cccccc---ccc
Q 020132 115 DNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG--ANVLHP---RTI 189 (330)
Q Consensus 115 ~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g--~~v~~p---~a~ 189 (330)
+|++++++ +|.+|+.+|.+|+|+ +++||||+|||+.|| +++++++++|+.++...| ..+|.+ .|+
T Consensus 149 ~g~~~~~~---~D~~A~~lA~~l~A~-~i~ltdv~Gv~~~~~------~~i~~i~~~e~~~~~~~g~~~gGm~~kl~~a~ 218 (252)
T cd04249 149 QGQLMNVN---ADQAATAIAQLLNAD-LVLLSDVSGVLDADK------QLISELNAKQAAELIEQGVITDGMIVKVNAAL 218 (252)
T ss_pred CCCEeeec---HHHHHHHHHHHcCCC-EEEEeCCcccCCCCC------cCccccCHHHHHHHHhcCCCcCCcHHHHHHHH
Confidence 99999885 899999999999999 689999999999775 588999999999988654 356665 466
Q ss_pred ceeeecccceEEeeeccc
Q 020132 190 IPVMRYDIPIVIRNIFNL 207 (330)
Q Consensus 190 ~~a~~~~i~v~i~~~~~~ 207 (330)
+.+.+.+++++|.|+..|
T Consensus 219 ~~~~~~~~~v~I~~g~~~ 236 (252)
T cd04249 219 DAAQSLRRGIDIASWQYP 236 (252)
T ss_pred HHHHhCCCeEEEEeCCCc
Confidence 666666789999987654
No 54
>PRK00942 acetylglutamate kinase; Provisional
Probab=99.72 E-value=5.1e-18 Score=159.75 Aligned_cols=156 Identities=19% Similarity=0.210 Sum_probs=122.4
Q ss_pred cchhHHHHHHHHHHhcCCccccccceeEEEECCCCC---------CC-CCCCchhhHHHHHHhhccCCCccEEEeeeeec
Q 020132 43 GELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSS---------NQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIAS 112 (330)
Q Consensus 43 GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~---------g~-~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~ 112 (330)
| +++. .+.+.|.++|++++++++.+..+++...+ |. ..++. +.++.+++ .|.|||+++ ++.
T Consensus 102 G-~l~~-~i~~~L~~~Gv~a~~l~~~~~~~~ta~~~~~~~~~~~~g~i~~i~~----~~l~~ll~--~g~vpVv~~-~~~ 172 (283)
T PRK00942 102 G-KVNK-ELVSLINKHGGKAVGLSGKDGGLITAKKLEEDEDLGFVGEVTPVNP----ALLEALLE--AGYIPVISP-IGV 172 (283)
T ss_pred C-chHH-HHHHHHHhCCCCccceeeccCCEEEEEECCCCCCCccccceEEECH----HHHHHHHH--CCCEEEEcC-cEE
Confidence 5 4454 45599999999999999998766654332 11 12333 88899998 789999997 588
Q ss_pred CCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcc--ccccccc--c
Q 020132 113 TPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG--ANVLHPR--T 188 (330)
Q Consensus 113 ~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g--~~v~~p~--a 188 (330)
+.+|++++++ +|.+|+.||.+|+|++++|||||+|||++ +++++++++++|+.+++..+ .++|.|+ +
T Consensus 173 ~~~g~~~~l~---~D~~A~~lA~~l~A~~li~~tdv~Gv~~~------~~~~i~~i~~~e~~~~~~~~~~tggm~~Kl~~ 243 (283)
T PRK00942 173 GEDGETYNIN---ADTAAGAIAAALGAEKLILLTDVPGVLDD------KGQLISELTASEAEELIEDGVITGGMIPKVEA 243 (283)
T ss_pred CCCCcEEEEC---HHHHHHHHHHHcCCCEEEEEECCcccccC------CCcccccCCHHHHHHHHHcCCCCCchHHHHHH
Confidence 9889988874 89999999999999999999999999986 37899999999999998754 3677774 4
Q ss_pred cceeeeccc-ceEEeeeccc----------cCceeEeeC
Q 020132 189 IIPVMRYDI-PIVIRNIFNL----------SVPGIMICR 216 (330)
Q Consensus 189 ~~~a~~~~i-~v~i~~~~~~----------~~~GT~I~~ 216 (330)
+..+.++|+ +++|.|+..+ +..||.|.+
T Consensus 244 a~~~~~~gv~~v~I~~g~~~~~ll~~~~~~~~~GT~i~~ 282 (283)
T PRK00942 244 ALDAARGGVRSVHIIDGRVPHALLLELFTDEGIGTMIVP 282 (283)
T ss_pred HHHHHHhCCCEEEEeCCCCCchHHHHHhcCCCcceEEec
Confidence 555556777 5999987544 346898865
No 55
>cd04238 AAK_NAGK-like AAK_NAGK-like: N-Acetyl-L-glutamate kinase (NAGK)-like . Included in this CD are the Escherichia coli and Pseudomonas aeruginosa type NAGKs which catalyze the phosphorylation of N-acetyl-L-glutamate (NAG) by ATP in the second step of arginine biosynthesis found in bacteria and photosynthetic organisms using either the acetylated, noncyclic (NC), or non-acetylated, cyclic (C) route of ornithine biosynthesis. Also included in this CD is a distinct group of uncharacterized (UC) bacterial and archeal NAGKs. Members of this CD belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.70 E-value=1.1e-17 Score=155.25 Aligned_cols=147 Identities=16% Similarity=0.205 Sum_probs=116.1
Q ss_pred cchhHHHHHHHHHHhcCCccccccceeEEEECCCCC----------CC-CCCCchhhHHHHHHhhccCCCccEEEeeeee
Q 020132 43 GELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSS----------NQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIA 111 (330)
Q Consensus 43 GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~----------g~-~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~ 111 (330)
| +++.. +++.|+++|++|+++++.+..+++..+. |. .+++. +.++.+++ .|.|||++| ++
T Consensus 77 g-~ln~~-i~~~L~~~Gv~a~~l~~~~~~~~~~~~~~~~~~~~~~~g~i~~i~~----~~l~~ll~--~g~ipVv~~-~~ 147 (256)
T cd04238 77 G-KVNKE-LVSLLNRAGGKAVGLSGKDGGLIKAEKKEEKDIDLGFVGEVTEVNP----ELLETLLE--AGYIPVIAP-IA 147 (256)
T ss_pred C-chHHH-HHHHHHhCCCCCCCcccccCCEEEEEECCCCCCCcccccceEEECH----HHHHHHHH--CCCEEEECC-cE
Confidence 6 45555 4999999999999999998755554321 22 23444 88888998 789999998 58
Q ss_pred cCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhc--cccccccc--
Q 020132 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYF--GANVLHPR-- 187 (330)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~--g~~v~~p~-- 187 (330)
.+..|++++++ +|.+|+.+|.+|+|++++|||||+|||++ +++++++++++|+.+++.. ..++|.|+
T Consensus 148 ~~~~g~~~~~~---~D~~A~~lA~~l~a~~li~ltdv~Gv~~~------~~~~i~~i~~~e~~~~~~~~~~~ggm~~Kl~ 218 (256)
T cd04238 148 VDEDGETYNVN---ADTAAGAIAAALKAEKLILLTDVPGVLDD------PGSLISELTPKEAEELIEDGVISGGMIPKVE 218 (256)
T ss_pred ECCCCcEEEEC---HHHHHHHHHHHcCCCEEEEEeCCccccCC------CCCccccCCHHHHHHHHHcCCCCCChHHHHH
Confidence 88889988874 89999999999999999999999999987 2689999999999998753 34778774
Q ss_pred ccceeeeccc-ceEEeeeccc
Q 020132 188 TIIPVMRYDI-PIVIRNIFNL 207 (330)
Q Consensus 188 a~~~a~~~~i-~v~i~~~~~~ 207 (330)
++..+.++++ +++|.|+..+
T Consensus 219 ~a~~~~~~g~~~v~I~~g~~~ 239 (256)
T cd04238 219 AALEALEGGVRKVHIIDGRVP 239 (256)
T ss_pred HHHHHHHhCCCEEEEeCCCCC
Confidence 4555556666 5999987654
No 56
>PLN02512 acetylglutamate kinase
Probab=99.69 E-value=4.1e-17 Score=155.44 Aligned_cols=155 Identities=17% Similarity=0.204 Sum_probs=121.1
Q ss_pred HHHHHHHHHhcCCccccccceeEEEECCCCC---------CC-CCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCC
Q 020132 48 AQMLAAVVRKNGIDCKWMDTREVLIVNPTSS---------NQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNI 117 (330)
Q Consensus 48 a~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~---------g~-~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~ 117 (330)
...+++.|.++|++++++++.+..+++..++ |. .+++. +.++.+++ .+.|||++|+ +.+..|+
T Consensus 129 n~~lv~~L~~~Gv~av~l~g~d~~~i~a~~~~~~~~~~~~G~i~~v~~----~~i~~lL~--~g~IPVi~~~-~~d~~g~ 201 (309)
T PLN02512 129 NKSLVSLINKAGGTAVGLSGKDGRLLRARPSPNSADLGFVGEVTRVDP----TVLRPLVD--DGHIPVIATV-AADEDGQ 201 (309)
T ss_pred HHHHHHHHHHcCCCeEEeehhhCCEEEEEEcCcCccccccceeeecCH----HHHHHHHh--CCCEEEEeCc-eECCCCC
Confidence 4558899999999999999987543432222 11 23444 88899998 8899999996 8888888
Q ss_pred cccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcc--ccccccc--ccceee
Q 020132 118 PTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG--ANVLHPR--TIIPVM 193 (330)
Q Consensus 118 ~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g--~~v~~p~--a~~~a~ 193 (330)
++++ ++|.+|+.||.+|+|++++|+|||+|||+++|. +++++++++++|+.++...| .++|.|+ ++..+.
T Consensus 202 ~~~i---~~D~~A~~lA~~L~Ad~li~lTdV~GV~~~~~~---~~~lI~~i~~~e~~~l~~~~~vtGGM~~Kl~aa~~a~ 275 (309)
T PLN02512 202 AYNI---NADTAAGEIAAALGAEKLILLTDVAGVLEDKDD---PGSLVKELDIKGVRKLIADGKIAGGMIPKVECCVRSL 275 (309)
T ss_pred Eecc---CHHHHHHHHHHHcCCCEEEEEeCCcceeCCCCC---CcCCCcccCHHHHHHHHhCCCCCCcHHHHHHHHHHHH
Confidence 8777 489999999999999999999999999998643 37899999999999987543 5789885 445556
Q ss_pred ecccc-eEEeeeccc----------cCceeEee
Q 020132 194 RYDIP-IVIRNIFNL----------SVPGIMIC 215 (330)
Q Consensus 194 ~~~i~-v~i~~~~~~----------~~~GT~I~ 215 (330)
++|++ ++|.++..+ +..||.|.
T Consensus 276 ~~Gv~~v~I~~g~~~~~ll~~l~~~~~~GT~I~ 308 (309)
T PLN02512 276 AQGVKTAHIIDGRVPHSLLLEILTDEGAGTMIT 308 (309)
T ss_pred HcCCCEEEEecCCCCChHHHHHhcCCCCeeEEe
Confidence 77885 899887544 23588775
No 57
>cd04251 AAK_NAGK-UC AAK_NAGK-UC: N-Acetyl-L-glutamate kinase - uncharacterized (NAGK-UC). This domain is similar to Escherichia coli and Pseudomonas aeruginosa NAGKs which catalyze the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of microbial arginine biosynthesis. These uncharacterized domain sequences are found in some bacteria (Deinococci and Chloroflexi) and archea and belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.68 E-value=1.8e-17 Score=154.09 Aligned_cols=153 Identities=14% Similarity=0.193 Sum_probs=118.4
Q ss_pred ceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCC-------------------CCC-CCCCchhhHHHHHHhh
Q 020132 37 DFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTS-------------------SNQ-VDPDFSESEKRLEKWF 96 (330)
Q Consensus 37 ~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~-------------------~g~-~~~~~~~~~~~i~~~l 96 (330)
+.+....+.++..+ .+.|.++|++|+++++.+..+++.+. .|. ..++. +.++.++
T Consensus 68 ~~~~~a~~~ln~~i-v~~L~~~Gi~a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~G~v~~v~~----~~i~~ll 142 (257)
T cd04251 68 EVFVMVMGLINKKI-VARLHSLGVKAVGLTGLDGRLLEAKRKEIVRVNERGRKMIIRGGYTGKVEKVNS----DLIEALL 142 (257)
T ss_pred HHHHHHHHHHHHHH-HHHHHhCCCCceecccccCCEEEEEEeecccccccCcccccCCcceEEEEEEcH----HHHHHHH
Confidence 33343347777775 55999999999999998864332111 111 12344 8889999
Q ss_pred ccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhh
Q 020132 97 SQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEM 176 (330)
Q Consensus 97 ~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l 176 (330)
+ .+.|||++++ +.+.+|+++++ ++|++|+.+|.+|+|++++|||||+|||++ ++++++++++|+.++
T Consensus 143 ~--~g~vpVi~~~-~~~~~G~~~~i---~~D~~A~~lA~~L~A~~li~~tdv~Gv~~~-------~~~i~~i~~~e~~~l 209 (257)
T cd04251 143 D--AGYLPVVSPV-AYSEEGEPLNV---DGDRAAAAIAAALKAERLILLTDVEGLYLD-------GRVIERITVSDAESL 209 (257)
T ss_pred h--CCCeEEEeCc-EECCCCcEEec---CHHHHHHHHHHHcCCCEEEEEeCChhheeC-------CcccCccCHHHHHHH
Confidence 8 8899999887 66788988887 489999999999999999999999999963 679999999999999
Q ss_pred hhccccccccc--ccceeeeccc-ceEEeeeccc
Q 020132 177 SYFGANVLHPR--TIIPVMRYDI-PIVIRNIFNL 207 (330)
Q Consensus 177 ~~~g~~v~~p~--a~~~a~~~~i-~v~i~~~~~~ 207 (330)
...-.++|.|+ ++..+.++|+ .++|.++..|
T Consensus 210 ~~~~~ggm~~Kl~aa~~a~~~gv~~v~i~~g~~~ 243 (257)
T cd04251 210 LEKAGGGMKRKLLAAAEAVEGGVREVVIGDARAD 243 (257)
T ss_pred HhhCCCchHHHHHHHHHHHHcCCCEEEEecCCCc
Confidence 76556788884 6666677888 4888887655
No 58
>CHL00202 argB acetylglutamate kinase; Provisional
Probab=99.68 E-value=7.2e-17 Score=152.07 Aligned_cols=156 Identities=17% Similarity=0.253 Sum_probs=123.2
Q ss_pred cchhHHHHHHHHHHhcCCccccccceeEEEECCCC-----C---CC-CCCCchhhHHHHHHhhccCCCccEEEeeeeecC
Q 020132 43 GELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTS-----S---NQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIAST 113 (330)
Q Consensus 43 GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~-----~---g~-~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~ 113 (330)
|+. ...+++.|.+.|++|+++++.+..+++..+ + |. .+++. +.++.+++ .|.|||++|+ +.+
T Consensus 102 g~l--n~~lv~~L~~~Gv~av~l~~~d~~~i~a~~~~~~d~~~~G~i~~v~~----~~i~~ll~--~g~iPVi~~~-~~~ 172 (284)
T CHL00202 102 GKV--NKDLVGSINANGGKAVGLCGKDANLIVARASDKKDLGLVGEIQQVDP----QLIDMLLE--KNYIPVIASV-AAD 172 (284)
T ss_pred hHH--HHHHHHHHHhCCCCeeeeeeccCCEEEEEeCCCcccccceeEEecCH----HHHHHHHH--CCCEEEECCC-ccC
Confidence 444 677889999999999999999865443211 1 22 23555 88999998 7899999995 888
Q ss_pred CCCCcccccccCcchhHHHHHHHHhhceeEEEeeccccccc--CccchhHhhhhhhhhhHHhhhhhhcc--ccccccc--
Q 020132 114 PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSA--DPRKVSEAVILRTLSYQEAWEMSYFG--ANVLHPR-- 187 (330)
Q Consensus 114 ~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~--dP~~~~~a~~i~~is~~e~~~l~~~g--~~v~~p~-- 187 (330)
..|++++++ +|.+|+.+|.+|+|++++|+|||+|||++ ||. +++++++++|+.+++..| .++|.|+
T Consensus 173 ~~g~~~ni~---~D~~A~~lA~~l~Ad~li~lTdv~Gv~~~~~d~~-----~~i~~i~~~e~~~l~~~g~~tGGM~~Kl~ 244 (284)
T CHL00202 173 HDGQTYNIN---ADVVAGEIAAKLNAEKLILLTDTPGILADINDPN-----SLISTLNIKEARNLASTGIISGGMIPKVN 244 (284)
T ss_pred CCCcEEecC---HHHHHHHHHHHhCCCEEEEEeCChhhcCCCCCCC-----CccccccHHHHHHHHhcCCCCCCHHHHHH
Confidence 889888874 89999999999999999999999999984 333 799999999999998654 4789885
Q ss_pred ccceeeecccc-eEEeeecccc----------CceeEee
Q 020132 188 TIIPVMRYDIP-IVIRNIFNLS----------VPGIMIC 215 (330)
Q Consensus 188 a~~~a~~~~i~-v~i~~~~~~~----------~~GT~I~ 215 (330)
++..|.++|++ ++|.++..++ ..||.|.
T Consensus 245 aa~~a~~~Gv~~v~I~~g~~~~~ll~el~~~~g~GT~i~ 283 (284)
T CHL00202 245 CCIRALAQGVEAAHIIDGKEKHALLLEILTEKGIGSMLV 283 (284)
T ss_pred HHHHHHHcCCCEEEEeCCCCCChHHHHHhcCCCCceEEe
Confidence 55666678886 7898876553 3588774
No 59
>cd04255 AAK_UMPK-MosAB AAK_UMPK-MosAB: This CD includes the alpha and beta subunits of the Mo storage protein (MosA and MosB) which are related to uridine monophosphate kinase (UMPK) enzymes that catalyze the phosphorylation of UMP by ATP, yielding UDP, and playing a key role in pyrimidine nucleotide biosynthesis. The Mo storage protein from the nitrogen-fixing bacterium, Azotobacter vinelandii, is characterized as an alpha4-beta4 octamer containing a polynuclear molybdenum-oxide cluster which is ATP-dependent to bind Mo and pH-dependent to release Mo. These and related bacterial sequences in this CD are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.66 E-value=6.9e-17 Score=150.32 Aligned_cols=182 Identities=14% Similarity=0.156 Sum_probs=119.5
Q ss_pred HHHHHhhhcccccCCCCCccccccceeeeccchhHHHHHHHHHHhcCCcccccc------cee-EEEECC--CCCCCCCC
Q 020132 13 YEFIRSTYNFLSNVDSGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMD------TRE-VLIVNP--TSSNQVDP 83 (330)
Q Consensus 13 ~~~i~~~~~~l~~~~~~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~------~~~-~~~~~~--~~~g~~~~ 83 (330)
.+.|+.+.+.|+++.+ ..+.++.+|+--+++....+....|++....+ ... .++... ..+|...+
T Consensus 47 ~~~i~~la~~i~~~~~------~~~vilV~GGG~~~r~~~~~~~~~g~~~~~~~~~~~aa~~ln~lv~~~~l~~~g~~~i 120 (262)
T cd04255 47 AEAVLPLVEEIVALRP------EHKLLILTGGGTRARHVYSIGLDLGMPTGVLAKLGASVSEQNAEMLATLLAKHGGSKV 120 (262)
T ss_pred HHHHHHHHHHHHHHhC------CCcEEEEECCHHHHHHHHHHHHHcCCCchHHHHHHHHHHHHHHHHHHHHHHHcCCCcc
Confidence 4567777777777654 14566777777677643444446676654443 111 001111 11222212
Q ss_pred CchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccC------cchhHHHHHHHHhhceeEEEeecccccccCcc
Q 020132 84 DFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG------SDFSAAIMGALLRAHQVTIWTDVDGVYSADPR 157 (330)
Q Consensus 84 ~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrgg------sD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~ 157 (330)
.. .....++++++ .|.|||++|+.+.+ ..++++|+| +|++|+++|.+++|+.++++|||||||++||+
T Consensus 121 ~~-~~~~~l~~lL~--~g~vPVi~g~~~~~---~~~i~~~~g~~~~~~~D~~Aa~lA~~l~ad~li~~TdVdGVy~~dP~ 194 (262)
T cd04255 121 GH-GDLLQLPTFLK--AGRAPVISGMPPYG---LWEHPAEEGRIPPHRTDVGAFLLAEVIGARNLIFVKDEDGLYTADPK 194 (262)
T ss_pred cc-ccHHHHHHHHH--CCCeEEEeCCcCCC---eeeecCCCccCCCCCcHHHHHHHHHHhCCCEEEEEeccCeeECCCCC
Confidence 11 11256888888 89999999996533 223334443 89999999999999999999999999999999
Q ss_pred chhHhhhhhhhhhHHhhhhhhcccccccccccceeeec--ccceEEeeeccc
Q 020132 158 KVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRY--DIPIVIRNIFNL 207 (330)
Q Consensus 158 ~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~~~--~i~v~i~~~~~~ 207 (330)
.+|+++++++++++++.++.. +..+|...+...+..+ .++++|.|+..|
T Consensus 195 ~~~~a~~i~~i~~~~~~~~~~-~~~~~~~~~~~~l~aa~~~~~v~I~~g~~~ 245 (262)
T cd04255 195 KNKKAEFIPEISAAELLKKDL-DDLVLERPVLDLLQNARHVKEVQIVNGLVP 245 (262)
T ss_pred CCCCCeEccEeCHHHHHHHhc-CCCCCcHHHHHHHHHhCCCCcEEEEeCCCC
Confidence 999999999999988877641 2234655444444422 258999998755
No 60
>cd04256 AAK_P5CS_ProBA AAK_P5CS_ProBA: Glutamate-5-kinase (G5K) domain of the bifunctional delta 1-pyrroline-5-carboxylate synthetase (P5CS), composed of an N-terminal G5K (ProB) and a C-terminal glutamyl 5- phosphate reductase (G5PR, ProA), the first and second enzyme catalyzing proline (and, in mammals, ornithine) biosynthesis. G5K transfers the terminal phosphoryl group of ATP to the gamma-carboxyl group of glutamate, and is subject to feedback allosteric inhibition by proline or ornithine. In plants, proline plays an important role as an osmoprotectant and, in mammals, ornithine biosynthesis is crucial for proper ammonia detoxification, since a G5K mutation has been shown to cause human hyperammonaemia.
Probab=99.65 E-value=1.3e-16 Score=150.22 Aligned_cols=167 Identities=18% Similarity=0.222 Sum_probs=122.7
Q ss_pred ceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEee-eeecCC-
Q 020132 37 DFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATG-FIASTP- 114 (330)
Q Consensus 37 ~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G-~i~~~~- 114 (330)
-.+.+.|+..-..++...|..+|+++ .++++ +.+.+.+.+ .+....+.++.+++ .|.|||+.| +...+.
T Consensus 95 qa~aa~gq~~L~~~y~~~f~~~~~~~-----~q~ll-t~~d~~~~~-~~~~~~~~l~~lL~--~g~iPVi~~nD~v~~~~ 165 (284)
T cd04256 95 RACAAVGQSGLMALYEAMFTQYGITV-----AQVLV-TKPDFYDEQ-TRRNLNGTLEELLR--LNIIPIINTNDAVSPPP 165 (284)
T ss_pred HHHHHcccHHHHHHHHHHHHHcCCcH-----HHeee-eccccccHH-HHHHHHHHHHHHHH--CCCEEEEeCCCcccccc
Confidence 34667888888888888898888875 56544 544444322 12234577888887 889999996 332221
Q ss_pred ----CCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhh-----ccccccc
Q 020132 115 ----DNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSY-----FGANVLH 185 (330)
Q Consensus 115 ----~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~-----~g~~v~~ 185 (330)
+|+..+ ..+++|.+|+++|.+++|+.++++|||||||++||+ .|+++++++++..+..++.. .|.++|.
T Consensus 166 ~~~~~~~~~~-~i~d~D~lAa~lA~~l~Ad~Li~lTDVdGVy~~dP~-~~~a~~I~~i~~~~~~~~~~~~~s~~gtGGM~ 243 (284)
T cd04256 166 EPDEDLQGVI-SIKDNDSLAARLAVELKADLLILLSDVDGLYDGPPG-SDDAKLIHTFYPGDQQSITFGTKSRVGTGGME 243 (284)
T ss_pred cccccccccc-cccChHHHHHHHHHHcCCCEEEEEeCCCeeecCCCC-CCCCeEcccccHhHHHHhhcccccCcccCCcH
Confidence 122211 124689999999999999999999999999999997 58999999999877665532 3578999
Q ss_pred cc--ccceeeecccceEEeeeccc---------cCceeEe
Q 020132 186 PR--TIIPVMRYDIPIVIRNIFNL---------SVPGIMI 214 (330)
Q Consensus 186 p~--a~~~a~~~~i~v~i~~~~~~---------~~~GT~I 214 (330)
|+ ++..|.++|++++|.|+..| +..||+|
T Consensus 244 ~Kl~Aa~~a~~~Gi~v~I~~G~~~~~i~~~l~G~~~GT~~ 283 (284)
T cd04256 244 AKVKAALWALQGGTSVVITNGMAGDVITKILEGKKVGTFF 283 (284)
T ss_pred HHHHHHHHHHHCCCeEEEEcCCCccHHHHHHcCCCCCEEe
Confidence 84 88888899999999998655 2457776
No 61
>PTZ00489 glutamate 5-kinase; Provisional
Probab=99.65 E-value=3.1e-16 Score=145.97 Aligned_cols=164 Identities=18% Similarity=0.235 Sum_probs=116.8
Q ss_pred eccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCccc
Q 020132 41 GHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTT 120 (330)
Q Consensus 41 ~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~ 120 (330)
+.|...-..++...|.++|+++. ++.++ ...+. ....+....+.++++++ .|.|||+.|. ......+..
T Consensus 77 aiGq~~L~~~y~~~f~~~~~~~a-----qiLlt-~~d~~-~~~~~~n~~~~l~~lL~--~g~VPIinen-d~~~~~e~~- 145 (264)
T PTZ00489 77 SMGQPLLMHMYYTELQKHGILCA-----QMLLA-AYDLD-SRKRTINAHNTIEVLIS--HKVIPIINEN-DATALHELV- 145 (264)
T ss_pred HhCHHHHHHHHHHHHHhCCCeEE-----Eeeee-ccccc-cchhhHHHHHHHHHHHH--CCCEEEECCC-CCcccceeE-
Confidence 34443444557788888998873 33322 22221 12234456788999998 7999999883 111112322
Q ss_pred ccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhh---hhhhhhHHhhhhh----hcccccccc--cccce
Q 020132 121 LKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVI---LRTLSYQEAWEMS----YFGANVLHP--RTIIP 191 (330)
Q Consensus 121 lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~---i~~is~~e~~~l~----~~g~~v~~p--~a~~~ 191 (330)
.|++|.+|+++|..++|+.++++|||||||++||+.+|+|++ ++++++++..... ..+.++|.+ .++..
T Consensus 146 --~gdnD~lAa~lA~~l~Ad~LiilTDVdGVy~~dP~~~~~A~~~~~i~~i~~~~~~~~~~~~~~~~tGGM~~Kl~aa~~ 223 (264)
T PTZ00489 146 --FGDNDRLSALVAHHFKADLLVILSDIDGYYTENPRTSTDAKIRSVVHELSPDDLVAEATPNNRFATGGIVTKLQAAQF 223 (264)
T ss_pred --eCChHHHHHHHHHHhCCCEEEEeeccCeeEcCCCCCCCccceeeeeccCCHHHHHHhcCcCCCcccCChHHHHHHHHH
Confidence 356899999999999999999999999999999999999998 7788877664332 245688988 48888
Q ss_pred eeecccceEEeeecccc-----------CceeEeeCC
Q 020132 192 VMRYDIPIVIRNIFNLS-----------VPGIMICRP 217 (330)
Q Consensus 192 a~~~~i~v~i~~~~~~~-----------~~GT~I~~~ 217 (330)
|.++|++++|.|+..|+ ..||+|.+.
T Consensus 224 a~~~Gi~v~I~~g~~~~~i~~~l~g~~~~~GT~~~~~ 260 (264)
T PTZ00489 224 LLERGGKMYLSSGFHLEKARDFLIGGSHEIGTLFYPR 260 (264)
T ss_pred HHHCCCCEEEEeCCCchHHHHHHcCCCCCCceEEeec
Confidence 88999999999986442 258988653
No 62
>PLN02418 delta-1-pyrroline-5-carboxylate synthase
Probab=99.64 E-value=1.8e-16 Score=166.11 Aligned_cols=168 Identities=15% Similarity=0.226 Sum_probs=125.5
Q ss_pred eeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeee-eecCCCC
Q 020132 38 FVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGF-IASTPDN 116 (330)
Q Consensus 38 ~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~-i~~~~~g 116 (330)
.++|+||.++.+++...|++.|+ ++.+++ .+++.+++.+. +....+.++.+++ .|.|||+.|. ...+..+
T Consensus 95 a~aa~Gq~~l~~~~~~~f~~~g~-----~~~qil-lT~~~~~~~~~-~~~~~~~l~~ll~--~g~iPVv~~nd~v~~~~~ 165 (718)
T PLN02418 95 ACAAVGQSELMALYDTLFSQLDV-----TASQLL-VTDSDFRDPDF-RKQLSETVESLLD--LRVIPIFNENDAVSTRRA 165 (718)
T ss_pred HHHHhhHHHHHHHHHHHHHHcCC-----eEEEEE-ecHhHhcchhH-hHhHHHHHHHHHH--CCCEEEEcCCCCcccccc
Confidence 67999999999999999999999 456664 45454543221 2334578888888 7899999773 2111111
Q ss_pred C----cccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhh-hhh-----cccccccc
Q 020132 117 I----PTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWE-MSY-----FGANVLHP 186 (330)
Q Consensus 117 ~----~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~-l~~-----~g~~v~~p 186 (330)
. ...+ +++|++|+++|.+++|+.++|+|||||||++||+ .++++++++++..+... +.. .+.++|.|
T Consensus 166 ~~~~~~~~~--~d~D~~A~~lA~~l~Ad~li~~TdVdGvy~~~p~-~~~a~~i~~i~~~~~~~~i~~~~~s~~~tGGM~~ 242 (718)
T PLN02418 166 PYEDSSGIF--WDNDSLAALLALELKADLLILLSDVEGLYTGPPS-DPSSKLIHTYIKEKHQDEITFGEKSRVGRGGMTA 242 (718)
T ss_pred ccccccCee--cCcHHHHHHHHHHcCCCEEEEeecCCeeecCCCC-CCCceEcceecccchhhhhhcccccccCCCCcHH
Confidence 0 0112 3689999999999999999999999999999998 48999999997655432 221 35689999
Q ss_pred --cccceeeecccceEEeeeccc---------cCceeEeeCC
Q 020132 187 --RTIIPVMRYDIPIVIRNIFNL---------SVPGIMICRP 217 (330)
Q Consensus 187 --~a~~~a~~~~i~v~i~~~~~~---------~~~GT~I~~~ 217 (330)
.++..|.++|++++|.|+..+ +..||+|.+.
T Consensus 243 Kl~Aa~~a~~~Gi~v~I~~g~~~~~l~~~l~g~~~GT~i~~~ 284 (718)
T PLN02418 243 KVKAAVNAASAGIPVVITSGYALDNIRKVLRGERVGTLFHQD 284 (718)
T ss_pred HHHHHHHHHHCCCcEEEeCCCCcchHHHHhcCCCCceEeccc
Confidence 588888899999999998654 2469999764
No 63
>COG0263 ProB Glutamate 5-kinase [Amino acid transport and metabolism]
Probab=99.63 E-value=4.1e-16 Score=147.35 Aligned_cols=167 Identities=17% Similarity=0.291 Sum_probs=132.9
Q ss_pred ceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCC
Q 020132 37 DFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDN 116 (330)
Q Consensus 37 ~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g 116 (330)
-.+.|.|...-...+...|..+|+++ .++.+ |.+.+.+ +-.|...+..+..+++ .|.|||+ |+|.
T Consensus 75 QA~AAVGQ~~Lm~~y~~~f~~~g~~v-----~QiLL-Tr~D~~~-r~ry~Nar~Tl~~Ll~--~gvVPII------NEND 139 (369)
T COG0263 75 QAAAAVGQVRLMQLYEELFARYGIKV-----GQILL-TRDDFSD-RRRYLNARNTLSALLE--LGVVPII------NEND 139 (369)
T ss_pred HHHHHhCHHHHHHHHHHHHHhcCCee-----eEEEe-ehhhhhh-HHHHHHHHHHHHHHHH--CCceeee------cCCC
Confidence 34677888888889999999999975 55554 4333322 1234556788888898 8999997 5665
Q ss_pred Cccc--ccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhh--HHhhhhhh-----ccccccccc
Q 020132 117 IPTT--LKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY--QEAWEMSY-----FGANVLHPR 187 (330)
Q Consensus 117 ~~~~--lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~--~e~~~l~~-----~g~~v~~p~ 187 (330)
-+.+ +-+|++|.+++++|...+||.|+++||+||+||+||+.+|+|+++++++- .|...++. +|.++|..+
T Consensus 140 tva~~EikfGDND~LsA~VA~lv~ADlLvlLsDiDGLyd~nPr~~pdAk~i~~V~~it~ei~~~aggsgs~~GTGGM~TK 219 (369)
T COG0263 140 TVATEEIKFGDNDTLSALVAILVGADLLVLLSDIDGLYDANPRTNPDAKLIPEVEEITPEIEAMAGGSGSELGTGGMRTK 219 (369)
T ss_pred ceeeeeeeecCCchHHHHHHHHhCCCEEEEEEccCcccCCCCCCCCCCeeehhhcccCHHHHHHhcCCCCCCCcccHHHH
Confidence 5444 45678899999999999999999999999999999999999999999873 46666664 677899984
Q ss_pred --ccceeeecccceEEeeecccc---------CceeEeeCCC
Q 020132 188 --TIIPVMRYDIPIVIRNIFNLS---------VPGIMICRPP 218 (330)
Q Consensus 188 --a~~~a~~~~i~v~i~~~~~~~---------~~GT~I~~~~ 218 (330)
|++.|.++|+++.|.++..|. ..||++.+..
T Consensus 220 l~AA~iA~~aG~~~iI~~g~~~~~i~~~~~~~~~GT~F~~~~ 261 (369)
T COG0263 220 LEAAKIATRAGVPVIIASGSKPDVILDALEGEAVGTLFEPQA 261 (369)
T ss_pred HHHHHHHHHcCCcEEEecCCCcchHHHHHhCCCCccEEecCC
Confidence 899999999999999998763 4699998653
No 64
>COG1608 Predicted archaeal kinase [General function prediction only]
Probab=99.59 E-value=2.6e-15 Score=135.18 Aligned_cols=155 Identities=18% Similarity=0.160 Sum_probs=115.8
Q ss_pred HHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhh-HHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCc
Q 020132 48 AQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSES-EKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGS 126 (330)
Q Consensus 48 a~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~-~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggs 126 (330)
+..++..|.+.|++++...|.++. +.++++ .+ + -+.++.+++ .+.|||++|++..+.++...+++ +
T Consensus 83 ~~~V~~~l~~~Gv~av~~~P~s~~-~~~gr~-----~~--~~l~~i~~~l~--~gfvPvl~GDVv~d~~~g~~IiS---G 149 (252)
T COG1608 83 NSIVVDALLDAGVRAVSVVPISFS-TFNGRI-----LY--TYLEAIKDALE--KGFVPVLYGDVVPDDDNGYEIIS---G 149 (252)
T ss_pred HHHHHHHHHhcCCccccccCccee-ecCCce-----ee--chHHHHHHHHH--cCCEeeeecceEEcCCCceEEEe---c
Confidence 446788999999999999999886 334432 22 2 377888888 89999999999999874445554 4
Q ss_pred chhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhh--cccccccc--cccceeeecccceEEe
Q 020132 127 DFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSY--FGANVLHP--RTIIPVMRYDIPIVIR 202 (330)
Q Consensus 127 D~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~--~g~~v~~p--~a~~~a~~~~i~v~i~ 202 (330)
|..+.+||+.|++++++|+|||||||+.||.++|+++.++++....+..=.. .=.++|-- +++..+.+++.+++++
T Consensus 150 DdIv~~LA~~l~pd~v~f~tdVdGVy~~~p~~~p~~~~l~~i~~~~~~~gs~~~DVTGGi~~Kl~~~~~~~~~~~~vyi~ 229 (252)
T COG1608 150 DDIVLHLAKELKPDRVIFLTDVDGVYDRDPGKVPDARLLSEIEGRVALGGSGGTDVTGGIAKKLEALLEIARYGKEVYIF 229 (252)
T ss_pred cHHHHHHHHHhCCCEEEEEecCCceecCCCCcCccccchhhhhhhhhhcCcCcccchhhHHHHHHHHHHHHhcCceEEEE
Confidence 9999999999999999999999999999999999999998877653322111 00234543 3444445566779999
Q ss_pred eeccc---------cCceeEee
Q 020132 203 NIFNL---------SVPGIMIC 215 (330)
Q Consensus 203 ~~~~~---------~~~GT~I~ 215 (330)
|+..| +..||+|.
T Consensus 230 ng~~~~ni~~~l~G~~vGT~I~ 251 (252)
T COG1608 230 NGNKPENIYRALRGENVGTRID 251 (252)
T ss_pred CCCCHHHHHHHhcCCCCceEec
Confidence 98654 46789884
No 65
>COG0548 ArgB Acetylglutamate kinase [Amino acid transport and metabolism]
Probab=99.55 E-value=6.9e-15 Score=135.75 Aligned_cols=150 Identities=17% Similarity=0.201 Sum_probs=122.8
Q ss_pred ccchhHHHHHHHHHHhcCCccccccceeEEEECCCC--------CC---C-CCCCchhhHHHHHHhhccCCCccEEEeee
Q 020132 42 HGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTS--------SN---Q-VDPDFSESEKRLEKWFSQSPSNTIIATGF 109 (330)
Q Consensus 42 ~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~--------~g---~-~~~~~~~~~~~i~~~l~~~~~~VpVv~G~ 109 (330)
.|.. .+-+++.|...|..|+++++.+-.+++..+ +| + ..+|. +.++.+++ ++.|||+++.
T Consensus 80 ~G~v--Nk~iva~l~~~g~~avGlsg~Dg~li~A~~~~~~~~id~g~vG~i~~Vn~----~~i~~ll~--~~~IpViapi 151 (265)
T COG0548 80 GGTV--NKEIVARLSKHGGQAVGLSGVDGNLVTAKKLDVDDGVDLGYVGEIRKVNP----ELIERLLD--NGAIPVIAPI 151 (265)
T ss_pred HHHH--HHHHHHHHHHhCCcceeeeecCCCEEEEEEcccccccccceeeeEEEECH----HHHHHHHh--CCCceEEecc
Confidence 4455 678899999999999999998844442221 22 1 23444 78888888 8899999996
Q ss_pred eecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcc--cccccc-
Q 020132 110 IASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG--ANVLHP- 186 (330)
Q Consensus 110 i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g--~~v~~p- 186 (330)
+.+.+|++.++. +|++|+.+|.+|+|++++++|||+||++..|. + +++++++.+|+.++...| ..+|.|
T Consensus 152 -a~~~~G~~~Nvn---aD~~A~~iA~aLkAekLi~ltdv~Gvl~~~~~--~--s~i~~~~~~~~~~li~~~~i~~GMi~K 223 (265)
T COG0548 152 -AVDEDGETLNVN---ADTAAGALAAALKAEKLILLTDVPGVLDDKGD--P--SLISELDAEEAEELIEQGIITGGMIPK 223 (265)
T ss_pred -eECCCCcEEeeC---HHHHHHHHHHHcCCCeEEEEeCCcccccCCCC--c--eeeccCCHHHHHHHHhcCCccCccHHH
Confidence 889999999984 89999999999999999999999999998755 2 689999999999999887 579999
Q ss_pred -cccceeeecccc-eEEeeeccc
Q 020132 187 -RTIIPVMRYDIP-IVIRNIFNL 207 (330)
Q Consensus 187 -~a~~~a~~~~i~-v~i~~~~~~ 207 (330)
+++..|.+.|++ ++|.|+..+
T Consensus 224 v~~a~~A~~~Gv~~v~ii~g~~~ 246 (265)
T COG0548 224 VEAALEALESGVRRVHIISGRVP 246 (265)
T ss_pred HHHHHHHHHhCCCeEEEecCCCc
Confidence 477778889995 999998654
No 66
>cd04915 ACT_AK-Ectoine_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinas
Probab=99.49 E-value=4.6e-14 Score=104.29 Aligned_cols=64 Identities=23% Similarity=0.363 Sum_probs=62.1
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
+++|+++|.+|. ++|+.+++|++|++.||++.|++|++|+++|||+|+++|.+++++.||+.|+
T Consensus 2 ~a~VsvVG~gm~-~~gv~~ki~~~L~~~~I~v~~i~~~~s~~~is~~V~~~~~~~av~~Lh~~f~ 65 (66)
T cd04915 2 VAIVSVIGRDLS-TPGVLARGLAALAEAGIEPIAAHQSMRNVDVQFVVDRDDYDNAIKALHAALV 65 (66)
T ss_pred EEEEEEECCCCC-cchHHHHHHHHHHHCCCCEEEEEecCCeeEEEEEEEHHHHHHHHHHHHHHHh
Confidence 689999999995 8999999999999999999999999999999999999999999999999987
No 67
>cd04236 AAK_NAGS-Urea AAK_NAGS-Urea: N-acetylglutamate (NAG) kinase-like domain of the NAG Synthase (NAGS) of the urea cycle found in animals. Ureogenic NAGS is a mitochondrial enzyme catalyzing the formation of NAG from acetylcoenzyme A and L-glutamate; NAG is an essential allosteric activator of carbamylphosphate synthase I, the first and rate limiting enzyme of the urea cycle. Ureogenic NAGS activity is dependent on the concentration of glutamate (substrate) and arginine (activator). Domain architecture of ureogenic NAGS consists of an N-terminal NAG kinase-like (ArgB) domain (this CD) and a C-terminal DUF619 domain. Members of this CD belong to the protein superfamily, the Amino Acid Kinase Family (AAKF).
Probab=99.48 E-value=8.2e-14 Score=130.03 Aligned_cols=140 Identities=14% Similarity=0.130 Sum_probs=113.5
Q ss_pred HHHHHHHHHhcCCccccccceeEEEE-----CCCCCCC-CCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccc
Q 020132 48 AQMLAAVVRKNGIDCKWMDTREVLIV-----NPTSSNQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTL 121 (330)
Q Consensus 48 a~~~~~~L~~~Gi~a~~l~~~~~~~~-----~~~~~g~-~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~l 121 (330)
...+++.|++.|++|+++.+.+.++. +.+.-|. .++|. +.++.+++ .|.|||+++ ++.+.+|++.++
T Consensus 100 n~~Lv~~L~~~G~~A~gl~g~~~~i~a~~~~d~g~vG~V~~Vd~----~~I~~lL~--~g~IPVisp-lg~~~~G~~~Ni 172 (271)
T cd04236 100 CKTLVEALQANSAAAHPLFSGESVLQAEEPEPGASKGPSVSVDT----ELLQWCLG--SGHIPLVCP-IGETSSGRSVSL 172 (271)
T ss_pred HHHHHHHHHhCCCCeeeecCccceEEEEEcccCCccceEEEECH----HHHHHHHh--CCCeEEECC-ceECCCCCEEEE
Confidence 55688999999999999998753332 1112233 34666 88999998 899999999 489999999998
Q ss_pred cccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhh-HHhhhhhhcc--cccc---cc--cccceee
Q 020132 122 KRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY-QEAWEMSYFG--ANVL---HP--RTIIPVM 193 (330)
Q Consensus 122 grggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~-~e~~~l~~~g--~~v~---~p--~a~~~a~ 193 (330)
+ +|..|+.+|.+|+|++++|+||++||++.+ .+++++++. +|+.+|...| .++| .| +++..++
T Consensus 173 N---aD~~A~~lA~aL~A~KLIfltd~~GV~~~~------g~lI~~l~~~~e~~~li~~g~i~gGm~~ki~ki~~~l~~l 243 (271)
T cd04236 173 D---SSEVTTAIAKALQPIKVIFLNRSGGLRDQK------HKVLPQVHLPADLPSLSDAEWLSETEQNRIQDIATLLNAL 243 (271)
T ss_pred C---HHHHHHHHHHHcCCCEEEEEeCCcceECCC------CCCccccCcHHHHHHHHhCCEEcCCeeechHHHHHHHHhc
Confidence 4 899999999999999999999999999742 578999995 9999999887 3788 55 3566677
Q ss_pred ecccceEEee
Q 020132 194 RYDIPIVIRN 203 (330)
Q Consensus 194 ~~~i~v~i~~ 203 (330)
..+++++|.+
T Consensus 244 ~~g~sv~I~~ 253 (271)
T cd04236 244 PSMSSAVITS 253 (271)
T ss_pred ccCCeEEEeC
Confidence 8899988887
No 68
>TIGR01092 P5CS delta l-pyrroline-5-carboxylate synthetase. This protein contains a glutamate 5-kinase (ProB, EC 2.7.2.11) region followed by a gamma-glutamyl phosphate reductase (ProA, EC 1.2.1.41) region.
Probab=99.45 E-value=5.8e-14 Score=147.38 Aligned_cols=144 Identities=13% Similarity=0.197 Sum_probs=105.1
Q ss_pred ccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccc---------cCcchhHHHH
Q 020132 63 KWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKR---------DGSDFSAAIM 133 (330)
Q Consensus 63 ~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgr---------ggsD~~A~~l 133 (330)
..+.+.++++ +++.+.+.+. +....+.++.+++ .|.|||+.| ++.+++.++ +++|++|+++
T Consensus 107 ~~i~~aQ~Ll-t~~d~~~~~~-~~~~~~~l~~lL~--~g~iPVin~------nD~V~~~~~~~~~~~g~~~d~D~lAa~l 176 (715)
T TIGR01092 107 LDITAAQILV-TDLDFRDEQF-RRQLNETVHELLR--MNVVPVVNE------NDAVSTRAAPYSDSQGIFWDNDSLAALL 176 (715)
T ss_pred cCCeeEEEEe-chhhcccHHH-HHHHHHHHHHHHH--CCCEEEEcC------CCcccccccccccccceecchHHHHHHH
Confidence 3666688754 5444432111 2234578888888 789999975 122333332 3479999999
Q ss_pred HHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhh-hhhh-----cccccccc--cccceeeecccceEEeeec
Q 020132 134 GALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAW-EMSY-----FGANVLHP--RTIIPVMRYDIPIVIRNIF 205 (330)
Q Consensus 134 A~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~-~l~~-----~g~~v~~p--~a~~~a~~~~i~v~i~~~~ 205 (330)
|.+++|+.++++|||||||++||+ .|+++++++++..+.. ++.. .+.++|.+ +++..|.++|++++|.|+.
T Consensus 177 A~~l~Ad~LiilTDVdGVy~~dP~-~~~a~~I~~i~~~~~~~~i~~~~~~~~~tGGM~~Kl~aa~~a~~~gi~v~I~~g~ 255 (715)
T TIGR01092 177 ALELKADLLILLSDVEGLYDGPPS-DDDSKLIDTFYKEKHQGEITFGTKSRLGRGGMTAKVKAAVWAAYGGTPVIIASGT 255 (715)
T ss_pred HHHcCCCEEEEEeCCCeeeCCCCC-CCCCeEeeeecccchhhhhccCcccccCCCCchHHHHHHHHHHHCCCeEEEeCCC
Confidence 999999999999999999999997 5899999999875444 3322 34678988 5788888999999999986
Q ss_pred cc---------cCceeEeeCC
Q 020132 206 NL---------SVPGIMICRP 217 (330)
Q Consensus 206 ~~---------~~~GT~I~~~ 217 (330)
.+ +..||+|.+.
T Consensus 256 ~~~~l~~~l~g~~~GT~~~~~ 276 (715)
T TIGR01092 256 APKNITKVVEGKKVGTLFHED 276 (715)
T ss_pred CcchHHHHhcCCCCceEeccc
Confidence 54 2469999664
No 69
>cd04918 ACT_AK1-AT_2 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the second of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine (SAM). This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. In its inactive state, Arabidopsis AK1 binds the effectors lysine and SAM (two molecules each) at the interface of two ACT1 domain subunits. The second ACT domain (ACT2), this CD, does not interact with an effector. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.44 E-value=1.8e-13 Score=100.65 Aligned_cols=63 Identities=24% Similarity=0.360 Sum_probs=60.7
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
++|++||. +...+|+++++|++|+++||++.||+|++|+.+|||+|+++|.+++++.||++|+
T Consensus 2 a~VsvVG~-~~~~~~~~~~i~~aL~~~~I~v~~i~~g~s~~sis~~v~~~~~~~av~~Lh~~f~ 64 (65)
T cd04918 2 SIISLIGN-VQRSSLILERAFHVLYTKGVNVQMISQGASKVNISLIVNDSEAEGCVQALHKSFF 64 (65)
T ss_pred cEEEEECC-CCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHHh
Confidence 68999999 7788999999999999999999999999999999999999999999999999985
No 70
>cd04252 AAK_NAGK-fArgBP AAK_NAGK-fArgBP: N-Acetyl-L-glutamate kinase (NAGK) of the fungal arginine-biosynthetic pathway (fArgBP). The nuclear-encoded, mitochondrial polyprotein precursor with an N-terminal NAGK (ArgB) domain (this CD), a central DUF619 domain, and a C-terminal reductase domain (ArgC, N-Acetylglutamate Phosphate Reductase, NAGPR). The precursor is cleaved in the mitochondria into two distinct enzymes (NAGK-DUF619 and NAGPR). Native molecular weights of these proteins indicate that the kinase is an octamer whereas the reductase is a dimer. This CD also includes some gamma-proteobacteria (Xanthomonas and Xylella) NAG kinases with an N-terminal NAGK (ArgB) domain (this CD) and a C-terminal DUF619 domain. The DUF619 domain is described as a putative distant homolog of the acetyltransferase, ArgA, predicted to function in NAG synthase association in fungi. Eukaryotic sequences have an N-terminal mitochondrial transit peptide. Members of this NAG kinase domain CD belong to th
Probab=99.43 E-value=2.9e-13 Score=125.26 Aligned_cols=140 Identities=11% Similarity=0.140 Sum_probs=103.7
Q ss_pred HHHHHHHHHhcCCccccccceeEEEEC---CCCC---CC-CCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCccc
Q 020132 48 AQMLAAVVRKNGIDCKWMDTREVLIVN---PTSS---NQ-VDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTT 120 (330)
Q Consensus 48 a~~~~~~L~~~Gi~a~~l~~~~~~~~~---~~~~---g~-~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~ 120 (330)
.+.+.+.|.++|++|+++.+..+ ... ...+ |. .++|. +.++.+++ .|.|||++|+ +.+..|++.+
T Consensus 77 n~~iv~~l~~~g~~a~~l~~~~~-~a~~~~~~d~g~~G~v~~i~~----~~i~~~L~--~g~IPVi~p~-~~~~~g~~~n 148 (248)
T cd04252 77 NLKLVEALERNGARARPITSGVF-EAEYLDKDKYGLVGKITGVNK----APIEAAIR--AGYLPILTSL-AETPSGQLLN 148 (248)
T ss_pred HHHHHHHHHhCCCCcccccCceE-EEEECcCccCCccCceeeECH----HHHHHHHH--CCCeEEECCc-eECCCCCEEE
Confidence 45567789999999999998744 221 1112 22 34566 88999998 8999999996 7788888888
Q ss_pred ccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhh-HHhhhhhhcc--ccccccc--ccceeeec
Q 020132 121 LKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY-QEAWEMSYFG--ANVLHPR--TIIPVMRY 195 (330)
Q Consensus 121 lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~-~e~~~l~~~g--~~v~~p~--a~~~a~~~ 195 (330)
++ +|..|+.+|.+|+|++++|+|||+|||+.+ .+++++++. +++.++...| .++|.|+ ++..+.++
T Consensus 149 vn---aD~~A~~lA~aL~a~kli~ltdv~GV~~~~------g~~i~~i~~~~~~~~l~~~~~vtgGM~~Kl~~~~~~~~~ 219 (248)
T cd04252 149 VN---ADVAAGELARVLEPLKIVFLNETGGLLDGT------GKKISAINLDEEYDDLMKQPWVKYGTKLKIKEIKELLDT 219 (248)
T ss_pred EC---HHHHHHHHHHHcCCCeEEEEECCcccCCCC------CCcccccCHHHHHHHHHHcCCcCCchHHHHHHHHHHHHh
Confidence 74 899999999999999999999999999742 568999986 4676777655 3678885 33344444
Q ss_pred --cc-ceEEeee
Q 020132 196 --DI-PIVIRNI 204 (330)
Q Consensus 196 --~i-~v~i~~~ 204 (330)
++ .++|.+.
T Consensus 220 ~~~~~~v~i~~~ 231 (248)
T cd04252 220 LPRSSSVSITSP 231 (248)
T ss_pred CCCceEEEEECC
Confidence 33 4666653
No 71
>cd04919 ACT_AK-Hom3_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydrodynamic size. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.42 E-value=3.4e-13 Score=98.81 Aligned_cols=65 Identities=26% Similarity=0.412 Sum_probs=63.0
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
+++|+++|.++.+.+++.+++|+.|+++||+++|++|++|+.+++|++++++.+++++.||+.|+
T Consensus 1 ~~~isvvg~~~~~~~~~~~~if~~L~~~~I~v~~i~q~~s~~~isf~v~~~~~~~a~~~lh~~~~ 65 (66)
T cd04919 1 LAILSLVGKHMKNMIGIAGRMFTTLADHRINIEMISQGASEINISCVIDEKDAVKALNIIHTNLL 65 (66)
T ss_pred CeEEEEECCCCCCCcCHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHHh
Confidence 57999999999999999999999999999999999999999999999999999999999999986
No 72
>cd04235 AAK_CK AAK_CK: Carbamate kinase (CK) catalyzes both the ATP-phosphorylation of carbamate and carbamoyl phosphate (CP) utilization with the production of ATP from ADP and CP. Both CK (this CD) and nonhomologous CP synthetase synthesize carbamoyl phosphate, an essential precursor of arginine and pyrimidine bases, in the presence of ATP, bicarbonate, and ammonia. CK is a homodimer of 33 kDa subunits and is a member of the Amino Acid Kinase Superfamily (AAK).
Probab=99.42 E-value=5.9e-13 Score=126.07 Aligned_cols=120 Identities=19% Similarity=0.222 Sum_probs=90.4
Q ss_pred HHHHHhhccCCCccEEEeee----eecCCCCCccccc-ccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGF----IASTPDNIPTTLK-RDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVI 164 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~----i~~~~~g~~~~lg-rggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~ 164 (330)
+.++.+++ .|.|||++|. +..+ +|...+.. ..+.|.+|+++|..++|+.++++|||||||+++| .|++++
T Consensus 172 ~~I~~Ll~--~g~IpI~~GggGiPv~~~-~~~~~gveaVid~D~~AallA~~l~Ad~LiilTdVdGVy~~~~--~pda~~ 246 (308)
T cd04235 172 EAIKTLVD--NGVIVIAAGGGGIPVVRE-GGGLKGVEAVIDKDLASALLAEEINADLLVILTDVDNVYINFG--KPNQKA 246 (308)
T ss_pred HHHHHHHH--CCCEEEEECCCccCEEEc-CCceeeeeeccCccHHHHHHHHHcCCCEEEEEecCCeEECCCC--CCCCeE
Confidence 56777887 8999999987 3322 23322210 2356999999999999999999999999999654 378999
Q ss_pred hhhhhhHHhhhhhh---ccccccccc---ccceeeecccceEEeeeccc-----cCceeEe
Q 020132 165 LRTLSYQEAWEMSY---FGANVLHPR---TIIPVMRYDIPIVIRNIFNL-----SVPGIMI 214 (330)
Q Consensus 165 i~~is~~e~~~l~~---~g~~v~~p~---a~~~a~~~~i~v~i~~~~~~-----~~~GT~I 214 (330)
+++++++|+.++.. ++.++|.|+ |++.+.+.+.+++|.+..+. ...||+|
T Consensus 247 i~~Is~~e~~~l~~~g~~~tGGM~pKv~aA~~~a~~gg~~v~I~~~~~i~~aL~G~~GT~I 307 (308)
T cd04235 247 LEQVTVEELEKYIEEGQFAPGSMGPKVEAAIRFVESGGKKAIITSLENAEAALEGKAGTVI 307 (308)
T ss_pred cCCcCHHHHHHHHhcCccccCCcHHHHHHHHHHHHhCCCeEEECCHHHHHHHHCCCCCeEE
Confidence 99999999999885 456899997 66777666778888775321 1258876
No 73
>PRK12353 putative amino acid kinase; Reviewed
Probab=99.39 E-value=7.9e-13 Score=126.19 Aligned_cols=121 Identities=21% Similarity=0.224 Sum_probs=91.1
Q ss_pred HHHHHhhccCCCccEEEeee--ee-cCCCCCcccc-cccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGF--IA-STPDNIPTTL-KRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~--i~-~~~~g~~~~l-grggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i 165 (330)
+.++.+|+ .|.|||++|+ ++ .++++.+.+. ..+++|.+|+++|.+|+|++++++|||||||+++|+ |+++++
T Consensus 176 ~~i~~lL~--~g~IpV~~g~gg~Pi~~~~~~~~~~~~~~d~D~lAa~lA~~l~Ad~Li~lTdvdGVy~~~~~--~~a~~i 251 (314)
T PRK12353 176 EAIKTLVD--AGQVVIAAGGGGIPVIREGGGLKGVEAVIDKDFASAKLAELVDADLLIILTAVDKVYINFGK--PNQKKL 251 (314)
T ss_pred HHHHHHHH--CCCEEEEcCCCCCCEEEeCCceeeeeEecCHHHHHHHHHHHhCCCEEEEEeCCccccCCCCC--CCCeEC
Confidence 78888888 8999999987 11 1233332220 024679999999999999999999999999997663 789999
Q ss_pred hhhhhHHhhhhhh---ccccccccc--cc-cee-eecccceEEeeecc------ccCceeEee
Q 020132 166 RTLSYQEAWEMSY---FGANVLHPR--TI-IPV-MRYDIPIVIRNIFN------LSVPGIMIC 215 (330)
Q Consensus 166 ~~is~~e~~~l~~---~g~~v~~p~--a~-~~a-~~~~i~v~i~~~~~------~~~~GT~I~ 215 (330)
++++++++.++.. .+.++|.|+ ++ +.+ .+.+++++|.+... .+ .||+|.
T Consensus 252 ~~i~~~e~~~~~~~~~~~tGGM~~Kl~aA~~a~~~~~g~~v~I~~~~~i~~~l~g~-~GT~i~ 313 (314)
T PRK12353 252 DEVTVSEAEKYIEEGQFAPGSMLPKVEAAISFVESRPGRKAIITSLEKAKEALEGK-AGTVIV 313 (314)
T ss_pred cCcCHHHHHHHHhcCCcCCCCcHHHHHHHHHHHHHcCCCEEEECCchHHHHHhCCC-CCeEec
Confidence 9999999988874 345789884 34 444 47789999987532 22 688874
No 74
>cd04922 ACT_AKi-HSDH-ThrA_2 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the second of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathwa
Probab=99.38 E-value=9.1e-13 Score=96.27 Aligned_cols=65 Identities=31% Similarity=0.556 Sum_probs=62.8
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
+++|+++|.++...+++.+++|+.|+++||+++|++|+.|+.+++|++++++.++++++||+.|+
T Consensus 1 ~~~isvvg~~~~~~~~~~~~i~~~l~~~~I~v~~i~~~~s~~~is~~v~~~~~~~~~~~lh~~~~ 65 (66)
T cd04922 1 LSILALVGDGMAGTPGVAATFFSALAKANVNIRAIAQGSSERNISAVIDEDDATKALRAVHERFF 65 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHHHHHHHHHHHHHHh
Confidence 47899999999999999999999999999999999998899999999999999999999999986
No 75
>cd04937 ACT_AKi-DapG-BS_2 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive AK isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The BS AKI is tetrameric consisting of two alpha and two beta subunits; th
Probab=99.37 E-value=1.2e-12 Score=96.00 Aligned_cols=63 Identities=30% Similarity=0.524 Sum_probs=60.0
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
+++|+++|.+|...||+++|+|++|+++||++.+++| |+++|||+|+++|.++++++||++|+
T Consensus 1 ~~~isvvG~~~~~~~gi~~~if~aL~~~~I~v~~~~~--Se~~is~~v~~~~~~~av~~Lh~~f~ 63 (64)
T cd04937 1 CAKVTIIGSRIRGVPGVMAKIVGALSKEGIEILQTAD--SHTTISCLVSEDDVKEAVNALHEAFE 63 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHHHCCCCEEEEEc--CccEEEEEEcHHHHHHHHHHHHHHhc
Confidence 4799999999999999999999999999999999884 79999999999999999999999984
No 76
>cd04920 ACT_AKiii-DAPDC_2 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC). This CD includes the second of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.35 E-value=1.3e-12 Score=95.57 Aligned_cols=62 Identities=19% Similarity=0.304 Sum_probs=57.9
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
++|++||.+|...+|+.+++|++|++. +|.+++|++|+++|||+|+++|.+++++.||+.|+
T Consensus 1 a~VsvVG~g~~~~~gv~~~~~~~L~~~--~i~~i~~~~s~~~is~vv~~~d~~~av~~LH~~f~ 62 (63)
T cd04920 1 AAVSLVGRGIRSLLHKLGPALEVFGKK--PVHLVSQAANDLNLTFVVDEDQADGLCARLHFQLI 62 (63)
T ss_pred CEEEEECCCcccCccHHHHHHHHHhcC--CceEEEEeCCCCeEEEEEeHHHHHHHHHHHHHHHh
Confidence 589999999999999999999999886 56668888999999999999999999999999997
No 77
>cd04921 ACT_AKi-HSDH-ThrA-like_1 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the first of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pat
Probab=99.35 E-value=2.4e-12 Score=97.96 Aligned_cols=78 Identities=50% Similarity=0.754 Sum_probs=74.8
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHHHhccCcccccCC
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREALNAGRLSQHSS 318 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~~~~~~~i~~~~~ 318 (330)
+++|+++|.++...+++.+++|+.|++++|+++|++|++++.++||+++.++..++++.||+.|+.+++++.+.||..
T Consensus 1 ~~~I~vvg~~~~~~~~~~~~i~~~L~~~~I~v~~i~~~~~~~~isf~v~~~d~~~~~~~l~~~~~~~~~~~~~~~~~~ 78 (80)
T cd04921 1 VALINIEGTGMVGVPGIAARIFSALARAGINVILISQASSEHSISFVVDESDADKALEALEEEFALEIKAGLIKPIEV 78 (80)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHCCCcEEEEEecCCcceEEEEEeHHHHHHHHHHHHHHHHhhhhhCcccceEe
Confidence 578999999999999999999999999999999999998899999999999999999999999999999999999864
No 78
>cd04237 AAK_NAGS-ABP AAK_NAGS-ABP: N-acetylglutamate (NAG) kinase-like domain of the NAG Synthase (NAGS) of the arginine-biosynthesis pathway (ABP) found in gamma- and beta-proteobacteria and higher plant chloroplasts. Domain architecture of these NAGS consisted of an N-terminal NAG kinase-like (ArgB) domain (this CD) and a C-terminal NAG synthase, acetyltransferase (ArgA) domain. Both bacterial and plant sequences in this CD have a conserved N-terminal extension; a similar sequence in the NAG kinases of the cyclic arginine-biosynthesis pathway has been implicated in feedback inhibition sensing. Plant sequences also have an N-terminal chloroplast transit peptide and an insert (approx. 70 residues) in the C-terminal region of ArgB. Members of this CD belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.34 E-value=1.1e-12 Score=123.47 Aligned_cols=147 Identities=16% Similarity=0.187 Sum_probs=109.4
Q ss_pred ccchhHHHHHHHHHHhcCCccccccceeEEEEC-----CC--------CC---CC-CCCCchhhHHHHHHhhccCCCccE
Q 020132 42 HGELWSAQMLAAVVRKNGIDCKWMDTREVLIVN-----PT--------SS---NQ-VDPDFSESEKRLEKWFSQSPSNTI 104 (330)
Q Consensus 42 ~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~-----~~--------~~---g~-~~~~~~~~~~~i~~~l~~~~~~Vp 104 (330)
.|+. ...+.+.|+. |++++++++..+...+ .. .+ |. ..++. +.++.+++ .|.||
T Consensus 94 ~g~v--~~~l~~~l~~-~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~g~~G~v~~v~~----~~i~~lL~--~g~ip 164 (280)
T cd04237 94 AGAV--RLEIEALLSM-GLPNSPMAGARIRVVSGNFVTARPLGVVDGVDFGHTGEVRRIDA----DAIRRQLD--QGSIV 164 (280)
T ss_pred HHHH--HHHHHHHHHh-hccccCcCCCceEEecCeEEEEEECCcccCceEeeeccEEEEcH----HHHHHHHH--CCCEE
Confidence 3555 5556777754 9998877543322210 00 11 11 22444 88899998 78999
Q ss_pred EEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcc---c
Q 020132 105 IATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFG---A 181 (330)
Q Consensus 105 Vv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g---~ 181 (330)
|+++. +.+.+|+..+++ +|..|+.||.+|+|++++|+|||||||++ +++++++++.+|+.++...| .
T Consensus 165 v~~~~-g~~~~g~~lnvn---aD~~A~~LA~~L~a~klv~ltdv~GV~~~------~~~~i~~i~~~e~~~l~~~~~~~~ 234 (280)
T cd04237 165 LLSPL-GYSPTGEVFNLS---MEDVATAVAIALKADKLIFLTDGPGLLDD------DGELIRELTAQEAEALLETGALLT 234 (280)
T ss_pred EECCc-eECCCCCEEeeC---HHHHHHHHHHHcCCCEEEEEeCCCcccCC------CCCccccCCHHHHHHHHHcCCCCC
Confidence 99885 888889988874 79999999999999999999999999974 26799999999999998765 4
Q ss_pred cccccc--ccceeeeccc-ceEEeeeccc
Q 020132 182 NVLHPR--TIIPVMRYDI-PIVIRNIFNL 207 (330)
Q Consensus 182 ~v~~p~--a~~~a~~~~i-~v~i~~~~~~ 207 (330)
.+|.|+ ++..+.++|+ +++|.++..|
T Consensus 235 ggM~~Kv~~a~~a~~~Gv~~v~I~~~~~~ 263 (280)
T cd04237 235 NDTARLLQAAIEACRGGVPRVHLISYAED 263 (280)
T ss_pred CCHHHHHHHHHHHHHcCCCEEEEeCCCCC
Confidence 789995 5555567799 5999988654
No 79
>PRK05279 N-acetylglutamate synthase; Validated
Probab=99.34 E-value=1.8e-12 Score=129.24 Aligned_cols=153 Identities=15% Similarity=0.158 Sum_probs=114.2
Q ss_pred HHHHHHHHHhcCCccccccceeEEEECCC-------------CCCC----CCCCchhhHHHHHHhhccCCCccEEEeeee
Q 020132 48 AQMLAAVVRKNGIDCKWMDTREVLIVNPT-------------SSNQ----VDPDFSESEKRLEKWFSQSPSNTIIATGFI 110 (330)
Q Consensus 48 a~~~~~~L~~~Gi~a~~l~~~~~~~~~~~-------------~~g~----~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i 110 (330)
...+.+.|+ +|++++++.+..+...+.. .+|. ..++. +.++.+++ .|.|||+++ +
T Consensus 105 ~~~l~~~l~-~g~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~G~v~~v~~----~~i~~ll~--~g~ipV~~~-i 176 (441)
T PRK05279 105 RLDIEARLS-MGLPNTPMAGAHIRVVSGNFVTARPLGVDDGVDYQHTGEVRRIDA----EAIRRQLD--SGAIVLLSP-L 176 (441)
T ss_pred HHHHHHHHh-ccCCCCcccCCcceEeeccEEEEEECCCCCCccccceeeEEEEeH----HHHHHHHH--CCCeEEECC-c
Confidence 555677774 5999988876654333211 1111 12344 88898998 789999955 5
Q ss_pred ecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhh---cc--ccccc
Q 020132 111 ASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSY---FG--ANVLH 185 (330)
Q Consensus 111 ~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~---~g--~~v~~ 185 (330)
+.+.+|++.+++ +|.+|+.||.+|+|++++|+|||+|||++ +++++++++.+++.++.. .| .++|.
T Consensus 177 ~~~~~g~~~ni~---~D~~a~~lA~~l~a~~lv~ltdv~GV~~~------~~~~i~~i~~~~~~~~~~~~~~~~~~ggM~ 247 (441)
T PRK05279 177 GYSPTGESFNLT---MEEVATQVAIALKADKLIFFTESQGVLDE------DGELIRELSPNEAQALLEALEDGDYNSGTA 247 (441)
T ss_pred eECCCCCEEEEC---HHHHHHHHHHHcCCCEEEEEECCCCccCC------CCchhhhCCHHHHHHHHhhhhcCCCCccHH
Confidence 888889888774 79999999999999999999999999953 368999999999988875 34 47888
Q ss_pred cc--ccceeeeccc-ceEEeeeccc----------cCceeEeeCC
Q 020132 186 PR--TIIPVMRYDI-PIVIRNIFNL----------SVPGIMICRP 217 (330)
Q Consensus 186 p~--a~~~a~~~~i-~v~i~~~~~~----------~~~GT~I~~~ 217 (330)
|+ ++..+.++|+ +++|.++..| +..||.|...
T Consensus 248 ~Kv~~a~~~~~~gv~~v~i~~~~~~~~l~~~l~~~~g~GT~i~~~ 292 (441)
T PRK05279 248 RFLRAAVKACRGGVRRSHLISYAEDGALLQELFTRDGIGTMIVME 292 (441)
T ss_pred HHHHHHHHHHHcCCCEEEEecCCCCcHHHHHHhcCCCCceEEecC
Confidence 85 4445556799 5999987544 2469999865
No 80
>cd04917 ACT_AKiii-LysC-EC_2 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The second ACT domain (ACT2), this CD, is not involved in the binding of heterotrophic effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.33 E-value=2.7e-12 Score=93.90 Aligned_cols=63 Identities=37% Similarity=0.604 Sum_probs=60.2
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
+++|+++|.+|...+++.+++|++|++ +++.+++|++|+++++|+|+++|.+++++.||+.|+
T Consensus 1 ~alIsvvG~~~~~~~~v~~~i~~~L~~--i~i~~i~~~~s~~~is~~V~~~~~~~a~~~Lh~~f~ 63 (64)
T cd04917 1 LALVALIGNDISETAGVEKRIFDALED--INVRMICYGASNHNLCFLVKEEDKDEVVQRLHSRLF 63 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHHh--CCeEEEEEecCccEEEEEEeHHHHHHHHHHHHHHHh
Confidence 589999999999999999999999975 899999999999999999999999999999999987
No 81
>TIGR00746 arcC carbamate kinase. The seed alignment for this model includes experimentally confirmed examples from a set of phylogenetically distinct species. In a neighbor-joining tree constructed from an alignment of candidate carbamate kinases and several acetylglutamate kinases, the latter group forms a clear outgroup which roots the tree of carbamate kinase-like proteins. This analysis suggests that in E. coli, the ArcC paralog YqeA may be a second isozyme, while the paralog YahI branches as an outlier and is less likely to be an authentic carbamate kinase. The homolog from Mycoplasma pneumoniae likewise branches outside the set containing known carbamate kinases and also scores below the trusted cutoff.
Probab=99.30 E-value=8e-12 Score=118.81 Aligned_cols=175 Identities=17% Similarity=0.184 Sum_probs=114.3
Q ss_pred cceeeeccchhHHHHHHHHHH----hcCCccccccceeEEEECCCC--CCCC----------------------------
Q 020132 36 TDFVVGHGELWSAQMLAAVVR----KNGIDCKWMDTREVLIVNPTS--SNQV---------------------------- 81 (330)
Q Consensus 36 ~~~v~~~GE~~sa~~~~~~L~----~~Gi~a~~l~~~~~~~~~~~~--~g~~---------------------------- 81 (330)
.+.+.|.|+-+-+.++...|+ ++|++........-...+.+. |.++
T Consensus 74 ~~~~~A~~qg~lg~~~~~~l~~~l~~~g~~~~v~~~vtqv~v~~~D~af~~p~k~ig~~y~~~~a~~~~~~~~~~~~~d~ 153 (310)
T TIGR00746 74 LDVLGAMSQGMIGYMLQQALNNELPKRGMEKPVATVLTQTIVDPKDPAFQNPTKPIGPFYTEEEAKRLAAEKGWIVKEDA 153 (310)
T ss_pred chHHHHhhHHHHHHHHHHHHHHHHHhcCCCccceEEEEEEEECCCcccccCCCCcCCCCcCHHHHHHHHHHcCCeEeecC
Confidence 477888888887888888777 888766443332222233222 2110
Q ss_pred ---------CCCch--hhHHHHHHhhccCCCccEEEeee--eec-CCCCCcccc-cccCcchhHHHHHHHHhhceeEEEe
Q 020132 82 ---------DPDFS--ESEKRLEKWFSQSPSNTIIATGF--IAS-TPDNIPTTL-KRDGSDFSAAIMGALLRAHQVTIWT 146 (330)
Q Consensus 82 ---------~~~~~--~~~~~i~~~l~~~~~~VpVv~G~--i~~-~~~g~~~~l-grggsD~~A~~lA~~l~A~~l~~~t 146 (330)
.+.+. --.+.++.+|+ .|.|+|.+|- ++. +++|.+... -.++.|.+|+.+|.+|+||.++++|
T Consensus 154 ~~~~rrvv~sp~p~~iv~~~~I~~LL~--~G~iVI~~ggggiPvi~e~~~~~g~e~~id~D~lAa~lA~~l~AD~LIiLT 231 (310)
T TIGR00746 154 GRGWRRVVPSPRPKDIVEAETIKTLVE--NGVIVISSGGGGVPVVLEGAELKGVEAVIDKDLASEKLAEEVNADILVILT 231 (310)
T ss_pred CCcceEeecCCCchhhccHHHHHHHHH--CCCEEEeCCCCCcCEEecCCeEEeeEecCCHHHHHHHHHHHhCCCEEEEEe
Confidence 01110 01257888888 6776665543 111 233432110 0246899999999999999999999
Q ss_pred ecccccccCccchhHhhhhhhhhhHHhhhhhh---ccccccccc---ccceeeecccceEEeeec------cccCceeEe
Q 020132 147 DVDGVYSADPRKVSEAVILRTLSYQEAWEMSY---FGANVLHPR---TIIPVMRYDIPIVIRNIF------NLSVPGIMI 214 (330)
Q Consensus 147 dv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~---~g~~v~~p~---a~~~a~~~~i~v~i~~~~------~~~~~GT~I 214 (330)
||||||+++ + .|+++++++++++|+.++.. ++.++|.|+ |++.+.+.+++++|.+.. +.+ .||+|
T Consensus 232 DVdGVy~~~-~-~p~a~~i~~it~~e~~~~~~~g~~~tGgM~~Kl~AA~~~~~~g~~~v~I~~~~~i~~~l~G~-~GT~I 308 (310)
T TIGR00746 232 DVDAVYINY-G-KPDEKALREVTVEELEDYYKAGHFAAGSMGPKVEAAIEFVESGGKRAIITSLENAVEALEGK-AGTRV 308 (310)
T ss_pred CCCceeCCC-C-CCCCcCCcCcCHHHHHHHHhcCCcCCCCcHHHHHHHHHHHHhCCCeEEEechHHHHHHHCCC-CCcEE
Confidence 999999863 3 47899999999999998874 456788883 446666667889888743 223 68887
Q ss_pred e
Q 020132 215 C 215 (330)
Q Consensus 215 ~ 215 (330)
.
T Consensus 309 ~ 309 (310)
T TIGR00746 309 T 309 (310)
T ss_pred e
Confidence 4
No 82
>cd04916 ACT_AKiii-YclM-BS_2 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. B. subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from B. subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.30 E-value=5.8e-12 Score=91.97 Aligned_cols=65 Identities=32% Similarity=0.452 Sum_probs=62.7
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
+++|+++|.++...+++.+++|+.|++.||+++|++|+.++.+++|+++++|..++++.||++|+
T Consensus 1 ~~lisivg~~~~~~~~~~~~i~~~L~~~~i~v~~i~~~~s~~~isf~v~~~d~~~~~~~lh~~~~ 65 (66)
T cd04916 1 LALIMVVGEGMKNTVGVSARATAALAKAGINIRMINQGSSEISIMIGVHNEDADKAVKAIYEEFF 65 (66)
T ss_pred CeEEEEEcCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHHHHHHHHHHHHHHh
Confidence 47899999999999999999999999999999999998899999999999999999999999987
No 83
>cd04924 ACT_AK-Arch_2 ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). Included in this CD is the second of two ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). The first or N-terminal ACT domain of these proteins cluster with the ThrA-like ACT 1 domains (ACT_AKi-HSDH-ThrA-like_1) which includes the threonine-sensitive archaeal Methanococcus jannaschii aspartokinase ACT 1 domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.28 E-value=9.3e-12 Score=90.77 Aligned_cols=64 Identities=47% Similarity=0.734 Sum_probs=61.9
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKF 304 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f 304 (330)
+++|+++|.++...+++.+++|+.|++.||+++|++|+.++.+++|+++++|.+++.+.||+.|
T Consensus 1 ~~~isivg~~~~~~~~~~~~i~~~L~~~~I~v~~i~q~~s~~~isf~i~~~~~~~~~~~Lh~~~ 64 (66)
T cd04924 1 VAVVAVVGSGMRGTPGVAGRVFGALGKAGINVIMISQGSSEYNISFVVAEDDGWAAVKAVHDEF 64 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHh
Confidence 4799999999999999999999999999999999999889999999999999999999999987
No 84
>TIGR01890 N-Ac-Glu-synth amino-acid N-acetyltransferase. This model represents a clade of amino-acid N-acetyltransferases acting mainly on glutamate in the first step of the "acetylated" ornithine biosynthesis pathway. For this reason it is also called N-acetylglutamate synthase. The enzyme may also act on aspartate.
Probab=99.27 E-value=8.4e-12 Score=124.15 Aligned_cols=116 Identities=13% Similarity=0.123 Sum_probs=94.3
Q ss_pred HHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLS 169 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is 169 (330)
+.++.+++ .|.|||+++. +.+.+|++.+++ +|..|+.||.+|+|++++|+|||+|||++ +.+++++|+
T Consensus 151 ~~l~~ll~--~g~ipvi~pi-~~~~~g~~~nvn---aD~~A~~lA~al~a~kli~ltdv~Gv~~~------~g~~i~~i~ 218 (429)
T TIGR01890 151 EGIRRQLD--AGSIVLLSPL-GHSPTGETFNLD---MEDVATSVAISLKADKLIYFTLSPGISDP------DGTLAAELS 218 (429)
T ss_pred HHHHHHHH--CCCeEEECCc-ccCCCCCEEEeC---HHHHHHHHHHHcCCCEEEEEeCCCcccCC------CCCCcccCC
Confidence 88999998 7899999885 888889999884 89999999999999999999999999963 257999999
Q ss_pred hHHhhhhhhccccc-cccc--ccceeeeccc-ceEEeeeccc----------cCceeEeeCC
Q 020132 170 YQEAWEMSYFGANV-LHPR--TIIPVMRYDI-PIVIRNIFNL----------SVPGIMICRP 217 (330)
Q Consensus 170 ~~e~~~l~~~g~~v-~~p~--a~~~a~~~~i-~v~i~~~~~~----------~~~GT~I~~~ 217 (330)
.+|+.++....... |.|+ ++..|.+.|+ +++|.++..| +..||.|...
T Consensus 219 ~~~~~~l~~~~~~~~~~~kl~~a~~a~~~gv~~v~i~~g~~~~~l~~el~~~~g~GT~i~~d 280 (429)
T TIGR01890 219 PQEVESLAERLGSETTRRLLSAAVKACRGGVHRSHIVSYAEDGSLLQELFTRDGIGTSISKE 280 (429)
T ss_pred HHHHHHHHHhccCCCcHHHHHHHHHHHHcCCCeEEEECCCCCcHHHHHHhcCCCCcceEecc
Confidence 99988887543334 3674 5566677887 5999997544 3469999764
No 85
>PRK12686 carbamate kinase; Reviewed
Probab=99.25 E-value=6.6e-12 Score=119.10 Aligned_cols=122 Identities=19% Similarity=0.237 Sum_probs=89.8
Q ss_pred HHHHHhhccCCCccEEEeee--ee-cCCCCCccccc-ccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGF--IA-STPDNIPTTLK-RDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~--i~-~~~~g~~~~lg-rggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i 165 (330)
+.++.+++ .|.|||.+|. ++ .++++....+. .+++|.+|+.||.+|+|++++|+|||+|||++ |. .++++++
T Consensus 174 ~~I~~Ll~--~G~IpI~~GgggIPVv~~~~~~~gv~avid~D~~Aa~LA~~L~Ad~LIiLTDVdGVy~~-~~-~p~ak~I 249 (312)
T PRK12686 174 DTIRTLVD--GGNIVIACGGGGIPVIRDDNTLKGVEAVIDKDFASEKLAEQIDADLLIILTGVENVFIN-FN-KPNQQKL 249 (312)
T ss_pred HHHHHHHH--CCCEEEEeCCCCCCeEecCCcEEeeecccCccHHHHHHHHHcCCCEEEEEeCchhhccC-CC-CCCCeEC
Confidence 77888888 8999999876 11 22344333221 35689999999999999999999999999984 55 3789999
Q ss_pred hhhhhHHhhhhhh---ccccccccc--ccceeee--cccceEEeeeccc-----cCceeEee
Q 020132 166 RTLSYQEAWEMSY---FGANVLHPR--TIIPVMR--YDIPIVIRNIFNL-----SVPGIMIC 215 (330)
Q Consensus 166 ~~is~~e~~~l~~---~g~~v~~p~--a~~~a~~--~~i~v~i~~~~~~-----~~~GT~I~ 215 (330)
++++.+|+.++.. ++.++|.|+ |+..+.+ .+.+++|.+..+. ...||+|.
T Consensus 250 ~~I~~~e~~~li~~g~~~tGGM~pKveAA~~av~~g~g~~viI~~~~~i~~aL~G~~GT~I~ 311 (312)
T PRK12686 250 DDITVAEAKQYIAEGQFAPGSMLPKVEAAIDFVESGEGKKAIITSLEQAKEALAGNAGTHIT 311 (312)
T ss_pred CccCHHHHHHHhhCCCccCCCcHHHHHHHHHHHHhCCCCEEEEeCchHHHHHhCCCCCeEEe
Confidence 9999999999875 345789995 4444443 3567888875321 12688874
No 86
>cd04240 AAK_UC AAK_UC: Uncharacterized (UC) amino acid kinase-like proteins found mainly in archaea and a few bacteria. Sequences in this CD are members of the Amino Acid Kinase (AAK) superfamily.
Probab=99.22 E-value=9.2e-12 Score=111.88 Aligned_cols=148 Identities=19% Similarity=0.162 Sum_probs=102.2
Q ss_pred cccceeeeccchhHHHHHHHHHHhcC----------CccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCcc
Q 020132 34 SFTDFVVGHGELWSAQMLAAVVRKNG----------IDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNT 103 (330)
Q Consensus 34 ~~~~~v~~~GE~~sa~~~~~~L~~~G----------i~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~V 103 (330)
.....|.+.|.. |+.+-..-.+.| +-|+.+++.-+. + .. .... ..+...+...+. .+.|
T Consensus 25 ~~v~iV~GGG~~--A~~~r~~~~~~g~~~~~ad~mgilat~~na~~l~--~--~~-~~~~--~~~~~~~~~~~~--~g~i 93 (203)
T cd04240 25 GGVVIVPGGGPF--ADVVRRYQERKGLSDAAAHWMAILAMEQYGYLLA--D--LE-PRLV--ARTLAELTDVLE--RGKI 93 (203)
T ss_pred CCEEEEcCCcHH--HHHHHHHHHHcCCChHHHHHHHHHHHHHHHHHHh--c--cC-Cccc--cCCHHHHHHHHH--CCCc
Confidence 455678889988 666654444444 444555544321 1 11 1111 233367777776 7899
Q ss_pred EEEeeeeec----CCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhc
Q 020132 104 IIATGFIAS----TPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYF 179 (330)
Q Consensus 104 pVv~G~i~~----~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~ 179 (330)
||+.++ +. +..++..++ .+|..|+.+|..|+|++++++|||||||++| +++++++++.|+..
T Consensus 94 pV~~P~-~~~~~~~~~~~~~~~---ttD~lAa~lA~~l~A~~Li~ltdVdGVy~~d------a~~i~~i~~~e~~~---- 159 (203)
T cd04240 94 AILLPY-RLLLDTDPLPHSWEV---TSDSIAAWLAKKLGAKRLVIVTDVDGIYEKD------GKLVNEIAAAELLG---- 159 (203)
T ss_pred EEEeCc-hhhcccCCCCccccc---CHHHHHHHHHHHcCCCEEEEEeCCccccCCC------CcCccccCHHHhCC----
Confidence 999876 33 223333333 3799999999999999999999999999865 78999999887643
Q ss_pred ccccccccccceeeecccceEEeeeccc
Q 020132 180 GANVLHPRTIIPVMRYDIPIVIRNIFNL 207 (330)
Q Consensus 180 g~~v~~p~a~~~a~~~~i~v~i~~~~~~ 207 (330)
..++++.+.+.+.+++++++|.|+..|
T Consensus 160 -~~~id~~~~~~~~~~gi~v~I~~g~~~ 186 (203)
T cd04240 160 -ETSVDPAFPRLLTKYGIRCYVVNGDDP 186 (203)
T ss_pred -CCeehhhHHHHHHhCCCeEEEECCCCc
Confidence 556666566777889999999998765
No 87
>PRK12454 carbamate kinase-like carbamoyl phosphate synthetase; Reviewed
Probab=99.19 E-value=2e-11 Score=115.72 Aligned_cols=122 Identities=20% Similarity=0.178 Sum_probs=90.0
Q ss_pred HHHHHhhccCCCccEEEeeee---ecCCCCCccccc-ccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGFI---ASTPDNIPTTLK-RDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~i---~~~~~g~~~~lg-rggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i 165 (330)
+.++.+++ .|.|||++|.- ..+.+|.+.++. -.+.|.+|+.+|.+|+|++++|+|||||||++ |+ .|+++++
T Consensus 176 ~aI~~LLe--~G~IvI~~GgGGiPV~~~~g~~~gveaViD~D~aAa~LA~~L~AD~LIiLTdVdGVy~~-~~-~p~~~~i 251 (313)
T PRK12454 176 EVIKALVE--NGFIVIASGGGGIPVIEEDGELKGVEAVIDKDLASELLAEELNADIFIILTDVEKVYLN-YG-KPDQKPL 251 (313)
T ss_pred HHHHHHHH--CCCEEEEeCCCccceEcCCCcEEeeeeecCccHHHHHHHHHcCCCEEEEEeCCceeeCC-CC-CCCCeEc
Confidence 67788888 89999999872 244555544322 13569999999999999999999999999986 43 3788999
Q ss_pred hhhhhHHhhhhhh---ccccccccc---ccceeeecccceEEeeeccc-----cCceeEee
Q 020132 166 RTLSYQEAWEMSY---FGANVLHPR---TIIPVMRYDIPIVIRNIFNL-----SVPGIMIC 215 (330)
Q Consensus 166 ~~is~~e~~~l~~---~g~~v~~p~---a~~~a~~~~i~v~i~~~~~~-----~~~GT~I~ 215 (330)
++++++|+.++.. ++.+.|.|+ |++.+.+.+.+++|.+..+. ...||+|.
T Consensus 252 ~~It~~e~~~~i~~g~~~~GgM~pKv~AA~~~v~~gg~~a~I~~~~~i~~aL~G~~GT~I~ 312 (313)
T PRK12454 252 DKVTVEEAKKYYEEGHFKAGSMGPKILAAIRFVENGGKRAIIASLEKAVEALEGKTGTRII 312 (313)
T ss_pred cccCHHHHHHHHhcCCcCCCChHHHHHHHHHHHHcCCCeEEECchHHHHHHHCCCCCeEeC
Confidence 9999999988774 335679884 44555555567888764321 12689885
No 88
>PRK06291 aspartate kinase; Provisional
Probab=99.18 E-value=3.6e-11 Score=120.81 Aligned_cols=118 Identities=26% Similarity=0.396 Sum_probs=89.4
Q ss_pred cccceeeecccceEEeeeccccCceeEe-eCCCCCCCcccc-----cccCCcccceeecceeEEeeecccccCCCCchhh
Q 020132 187 RTIIPVMRYDIPIVIRNIFNLSVPGIMI-CRPPVDENEDEQ-----IIDSPVKGFATIDNLALVNVEGTGMAGVPGTANA 260 (330)
Q Consensus 187 ~a~~~a~~~~i~v~i~~~~~~~~~GT~I-~~~~~~~~~~~~-----~~~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~ 260 (330)
+.+..+.++||++..++....+ ..-.+ .+.. +.+...+ .....+..+++.+|+++|+++|.+|+.++|+++|
T Consensus 340 rvf~~L~~~gI~V~mIsq~sse-~sIsf~V~~~-d~~~av~~L~~~~~~~~~~~i~~~~~~a~IsvvG~gm~~~~gv~~r 417 (465)
T PRK06291 340 RIFSALAEEGVNVIMISQGSSE-SNISLVVDEA-DLEKALKALRREFGEGLVRDVTFDKDVCVVAVVGAGMAGTPGVAGR 417 (465)
T ss_pred HHHHHHHHCCCcEEEEEecCCC-ceEEEEEeHH-HHHHHHHHHHHHHHHhcCcceEEeCCEEEEEEEcCCccCCcChHHH
Confidence 4566677889988776643222 11112 1211 0000000 0111356789999999999999999999999999
Q ss_pred hhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHH
Q 020132 261 IFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (330)
Q Consensus 261 if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~ 306 (330)
+|++|++.||+|.||+|++|+++|||+|+++|.+++++.||++|+.
T Consensus 418 if~aL~~~~I~v~~isqgsSe~~Is~vV~~~d~~~av~~Lh~~f~~ 463 (465)
T PRK06291 418 IFSALGESGINIKMISQGSSEVNISFVVDEEDGERAVKVLHDEFIL 463 (465)
T ss_pred HHHHHHHCCCCEEEEEeccccCeEEEEEeHHHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999999999999999999999953
No 89
>COG0527 LysC Aspartokinases [Amino acid transport and metabolism]
Probab=99.16 E-value=4.3e-11 Score=119.06 Aligned_cols=71 Identities=41% Similarity=0.574 Sum_probs=68.5
Q ss_pred cceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHH
Q 020132 234 GFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (330)
Q Consensus 234 ~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~ 306 (330)
.+.+++++++|++||.||+.+||+++++|++|+++||||.||+ +|+++|||+|+++|.++|++.||+.|+.
T Consensus 376 ~v~~~~~~a~vsiVG~gm~~~~gvaa~~f~aL~~~~ini~~is--sSe~~Is~vV~~~~~~~av~~LH~~~~~ 446 (447)
T COG0527 376 EVEVEEGLALVSIVGAGMRSNPGVAARIFQALAEENINIIMIS--SSEISISFVVDEKDAEKAVRALHEAFFL 446 (447)
T ss_pred eEEeeCCeeEEEEEccccccCcCHHHHHHHHHHhCCCcEEEEE--cCCceEEEEEccHHHHHHHHHHHHHHhc
Confidence 6788999999999999999999999999999999999999998 8899999999999999999999999974
No 90
>PF13840 ACT_7: ACT domain ; PDB: 3S1T_A 1ZHV_A 3AB4_K 3AB2_O 2DTJ_A 3AAW_A 2RE1_B 3MAH_A 1ZVP_D.
Probab=99.14 E-value=4.5e-11 Score=88.00 Aligned_cols=63 Identities=38% Similarity=0.588 Sum_probs=58.8
Q ss_pred eecceeEEeeecccccC-CCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHH
Q 020132 237 TIDNLALVNVEGTGMAG-VPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 237 ~~~nia~IsvvG~~~~~-~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~ 302 (330)
+.+++++|+++|.+|.. .||+.+++|++|+++||+|.+++ |+.+++++|+++|.++|+++||+
T Consensus 2 ~~~~~~~i~v~g~g~~~~~~Gv~a~i~~~La~~~I~i~~is---S~~~~~ilV~~~~~~~A~~~L~~ 65 (65)
T PF13840_consen 2 IEEDWAKISVVGPGLRFDVPGVAAKIFSALAEAGINIFMIS---SEISISILVKEEDLEKAVEALHE 65 (65)
T ss_dssp EESEEEEEEEEEECGTTTSHHHHHHHHHHHHHTTS-ECEEE---ESSEEEEEEEGGGHHHHHHHHHH
T ss_pred ccCCEEEEEEEccccCCCcccHHHHHHHHHHHCCCCEEEEE---EeeeEEEEEeHHHHHHHHHHhcC
Confidence 46799999999999977 99999999999999999999998 79999999999999999999996
No 91
>PRK09034 aspartate kinase; Reviewed
Probab=99.12 E-value=1e-10 Score=117.12 Aligned_cols=76 Identities=29% Similarity=0.409 Sum_probs=72.6
Q ss_pred cccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHHH
Q 020132 232 VKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREA 307 (330)
Q Consensus 232 ~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~~ 307 (330)
+.++++.+|+++|+++|.+|...+|+++++|++|+++||||+||+|++|+.+|||+|+++|..++++.||++|+.+
T Consensus 376 ~~~I~~~~~va~VsivG~g~~~~~gv~arif~aL~~~~InV~mIsq~~Se~~Is~vV~~~d~~~av~~LH~~f~~~ 451 (454)
T PRK09034 376 PDELEIEHDLAIIMVVGEGMRQTVGVAAKITKALAEANINIQMINQGSSEISIMFGVKNEDAEKAVKAIYNAFFKE 451 (454)
T ss_pred CceEEEeCCEEEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCCcceEEEEEcHHHHHHHHHHHHHHHhcc
Confidence 4678999999999999999999999999999999999999999999999999999999999999999999999753
No 92
>PRK12354 carbamate kinase; Reviewed
Probab=99.11 E-value=1.6e-10 Score=109.31 Aligned_cols=123 Identities=20% Similarity=0.176 Sum_probs=87.0
Q ss_pred HHHHHhhccCCCccEEEeeeee----cCCCCCccccc-ccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGFIA----STPDNIPTTLK-RDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVI 164 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~i~----~~~~g~~~~lg-rggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~ 164 (330)
+.++.+++ .+.|||.+|.=| .+.++....+. ..++|.+|+.||.+++|+.++|+|||||||++++ .|++++
T Consensus 166 ~~I~~Ll~--~g~ivIa~GGGGIPV~~~~~~~~~gv~aViD~D~~Aa~LA~~l~Ad~LiiLTdVdGVy~~~~--~p~~k~ 241 (307)
T PRK12354 166 RPIRWLLE--KGHLVICAGGGGIPVVYDADGKLHGVEAVIDKDLAAALLAEQLDADLLLILTDVDAVYLDWG--KPTQRA 241 (307)
T ss_pred HHHHHHHH--CCCEEEEeCCCccCeEecCCCceeeeeecCCccHHHHHHHHHcCCCEEEEEeCCcceecCCC--CCCCeE
Confidence 78889998 788766653211 11123222211 2467999999999999999999999999999753 378899
Q ss_pred hhhhhhHHhhhhhhccccccccc---ccceeeecccceEEeeeccc-----cCceeEeeCC
Q 020132 165 LRTLSYQEAWEMSYFGANVLHPR---TIIPVMRYDIPIVIRNIFNL-----SVPGIMICRP 217 (330)
Q Consensus 165 i~~is~~e~~~l~~~g~~v~~p~---a~~~a~~~~i~v~i~~~~~~-----~~~GT~I~~~ 217 (330)
+++++.+|+.++ .+..+.|.|+ |++.+.+.+.+++|.+.... ...||+|.+.
T Consensus 242 i~~it~~e~~~~-~f~~GgM~pKV~AA~~~~~~gg~~viI~~~~~l~~al~G~~GT~I~~~ 301 (307)
T PRK12354 242 IAQATPDELREL-GFAAGSMGPKVEAACEFVRATGKIAGIGSLEDIQAILAGEAGTRISPE 301 (307)
T ss_pred CCCCCHHHHHhh-CCCcCChHHHHHHHHHHHHhCCCEEEECCHHHHHHHHCCCCceEEecC
Confidence 999999999888 5678899995 34444445556777654221 1269999763
No 93
>PRK09436 thrA bifunctional aspartokinase I/homoserine dehydrogenase I; Provisional
Probab=99.10 E-value=1.3e-10 Score=123.76 Aligned_cols=120 Identities=23% Similarity=0.318 Sum_probs=92.0
Q ss_pred cccceeeecccceEEeeeccccCceeEe-eCCCCCCC---------cccccccCCcccceeecceeEEeeecccccCCCC
Q 020132 187 RTIIPVMRYDIPIVIRNIFNLSVPGIMI-CRPPVDEN---------EDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPG 256 (330)
Q Consensus 187 ~a~~~a~~~~i~v~i~~~~~~~~~GT~I-~~~~~~~~---------~~~~~~~~~~~~i~~~~nia~IsvvG~~~~~~~g 256 (330)
+.+..+.++||++...+....+ ..-.+ .+.. +.. +..+.....++.+++.+|+++|+++|.+|+..+|
T Consensus 334 rIf~~La~~gI~V~mIsqssSe-~sIsf~V~~~-d~~~av~~L~~~f~~el~~~~~~~i~~~~~valIsvvG~gm~~~~g 411 (819)
T PRK09436 334 RVFAALSRAGISVVLITQSSSE-YSISFCVPQS-DAAKAKRALEEEFALELKEGLLEPLEVEENLAIISVVGDGMRTHPG 411 (819)
T ss_pred HHHHHHHHCCCcEEEEEcCCCC-ceEEEEEeHH-HHHHHHHHHHHHHHHHhccCCcceEEEeCCEEEEEEEccCcccCcC
Confidence 4566677889988777643222 12122 1211 100 0001112356789999999999999999999999
Q ss_pred chhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHHHh
Q 020132 257 TANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREAL 308 (330)
Q Consensus 257 v~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~~~ 308 (330)
+++|+|++|++.||||.||+|++|+++|||+|+++|.+++++.||+.|+.+-
T Consensus 412 v~arif~aL~~~~InI~~IsqgsSe~~Is~vV~~~d~~~al~~LH~~f~~~~ 463 (819)
T PRK09436 412 IAAKFFSALGRANINIVAIAQGSSERSISVVIDNDDATKALRACHQSFFLSD 463 (819)
T ss_pred HHHHHHHHHHHCCCCEEEEEeccccceEEEEEcHHHHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999999999999999999999997653
No 94
>KOG1154 consensus Gamma-glutamyl kinase [Amino acid transport and metabolism]
Probab=99.08 E-value=7.7e-11 Score=105.76 Aligned_cols=156 Identities=15% Similarity=0.243 Sum_probs=108.8
Q ss_pred eeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCc
Q 020132 39 VVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIP 118 (330)
Q Consensus 39 v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~ 118 (330)
+.|.|.----.++-..|.++|+++ .++.+ |+..+-+ +-.+......+.++|. -+.|||+. +|.-+
T Consensus 92 ~AAvGQ~~Lmalye~lF~Qy~~~i-----AQvLv-T~~Di~d-~~~r~Nl~~Ti~eLL~--m~viPIvN------eNDav 156 (285)
T KOG1154|consen 92 CAAVGQSGLMALYETLFTQYGITI-----AQVLV-TRNDILD-EQQRKNLQNTISELLS--MNVIPIVN------ENDAV 156 (285)
T ss_pred HHHhCcchHHHHHHHHHHHhccch-----heeee-cCcchhh-HHHHHHHHHHHHHHHh--CCceeeec------CCCcc
Confidence 455666544556677899999986 45544 4333311 0112223466777777 78999973 33322
Q ss_pred cc--ccccC---cchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhh-hhh-----hcccccccc-
Q 020132 119 TT--LKRDG---SDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAW-EMS-----YFGANVLHP- 186 (330)
Q Consensus 119 ~~--lgrgg---sD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~-~l~-----~~g~~v~~p- 186 (330)
.. .-+|. +|.+|+.+|..++||.++++|||||+||..|.. ..+++++..+..+.. +.. ..|.++|..
T Consensus 157 s~~~~~~~D~~dNDsLsA~laaei~ADlLilLsDVdglYt~PPd~-~~~~li~~~~~~~~~v~~tfG~~SkvGtGGM~tK 235 (285)
T KOG1154|consen 157 SPREIPFGDSSDNDSLAAILAAEIKADLLILLSDVDGLYTGPPDA-DPSKLIHTFSPGDPQVSTTFGSKSKVGTGGMETK 235 (285)
T ss_pred CCcccccCCCCcccHHHHHHHHHhccCEEEEEecccccccCCCCC-CcceeeeeeccCCCCCccccCccCccCcCcchhh
Confidence 11 33445 799999999999999999999999999965554 447888888776554 222 356789998
Q ss_pred -cccceeeecccceEEeeeccccCc
Q 020132 187 -RTIIPVMRYDIPIVIRNIFNLSVP 210 (330)
Q Consensus 187 -~a~~~a~~~~i~v~i~~~~~~~~~ 210 (330)
+|+..|...|+++.|.|+..|+..
T Consensus 236 v~AA~~A~~~Gv~viI~~g~~p~~I 260 (285)
T KOG1154|consen 236 VKAAVNALNAGVSVIITNGDAPENI 260 (285)
T ss_pred HHHHHHHhcCCceEEEeCCCChHHH
Confidence 488999999999999999888643
No 95
>PRK09411 carbamate kinase; Reviewed
Probab=99.08 E-value=3.1e-10 Score=106.66 Aligned_cols=118 Identities=18% Similarity=0.230 Sum_probs=86.5
Q ss_pred HHHHHhhccCCCccEEEeee--e--ecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGF--I--ASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~--i--~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i 165 (330)
+.++.+++ .|.|||.+|. + +.+.+|...+ .+.|.+|+.||.+|+|++++|+|||||||..++ .|+++++
T Consensus 167 ~~I~~Ll~--~G~IVI~~gGGGIPV~~~~~G~e~v---IDkD~~Aa~LA~~L~Ad~LIiLTDVdGV~~n~~--~p~~~~I 239 (297)
T PRK09411 167 EAIELLLK--EGHVVICSGGGGVPVTEDGAGSEAV---IDKDLAAALLAEQINADGLVILTDADAVYENWG--TPQQRAI 239 (297)
T ss_pred HHHHHHHH--CCCEEEecCCCCCCeEEcCCCeEEe---cCHHHHHHHHHHHhCCCEEEEEeCchhhccCCC--CCCCcCC
Confidence 78899998 7888777643 1 1222344343 357999999999999999999999999998642 4678999
Q ss_pred hhhhhHHhhhhhhccccccccc---ccceeeecccceEEeeeccc-----cCceeEee
Q 020132 166 RTLSYQEAWEMSYFGANVLHPR---TIIPVMRYDIPIVIRNIFNL-----SVPGIMIC 215 (330)
Q Consensus 166 ~~is~~e~~~l~~~g~~v~~p~---a~~~a~~~~i~v~i~~~~~~-----~~~GT~I~ 215 (330)
++++.+|+.++.. ..+.|.|+ |++.+...+.+++|.+..+. ...||+|.
T Consensus 240 ~~it~~e~~~~~~-~~GgM~pKVeAA~~~v~~~g~~a~I~~l~~~~~~l~G~~GT~I~ 296 (297)
T PRK09411 240 RHATPDELAPFAK-ADGAMGPKVTAVSGYVRSRGKPAWIGALSRIEETLAGEAGTCIS 296 (297)
T ss_pred CCcCHHHHHHhcc-CCCCcHHHHHHHHHHHHhCCCeEEECChhHHHHHHCCCCCeEEe
Confidence 9999999987765 45678885 44555556778888764321 12588874
No 96
>PRK12352 putative carbamate kinase; Reviewed
Probab=99.01 E-value=3.3e-10 Score=108.01 Aligned_cols=122 Identities=14% Similarity=0.142 Sum_probs=85.5
Q ss_pred HHHHHhhccCCCccEEEe-----eeeecCCCCCcccccc-cCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhh
Q 020132 90 KRLEKWFSQSPSNTIIAT-----GFIASTPDNIPTTLKR-DGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAV 163 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~-----G~i~~~~~g~~~~lgr-ggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~ 163 (330)
+.|+.+++ .+.|+|.+ +. +.+..|+..++.- -+.|..|+.+|.+|+|++|+|+|||+|||.++|+ ++++
T Consensus 177 ~~I~~ll~--~g~iVi~~ggggiPv-~~~~~g~~~n~~~nInaD~aAa~iA~aL~AdkLI~LTDV~GV~~d~~~--~~~~ 251 (316)
T PRK12352 177 PAIKALIQ--QGFVVIGAGGGGIPV-VRTDAGDYQSVDAVIDKDLSTALLAREIHADILVITTGVEKVCIHFGK--PQQQ 251 (316)
T ss_pred HHHHHHHH--CCCEEEecCCCCCCE-EeCCCCCccCceeeecHHHHHHHHHHHhCCCEEEEEeCchhhccCCCC--CCcc
Confidence 78888888 78885554 22 2233333322110 1379999999999999999999999999987654 6678
Q ss_pred hhhhhhhHHhhhhhhcc---ccccccc--ccceeeeccc-ceEEeeeccc-----cCceeEeeC
Q 020132 164 ILRTLSYQEAWEMSYFG---ANVLHPR--TIIPVMRYDI-PIVIRNIFNL-----SVPGIMICR 216 (330)
Q Consensus 164 ~i~~is~~e~~~l~~~g---~~v~~p~--a~~~a~~~~i-~v~i~~~~~~-----~~~GT~I~~ 216 (330)
++++++..|+.++...| .++|.|+ ++..+.+.|+ +++|.+.... ...||+|..
T Consensus 252 li~~lt~~e~~~li~~g~i~~GgM~pKl~aA~~al~~Gv~~v~I~~~~~i~~al~g~~GT~I~~ 315 (316)
T PRK12352 252 ALDRVDIATMTRYMQEGHFPPGSMLPKIIASLTFLEQGGKEVIITTPECLPAALRGETGTHIIK 315 (316)
T ss_pred cccccCHHHHHHHHhcCCcCCCCCHHHHHHHHHHHHhCCCeEEEcchHHHHHHHcCCCCeEEEe
Confidence 99999999999998754 4689984 4434445555 6888874321 126888853
No 97
>cd04892 ACT_AK-like_2 ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the second of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). The exception in this group, is the inclusion of the first ACT domain of the bifunctional aspartokinase - homoserine dehydrogenase-like enzyme group (ACT_AKi-HSDH-ThrA-like_1) which includes the monofunctional, threonine-sensitive, aspartokinase found in Methanococcus jannaschii and other related archaeal species. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. AK is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of AK with different repressors an
Probab=99.00 E-value=1.1e-09 Score=78.61 Aligned_cols=64 Identities=47% Similarity=0.733 Sum_probs=60.6
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
++|+++|.++...+++.+++|+.|++++|++.+++|+.++.+++|++++++.+++++.||+.|+
T Consensus 1 ~~i~i~g~~~~~~~~~~~~i~~~l~~~~i~v~~i~~~~~~~~i~~~v~~~~~~~~~~~l~~~~~ 64 (65)
T cd04892 1 ALVSVVGAGMRGTPGVAARIFSALAEAGINIIMISQGSSEVNISFVVDEDDADKAVKALHEEFF 64 (65)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEcCCCceeEEEEEeHHHHHHHHHHHHHHHh
Confidence 5799999999999999999999999999999999998778999999999999999999999885
No 98
>cd04936 ACT_AKii-LysC-BS-like_2 ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis strain 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive AK isoenzymes. The B. subtilis strain 168 AKII is induced by methionine and repressed and inhibited by lysine. Although C. glutamicum is known to contain a single AK, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is feedback regu
Probab=98.97 E-value=1.3e-09 Score=78.39 Aligned_cols=62 Identities=34% Similarity=0.554 Sum_probs=58.1
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
++|+++|.++.+.+++.+++|+.|++.||+++|+++ ++.+++|++++.|.+++++.||+.|+
T Consensus 1 ~~i~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~~--s~~~is~~v~~~d~~~~~~~l~~~~~ 62 (63)
T cd04936 1 AKVSIVGAGMRSHPGVAAKMFEALAEAGINIEMIST--SEIKISCLIDEDDAEKAVRALHEAFE 62 (63)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEc--cCceEEEEEeHHHHHHHHHHHHHHhc
Confidence 478999999999999999999999999999999985 57999999999999999999999984
No 99
>cd04923 ACT_AK-LysC-DapG-like_2 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the second and fourth, of four, ACT domains present in cyanobacteria AK. Also included are the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (B. subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.95 E-value=1.6e-09 Score=77.85 Aligned_cols=62 Identities=35% Similarity=0.554 Sum_probs=58.1
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
++|+++|.++...+++.+++|+.|++++|+++++++ ++.+++|+++++|.+++++.||+.|+
T Consensus 1 ~~v~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~~--s~~~is~~v~~~~~~~~~~~l~~~l~ 62 (63)
T cd04923 1 AKVSIVGAGMRSHPGVAAKMFKALAEAGINIEMIST--SEIKISCLVDEDDAEKAVRALHEAFE 62 (63)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEc--cCCeEEEEEeHHHHHHHHHHHHHHhc
Confidence 478999999999999999999999999999999984 58999999999999999999999984
No 100
>TIGR00656 asp_kin_monofn aspartate kinase, monofunctional class. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. The protein slr0657 from Synechocystis PCC6803 is extended by a duplication of the C-terminal region corresponding to the beta chain. Incorporation of a second copy of the C-terminal domain may be quite common in this subgroup of aspartokinases.
Probab=98.90 E-value=2.3e-09 Score=105.67 Aligned_cols=116 Identities=27% Similarity=0.436 Sum_probs=85.7
Q ss_pred cccceeeecccceEEeeeccccCceeEe-eCCCCCCCcccccc-----cCCcccceeecceeEEeeecccccCCCCchhh
Q 020132 187 RTIIPVMRYDIPIVIRNIFNLSVPGIMI-CRPPVDENEDEQII-----DSPVKGFATIDNLALVNVEGTGMAGVPGTANA 260 (330)
Q Consensus 187 ~a~~~a~~~~i~v~i~~~~~~~~~GT~I-~~~~~~~~~~~~~~-----~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~ 260 (330)
+.+..+.+++|++...+....+ ..-++ .+.. +.....+.. ...+..+.+++|+++|+++|.+|++.||++++
T Consensus 279 ~if~~L~~~~I~i~~i~~~~s~-~~Is~~V~~~-d~~~a~~~L~~~~~~~~~~~i~~~~~~a~IsvVG~~~~~~~g~~a~ 356 (401)
T TIGR00656 279 RIFGALAERNINVDLISQTPSE-TSISLTVDET-DADEAVRALKDQSGAAGLDRVEVEEGLAKVSIVGAGMVGAPGVASE 356 (401)
T ss_pred HHHHHHHHcCCcEEEEEcCCCC-ceEEEEEeHH-HHHHHHHHHHHHHHhcCCceEEEeCCeEEEEEECCCcccCccHHHH
Confidence 4556667788887776653322 12122 2211 110000100 11245678889999999999999999999999
Q ss_pred hhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHH
Q 020132 261 IFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFRE 306 (330)
Q Consensus 261 if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~ 306 (330)
+|++|+++|||+.+++ +|+.+++|+|+++|.+++++.||+.|+.
T Consensus 357 i~~~L~~~gIni~~i~--~s~~~is~vv~~~d~~~av~~Lh~~f~~ 400 (401)
T TIGR00656 357 IFSALEEKNINILMIG--SSETNISFLVDEKDAEKAVRKLHEVFEE 400 (401)
T ss_pred HHHHHHHCCCcEEEEE--cCCCEEEEEEeHHHHHHHHHHHHHHHcc
Confidence 9999999999999987 8899999999999999999999999864
No 101
>PRK04531 acetylglutamate kinase; Provisional
Probab=98.89 E-value=3.3e-09 Score=104.37 Aligned_cols=84 Identities=13% Similarity=0.209 Sum_probs=68.4
Q ss_pred HHHhhccCCCccEEEeeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhh-
Q 020132 92 LEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSY- 170 (330)
Q Consensus 92 i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~- 170 (330)
++.+++ .|.|||++++ +.+..|++.+++ +|..|+.||.+|+|++++++|||+|||+.| .+++++++.
T Consensus 122 I~~~L~--~g~IPVlspl-g~~~~G~~~Nvn---aD~vA~~LA~aL~a~KLIfltdv~GV~d~~------g~~i~~i~~~ 189 (398)
T PRK04531 122 VESSLR--AGSIPVIASL-GETPSGQILNIN---ADVAANELVSALQPYKIIFLTGTGGLLDAD------GKLISSINLS 189 (398)
T ss_pred HHHHHH--CCCEEEEeCc-EECCCCcEEEEC---HHHHHHHHHHHcCCCEEEEEECCCCccCCC------CCCcccCCHH
Confidence 666776 8999999987 777889888874 799999999999999999999999999753 578899986
Q ss_pred HHhhhhhhcc--ccccccc
Q 020132 171 QEAWEMSYFG--ANVLHPR 187 (330)
Q Consensus 171 ~e~~~l~~~g--~~v~~p~ 187 (330)
++...+...| .++|.|+
T Consensus 190 ~e~~~l~~~~~vtgGM~~K 208 (398)
T PRK04531 190 TEYDHLMQQPWINGGMKLK 208 (398)
T ss_pred HHHHHHHhcCCCCccHHHH
Confidence 5677775433 3677774
No 102
>PRK07431 aspartate kinase; Provisional
Probab=98.87 E-value=2.8e-09 Score=110.11 Aligned_cols=71 Identities=31% Similarity=0.469 Sum_probs=67.1
Q ss_pred ccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 233 KGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 233 ~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
..+.+++++++|++||.+|+.+||+++|+|++|+++||++.+++ +|+.+|||+|+++|.++++++||+.|+
T Consensus 511 ~~i~~~~~va~VSvVG~gm~~~~gv~~ri~~aL~~~~I~v~~i~--~S~~~Is~vV~~~~~~~av~~Lh~~f~ 581 (587)
T PRK07431 511 AEVEDGPAIAKVSIVGAGMPGTPGVAARMFRALADAGINIEMIA--TSEIRTSCVVAEDDGVKALQAVHQAFG 581 (587)
T ss_pred ceEEEeCCeEEEEEECCCccCCcCHHHHHHHHHHHCCCcEEEee--ccceEEEEEEeHHHHHHHHHHHHHHhc
Confidence 33677899999999999999999999999999999999999998 789999999999999999999999994
No 103
>COG2054 Uncharacterized archaeal kinase related to aspartokinases, uridylate kinases [General function prediction only]
Probab=98.84 E-value=2.7e-09 Score=92.52 Aligned_cols=83 Identities=25% Similarity=0.350 Sum_probs=72.6
Q ss_pred cchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccceeeecccceEEeeec
Q 020132 126 SDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIF 205 (330)
Q Consensus 126 sD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~ 205 (330)
||..++++|+.+++.++++.|||||||+.+|. ++++++|+..|..+ |-..++|-+-.++.++++.++++|+.
T Consensus 118 SDsis~~Ia~~~~~~~vv~aTDVdGI~~~~~~----~kLv~eI~A~dl~~----~~t~vD~~~P~Ll~k~~m~~~Vvng~ 189 (212)
T COG2054 118 SDSISVWIAAKAGATEVVKATDVDGIYEEDPK----GKLVREIRASDLKT----GETSVDPYLPKLLVKYKMNCRVVNGK 189 (212)
T ss_pred ccHHHHHHHHHcCCcEEEEEecCCcccccCCc----chhhhhhhHhhccc----CcccccchhhHHHHHcCCceEEECCC
Confidence 69999999999999999999999999998865 58999998887653 67889998889999999999999998
Q ss_pred ccc----------CceeEeeC
Q 020132 206 NLS----------VPGIMICR 216 (330)
Q Consensus 206 ~~~----------~~GT~I~~ 216 (330)
.|+ .+||.|.+
T Consensus 190 ~pervi~~lrGk~~v~T~Ivg 210 (212)
T COG2054 190 EPERVILALRGKEVVGTLIVG 210 (212)
T ss_pred CHHHHHHHHhccccceEEEeC
Confidence 774 46788764
No 104
>PLN02825 amino-acid N-acetyltransferase
Probab=98.84 E-value=2.8e-09 Score=107.69 Aligned_cols=108 Identities=9% Similarity=0.107 Sum_probs=83.5
Q ss_pred HHHhcCCcc----ccccceeEEEECCC--------CCC---C-CCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCC
Q 020132 54 VVRKNGIDC----KWMDTREVLIVNPT--------SSN---Q-VDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNI 117 (330)
Q Consensus 54 ~L~~~Gi~a----~~l~~~~~~~~~~~--------~~g---~-~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~ 117 (330)
.|++.|+++ ..+...+-..++.. .+| + .++|. +.|+.+++ .|.|||+++. |.+.+|+
T Consensus 112 ~l~~~G~~a~~~~~gl~~~~Gn~v~a~~~gv~dgvD~g~vG~V~~Vd~----~~i~~~L~--~g~Ipvispl-g~s~~Ge 184 (515)
T PLN02825 112 NLRRHGDNSRWHEVGVSVASGNFLAAKRRGVVNGVDFGATGEVKKIDV----SRIKERLD--SNCIVLLSNL-GYSSSGE 184 (515)
T ss_pred HHHhcCCCCccccCceEeccCcEEEEEECCCCcCccccceeeEEEEcH----HHHHHHHh--CCCeEEECCc-eECCCCC
Confidence 469999998 66766553222211 222 2 34555 88899998 8999999996 9999999
Q ss_pred cccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhhh
Q 020132 118 PTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSY 178 (330)
Q Consensus 118 ~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~ 178 (330)
+.++. +|..|+.+|.+|+|++++|+||++ +++. +.+++++++.+|+.++..
T Consensus 185 ~~Nin---aD~vA~avA~aL~A~KLI~ltd~~-~~~~------~g~li~~l~~~e~~~li~ 235 (515)
T PLN02825 185 VLNCN---TYEVATACALAIGADKLICIVDGP-ILDE------NGRLIRFMTLEEADMLIR 235 (515)
T ss_pred EEeeC---HHHHHHHHHHHcCCCeEEEEeCcc-eecC------CCCCcCcCCHHHHHHHHH
Confidence 99984 899999999999999999999977 5543 246889999988888864
No 105
>TIGR00657 asp_kinases aspartate kinase. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. This may be a feature of a number of closely related forms, including a paralog from B. subtilis.
Probab=98.81 E-value=6.6e-09 Score=103.81 Aligned_cols=116 Identities=26% Similarity=0.336 Sum_probs=86.2
Q ss_pred cccceeeecccceEEeeeccccCceeEeeCCCCCCCcccc-----cccCCcccceeecceeEEeeecccccCCCCchhhh
Q 020132 187 RTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQ-----IIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAI 261 (330)
Q Consensus 187 ~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~-----~~~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~i 261 (330)
+.+..+.++||++.......++ ....+.-...+...... .....++.+++.+|+++|+++|.+|.+.||+.+++
T Consensus 320 ~if~~L~~~~I~I~~i~q~~se-~sIs~~I~~~~~~~a~~~L~~~~~~~~~~~I~~~~~~a~VsvvG~~~~~~~g~~a~i 398 (441)
T TIGR00657 320 RVFGALAEAGINVDLITQSSSE-TSISFTVDKEDADQAKTLLKSELNLSALSSVEVEKGLAKVSLVGAGMKSAPGVASKI 398 (441)
T ss_pred HHHHHHHHcCCeEEEEEecCCC-ceEEEEEEHHHHHHHHHHHHHHHHhcCcceEEEcCCeEEEEEEcCCCCCCCchHHHH
Confidence 4556677888987766532222 12222111110000000 11245678999999999999999999999999999
Q ss_pred hhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 262 FGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 262 f~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
|+.|+++||||.||+ +|+.+|+|+|+++|.+++++.||++|+
T Consensus 399 f~~La~~~Inv~~i~--~se~~Is~vV~~~d~~~a~~~Lh~~f~ 440 (441)
T TIGR00657 399 FEALAQNGINIEMIS--SSEINISFVVDEKDAEKAVRLLHNALF 440 (441)
T ss_pred HHHHHHCCCCEEEEE--ecCCcEEEEEeHHHHHHHHHHHHHHhh
Confidence 999999999999998 468999999999999999999999986
No 106
>cd04868 ACT_AK-like ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes each of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). Typically, AK consists of two ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Aspartokinase is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of aspartokinase with different repressors and allosteric inhibitors. Pairs of ACT domains are proposed to specifically bind am
Probab=98.77 E-value=1.2e-08 Score=71.66 Aligned_cols=60 Identities=43% Similarity=0.680 Sum_probs=56.1
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALE 301 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh 301 (330)
++|+++|.+|...+++.+++|+.|++++|++++++|+.++.+++|++++++.+++++.||
T Consensus 1 ~~i~v~g~~~~~~~~~~~~i~~~l~~~~i~i~~i~~~~~~~~~s~~v~~~~~~~~~~~lh 60 (60)
T cd04868 1 AKVSIVGVGMRGTPGVAAKIFSALAEAGINVDMISQSESEVNISFTVDESDLEKAVKALH 60 (60)
T ss_pred CEEEEECCCCCCCCCHHHHHHHHHHHCCCcEEEEEcCCCcEEEEEEEeHHHHHHHHHHhC
Confidence 478999999989999999999999999999999999877799999999999999999887
No 107
>PRK09466 metL bifunctional aspartate kinase II/homoserine dehydrogenase II; Provisional
Probab=98.74 E-value=1.2e-08 Score=108.41 Aligned_cols=118 Identities=13% Similarity=0.138 Sum_probs=83.8
Q ss_pred cccceeeecccceEEeeeccccCceeEeeCCCCCCCcccccc--cCCcccceeecceeEEeeecccccCCCCchhhhhhh
Q 020132 187 RTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQII--DSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGA 264 (330)
Q Consensus 187 ~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~--~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~ 264 (330)
+.+..+.+++|++...+....+ ....+.-...+.+...+.. ......+.+++++++|++||.+|+.++|+++++|++
T Consensus 336 ~if~~l~~~~I~v~~i~~~~s~-~sis~~i~~~~~~~~~~~l~~~~~~~~i~v~~~~a~VsvVG~gm~~~~gv~~~~f~a 414 (810)
T PRK09466 336 ELDQLLKRAQLRPLAVGVHPDR-QLLQLAYTSEVADSALKLLDDAALPGELKLREGLALVALVGAGVTRNPLHCHRFYQQ 414 (810)
T ss_pred HHHHHHHHCCCeEEEEEecCCC-cEEEEEEeHHHHHHHHHHHHhhcCCCcEEEeCCeEEEEEeCCCcccCccHHHHHHHH
Confidence 4456667788887766544322 2223322111111000000 012366888999999999999999999999999999
Q ss_pred hcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHHHH
Q 020132 265 VKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFREA 307 (330)
Q Consensus 265 L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~~~ 307 (330)
|++.||++ ++|++|+++|||+|+++|.+++++.||+.|+..
T Consensus 415 L~~~~I~i--i~~~~s~~sis~vV~~~d~~~av~~LH~~f~~~ 455 (810)
T PRK09466 415 LKDQPVEF--IWQSEDGLSLVAVLRQGPTESLIQGLHQSLFRA 455 (810)
T ss_pred HHhCCCcE--EEEeCCCcEEEEEEehHHHHHHHHHHHHHHhCc
Confidence 99997766 455578999999999999999999999999764
No 108
>PRK08210 aspartate kinase I; Reviewed
Probab=98.73 E-value=1.8e-08 Score=99.52 Aligned_cols=114 Identities=23% Similarity=0.379 Sum_probs=83.6
Q ss_pred cccceeeecccceEEeeeccccCceeEeeCCCCCCCcccccccCCcccceeecceeEEeeecccccCCCCchhhhhhhhc
Q 020132 187 RTIIPVMRYDIPIVIRNIFNLSVPGIMICRPPVDENEDEQIIDSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVK 266 (330)
Q Consensus 187 ~a~~~a~~~~i~v~i~~~~~~~~~GT~I~~~~~~~~~~~~~~~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~ 266 (330)
+-+..+.++||++...+... + ..+...... +.+...+.....-..+.+.+|+++|+++|.+|++.||+++++|++|+
T Consensus 288 ~If~~L~~~~I~i~~i~~~~-~-~is~~v~~~-~~~~a~~~l~~~~~~v~~~~~~a~isvvG~~~~~~~g~~~~i~~aL~ 364 (403)
T PRK08210 288 EVFKALAEAGISVDFINIFP-T-EVVFTVSDE-DSEKAKEILENLGLKPSVRENCAKVSIVGAGMAGVPGVMAKIVTALS 364 (403)
T ss_pred HHHHHHHHcCCeEEEEEecC-c-eEEEEEcHH-HHHHHHHHHHHhCCcEEEeCCcEEEEEEcCCcCCCccHHHHHHHHHH
Confidence 45566778899877665542 2 233222211 11100000011111577889999999999999999999999999999
Q ss_pred ccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 267 DVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 267 ~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
++||++.+++ +|+.+++|+|+++|.+++++.||++|+
T Consensus 365 ~~~I~i~~~~--~s~~~is~vv~~~~~~~a~~~Lh~~f~ 401 (403)
T PRK08210 365 EEGIEILQSA--DSHTTIWVLVKEEDMEKAVNALHDAFE 401 (403)
T ss_pred hCCCCEEEEe--cCCCEEEEEEcHHHHHHHHHHHHHHhc
Confidence 9999999876 489999999999999999999999984
No 109
>cd04912 ACT_AKiii-LysC-EC-like_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC) and plants, (Zea mays Ask1, Ask2, and Arabidopsis thaliana AK1). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Like the A. thaliana AK1 (AK1-AT), the E. coli AKIII (LysC) has two bound feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The lysine-sensitive plant isoenzyme is synergistically inhibited by S-adenosylmethionine. A homolog of this group appears to be the Saccharomyces cerevisiae AK (Hom3) which clusters with this group as well. Members of this CD
Probab=98.64 E-value=6.3e-08 Score=73.11 Aligned_cols=64 Identities=25% Similarity=0.394 Sum_probs=56.1
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhH---HHHHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEV---KAVAEALESKFRE 306 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~---~~av~~Lh~~f~~ 306 (330)
+++|+++|.++...+|+.+++|++|+++||++++++ +|+.++||++++++. ...++.|-++|..
T Consensus 1 ~~~Vsi~g~~l~~~~g~~~~if~~L~~~~I~v~~i~--~s~~~is~~v~~~~~~~~~~~~~~~~~~l~~ 67 (75)
T cd04912 1 ITLLNIKSNRMLGAHGFLAKVFEIFAKHGLSVDLIS--TSEVSVSLTLDPTKNLSDQLLLDALVKDLSQ 67 (75)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHcCCeEEEEE--cCCcEEEEEEEchhhccchHHHHHHHHHHHh
Confidence 478999999999999999999999999999999998 468999999999987 5577777776654
No 110
>cd04933 ACT_AK1-AT_1 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the first of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine. This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. Like the Escherichia coli AKIII (LysC), Arabidopsis AK1 binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. A loop in common is involved in the binding of both Lys and S-adenosylmethionine providing an explanation for the synergistic inhibition by these effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.64 E-value=7.9e-08 Score=73.30 Aligned_cols=63 Identities=16% Similarity=0.324 Sum_probs=54.4
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHH------HHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVK------AVAEALESKFR 305 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~------~av~~Lh~~f~ 305 (330)
+++|++.+.++...||+.+++|+.|+++||+|+||+| ++.++||++++++.. .+++.|.++|.
T Consensus 1 ~~~i~i~~~~~~~~~g~~a~IF~~La~~~InVDmI~q--s~~sISftV~~sd~~~~~~~~~~l~~~~~~~~ 69 (78)
T cd04933 1 VTMLDITSTRMLGQYGFLAKVFSIFETLGISVDVVAT--SEVSISLTLDPSKLWSRELIQQELDHVVEELE 69 (78)
T ss_pred CEEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEe--cCCEEEEEEEhhhhhhhhhHHHHHHHHHHHHH
Confidence 3689999999999999999999999999999999997 579999999999984 46666665553
No 111
>PRK06635 aspartate kinase; Reviewed
Probab=98.62 E-value=5.8e-08 Score=95.89 Aligned_cols=117 Identities=24% Similarity=0.312 Sum_probs=86.3
Q ss_pred cccceeeecccceEEeeeccccC--ceeEeeCCCCCCCcccccc-----cCCcccceeecceeEEeeecccccCCCCchh
Q 020132 187 RTIIPVMRYDIPIVIRNIFNLSV--PGIMICRPPVDENEDEQII-----DSPVKGFATIDNLALVNVEGTGMAGVPGTAN 259 (330)
Q Consensus 187 ~a~~~a~~~~i~v~i~~~~~~~~--~GT~I~~~~~~~~~~~~~~-----~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a 259 (330)
+.+..+.++||++...++..++. ..-.+.-...+.+...+.. .-.++.+++.+|+++|+++|.+|++.||+++
T Consensus 279 ~i~~~L~~~~I~i~~is~s~~~~~~~~is~~v~~~~~~~a~~~L~~~~~~~~~~~i~~~~~ia~isvvG~~~~~~~g~~a 358 (404)
T PRK06635 279 QIFGALAEANINVDMIVQNVSEDGKTDITFTVPRDDLEKALELLEEVKDEIGAESVTYDDDIAKVSVVGVGMRSHPGVAA 358 (404)
T ss_pred HHHHHHHHcCCeEEEEEecCCCCCceeEEEEEcHHHHHHHHHHHHHHHHHcCcceEEEcCCeEEEEEECCCCCCCchHHH
Confidence 44566778899888776654331 1222211111001011101 1135678899999999999999999999999
Q ss_pred hhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 260 AIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 260 ~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
++|++|+++||||.+++ +|+.+++|+++++|.+++++.||++|.
T Consensus 359 ~i~~~La~~~Ini~~i~--ss~~~is~vv~~~d~~~a~~~Lh~~f~ 402 (404)
T PRK06635 359 KMFEALAEEGINIQMIS--TSEIKISVLIDEKYLELAVRALHEAFG 402 (404)
T ss_pred HHHHHHHHCCCCEEEEE--ecCCeEEEEEcHHHHHHHHHHHHHHHC
Confidence 99999999999999998 478999999999999999999999984
No 112
>cd04932 ACT_AKiii-LysC-EC_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.53 E-value=1.7e-07 Score=70.89 Aligned_cols=62 Identities=23% Similarity=0.319 Sum_probs=51.7
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHH--HHHH-HHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVK--AVAE-ALESKF 304 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~--~av~-~Lh~~f 304 (330)
+++|++.|.++...||+.+++|+.|+++||+|+||+| ++.++||+++.++.. ++++ .|-+.|
T Consensus 1 ~~~ItI~~~~~~~~~g~~~~IF~~La~~~I~VDmI~~--s~~~iSftv~~~d~~~~~~~~~~l~~~l 65 (75)
T cd04932 1 QTLVTLKSPNMLHAQGFLAKVFGILAKHNISVDLITT--SEISVALTLDNTGSTSDQLLTQALLKEL 65 (75)
T ss_pred CEEEEEecCCCCCCcCHHHHHHHHHHHcCCcEEEEee--cCCEEEEEEeccccchhHHHHHHHHHHH
Confidence 4789998888999999999999999999999999997 569999999998853 2443 455544
No 113
>cd04934 ACT_AK-Hom3_1 CT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydro
Probab=98.50 E-value=2.4e-07 Score=69.80 Aligned_cols=64 Identities=19% Similarity=0.239 Sum_probs=56.1
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHH-HHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKA-VAEALESKFRE 306 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~-av~~Lh~~f~~ 306 (330)
++.|++.+.+|...+|+.+++|+.|+++||+++||+| ++.++||++++++... .++.|.+++..
T Consensus 1 ~~~I~i~~~~m~~~~g~~~~If~~la~~~I~vd~I~~--s~~~isftv~~~~~~~~~l~~l~~el~~ 65 (73)
T cd04934 1 ILVINIHSNKKSLSHGFLARIFAILDKYRLSVDLIST--SEVHVSMALHMENAEDTNLDAAVKDLQK 65 (73)
T ss_pred CEEEEEEcccCccccCHHHHHHHHHHHcCCcEEEEEe--CCCEEEEEEehhhcChHHHHHHHHHHHH
Confidence 4678999999999999999999999999999999997 5699999999988755 77777777654
No 114
>cd04913 ACT_AKii-LysC-BS-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive aspartokinase isoenzymes. The B. subtilis 168 AKII is induced by methionine and repressed and inhibited by lysine. Although Corynebacterium glutamicum is known to contain a single aspartokinase, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is fee
Probab=98.47 E-value=4.2e-07 Score=67.10 Aligned_cols=61 Identities=34% Similarity=0.550 Sum_probs=54.6
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCC---cceeeeecchhhHHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPEKEVKAVAEALESK 303 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s---e~sIS~vv~~~d~~~av~~Lh~~ 303 (330)
+++|+++| +.+.+|+.+++|+.|+++||++++++|+.+ ..+++|+++++|.+.+++.||+.
T Consensus 1 ~~~v~v~~--~~~~~g~~~~i~~~L~~~~I~i~~i~~~~~~~~~~~is~~v~~~d~~~~~~~l~~~ 64 (75)
T cd04913 1 QAKITLRG--VPDKPGVAAKIFGALAEANINVDMIVQNVSRDGTTDISFTVPKSDLKKALAVLEKL 64 (75)
T ss_pred CeEEEECC--CCCCCcHHHHHHHHHHHcCCeEEEEEeCCCCCCcEEEEEEecHHHHHHHHHHHHHH
Confidence 36888987 678899999999999999999999999766 35799999999999999999994
No 115
>cd04891 ACT_AK-LysC-DapG-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the first and third, of four, ACT domains present in cyanobacteria AK. Also included are the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (Bacillus subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.47 E-value=3.3e-07 Score=64.80 Aligned_cols=57 Identities=35% Similarity=0.599 Sum_probs=50.8
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCc---ceeeeecchhhHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE---HSVCFAVPEKEVKAVAEAL 300 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se---~sIS~vv~~~d~~~av~~L 300 (330)
++|+++| +.+.+|+.+++|+.|+++||++++++|+.+. .+++|+++++|.+++++.|
T Consensus 1 ~~v~v~~--~~~~~~~~~~i~~~L~~~~i~i~~i~~~~~~~~~~~is~~v~~~~~~~~~~~l 60 (61)
T cd04891 1 AQVTIKG--VPDKPGVAAKIFSALAEAGINVDMIVQSVSRGGTTDISFTVPKSDLEKALAIL 60 (61)
T ss_pred CEEEEec--CCCCCcHHHHHHHHHHHcCCcEEEEEEcCCCCCcEEEEEEEeHHHHHHHHHHh
Confidence 4678877 6788999999999999999999999998765 8899999999999988765
No 116
>cd04935 ACT_AKiii-DAPDC_1 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. This CD includes the first of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.44 E-value=4.3e-07 Score=68.72 Aligned_cols=64 Identities=27% Similarity=0.387 Sum_probs=54.3
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhh--HHH-HHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKE--VKA-VAEALESKFRE 306 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d--~~~-av~~Lh~~f~~ 306 (330)
+++|++.+.+|...+|+.+++|+.|++++|+++||+| ++.++||++++++ ... .++.|-+++..
T Consensus 1 ~~~i~i~~~~~~~~~g~~~~IF~~La~~~I~vDmI~~--s~~~isftv~~~~~~~~~~~~~~l~~el~~ 67 (75)
T cd04935 1 IRLVSMETLGMWQQVGFLADVFAPFKKHGVSVDLVST--SETNVTVSLDPDPNGLDPDVLDALLDDLNQ 67 (75)
T ss_pred CEEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEe--CCCEEEEEEeCcccccchHHHHHHHHHHHh
Confidence 3689999999999999999999999999999999996 5699999999988 333 66666666543
No 117
>cd04890 ACT_AK-like_1 ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the first of two ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids, lysine, threonine, methionine, and isoleucine. This CD, includes the first ACT domain of the Escherichia coli (EC) isoenzyme, AKIII (LysC) and the Arabidopsis isoenzyme, asparate kinase 1, both enzymes monofunctional and involved in lysine synthesis, as well as the the first ACT domain of Bacillus subtilis (BS) isoenzyme, AKIII (YclM), and of the Saccharomyces cerevisiae AK (Hom3). Also included are the first ACT domains of the Methylomicrobium alcaliphilum AK, the first enzyme of the ectoine biosynthetic pathway. Members of this CD bel
Probab=98.41 E-value=6.1e-07 Score=64.73 Aligned_cols=60 Identities=22% Similarity=0.274 Sum_probs=53.7
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHH
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKF 304 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f 304 (330)
.|++.|.+|...+|+.+++|+.|++++|+++||+| ++.++||+++..+.++.++.|-+++
T Consensus 2 ~i~i~~~~m~~~~~~~~~if~~l~~~~i~v~~i~t--~~~~is~~v~~~~~~~~~~~l~~~l 61 (62)
T cd04890 2 AIEIFDQLMNGEVGFLRKIFEILEKHGISVDLIPT--SENSVTLYLDDSLLPKKLKRLLAEL 61 (62)
T ss_pred EEEEeccccCcccCHHHHHHHHHHHcCCeEEEEec--CCCEEEEEEehhhhhHHHHHHHHhh
Confidence 57899999999999999999999999999999985 5799999999999888887776643
No 118
>COG0549 ArcC Carbamate kinase [Amino acid transport and metabolism]
Probab=98.23 E-value=2e-06 Score=79.86 Aligned_cols=122 Identities=20% Similarity=0.264 Sum_probs=85.4
Q ss_pred HHHHHhhccCCCccEEEeeeeec----CCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGFIAS----TPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVIL 165 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~i~~----~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i 165 (330)
+.|+.+++ +|.++|..|-=|. +..|..-.=.--+-|.+++.||..++||.++|+||||+||-.=-+ |+.+.+
T Consensus 175 ~~Ik~L~~--~g~vVI~~GGGGIPVv~~~~~~~GVeAVIDKDlasalLA~~i~AD~liILTdVd~Vy~n~gk--p~q~~L 250 (312)
T COG0549 175 EAIKALLE--SGHVVIAAGGGGIPVVEEGAGLQGVEAVIDKDLASALLAEQIDADLLIILTDVDAVYVNFGK--PNQQAL 250 (312)
T ss_pred HHHHHHHh--CCCEEEEeCCCCcceEecCCCcceeeEEEccHHHHHHHHHHhcCCEEEEEeccchheecCCC--ccchhh
Confidence 67888887 7788877763111 111100000011359999999999999999999999999976322 678899
Q ss_pred hhhhhHHhhhhhh---ccccccccc---ccceeeecccceEEeeeccc-----cCceeEee
Q 020132 166 RTLSYQEAWEMSY---FGANVLHPR---TIIPVMRYDIPIVIRNIFNL-----SVPGIMIC 215 (330)
Q Consensus 166 ~~is~~e~~~l~~---~g~~v~~p~---a~~~a~~~~i~v~i~~~~~~-----~~~GT~I~ 215 (330)
+.++.+|+++... |..+-|-|+ |+......|=+..|.+..+. ...||.|.
T Consensus 251 ~~v~~~e~~~yl~eg~Fa~GSM~PKVeAai~Fv~~~gk~A~ItsLe~~~~~l~g~~GT~I~ 311 (312)
T COG0549 251 DRVTVDEMEKYLAEGQFAAGSMGPKVEAAISFVENTGKPAIITSLENAEAALEGKAGTVIV 311 (312)
T ss_pred cccCHHHHHHHHhcCCCCCCCccHHHHHHHHHHHcCCCceEECcHHHHHHHhccCCCcEec
Confidence 9999999888875 345788885 66777766777877765432 24588875
No 119
>cd04914 ACT_AKi-DapG-BS_1 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria, bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The B. subtilis AKI is tetrameric consisting of two alpha and
Probab=98.16 E-value=4.5e-06 Score=61.65 Aligned_cols=57 Identities=21% Similarity=0.337 Sum_probs=47.9
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~ 302 (330)
++|++.| ..+.+|+.+++|+.|+++||+++||+|. ++ ++||+++..|.+++.+.|.+
T Consensus 2 ~~vtv~~--~~~~~~~~a~if~~La~~~InvDmI~~~-~~-~isFtv~~~d~~~~~~il~~ 58 (67)
T cd04914 2 TQIKVKA--KDNENDLQQRVFKALANAGISVDLINVS-PE-EVIFTVDGEVAEKAVDILEK 58 (67)
T ss_pred eEEEEec--CCCCccHHHHHHHHHHHcCCcEEEEEec-CC-CEEEEEchhhHHHHHHHHHH
Confidence 6788877 4466899999999999999999999876 34 79999999999998666544
No 120
>PRK09084 aspartate kinase III; Validated
Probab=98.09 E-value=6.1e-06 Score=82.75 Aligned_cols=77 Identities=19% Similarity=0.229 Sum_probs=65.5
Q ss_pred CcccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhH-HHHHHHHHHHHHHHhc
Q 020132 231 PVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEV-KAVAEALESKFREALN 309 (330)
Q Consensus 231 ~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~-~~av~~Lh~~f~~~~~ 309 (330)
.+++|+..+|+++|++.|.+|...+|+++++|+.|++++|+|+||+| |+.+|||++++++. .++...+++++..+++
T Consensus 296 ~v~~it~~~~i~lItv~~~~~~~~~g~~a~if~~l~~~~I~Vd~I~s--se~sIs~~i~~~~~~~~~~~~~~~~l~~el~ 373 (448)
T PRK09084 296 LFRAIALRRNQTLLTLHSLNMLHARGFLAEVFGILARHKISVDLITT--SEVSVSLTLDTTGSTSTGDTLLTQALLTELS 373 (448)
T ss_pred eeEEEEeeCCEEEEEEecCCCCccccHHHHHHHHHHHcCCeEEEEec--cCcEEEEEEechhhhhhhhHHHHHHHHHHHh
Confidence 58899999999999999999999999999999999999999999995 58999999999984 3455555555555543
No 121
>PLN02551 aspartokinase
Probab=98.03 E-value=9e-06 Score=82.85 Aligned_cols=64 Identities=19% Similarity=0.349 Sum_probs=59.5
Q ss_pred CCcccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHH
Q 020132 230 SPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKA 295 (330)
Q Consensus 230 ~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~ 295 (330)
..+++|+..+|+++|++.|.+|.+.+|+++++|+.|+++||+|+||+| |+.+|||+++.++...
T Consensus 355 ~~v~~It~~~~v~li~i~~~~m~~~~g~~arvf~~l~~~~I~Vd~Iss--Se~sIs~~v~~~~~~~ 418 (521)
T PLN02551 355 AVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSISLTLDPSKLWS 418 (521)
T ss_pred CcccceecCCCeEEEEEecCCCCCcccHHHHHHHHHHHcCCcEEEEec--cCCEEEEEEehhHhhh
Confidence 458999999999999999999999999999999999999999999984 5899999999998755
No 122
>PRK09181 aspartate kinase; Validated
Probab=97.89 E-value=1.9e-05 Score=79.58 Aligned_cols=72 Identities=18% Similarity=0.206 Sum_probs=63.4
Q ss_pred CcccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchh--hHHHHHHHHHHHH
Q 020132 231 PVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEK--EVKAVAEALESKF 304 (330)
Q Consensus 231 ~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~--d~~~av~~Lh~~f 304 (330)
.++.|+..+|+++|++.|.+|...+|+.+++|+.|++++|+|+|++ +|+.++||+++.+ +.+++++.|++.|
T Consensus 319 ~ik~It~~~~~~~i~i~~~~~~~~~g~~~~if~~l~~~~i~v~~i~--ss~~sis~~v~~~~~~~~~~~~~L~~~~ 392 (475)
T PRK09181 319 RVEIIAGSDKVFALEVFDQDMVGEDGYDLEILEILTRHKVSYISKA--TNANTITHYLWGSLKTLKRVIAELEKRY 392 (475)
T ss_pred cceeEeccCCEEEEEEcCCCCCCcchHHHHHHHHHHHcCCeEEEEE--ecCcEEEEEEcCChHHHHHHHHHHHHhc
Confidence 4788999999999999999999999999999999999999999997 4589999999987 3567777777665
No 123
>PRK08961 bifunctional aspartate kinase/diaminopimelate decarboxylase protein; Provisional
Probab=97.68 E-value=6.7e-05 Score=81.09 Aligned_cols=73 Identities=30% Similarity=0.357 Sum_probs=63.9
Q ss_pred CCcccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHH---HHHHHHHHHH
Q 020132 230 SPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVK---AVAEALESKF 304 (330)
Q Consensus 230 ~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~---~av~~Lh~~f 304 (330)
..+++|+..+|+++|++.|.+|...+|+++++|+.|++++|+|+||+ +|+.++||++++.+.. ++++.+.+.|
T Consensus 311 ~~v~~It~~~~v~lItv~~~~~~~~~g~~a~if~~la~~~I~Vd~I~--sse~sis~~i~~~~~~~~~~~~~~l~~~l 386 (861)
T PRK08961 311 PGVKAISRKNGIVLVSMETIGMWQQVGFLADVFTLFKKHGLSVDLIS--SSETNVTVSLDPSENLVNTDVLAALSADL 386 (861)
T ss_pred CcceeEEEECCEEEEEEecCCccccccHHHHHHHHHHHcCCeEEEEE--cCCCEEEEEEccccccchHHHHHHHHHHH
Confidence 45899999999999999999999999999999999999999999998 4689999999998753 5666666554
No 124
>cd04910 ACT_AK-Ectoine_1 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinase
Probab=97.28 E-value=0.00062 Score=50.88 Aligned_cols=64 Identities=20% Similarity=0.253 Sum_probs=58.2
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
..|.+-+.+|.+.+|+.++||+.|+++++++.+...++.++++++..+.+..++++..|++.|.
T Consensus 2 ~alevfdqdMvG~~g~d~~i~~~l~~~~v~ii~K~~nANtit~yl~~~~k~~~r~~~~Le~~~p 65 (71)
T cd04910 2 FALEVFDQDMVGEVGYDLEILELLQRFKVSIIAKDTNANTITHYLAGSLKTIKRLTEDLENRFP 65 (71)
T ss_pred eEEEEeCCCccCChhHHHHHHHHHHHcCCeEEEEecCCCeEEEEEEcCHHHHHHHHHHHHHhCc
Confidence 3467888999999999999999999999999999988889999999999999999999999874
No 125
>PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C ....
Probab=96.97 E-value=0.00095 Score=47.85 Aligned_cols=54 Identities=26% Similarity=0.342 Sum_probs=46.0
Q ss_pred cccCCCCchhhhhhhhcccCccEEEEeccCCc-----ceeeeecchhhHHHHHHHHHHH
Q 020132 250 GMAGVPGTANAIFGAVKDVGANVIMISQASSE-----HSVCFAVPEKEVKAVAEALESK 303 (330)
Q Consensus 250 ~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se-----~sIS~vv~~~d~~~av~~Lh~~ 303 (330)
.+.+.||+++++++.|+++|+||.++.|..+. ..+.+..+..+..++++.|++.
T Consensus 6 ~~~drpG~l~~v~~~la~~~inI~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 64 (66)
T PF01842_consen 6 IVPDRPGILADVTEILADHGINIDSISQSSDKDGVGIVFIVIVVDEEDLEKLLEELEAL 64 (66)
T ss_dssp EEETSTTHHHHHHHHHHHTTEEEEEEEEEEESSTTEEEEEEEEEEGHGHHHHHHHHHHH
T ss_pred EcCCCCCHHHHHHHHHHHcCCCHHHeEEEecCCCceEEEEEEECCCCCHHHHHHHHHcc
Confidence 36789999999999999999999999987653 4566667888999999999874
No 126
>PRK05925 aspartate kinase; Provisional
Probab=96.86 E-value=0.0019 Score=64.73 Aligned_cols=70 Identities=14% Similarity=0.240 Sum_probs=55.5
Q ss_pred CCcccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhH-HHHHHHHHHH
Q 020132 230 SPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEV-KAVAEALESK 303 (330)
Q Consensus 230 ~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~-~~av~~Lh~~ 303 (330)
..+++|+..+|+++|++.+.. ..+++++++|+.|+++||+|++++ +++.+|||++++++. ..+++.|.+.
T Consensus 289 ~~ik~It~~~~~~~i~v~~~~--~~~~~~~~if~~l~~~~I~vd~i~--s~~~sis~~i~~~~~~~~~~~~l~~~ 359 (440)
T PRK05925 289 PRIKALSLKQNQALWSVDYNS--LGLVRLEDVLGILRSLGIVPGLVM--AQNLGVYFTIDDDDISEEYPQHLTDA 359 (440)
T ss_pred CceEEEEEeCCEEEEEEecCC--cchhHHHHHHHHHHHcCCcEEEEe--ccCCEEEEEEechhccHHHHHHHHHH
Confidence 358899999999999997643 357788999999999999999985 346799999999876 3355555443
No 127
>cd04911 ACT_AKiii-YclM-BS_1 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Bacillus subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from Bacillus subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=96.69 E-value=0.0022 Score=48.57 Aligned_cols=70 Identities=10% Similarity=0.219 Sum_probs=55.1
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHH-HHHHHHHHHHHHhccCcc
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKA-VAEALESKFREALNAGRL 313 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~-av~~Lh~~f~~~~~~~~i 313 (330)
+.|++.-..|....||..|+++.|.++||+++++. ++--++|++++++++.. .++.+-+++..++....+
T Consensus 2 ~~I~i~K~~Mn~evGF~rk~L~I~E~~~is~Eh~P--SGID~~Siii~~~~~~~~~~~~i~~~i~~~~~pD~i 72 (76)
T cd04911 2 CSIYISKYLMNREVGFGRKLLSILEDNGISYEHMP--SGIDDISIIIRDNQLTDEKEQKILAEIKEELHPDEI 72 (76)
T ss_pred ceEehhHhhccchhcHHHHHHHHHHHcCCCEeeec--CCCccEEEEEEccccchhhHHHHHHHHHHhcCCCEE
Confidence 34566667788888999999999999999999997 67889999999997776 666555556665554443
No 128
>COG3830 ACT domain-containing protein [Signal transduction mechanisms]
Probab=96.57 E-value=0.0034 Score=48.75 Aligned_cols=67 Identities=19% Similarity=0.174 Sum_probs=54.8
Q ss_pred ceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCC--cceeeeecchhhHHHHHHHHHHHHHHHhc
Q 020132 240 NLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVPEKEVKAVAEALESKFREALN 309 (330)
Q Consensus 240 nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s--e~sIS~vv~~~d~~~av~~Lh~~f~~~~~ 309 (330)
..++|++.|. ++||+.+.+++.|+++|+||.-|+|..- -.++-++++-.+...-..++.+++..+.+
T Consensus 2 ~~avITV~Gk---Dr~GIva~is~vLAe~~vNIldisQtvm~~~ftm~~lV~~~~~~~d~~~lr~~l~~~~~ 70 (90)
T COG3830 2 MRAVITVIGK---DRVGIVAAVSRVLAEHGVNILDISQTVMDGFFTMIMLVDISKEVVDFAALRDELAAEGK 70 (90)
T ss_pred ceEEEEEEcC---CCCchhHHHHHHHHHcCCcEEEHHHHHHhhhceeeeEEcCChHhccHHHHHHHHHHHHH
Confidence 4689999995 6899999999999999999999999764 47777888877777777777777665543
No 129
>KOG2436 consensus Acetylglutamate kinase/acetylglutamate synthase [Amino acid transport and metabolism]
Probab=95.74 E-value=0.0088 Score=59.80 Aligned_cols=119 Identities=13% Similarity=0.053 Sum_probs=83.7
Q ss_pred eccchhHHHHHHHHHHhcCCccccccceeEE--EEC-C-------CCCCC----CCCCchhhHHHHHHhhccCCCccEEE
Q 020132 41 GHGELWSAQMLAAVVRKNGIDCKWMDTREVL--IVN-P-------TSSNQ----VDPDFSESEKRLEKWFSQSPSNTIIA 106 (330)
Q Consensus 41 ~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~--~~~-~-------~~~g~----~~~~~~~~~~~i~~~l~~~~~~VpVv 106 (330)
-+||.- .-+...|++.|-.+++......- .++ + ..||. .+++. ++++.+++ .|.+|++
T Consensus 170 ~~~E~n--~~lv~nL~~~g~~ar~~s~g~~v~~~f~a~~~~v~d~~~y~~~gei~~vd~----d~i~~l~~--~G~mp~L 241 (520)
T KOG2436|consen 170 VSLEAN--LNLVINLSQLGTRARPSSSGVRVGNFFPADRNGVLDGEDYGLVGEIKKVDV----DRIRHLLD--AGSMPLL 241 (520)
T ss_pred chhhhh--hHHHHHHHHhhceeccccccccccceeecccccccccceeeeecccceech----hhhhhhhh--CCCchhe
Confidence 456773 33778889999999888766221 111 1 12221 23444 88888887 8999998
Q ss_pred eeeeecCCCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccccCccchhHhhhhhhhhhHHhhhhh
Q 020132 107 TGFIASTPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMS 177 (330)
Q Consensus 107 ~G~i~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~ 177 (330)
... +.+..|+++|+ ++|..|..+|.+|+|+++++++|+ |.+-. .+.+.++.++.+|...+.
T Consensus 242 ~sl-a~TaSGqvlnv---Na~~~a~elA~~L~~~kli~l~d~-g~~l~-----e~ge~~S~l~l~~e~~~l 302 (520)
T KOG2436|consen 242 RSL-AATASGQVLNV---NADEVAGELALALGPDKLILLMDK-GRILK-----ENGEDISSLILQEEDAGL 302 (520)
T ss_pred hhh-cccCccceEEe---eHHHHhhHHHhccCcceeEEeccc-ccccc-----cCcccccccccchhHhhh
Confidence 886 88889999987 389999999999999999999997 55433 234556666655554444
No 130
>cd04888 ACT_PheB-BS C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and related domains. This CD includes the C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and other related ACT domains. In B. subtilis, the upstream gene of pheB, pheA encodes prephenate dehydratase (PDT). The presumed product of the pheB gene is chorismate mutase (CM). The deduced product of the B. subtilis pheB gene, however, has no significant homology to the CM portion of the bifunctional CM-PDT of Escherichia coli. The presence of an ACT domain lends support to the prediction that these proteins function as a phenylalanine-binding regulatory protein. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=95.52 E-value=0.026 Score=41.66 Aligned_cols=54 Identities=17% Similarity=0.342 Sum_probs=42.3
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC---cceeeeecchhhHHHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPEKEVKAVAEALESKF 304 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s---e~sIS~vv~~~d~~~av~~Lh~~f 304 (330)
+.+.||+++++++.|++.|+++.+++|... ...++|.++..+.+..++.|.+.+
T Consensus 7 ~~d~~g~l~~I~~~la~~~inI~~i~~~~~~~~~~~i~~~v~v~~~~~~l~~l~~~L 63 (76)
T cd04888 7 LEHRPGVLSKVLNTIAQVRGNVLTINQNIPIHGRANVTISIDTSTMNGDIDELLEEL 63 (76)
T ss_pred ecCCCchHHHHHHHHHHcCCCEEEEEeCCCCCCeEEEEEEEEcCchHHHHHHHHHHH
Confidence 346799999999999999999999997432 366888888888875666665544
No 131
>PRK08841 aspartate kinase; Validated
Probab=95.10 E-value=0.031 Score=55.26 Aligned_cols=58 Identities=17% Similarity=0.264 Sum_probs=50.0
Q ss_pred CCcccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHH
Q 020132 230 SPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAV 296 (330)
Q Consensus 230 ~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~a 296 (330)
..+++|+..+|+++|++.|. ..+++|+.|+++||++++++| +..+++|++++.+..++
T Consensus 247 ~~i~~i~~~~~~~~i~v~~~-------~~~~i~~~l~~~~i~v~~i~~--~~~~~~~~v~~~~~~~~ 304 (392)
T PRK08841 247 QAVCGIALQRDLALIEVESE-------SLPSLTKQCQMLGIEVWNVIE--EADRAQIVIKQDACAKL 304 (392)
T ss_pred CcEEEEEEeCCeEEEEeccc-------hHHHHHHHHHHcCCCEEEEEe--cCCcEEEEECHHHHHHH
Confidence 46899999999999999763 368999999999999999986 46889999999887664
No 132
>COG3603 Uncharacterized conserved protein [Function unknown]
Probab=94.87 E-value=0.079 Score=43.23 Aligned_cols=69 Identities=17% Similarity=0.226 Sum_probs=57.8
Q ss_pred cccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHH
Q 020132 232 VKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESK 303 (330)
Q Consensus 232 ~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~ 303 (330)
...|.+..+-..+.+.|.---+.+|+++.+.+.|+++||.|..+|.- ..=-++|+++|.++|+++|.+.
T Consensus 54 p~~V~~~~GW~~lk~~gpf~FgltGilasV~~pLsd~gigIFavSty---dtDhiLVr~~dLekAv~~L~ea 122 (128)
T COG3603 54 PDVVQIEKGWSCLKFEGPFDFGLTGILASVSQPLSDNGIGIFAVSTY---DTDHILVREEDLEKAVKALEEA 122 (128)
T ss_pred CcceEecCCeEEEEEeccccCCcchhhhhhhhhHhhCCccEEEEEec---cCceEEEehhhHHHHHHHHHHc
Confidence 44567778889999999877788999999999999999999999833 2234778999999999999874
No 133
>cd04908 ACT_Bt0572_1 N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains. Included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains as seen in the uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related ACT domains. These tandem ACT domain proteins belong to the superfamily of ACT regulatory domains.
Probab=94.04 E-value=0.12 Score=37.44 Aligned_cols=52 Identities=19% Similarity=0.270 Sum_probs=38.3
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~ 302 (330)
+.+.||.++++.+.|+++|+||..+.-...+....+.+.-++.+++.+.|.+
T Consensus 8 v~d~pG~La~v~~~l~~~~inI~~i~~~~~~~~~~~rl~~~~~~~~~~~L~~ 59 (66)
T cd04908 8 LENKPGRLAAVTEILSEAGINIRALSIADTSEFGILRLIVSDPDKAKEALKE 59 (66)
T ss_pred EcCCCChHHHHHHHHHHCCCCEEEEEEEecCCCCEEEEEECCHHHHHHHHHH
Confidence 7789999999999999999999766533332245555555666778877765
No 134
>PRK13562 acetolactate synthase 1 regulatory subunit; Provisional
Probab=94.03 E-value=0.13 Score=39.69 Aligned_cols=52 Identities=19% Similarity=0.203 Sum_probs=40.1
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCCc----ceeeeecc---hhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASSE----HSVCFAVP---EKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~se----~sIS~vv~---~~d~~~av~~Lh~ 302 (330)
..+.||+++|+...|++.|.||+.++-+.++ .++++++. +..+++..+.|++
T Consensus 9 VeN~~GVL~Rit~lFsRRg~NI~SLtvg~Te~~~iSRmtivv~~~d~~~ieqI~kQL~K 67 (84)
T PRK13562 9 VADQVSTLNRITSAFVRLQYNIDTLHVTHSEQPGISNMEIQVDIQDDTSLHILIKKLKQ 67 (84)
T ss_pred EECCCCHHHHHHHHHhccCcCeeeEEecccCCCCceEEEEEEeCCCHHHHHHHHHHHhC
Confidence 5678999999999999999999999987764 37778775 2333555655555
No 135
>cd02116 ACT ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-p
Probab=93.87 E-value=0.093 Score=34.48 Aligned_cols=48 Identities=25% Similarity=0.450 Sum_probs=38.1
Q ss_pred CCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecchh-hHHHHHHHH
Q 020132 253 GVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEK-EVKAVAEAL 300 (330)
Q Consensus 253 ~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~~-d~~~av~~L 300 (330)
+.+|.++++++.|+++++++..+.+... ...+++.++.. +.+.+++.|
T Consensus 7 ~~~~~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 59 (60)
T cd02116 7 DRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGDGDLEKLLEAL 59 (60)
T ss_pred CCCchHHHHHHHHHHCCCcEEEEEeEEcCCCCeEEEEEEEechHHHHHHHHHh
Confidence 4689999999999999999999987543 36788888887 666665554
No 136
>PRK04435 hypothetical protein; Provisional
Probab=93.26 E-value=0.21 Score=42.54 Aligned_cols=63 Identities=14% Similarity=0.326 Sum_probs=46.3
Q ss_pred cceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCc---ceeeeecchhhHHHHHHHHHHHH
Q 020132 239 DNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE---HSVCFAVPEKEVKAVAEALESKF 304 (330)
Q Consensus 239 ~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se---~sIS~vv~~~d~~~av~~Lh~~f 304 (330)
...+.+.+. +.+.||+++++++.+++.|+||..|+|+... .+++|.++-.+....++.|-+.+
T Consensus 67 ~r~vtL~i~---l~Dr~GlLs~Il~~IA~~~aNIltI~q~i~~~g~a~vs~tVevs~~~~~L~~Li~~L 132 (147)
T PRK04435 67 GKIITLSLL---LEDRSGTLSKVLNVIAEAGGNILTINQSIPLQGRANVTISIDTSSMEGDIDELLEKL 132 (147)
T ss_pred CcEEEEEEE---EecCCCHHHHHHHHHHHcCCCeEEEEEEcCCCCEEEEEEEEEeCChHHHHHHHHHHH
Confidence 455666665 5567999999999999999999999986532 55778887776664455444433
No 137
>KOG0456 consensus Aspartate kinase [Amino acid transport and metabolism]
Probab=92.20 E-value=0.16 Score=49.74 Aligned_cols=74 Identities=16% Similarity=0.341 Sum_probs=63.3
Q ss_pred cCCcccceeecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHH--HHH-HHHHHHH
Q 020132 229 DSPVKGFATIDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVK--AVA-EALESKF 304 (330)
Q Consensus 229 ~~~~~~i~~~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~--~av-~~Lh~~f 304 (330)
+..++.|+.++|+.++.|-...|....||++++|..|.+.||.|+.|+ +||.+||..++..+.. +.+ +.||+.+
T Consensus 381 k~~~TsI~lK~nv~mldI~Str~l~q~GFLAkvFti~ek~~isVDvva--TSEV~iSltL~~~~~~sreliq~~l~~a~ 457 (559)
T KOG0456|consen 381 KAGLTSIVLKRNVTMLDIASTRMLGQHGFLAKVFTIFEKLGISVDVVA--TSEVSISLTLDPSKLDSRELIQGELDQAV 457 (559)
T ss_pred hccceEEEEeccEEEEEecccchhhhhhHHHHHHHHHHHhCcEEEEEE--eeeEEEEEecChhhhhhHHHHHhhHHHHH
Confidence 356788999999999999999999999999999999999999999998 8899999999877554 333 5555544
No 138
>cd04870 ACT_PSP_1 CT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_1 CD includes the first of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=91.82 E-value=0.3 Score=36.33 Aligned_cols=57 Identities=25% Similarity=0.390 Sum_probs=38.7
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEEeccCC--cceeeeec--chh-hHHHHHHHHHH
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAV--PEK-EVKAVAEALES 302 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s--e~sIS~vv--~~~-d~~~av~~Lh~ 302 (330)
+|+++|. ++||+.+++.+.|+++|+||.-++|..- ...+.+.+ +.. +...+-+.|..
T Consensus 1 ~vtv~G~---DrpGiv~~vt~~la~~~~nI~dl~~~~~~~~f~~~~~v~~p~~~~~~~l~~~l~~ 62 (75)
T cd04870 1 LITVTGP---DRPGLTSALTEVLAAHGVRILDVGQAVIHGRLSLGILVQIPDSADSEALLKDLLF 62 (75)
T ss_pred CEEEEcC---CCCCHHHHHHHHHHHCCCCEEecccEEEcCeeEEEEEEEcCCCCCHHHHHHHHHH
Confidence 3678884 6899999999999999999999876543 34444443 333 34444444433
No 139
>PF13740 ACT_6: ACT domain; PDB: 1ZPV_A 3P96_A 1U8S_A.
Probab=91.74 E-value=0.3 Score=36.54 Aligned_cols=58 Identities=24% Similarity=0.357 Sum_probs=38.9
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCC--cceeeeecch--hhHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVPE--KEVKAVAEALE 301 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s--e~sIS~vv~~--~d~~~av~~Lh 301 (330)
..+|++.|. ++||+.+.+++.|+++|.||.-+.|..- ..++.+.++- ++..++.+.|.
T Consensus 2 ~~vItv~G~---DrpGiv~~v~~~l~~~g~ni~d~~~~~~~~~f~~~~~v~~~~~~~~~l~~~L~ 63 (76)
T PF13740_consen 2 QLVITVVGP---DRPGIVAAVTGVLAEHGCNIEDSRQAVLGGRFTLIMLVSIPEDSLERLESALE 63 (76)
T ss_dssp EEEEEEEEE-----TTHHHHHHHHHHCTT-EEEEEEEEEETTEEEEEEEEEESHHHHHHHHHHHH
T ss_pred EEEEEEEec---CCCcHHHHHHHHHHHCCCcEEEEEEEEEcCeEEEEEEEEeCcccHHHHHHHHH
Confidence 357899985 6899999999999999999999988664 4455554433 34433444443
No 140
>PRK06737 acetolactate synthase 1 regulatory subunit; Validated
Probab=91.68 E-value=0.39 Score=36.32 Aligned_cols=52 Identities=13% Similarity=0.194 Sum_probs=38.4
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCCc----ceeeeec--chhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASSE----HSVCFAV--PEKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~se----~sIS~vv--~~~d~~~av~~Lh~ 302 (330)
..++||+++|+...++..|.||+.++-+.++ .++++++ ++..+++..+.|++
T Consensus 9 v~n~pGVL~Ri~~lf~rRgfNI~Sl~vg~te~~~~sriti~~~~~~~~i~qi~kQL~K 66 (76)
T PRK06737 9 IHNDPSVLLRISGIFARRGYYISSLNLNERDTSGVSEMKLTAVCTENEATLLVSQLKK 66 (76)
T ss_pred EecCCCHHHHHHHHHhccCcceEEEEecccCCCCeeEEEEEEECCHHHHHHHHHHHhC
Confidence 4578999999999999999999999977543 2445553 44555666666655
No 141
>PRK08178 acetolactate synthase 1 regulatory subunit; Reviewed
Probab=91.09 E-value=0.41 Score=37.87 Aligned_cols=58 Identities=14% Similarity=0.248 Sum_probs=40.3
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCCc----ceeeeecch-hhHHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE----HSVCFAVPE-KEVKAVAEALES 302 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se----~sIS~vv~~-~d~~~av~~Lh~ 302 (330)
..|++. ..++||+++|+...|++.|.||+.++-+.++ .++++++.. ..++++++.|++
T Consensus 9 ~tisvl---v~N~pGVL~RIaglFsRRgyNIeSLtvg~te~~~iSRmtivv~~~~~i~Qi~kQL~K 71 (96)
T PRK08178 9 VILELT---VRNHPGVMSHVCGLFARRAFNVEGILCLPIQDGDKSRIWLLVNDDQRLEQMISQIEK 71 (96)
T ss_pred EEEEEE---EECCcCHHHHHHHHHhcCCcCeeeEEEeecCCCCceEEEEEEcCchHHHHHHHHHhC
Confidence 345555 5678999999999999999999999866552 456666662 334444444443
No 142
>cd04882 ACT_Bt0572_2 C-terminal ACT domain of a novel protein composed of just two ACT domains. Included in this CD is the C-terminal ACT domain of a novel protein composed of just two ACT domains, as seen in the yet uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related proteins. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=90.10 E-value=0.33 Score=34.27 Aligned_cols=51 Identities=16% Similarity=0.309 Sum_probs=35.7
Q ss_pred cccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecchhhHHHHHHHHHH
Q 020132 250 GMAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 250 ~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~~d~~~av~~Lh~ 302 (330)
.+.+.||.++++.+.|+++|+||..+.+... ...+.|-++ +.+++.+.|.+
T Consensus 5 ~~~d~pG~L~~i~~~l~~~~~nI~~i~~~~~~~~~~~~v~~~ve--~~~~~~~~L~~ 59 (65)
T cd04882 5 EVPDKPGGLHEILQILSEEGINIEYMYAFVEKKGGKALLIFRTE--DIEKAIEVLQE 59 (65)
T ss_pred EeCCCCcHHHHHHHHHHHCCCChhheEEEccCCCCeEEEEEEeC--CHHHHHHHHHH
Confidence 3678999999999999999999987764322 233444444 46666666654
No 143
>cd04872 ACT_1ZPV ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein. This CD, ACT_1ZPV, includes those single ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein (pdb structure 1ZPV). Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=89.22 E-value=0.27 Score=37.71 Aligned_cols=36 Identities=22% Similarity=0.342 Sum_probs=31.0
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCC
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS 280 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s 280 (330)
.+|++.|. +.||+.+++.+.|+++|+||.-++|...
T Consensus 2 ~vl~i~g~---D~pGiva~vt~~la~~g~nI~~~~~~~~ 37 (88)
T cd04872 2 AVITVVGK---DRVGIVAGVSTKLAELNVNILDISQTIM 37 (88)
T ss_pred EEEEEEcC---CCCCHHHHHHHHHHHcCCCEEechhHhh
Confidence 46778874 5899999999999999999999998653
No 144
>CHL00100 ilvH acetohydroxyacid synthase small subunit
Probab=88.85 E-value=1.1 Score=39.36 Aligned_cols=57 Identities=16% Similarity=0.228 Sum_probs=43.3
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEEeccC----Ccceeeeecchh--hHHHHHHHHHH
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS----SEHSVCFAVPEK--EVKAVAEALES 302 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~----se~sIS~vv~~~--d~~~av~~Lh~ 302 (330)
.+++.+ .++||+++|+...|+++|+||..++-+. ....++++++.+ ..++..+.|++
T Consensus 4 ~isvlv---~n~PGVL~RIt~lFsrRg~NIesLsv~~t~~~~~sr~TIvv~~~~~~ieqL~kQL~K 66 (174)
T CHL00100 4 TLSVLV---EDESGVLTRIAGLFARRGFNIESLAVGPAEQKGISRITMVVPGDDRTIEQLTKQLYK 66 (174)
T ss_pred EEEEEE---eCcCCHHHHHHHHHHhCCCCeeEEEeeEcCCCCccEEEEEEECCHHHHHHHHHHHHH
Confidence 356664 4789999999999999999999998654 245688888875 35566666666
No 145
>cd04875 ACT_F4HF-DF N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase). This CD includes the N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase) which catalyzes the hydrolysis of 10-formyltetrahydrofolate (formyl-FH4) to FH4 and formate. Formyl-FH4 hydrolase generates the formate that is used by purT-encoded 5'-phosphoribosylglycinamide transformylase for step three of de novo purine nucleotide synthesis. Formyl-FH4 hydrolase, a hexamer which is activated by methionine and inhibited by glycine, is proposed to regulate the balance FH4 and C1-FH4 in response to changing growth conditions. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=88.80 E-value=1.1 Score=33.06 Aligned_cols=33 Identities=21% Similarity=0.405 Sum_probs=28.9
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEEecc
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA 278 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~ 278 (330)
+|++.|. ++||+++++.+.|+++|+||.-++|.
T Consensus 1 ii~v~g~---D~~Giv~~it~~l~~~g~nI~~~~~~ 33 (74)
T cd04875 1 ILTLSCP---DRPGIVAAVSGFLAEHGGNIVESDQF 33 (74)
T ss_pred CEEEEcC---CCCCHHHHHHHHHHHcCCCEEeeeee
Confidence 3677774 68999999999999999999999876
No 146
>PRK11152 ilvM acetolactate synthase 2 regulatory subunit; Provisional
Probab=88.71 E-value=0.84 Score=34.53 Aligned_cols=52 Identities=12% Similarity=0.225 Sum_probs=37.9
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecch-hhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPE-KEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~-~d~~~av~~Lh~ 302 (330)
..+.||+++|+...++..|.||+.++-+.. -.+|++++.+ ..+++..+.|++
T Consensus 10 v~n~pGVL~Ri~~lf~rRGfnI~sl~v~~t~~~~~sriti~v~~~~~i~ql~kQL~K 66 (76)
T PRK11152 10 ARFRPEVLERVLRVVRHRGFQVCSMNMTQNTDAQNINIELTVASERPIDLLSSQLNK 66 (76)
T ss_pred EECCccHHHHHHHHHhcCCeeeeeEEeeecCCCCEEEEEEEECCCchHHHHHHHHhc
Confidence 567899999999999999999999987663 2567777753 233444444444
No 147
>cd04883 ACT_AcuB C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. This CD includes the C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. AcuB is putatively involved in the anaerobic catabolism of acetoin, and related proteins. Studies report the induction of AcuB by nitrate respiration and also by fermentation. Since acetoin can be secreted and later serve as a source of carbon, it has been proposed that, during anaerobic growth when other carbon sources are exhausted, the induction of the AcuB protein results in acetoin catabolism. AcuB-like proteins have two N-terminal tandem CBS domains and a single C-terminal ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=88.70 E-value=1.2 Score=32.22 Aligned_cols=53 Identities=23% Similarity=0.350 Sum_probs=38.8
Q ss_pred cccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecchhhHHHHHHHHHH
Q 020132 250 GMAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 250 ~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~~d~~~av~~Lh~ 302 (330)
.+.+.||.++++.+.|+++|+||..+..... ...+.|-++..+.+++.+.|.+
T Consensus 7 ~~~d~pG~l~~i~~~l~~~~inI~~i~~~~~~~~~~~~v~i~v~~~~~~~~~~~L~~ 63 (72)
T cd04883 7 RVPDRPGQLADIAAIFKDRGVNIVSVLVYPSKEEDNKILVFRVQTMNPRPIIEDLRR 63 (72)
T ss_pred EECCCCCHHHHHHHHHHHcCCCEEEEEEeccCCCCeEEEEEEEecCCHHHHHHHHHH
Confidence 3778999999999999999999987753222 3346666665666667766655
No 148
>COG4747 ACT domain-containing protein [General function prediction only]
Probab=87.71 E-value=1 Score=36.95 Aligned_cols=58 Identities=22% Similarity=0.279 Sum_probs=47.3
Q ss_pred eecccccCCCCchhhhhhhhcccCccEEEEeccCC-cceeeeecchhhHHHHHHHHHHH
Q 020132 246 VEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS-EHSVCFAVPEKEVKAVAEALESK 303 (330)
Q Consensus 246 vvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s-e~sIS~vv~~~d~~~av~~Lh~~ 303 (330)
+++-.|.+.||-+++|.+.|.+++||++.|--..+ ...--++++-+|.+++..+|.+.
T Consensus 71 VlaVEmeD~PG~l~~I~~vl~d~diNldYiYAFv~ek~KAlli~r~ed~d~~~~aLed~ 129 (142)
T COG4747 71 VLAVEMEDVPGGLSRIAEVLGDADINLDYIYAFVTEKQKALLIVRVEDIDRAIKALEDA 129 (142)
T ss_pred EEEEEecCCCCcHHHHHHHHhhcCcCceeeeeeeecCceEEEEEEhhHHHHHHHHHHHc
Confidence 45556899999999999999999999988754333 35556778889999999999875
No 149
>cd04886 ACT_ThrD-II-like C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. This CD includes the C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. The Escherichia coli tdcB gene product, ThrD-II, anaerobically catalyzes the pyridoxal phosphate-dependent dehydration of L-threonine and L-serine to ammonia and to alpha-ketobutyrate and pyruvate, respectively. Tetrameric ThrD-II is subject to allosteric activation by AMP, inhibition by alpha-keto acids, and catabolite inactivation by several metabolites of glycolysis and the citric acid cycle. Also included in this CD are N-terminal ACT domains present in smaller (~170 a.a.) archaeal proteins of unknown function. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=87.56 E-value=1.3 Score=31.38 Aligned_cols=28 Identities=25% Similarity=0.578 Sum_probs=24.4
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEecc
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQA 278 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~ 278 (330)
+.+.||.++++.+.++++|++|..+.+.
T Consensus 5 ~~d~~G~L~~i~~~i~~~~~nI~~i~~~ 32 (73)
T cd04886 5 LPDRPGQLAKLLAVIAEAGANIIEVSHD 32 (73)
T ss_pred eCCCCChHHHHHHHHHHcCCCEEEEEEE
Confidence 4678999999999999999999877653
No 150
>PRK00194 hypothetical protein; Validated
Probab=87.44 E-value=0.56 Score=35.97 Aligned_cols=36 Identities=22% Similarity=0.337 Sum_probs=31.2
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccC
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS 279 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~ 279 (330)
...|++.|. +.||+++++.+.|+++|+||.-++|..
T Consensus 3 ~~~ltv~g~---DrpGiva~vt~~la~~g~nI~~~~~~~ 38 (90)
T PRK00194 3 KAIITVIGK---DKVGIIAGVSTVLAELNVNILDISQTI 38 (90)
T ss_pred eEEEEEEcC---CCCCHHHHHHHHHHHcCCCEEehhhHh
Confidence 357788874 589999999999999999999998765
No 151
>cd04909 ACT_PDH-BS C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH). The C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback-inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=87.29 E-value=1.1 Score=32.33 Aligned_cols=52 Identities=13% Similarity=0.196 Sum_probs=36.4
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecch-hhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPE-KEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~-~d~~~av~~Lh~ 302 (330)
+.+.||.++++.+.|+++|++|..+.+... ...+.+.++. ++.+++.+.|.+
T Consensus 8 ~~d~~G~L~~l~~~l~~~~i~i~~~~~~~~~~~~~~~~~i~v~~~~~~~~~~~~L~~ 64 (69)
T cd04909 8 VPDEPGVIAEVTQILGDAGISIKNIEILEIREGIGGILRISFKTQEDRERAKEILKE 64 (69)
T ss_pred cCCCCCHHHHHHHHHHHcCCCceeeEeEEeecCCcEEEEEEECCHHHHHHHHHHHHH
Confidence 678999999999999999999986654332 3334555542 366666666654
No 152
>PRK11895 ilvH acetolactate synthase 3 regulatory subunit; Reviewed
Probab=87.24 E-value=1.3 Score=38.45 Aligned_cols=53 Identities=15% Similarity=0.320 Sum_probs=41.4
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCCc----ceeeeecc--hhhHHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASSE----HSVCFAVP--EKEVKAVAEALESK 303 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~se----~sIS~vv~--~~d~~~av~~Lh~~ 303 (330)
..+.||+++++...|+++|+||..++-+.++ ..+++.++ +..+++..+.|++.
T Consensus 9 veN~pGvL~rI~~lf~rrg~NI~Sl~v~~te~~~~sriti~V~~~~~~i~qi~kQl~KL 67 (161)
T PRK11895 9 VENEPGVLSRVAGLFSRRGYNIESLTVGPTEDPGLSRMTIVTSGDEQVIEQITKQLNKL 67 (161)
T ss_pred EcCCCcHHHHHHHHHHhCCCcEEEEEeeecCCCCEEEEEEEEECCHHHHHHHHHHHhcc
Confidence 5689999999999999999999988865543 34667765 45677777777774
No 153
>cd04869 ACT_GcvR_2 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the second of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR in
Probab=86.98 E-value=1.9 Score=32.05 Aligned_cols=56 Identities=23% Similarity=0.365 Sum_probs=38.0
Q ss_pred EeeecccccCCCCchhhhhhhhcccCccEEEEeccCCc----------ceeeeecchh-hHHHHHHHHHH
Q 020132 244 VNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASSE----------HSVCFAVPEK-EVKAVAEALES 302 (330)
Q Consensus 244 IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~se----------~sIS~vv~~~-d~~~av~~Lh~ 302 (330)
|++.|. +.||+.+++.+.|+++|+||.-+++.+.+ ..+.+-++.. +..+..+.|+.
T Consensus 2 l~v~g~---D~~Giv~~it~~l~~~~~nI~~~~~~~~~~~~~~~~~~~~~~~v~~p~~~~~~~l~~~l~~ 68 (81)
T cd04869 2 VEVVGN---DRPGIVHEVTQFLAQRNINIEDLSTETYSAPMSGTPLFKAQATLALPAGTDLDALREELEE 68 (81)
T ss_pred EEEEeC---CCCCHHHHHHHHHHHcCCCeEEeEeeeecCCCCCcceEEEEEEEecCCCCCHHHHHHHHHH
Confidence 556664 58999999999999999999999874332 2444555543 34444444444
No 154
>cd04889 ACT_PDH-BS-like C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate. Included in this CD is the C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Also included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem A
Probab=86.82 E-value=0.95 Score=31.27 Aligned_cols=50 Identities=18% Similarity=0.228 Sum_probs=32.5
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCCc-ceeeeecchhhHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASSE-HSVCFAVPEKEVKAVAEAL 300 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~se-~sIS~vv~~~d~~~av~~L 300 (330)
+.+.||.++++.+.|.++|+||..+.-.... ..-.+.+.-++.++|.+.|
T Consensus 5 ~~d~~G~l~~i~~~l~~~~inI~~~~~~~~~~~~~~~~~~v~~~~~a~~~l 55 (56)
T cd04889 5 VENKPGRLAEVTEILAEAGINIKAISIAETRGEFGILRLIFSDPERAKEVL 55 (56)
T ss_pred eCCCCChHHHHHHHHHHcCCCEeeEEEEEccCCcEEEEEEECCHHHHHHHh
Confidence 5688999999999999999999766522222 1122222333466666554
No 155
>cd04880 ACT_AAAH-PDT-like ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. Eukaryotic AAAHs have an N-terminal ACT (regulatory) domain, a middle catalytic domain and a C-terminal domain which is responsible for the oligomeric state of the enzyme forming a domain-swapped tetrameric coiled-coil. The PAH, TH, and TPH enzymes contain highly conserved catalytic domains but distinct N-terminal ACT domains and differ in their mech
Probab=85.27 E-value=1.6 Score=32.18 Aligned_cols=51 Identities=22% Similarity=0.317 Sum_probs=34.7
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeec------chhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAV------PEKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv------~~~d~~~av~~Lh~ 302 (330)
+.+.||.++++++.++++|+|+..|. +.+ .-...|++ .+.+.+++++.|.+
T Consensus 6 l~d~pG~L~~vL~~f~~~~vni~~I~-Srp~~~~~~~~~f~id~~~~~~~~~~~~~l~~l~~ 66 (75)
T cd04880 6 LKNKPGALAKALKVFAERGINLTKIE-SRPSRKGLWEYEFFVDFEGHIDDPDVKEALEELKR 66 (75)
T ss_pred eCCcCCHHHHHHHHHHHCCCCEEEEE-eeecCCCCceEEEEEEEECCCCCHHHHHHHHHHHH
Confidence 45689999999999999999999994 332 11123332 24456666666655
No 156
>cd04893 ACT_GcvR_1 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR int
Probab=84.62 E-value=1.8 Score=32.30 Aligned_cols=35 Identities=29% Similarity=0.419 Sum_probs=30.3
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccC
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS 279 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~ 279 (330)
.+|++.|. +.||+.+++.+.|+++|.||.-++|..
T Consensus 2 ~iltv~g~---Dr~GiVa~vs~~la~~g~nI~d~~q~~ 36 (77)
T cd04893 2 LVISALGT---DRPGILNELTRAVSESGCNILDSRMAI 36 (77)
T ss_pred EEEEEEeC---CCChHHHHHHHHHHHcCCCEEEceeeE
Confidence 35778874 689999999999999999999998864
No 157
>TIGR00119 acolac_sm acetolactate synthase, small subunit. acetohydroxyacid synthase is a synonym.
Probab=84.42 E-value=2.1 Score=36.98 Aligned_cols=53 Identities=17% Similarity=0.322 Sum_probs=38.0
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCCc----ceeeeecchhhHHHHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASSE----HSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~se----~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
..+.||+++++...|+++|+||..++-+.++ ..+++.++. + ++.++.|.+.+.
T Consensus 8 ven~pGvL~rI~~lf~rrg~NI~Sl~v~~t~~~~~sriti~V~~-d-~~~i~qi~kQl~ 64 (157)
T TIGR00119 8 VENEPGVLSRVAGLFTRRGFNIESLTVGPTEDPDLSRMTIVVVG-D-DKVLEQITKQLN 64 (157)
T ss_pred EcCCCcHHHHHHHHHHhCCceEEEEEEeecCCCCEEEEEEEEEC-C-HHHHHHHHHHHh
Confidence 5678999999999999999999988765543 346677754 2 344555555443
No 158
>cd04903 ACT_LSD C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit. The C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit, found in various bacterial anaerobes such as Clostridium, Bacillis, and Treponema species. These enzymes catalyze the deamination of L-serine, producing pyruvate and ammonia. Unlike the eukaryotic L-serine dehydratase, which requires the pyridoxal-5'-phosphate (PLP) cofactor, the prokaryotic L-serine dehydratase contains an [4Fe-4S] cluster instead of a PLP active site. The LSD alpha and beta subunits of the 'clostridial' enzyme are encoded by the sdhA and sdhB genes. The single subunit bacterial homologs of L-serine dehydratase (LSD1, LSD2, TdcG) present in Escherichia coli, and other enterobacterials, lack the ACT domain described here. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=81.45 E-value=1.8 Score=30.49 Aligned_cols=52 Identities=13% Similarity=0.223 Sum_probs=37.6
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecchhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~~d~~~av~~Lh~ 302 (330)
..+.||.++++.+.|+++|+++..+.+... ...+.+.++..+..++++.|.+
T Consensus 6 ~~d~~g~l~~i~~~l~~~~~~I~~~~~~~~~~~~~~~i~i~v~~~~~~~~i~~l~~ 61 (71)
T cd04903 6 HKDKPGAIAKVTSVLADHEINIAFMRVSRKEKGDQALMVIEVDQPIDEEVIEEIKK 61 (71)
T ss_pred eCCCCChHHHHHHHHHHcCcCeeeeEEEeccCCCeEEEEEEeCCCCCHHHHHHHHc
Confidence 457899999999999999999987764431 2335667766666666666654
No 159
>PRK13010 purU formyltetrahydrofolate deformylase; Reviewed
Probab=81.03 E-value=3.6 Score=39.07 Aligned_cols=35 Identities=17% Similarity=0.359 Sum_probs=31.6
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEecc
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA 278 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~ 278 (330)
.++|+++|. ++||+.+++.+.|+++|+||.-++|-
T Consensus 9 ~~iitv~G~---Dr~GIVA~Vs~~Lae~g~NI~disq~ 43 (289)
T PRK13010 9 SYVLTLACP---SAPGIVAAVSGFLAEKGCYIVELTQF 43 (289)
T ss_pred CEEEEEECC---CCCCcHHHHHHHHHHCCCCEEecccc
Confidence 468999985 68999999999999999999999984
No 160
>COG0440 IlvH Acetolactate synthase, small (regulatory) subunit [Amino acid transport and metabolism]
Probab=80.56 E-value=2.8 Score=36.36 Aligned_cols=53 Identities=13% Similarity=0.266 Sum_probs=43.0
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecch--hhHHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPE--KEVKAVAEALESK 303 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~--~d~~~av~~Lh~~ 303 (330)
..+.||+++|+...++..|.||++++-+.+ ...+++++.- ...+++.+.||+.
T Consensus 11 v~ne~GvLsRv~glfsrRG~NIeSltv~~tE~~~~SRiTivv~g~~~~~EQi~kQL~kL 69 (163)
T COG0440 11 VENEPGVLSRVTGLFSRRGYNIESLTVGPTETPGLSRITIVVSGDEQVLEQIIKQLNKL 69 (163)
T ss_pred EECCCCeeehhhHHHHhcCcccceEEEEecCCCCceEEEEEEcCCcchHHHHHHHHHhh
Confidence 457899999999999999999999986655 4567777776 3488888888874
No 161
>cd04874 ACT_Af1403 N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, and related domains. This CD includes the N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, from Archaeoglobus fulgidus and other related archeal ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=77.79 E-value=4 Score=28.83 Aligned_cols=41 Identities=15% Similarity=0.296 Sum_probs=30.5
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC---cceeeeecchh
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPEK 291 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s---e~sIS~vv~~~ 291 (330)
+.+.+|.++++.+.|+++++++..+.+... ...+.+.++..
T Consensus 7 ~~d~~g~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~i~~~~~ 50 (72)
T cd04874 7 AEDKPGVLRDLTGVIAEHGGNITYTQQFIEREGKARIYMELEGV 50 (72)
T ss_pred eCCCCChHHHHHHHHHhCCCCEEEEEEeccCCCeEEEEEEEecc
Confidence 567899999999999999999987765432 23455666554
No 162
>TIGR00655 PurU formyltetrahydrofolate deformylase. This model describes formyltetrahydrofolate deformylases. The enzyme is a homohexamer. Sequences from a related enzyme formyl tetrahydrofolate-specific enzyme, phosphoribosylglycinamide formyltransferase, serve as an outgroup for phylogenetic analysis. Putative members of this family, scoring below the trusted cutoff, include a sequence from Rhodobacter capsulatus that lacks an otherwise conserved C-terminal region.
Probab=77.61 E-value=2.5 Score=39.88 Aligned_cols=34 Identities=26% Similarity=0.270 Sum_probs=30.6
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEEeccC
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS 279 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~ 279 (330)
+|+++|. ++||+.+++.+.|+++|+||.-++|..
T Consensus 2 ~itv~g~---D~~GIVA~Vt~~La~~g~NI~d~sq~~ 35 (280)
T TIGR00655 2 ILLVSCP---DQKGLVAAISTFIAKHGANIISNDQHT 35 (280)
T ss_pred EEEEECC---CCCChHHHHHHHHHHCCCCEEeeeEEE
Confidence 5788874 689999999999999999999999976
No 163
>COG1058 CinA Predicted nucleotide-utilizing enzyme related to molybdopterin-biosynthesis enzyme MoeA [General function prediction only]
Probab=77.56 E-value=7.6 Score=36.23 Aligned_cols=68 Identities=22% Similarity=0.274 Sum_probs=49.7
Q ss_pred HHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCc
Q 020132 47 SAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGS 126 (330)
Q Consensus 47 sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggs 126 (330)
+|..++..|.++|++..... ++.| +...+.+.++.+++ .-.+.|++|-+|.+.+
T Consensus 22 Na~~la~~L~~~G~~v~~~~-----~VgD--------~~~~I~~~l~~a~~--r~D~vI~tGGLGPT~D----------- 75 (255)
T COG1058 22 NAAFLADELTELGVDLARIT-----TVGD--------NPDRIVEALREASE--RADVVITTGGLGPTHD----------- 75 (255)
T ss_pred hHHHHHHHHHhcCceEEEEE-----ecCC--------CHHHHHHHHHHHHh--CCCEEEECCCcCCCcc-----------
Confidence 46688999999999875531 2222 34556677887776 4678888887776544
Q ss_pred chhHHHHHHHHhhc
Q 020132 127 DFSAAIMGALLRAH 140 (330)
Q Consensus 127 D~~A~~lA~~l~A~ 140 (330)
|.|+-.+|++||-+
T Consensus 76 DiT~e~vAka~g~~ 89 (255)
T COG1058 76 DLTAEAVAKALGRP 89 (255)
T ss_pred HhHHHHHHHHhCCC
Confidence 99999999999954
No 164
>cd04881 ACT_HSDH-Hom ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) and related domains. The ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) encoded by the hom gene of Bacillus subtilis and other related sequences. HSDH reduces aspartate semi-aldehyde to the amino acid homoserine, one that is required for the biosynthesis of Met, Thr, and Ile from Asp. Neither the enzyme nor the aspartate pathway is found in the animal kingdom. This mostly bacterial HSDH group has a C-terminal ACT domain and is believed to be involved in enzyme regulation. A C-terminal deletion in the Corynebacterium glutamicum HSDH abolished allosteric inhibition by L-threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=77.45 E-value=4.8 Score=28.87 Aligned_cols=52 Identities=19% Similarity=0.320 Sum_probs=35.8
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecc---hhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVP---EKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~---~~d~~~av~~Lh~ 302 (330)
+.+.+|.++++.+.|+++++++.-+.+... ...+.+++. ..+++.+++.|.+
T Consensus 7 ~~d~~g~l~~i~~~l~~~~i~I~~~~~~~~~~~~~~~~~i~~~~~~~~~l~~~i~~L~~ 65 (79)
T cd04881 7 VKDKPGVLAKITGILAEHGISIESVIQKEADGGETAPVVIVTHETSEAALNAALAEIEA 65 (79)
T ss_pred eCCCCcHHHHHHHHHHHcCCCeEEEEEcccCCCCceeEEEEEccCCHHHHHHHHHHHHc
Confidence 457899999999999999999998875432 233555444 4455555555543
No 165
>cd04878 ACT_AHAS N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). ACT_AHAS: N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). AHAS catalyses the first common step in the biosynthesis of the three branched-chain amino acids. The first step involves the condensation of either pyruvate or 2-ketobutyrate with the two-carbon hydroxyethyl fragment derived from another pyruvate molecule, covalently bound to the coenzyme thiamine diphosphate. Bacterial AHASs generally consist of regulatory and catalytic subunits. The effector (valine) binding sites are proposed to be located in two symmetrically related positions in the interface between a pair of N-terminal ACT domains with the C-terminal domain of IlvH contacting the catalytic dimer. Plants Arabidopsis and Oryza have tandem IlvH subunits; both the first and second ACT domain sequences are present in this CD. Members of
Probab=75.91 E-value=4.9 Score=28.23 Aligned_cols=50 Identities=18% Similarity=0.310 Sum_probs=34.4
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecch--hhHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPE--KEVKAVAEAL 300 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~--~d~~~av~~L 300 (330)
..+.||.++++.+.|+++++++..+.+... ...+.+.+.. .+...+++.|
T Consensus 7 ~~d~~g~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 62 (72)
T cd04878 7 VENEPGVLNRISGLFARRGFNIESLTVGPTEDPGISRITIVVEGDDDVIEQIVKQL 62 (72)
T ss_pred EcCCCcHHHHHHHHHHhCCCCEEEEEeeecCCCCeEEEEEEEECCHHHHHHHHHHH
Confidence 457899999999999999999998876432 2345666555 3344444433
No 166
>PRK13011 formyltetrahydrofolate deformylase; Reviewed
Probab=74.95 E-value=8 Score=36.65 Aligned_cols=62 Identities=11% Similarity=0.200 Sum_probs=42.6
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccC--C--cceeeeec--c----hhhHHHHHHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS--S--EHSVCFAV--P----EKEVKAVAEALESKFR 305 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~--s--e~sIS~vv--~----~~d~~~av~~Lh~~f~ 305 (330)
-..|+++|. ++||+.+++.+.|+++|+||.-++|.. . ...+.+.+ + ..++.++++.+-+.+.
T Consensus 7 ~~vitv~G~---DrpGIVa~VT~~La~~~vNI~dls~~~~~~~~~F~m~~~~~~p~~~~~~~L~~~L~~l~~~l~ 78 (286)
T PRK13011 7 TFVLTLSCP---SAAGIVAAVTGFLAEHGCYITELHSFDDRLSGRFFMRVEFHSEEGLDEDALRAGFAPIAARFG 78 (286)
T ss_pred eEEEEEEeC---CCCCHHHHHHHHHHhCCCCEEEeeeeecCCCCeEEEEEEEecCCCCCHHHHHHHHHHHHHHhC
Confidence 467899985 689999999999999999999999842 1 23333333 3 3444555555555443
No 167
>PF13291 ACT_4: ACT domain; PDB: 2KO1_B 3IBW_A.
Probab=74.48 E-value=7 Score=28.97 Aligned_cols=58 Identities=16% Similarity=0.326 Sum_probs=38.1
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecchhhHHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~~d~~~av~~Lh~ 302 (330)
+.|.+. +.+.||++++|.+.+++.|+||..++.... ...+.|.+.-.|.++.-+.+++
T Consensus 7 ~~l~i~---~~dr~GlL~dI~~~i~~~~~nI~~i~~~~~~~~~~~~~~l~v~V~d~~~L~~ii~~ 68 (80)
T PF13291_consen 7 VRLRIE---AEDRPGLLADITSVISENGVNIRSINARTNKDDGTARITLTVEVKDLEHLNQIIRK 68 (80)
T ss_dssp EEEEEE---EE--TTHHHHHHHHHHCSSSEEEEEEEEE--ETTEEEEEEEEEESSHHHHHHHHHH
T ss_pred EEEEEE---EEcCCCHHHHHHHHHHHCCCCeEEEEeEEeccCCEEEEEEEEEECCHHHHHHHHHH
Confidence 445565 357899999999999999999999886553 2355555555555555444433
No 168
>cd04905 ACT_CM-PDT C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme. The C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme, found in plants, fungi, bacteria, and archaea. The P-protein of E. coli (CM-PDT, PheA) catalyzes the conversion of chorismate to prephenate and then the decarboxylation and dehydration to form phenylpyruvate. These are the first two steps in the biosynthesis of L-Phe and L-Tyr via the shikimate pathway in microorganisms and plants. The E. coli P-protein (CM-PDT) has three domains with an N-terminal domain with chorismate mutase activity, a middle domain with prephenate dehydratase activity, and an ACT regulatory C-terminal domain. The prephenate dehydratase enzyme has a PDT and ACT domain. The ACT domain is essential to bring about the negative allosteric regulation by L-Phe bindi
Probab=74.42 E-value=6.3 Score=29.34 Aligned_cols=52 Identities=21% Similarity=0.372 Sum_probs=35.2
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC---cceeeeecc------hhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVP------EKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s---e~sIS~vv~------~~d~~~av~~Lh~ 302 (330)
+.+.||.++++.+.++++|||+..+.--+. ...+.|.++ +.++.++++.|.+
T Consensus 8 ~~d~~G~L~~il~~f~~~~ini~~i~s~p~~~~~~~~~f~vd~~~~~~~~~~~~~l~~l~~ 68 (80)
T cd04905 8 LPNKPGALYDVLGVFAERGINLTKIESRPSKGGLWEYVFFIDFEGHIEDPNVAEALEELKR 68 (80)
T ss_pred ECCCCCHHHHHHHHHHHCCcCEEEEEEEEcCCCCceEEEEEEEECCCCCHHHHHHHHHHHH
Confidence 457899999999999999999977742222 223444443 4456666666655
No 169
>cd04879 ACT_3PGDH-like ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). ACT_3PGDH-like: The ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with or without an extended C-terminal (xct) region found in various bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback controlled by the end product L-serine in an allosteric manner. In the Escherichia coli homotetrameric enzyme, the interface at adjacent ACT (regulatory) domains couples to create an extended beta-sheet. Each regulatory interface forms two serine-binding sites. The mechanism by which serine transmits inhibition to the active
Probab=74.34 E-value=4.3 Score=28.36 Aligned_cols=51 Identities=18% Similarity=0.225 Sum_probs=34.2
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecchhhHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEKEVKAVAEALE 301 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~~d~~~av~~Lh 301 (330)
..+.+|.++++.+.|+++|++|..+..... ...+.+.++.....++++.|.
T Consensus 6 ~~d~~g~l~~i~~~l~~~~~nI~~~~~~~~~~~~~~~~~~~v~~~~~~~l~~~l~ 60 (71)
T cd04879 6 HKDVPGVIGKVGTILGEHGINIAAMQVGRKEKGGIAYMVLDVDSPVPEEVLEELK 60 (71)
T ss_pred ecCCCCHHHHHHHHHHhcCCCeeeEEEeccCCCCEEEEEEEcCCCCCHHHHHHHH
Confidence 457899999999999999999987754332 233566665544444444443
No 170
>cd04929 ACT_TPH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxytryptamine (serotonin) and the first reaction in the synthesis of melatonin. Very little is known about the role of the ACT domain in TPH, which appears to be regulated by phosphorylation but not by its substrate or cofactor. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=74.02 E-value=8.7 Score=28.66 Aligned_cols=51 Identities=16% Similarity=0.267 Sum_probs=35.2
Q ss_pred cCCCCchhhhhhhhcccCccEEEEeccCCcce-------eeeecchhhHHHHHHHHHH
Q 020132 252 AGVPGTANAIFGAVKDVGANVIMISQASSEHS-------VCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 252 ~~~~gv~a~if~~L~~~gI~I~~Isq~~se~s-------IS~vv~~~d~~~av~~Lh~ 302 (330)
.+.||-++++++.++++|||+..|..-++... |-+-.+..++.++++.|++
T Consensus 8 ~~~~g~L~~iL~~f~~~~inl~~IeSRP~~~~~~~y~F~id~e~~~~~i~~~l~~l~~ 65 (74)
T cd04929 8 KNEVGGLAKALKLFQELGINVVHIESRKSKRRSSEFEIFVDCECDQRRLDELVQLLKR 65 (74)
T ss_pred CCCCcHHHHHHHHHHHCCCCEEEEEeccCCCCCceEEEEEEEEcCHHHHHHHHHHHHH
Confidence 46799999999999999999999864333211 3333344566666666655
No 171
>PF13710 ACT_5: ACT domain; PDB: 2FGC_A 2PC6_A 2F1F_B.
Probab=73.85 E-value=3.2 Score=29.94 Aligned_cols=50 Identities=24% Similarity=0.413 Sum_probs=34.8
Q ss_pred CCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecch--hhHHHHHHHHHH
Q 020132 253 GVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPE--KEVKAVAEALES 302 (330)
Q Consensus 253 ~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~--~d~~~av~~Lh~ 302 (330)
+.||++.|+...+...|.||..++=+.+ -..+++++.. ..++++.+.|++
T Consensus 1 n~~GvL~Ri~~vf~rRg~nI~sl~v~~~~~~~~~riti~v~~~~~~i~~l~~Ql~K 56 (63)
T PF13710_consen 1 NQPGVLNRITGVFRRRGFNIESLSVGPTEDPGISRITIVVSGDDREIEQLVKQLEK 56 (63)
T ss_dssp SSTTHHHHHHHHHHTTT-EECEEEEEE-SSTTEEEEEEEEES-CCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCeEEeeEEeeecCCCCEEEEEEEEeeCchhHHHHHHHHhc
Confidence 4689999999999999999999885542 2456666655 455555555544
No 172
>PRK06027 purU formyltetrahydrofolate deformylase; Reviewed
Probab=73.06 E-value=7.5 Score=36.79 Aligned_cols=36 Identities=17% Similarity=0.240 Sum_probs=32.0
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccC
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS 279 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~ 279 (330)
...|+++|. ++||+.+++.+.|+++|+||.-++|..
T Consensus 6 ~~vitv~G~---DrpGIVa~Vt~~La~~g~NI~d~s~~~ 41 (286)
T PRK06027 6 RYVLTLSCP---DRPGIVAAVSNFLYEHGGNIVDADQFV 41 (286)
T ss_pred eEEEEEECC---CCCcHHHHHHHHHHHCCCCEEEceeEE
Confidence 467899985 689999999999999999999988765
No 173
>cd04884 ACT_CBS C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This CD includes the C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This protein has two N-terminal tandem CBS domains and a single C-terminal ACT domain. The CBS domain is found in a wide range of proteins, often in tandem arrangements and together with a variety of other functional domains. It has been proposed that the CBS domain may play a regulatory role, although its exact function is unknown. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=72.65 E-value=5.8 Score=28.79 Aligned_cols=29 Identities=24% Similarity=0.453 Sum_probs=25.3
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccC
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQAS 279 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~ 279 (330)
+.+.||.++++.+.|+++|+||..+.+..
T Consensus 6 ~~d~pG~L~~l~~~i~~~g~nI~~i~~~~ 34 (72)
T cd04884 6 LEDKPGTLKPVVDTLREFNARIISILTAF 34 (72)
T ss_pred ecCCCccHHHHHHHHHHCCCeEEEEEecc
Confidence 67899999999999999999998775543
No 174
>cd04904 ACT_AAAH ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe; TH catalyses the hydroxylation of L-Tyr to 3,4-dihydroxyphenylalanine, the rate limiting step in the biosynthesis of catecholamines; and TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxy
Probab=71.98 E-value=10 Score=28.00 Aligned_cols=52 Identities=15% Similarity=0.237 Sum_probs=34.4
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCCcc---e----eeeecchhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASSEH---S----VCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~se~---s----IS~vv~~~d~~~av~~Lh~ 302 (330)
+.+.||-++++++.++.+|||+-.|.--++.. . |-|-....++.++++.|.+
T Consensus 7 l~~~pG~L~~vL~~f~~~~iNlt~IeSRP~~~~~~~y~Ffvd~~~~~~~~~~~l~~L~~ 65 (74)
T cd04904 7 LKEEVGALARALKLFEEFGVNLTHIESRPSRRNGSEYEFFVDCEVDRGDLDQLISSLRR 65 (74)
T ss_pred eCCCCcHHHHHHHHHHHCCCcEEEEECCCCCCCCceEEEEEEEEcChHHHHHHHHHHHH
Confidence 34679999999999999999999986322221 1 2333344455666666654
No 175
>PRK11589 gcvR glycine cleavage system transcriptional repressor; Provisional
Probab=70.50 E-value=5.7 Score=35.33 Aligned_cols=61 Identities=20% Similarity=0.248 Sum_probs=45.0
Q ss_pred cceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccC--CcceeeeecchhhHHHHHHHHHHHH
Q 020132 239 DNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS--SEHSVCFAVPEKEVKAVAEALESKF 304 (330)
Q Consensus 239 ~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~--se~sIS~vv~~~d~~~av~~Lh~~f 304 (330)
.+..+|+++|. ++||+.+++.+.|+++|.||.=++|.. .++.+.+++..... .+..|...+
T Consensus 6 ~~~lviTviG~---DrpGIVa~vs~~l~~~g~NI~ds~~t~lgg~Fa~i~lvs~~~~--~~~~le~~L 68 (190)
T PRK11589 6 QHYLVITALGA---DRPGIVNTITRHVSSCGCNIEDSRLAMLGEEFTFIMLLSGSWN--AITLIESTL 68 (190)
T ss_pred ccEEEEEEEcC---CCChHHHHHHHHHHHcCCCeeehhhHhhCCceEEEEEEeCChh--HHHHHHHHH
Confidence 35688999995 689999999999999999999988754 36667666644322 344444443
No 176
>cd04877 ACT_TyrR N-terminal ACT domain of the TyrR protein. ACT_TyrR: N-terminal ACT domain of the TyrR protein. The TyrR protein of Escherichia coli controls the expression of a group of transcription units (TyrR regulon) whose gene products are involved in the biosynthesis or transport of the aromatic amino acids. Binding to specific DNA sequences known as TyrR boxes, the TyrR protein can either activate or repress transcription at different sigma70 promoters. Its regulatory activity occurs in response to intracellular levels of tyrosine, phenylalanine and tryptophan. The TyrR protein consists of an N-terminal region important for transcription activation with an ATP-independent aromatic amino acid binding site (contained within the ACT domain) and is involved in dimerization; a central region with an ATP binding site, an ATP-dependent aromatic amino acid binding site and is involved in hexamerization; and a helix turn helix DNA binding C-terminal region. In solution, in the absence
Probab=70.14 E-value=7.8 Score=28.41 Aligned_cols=46 Identities=9% Similarity=0.164 Sum_probs=33.3
Q ss_pred cCCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHH
Q 020132 252 AGVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAE 298 (330)
Q Consensus 252 ~~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~ 298 (330)
.+++|+++.+.+.+++.|+|+..+...+. ..+.+.+.-.+..+.-+
T Consensus 8 ~dr~Gll~dI~~~i~~~~~nI~~~~~~~~-~~i~l~i~v~~~~~L~~ 53 (74)
T cd04877 8 EDRLGITQEVLDLLVEHNIDLRGIEIDPK-GRIYLNFPTIEFEKLQT 53 (74)
T ss_pred EccchHHHHHHHHHHHCCCceEEEEEecC-CeEEEEeEecCHHHHHH
Confidence 46789999999999999999999986543 22555555555555433
No 177
>cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains. This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=69.21 E-value=16 Score=26.63 Aligned_cols=30 Identities=27% Similarity=0.356 Sum_probs=25.2
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEE
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMI 275 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~I 275 (330)
.|.|.+ +++||+++++..+|+.+|++|...
T Consensus 3 ~i~v~~---~Dr~gLl~~i~~~l~~~~l~I~~A 32 (73)
T cd04900 3 EVFIYT---PDRPGLFARIAGALDQLGLNILDA 32 (73)
T ss_pred EEEEEe---cCCCCHHHHHHHHHHHCCCCeEEe
Confidence 455664 478999999999999999999873
No 178
>cd04901 ACT_3PGDH C-terminal ACT (regulatory) domain of D-3-Phosphoglycerate Dehydrogenase (3PGDH) found in fungi and bacteria. The C-terminal ACT (regulatory) domain of D-3-Phosphoglycerate Dehydrogenase (3PGDH) found in fungi and bacteria. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In Escherichia coli, the SerA 3PGDH is feedback-controlled by the end product L-serine in an allosteric manner. In the homotetrameric enzyme, the interface at adjacent ACT (regulatory) domains couples to create an extended beta-sheet. Each regulatory interface forms two serine-binding sites. The mechanism by which serine transmits inhibition to the active site is postulated to involve the tethering of the regulatory domains together to create a rigid quaternary structure with a solvent-
Probab=68.96 E-value=1.9 Score=30.78 Aligned_cols=52 Identities=17% Similarity=0.193 Sum_probs=36.3
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccC--CcceeeeecchhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQAS--SEHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~--se~sIS~vv~~~d~~~av~~Lh~ 302 (330)
..+.||+++++.+.|+++|+|+..+...+ ....+.+.++..+.+.+++.|.+
T Consensus 6 ~~d~~g~l~~i~~~l~~~~~nI~~~~~~~~~~~a~~~~~~~~~~l~~li~~l~~ 59 (69)
T cd04901 6 HKNVPGVLGQINTILAEHNINIAAQYLQTRGEIGYVVIDIDSEVSEELLEALRA 59 (69)
T ss_pred ecCCCcHHHHHHHHHHHcCCCHHHHhccCCCCEEEEEEEcCCCCCHHHHHHHHc
Confidence 45789999999999999999986665433 13334455666666666666654
No 179
>PRK08577 hypothetical protein; Provisional
Probab=68.61 E-value=12 Score=31.08 Aligned_cols=36 Identities=17% Similarity=0.363 Sum_probs=29.4
Q ss_pred cceeEEeeecccccCCCCchhhhhhhhcccCccEEEEec
Q 020132 239 DNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQ 277 (330)
Q Consensus 239 ~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq 277 (330)
++.+.|.+. ..+.||+++++.+.|+++++++..+.+
T Consensus 54 k~~~~I~V~---~~Dr~GvLa~I~~~l~~~~inI~~i~~ 89 (136)
T PRK08577 54 KKLVEIELV---VEDRPGVLAKITGLLAEHGVDILATEC 89 (136)
T ss_pred ccEEEEEEE---EcCCCCHHHHHHHHHHHCCCCEEEEEE
Confidence 346777787 457899999999999999999986653
No 180
>cd04876 ACT_RelA-SpoT ACT domain found C-terminal of the RelA/SpoT domains. ACT_RelA-SpoT: the ACT domain found C-terminal of the RelA/SpoT domains. Enzymes of the Rel/Spo family enable bacteria to survive prolonged periods of nutrient limitation by controlling guanosine-3'-diphosphate-5'-(tri)diphosphate ((p)ppGpp) production and subsequent rRNA repression (stringent response). Both the synthesis of (p)ppGpp from ATP and GDP(GTP), and its hydrolysis to GDP(GTP) and pyrophosphate, are catalyzed by Rel/Spo proteins. In Escherichia coli and its close relatives, the metabolism of (p)ppGpp is governed by two homologous proteins, RelA and SpoT. The RelA protein catalyzes (p)ppGpp synthesis in a reaction requiring its binding to ribosomes bearing codon-specified uncharged tRNA. The major role of the SpoT protein is the breakdown of (p)ppGpp by a manganese-dependent (p)ppGpp pyrophosphohydrolase activity. Although the stringent response appears to be tightly regulated by these two enzymes i
Probab=66.53 E-value=10 Score=25.54 Aligned_cols=29 Identities=14% Similarity=0.269 Sum_probs=24.0
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccC
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQAS 279 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~ 279 (330)
..+.||.++++.+.|.++++++..+.+..
T Consensus 5 ~~~~~~~l~~i~~~l~~~~~~i~~~~~~~ 33 (71)
T cd04876 5 AIDRPGLLADITTVIAEEKINILSVNTRT 33 (71)
T ss_pred EeccCcHHHHHHHHHHhCCCCEEEEEeEE
Confidence 34678999999999999999998876543
No 181
>cd04931 ACT_PAH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe. In PAH, an autoregulatory sequence, N-terminal of the ACT domain, extends across the catalytic domain active site and regulates the enzyme by intrasteric regulation. It appears that the activation by L-Phe induces a conformational change that converts the enzyme to a high-affinity and high-activity state. Modulation of activity is achieved through inhibition by BH4 and activation by phosphorylation of serine residues of the autoregulatory region. The molecular basis for the cooperative activation process is not fully understood yet. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=66.39 E-value=13 Score=28.87 Aligned_cols=52 Identities=12% Similarity=0.217 Sum_probs=34.3
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCCc---ceeeeecc-----hhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASSE---HSVCFAVP-----EKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~se---~sIS~vv~-----~~d~~~av~~Lh~ 302 (330)
+.+.||-+.++++.|+++|||+..|.--++. -...|+|+ +..+.++++.|++
T Consensus 21 l~~~pGsL~~vL~~Fa~~~INLt~IeSRP~~~~~~~Y~FfVDieg~~~~~~~~~l~~L~~ 80 (90)
T cd04931 21 LKEEVGALAKVLRLFEEKDINLTHIESRPSRLNKDEYEFFINLDKKSAPALDPIIKSLRN 80 (90)
T ss_pred cCCCCcHHHHHHHHHHHCCCCEEEEEeccCCCCCceEEEEEEEEcCCCHHHHHHHHHHHH
Confidence 3557999999999999999999998633331 12344443 3345555555554
No 182
>cd04887 ACT_MalLac-Enz ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI and related domains. The ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI, a malolactic enzyme (MalLac-Enz) which converts malate to lactate, and other related ACT domains. The yqkJ product is predicted to convert malate directly to lactate, as opposed to related malic enzymes that convert malate to pyruvate. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=65.99 E-value=11 Score=27.13 Aligned_cols=52 Identities=12% Similarity=0.174 Sum_probs=36.4
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccC---CcceeeeecchhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQAS---SEHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~---se~sIS~vv~~~d~~~av~~Lh~ 302 (330)
..+.||.++++.+.+++.|+||.-+.... ....+.|.+.-.+.+++-+.+++
T Consensus 6 ~~d~~g~L~~i~~~i~~~~~nI~~v~~~~~~~~~~~~~~~vev~~~~~l~~i~~~ 60 (74)
T cd04887 6 LPNRPGMLGRVTTAIGEAGGDIGAIDLVEQGRDYTVRDITVDAPSEEHAETIVAA 60 (74)
T ss_pred eCCCCchHHHHHHHHHHcCCcEEEEEEEEecCCEEEEEEEEEcCCHHHHHHHHHH
Confidence 45789999999999999999998766432 23335566666666655555544
No 183
>PF11760 CbiG_N: Cobalamin synthesis G N-terminal; InterPro: IPR021744 Members of this family are involved in cobalamin synthesis. The gene encoded by P72862 from SWISSPROT has been designated cbiH but in fact represents a fusion between cbiH and cbiG. As other multi-functional proteins involved in cobalamin biosynthesis catalyse adjacent steps in the pathway, including CysG, CobL (CbiET), CobIJ and CobA-HemD, it is therefore possible that CbiG catalyses a reaction step adjacent to CbiH. In the anaerobic pathway such a step could be the formation of a gamma lactone, which is thought to help to mediate the anaerobic ring contraction process []. Within the cobalamin synthesis pathway CbiG catalyses the both the opening of the lactone ring and the extrusion of the two-carbon fragment of cobalt-precorrin-5A from C-20 and its associated methyl group (deacylation) to give cobalt-precorrin-5B. The N-terminal of the enzyme is conserved in this family, and the C-terminal and the mid-sections are conserved independently in other families, CbiG_C and CbiG_mid, although the distinct function of each region is unclear. ; PDB: 3EEQ_B.
Probab=65.30 E-value=8.4 Score=29.71 Aligned_cols=32 Identities=28% Similarity=0.264 Sum_probs=19.6
Q ss_pred ecCCCCCccc--cc--ccCcchhHHHHHHHHhhcee
Q 020132 111 ASTPDNIPTT--LK--RDGSDFSAAIMGALLRAHQV 142 (330)
Q Consensus 111 ~~~~~g~~~~--lg--rggsD~~A~~lA~~l~A~~l 142 (330)
+.|++|...+ +| +||++..|-.+|..|++..+
T Consensus 43 vvde~g~~vIplL~GH~GGan~lA~~iA~~lga~~V 78 (84)
T PF11760_consen 43 VVDEDGRFVIPLLGGHRGGANELARQIAELLGAQPV 78 (84)
T ss_dssp EE-TT--EEEEEE-TTTT-HHHHHHHHHHHTT-EE-
T ss_pred EEeCCCCEEEEeccCCcchHHHHHHHHHHHhCCEEE
Confidence 5667776432 33 78899999999999999654
No 184
>cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=64.16 E-value=18 Score=26.64 Aligned_cols=45 Identities=20% Similarity=0.379 Sum_probs=32.4
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEEeccC--Ccceeeeecch
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS--SEHSVCFAVPE 290 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~--se~sIS~vv~~ 290 (330)
+|.+.|. +.||+++++..+|+++|+||....-.+ ...--+|.|.+
T Consensus 2 ~~~v~~~---Dr~gLl~~i~~~l~~~~lnI~~A~i~t~~~~~~d~f~V~d 48 (74)
T cd04925 2 AIELTGT---DRPGLLSEVFAVLADLHCNVVEARAWTHNGRLACVIYVRD 48 (74)
T ss_pred EEEEEEC---CCCCHHHHHHHHHHHCCCcEEEEEEEEECCEEEEEEEEEc
Confidence 5677764 689999999999999999997743222 24455666643
No 185
>cd04902 ACT_3PGDH-xct C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). The C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with an extended C-terminal (xct) region from bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback-controlled by the end product L-serine in an allosteric manner. Some 3PGDH enzymes have an additional domain formed by an extended C-terminal region. This additional domain introduces significant asymmetry to the homotetramer. Adjacent ACT (regulatory) domains interact, creating two serine-binding sites, however, this asymmetric arrangement results in the formation of two different and distinct domain interfaces between iden
Probab=64.09 E-value=6.1 Score=28.28 Aligned_cols=51 Identities=20% Similarity=0.249 Sum_probs=32.0
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEe-ccC---CcceeeeecchhhHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMIS-QAS---SEHSVCFAVPEKEVKAVAEALE 301 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Is-q~~---se~sIS~vv~~~d~~~av~~Lh 301 (330)
..+.||.++++.+.|+++|+||..+. ... ....+.+-++......+++.|.
T Consensus 6 ~~d~~G~l~~i~~~l~~~~inI~~~~~~~~~~~~~~~~~i~v~~~~~~~~~~~l~ 60 (73)
T cd04902 6 NTDRPGVIGKVGTILGEAGINIAGMQVGRDEPGGEALMVLSVDEPVPDEVLEELR 60 (73)
T ss_pred eCCCCCHHHHHHHHHHHcCcChhheEeeccCCCCEEEEEEEeCCCCCHHHHHHHH
Confidence 56789999999999999999996542 111 1233455555533334444443
No 186
>cd04906 ACT_ThrD-I_1 First of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase). This CD includes the first of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase) which catalyzes the committed step in branched chain amino acid biosynthesis in plants and microorganisms, the pyridoxal 5'-phosphate (PLP)-dependent dehydration/deamination of L-threonine (or L-serine) to 2-ketobutyrate (or pyruvate). ThrD-I is a cooperative, feedback-regulated (isoleucine and valine) allosteric enzyme that forms a tetramer and contains four pyridoxal phosphate moieties. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=62.90 E-value=18 Score=27.44 Aligned_cols=52 Identities=13% Similarity=0.195 Sum_probs=35.8
Q ss_pred ccccCCCCchhhhhhhhcccCccEEEEeccC---Ccceeeeecch----hhHHHHHHHHHH
Q 020132 249 TGMAGVPGTANAIFGAVKDVGANVIMISQAS---SEHSVCFAVPE----KEVKAVAEALES 302 (330)
Q Consensus 249 ~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~---se~sIS~vv~~----~d~~~av~~Lh~ 302 (330)
..+++.||-+.++.+.|+..||+ .+.|.. ....+.+.++- ++.+++.+.|.+
T Consensus 6 v~ipD~PG~L~~ll~~l~~anI~--~~~y~~~~~~~~~v~i~ie~~~~~~~~~~i~~~L~~ 64 (85)
T cd04906 6 VTIPERPGSFKKFCELIGPRNIT--EFNYRYADEKDAHIFVGVSVANGAEELAELLEDLKS 64 (85)
T ss_pred EecCCCCcHHHHHHHHhCCCcee--EEEEEccCCCeeEEEEEEEeCCcHHHHHHHHHHHHH
Confidence 34889999999999999966665 444422 35667776774 447777766655
No 187
>COG4492 PheB ACT domain-containing protein [General function prediction only]
Probab=62.46 E-value=12 Score=31.44 Aligned_cols=52 Identities=19% Similarity=0.323 Sum_probs=37.5
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC-----cceeeeecc--hhhHHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS-----EHSVCFAVP--EKEVKAVAEALES 302 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s-----e~sIS~vv~--~~d~~~av~~Lh~ 302 (330)
+.+..|.+++++..+++.++||.-|.|+.+ ..++|+-.. +.++++.++.|.+
T Consensus 79 ledr~G~LS~vLd~iA~~~~nvLTI~Q~ipl~g~Anvtlsi~~ssm~~~V~~ii~kl~k 137 (150)
T COG4492 79 LEDRVGILSDVLDVIAREEINVLTIHQTIPLQGRANVTLSIDTSSMEKDVDKIIEKLRK 137 (150)
T ss_pred EhhhhhhHHHHHHHHHHhCCcEEEEecccccCceeeEEEEEEchhhhhhHHHHHHHHhc
Confidence 567789999999999999999999999765 344444333 3455555555543
No 188
>PRK08198 threonine dehydratase; Provisional
Probab=62.40 E-value=16 Score=35.97 Aligned_cols=59 Identities=20% Similarity=0.415 Sum_probs=42.5
Q ss_pred cceeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccC-------Ccceeeeecchhh---HHHHHHHH
Q 020132 239 DNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS-------SEHSVCFAVPEKE---VKAVAEAL 300 (330)
Q Consensus 239 ~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~-------se~sIS~vv~~~d---~~~av~~L 300 (330)
.....+++. +.+.||.++++++.+++.|.||.-|.|.- ....+++.++-.+ .+++++.|
T Consensus 325 gr~~~l~v~---l~D~PG~L~~ll~~i~~~g~NI~~i~~~~~~~~~~~~~~~v~v~ie~~~~~~~~~l~~~L 393 (404)
T PRK08198 325 GRYLKLRVR---LPDRPGQLAKLLSIIAELGANVIDVDHDRFSPDLRLGEVEVELTLETRGPEHIEEILDAL 393 (404)
T ss_pred CCEEEEEEE---eCCCCCHHHHHHHHHhhCCCceEEEEEEEccCCCCCceEEEEEEEEeCCHHHHHHHHHHH
Confidence 445566664 88999999999999999999999888852 2456666666544 44444444
No 189
>cd04873 ACT_UUR-ACR-like ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD. This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted t
Probab=62.07 E-value=17 Score=25.44 Aligned_cols=45 Identities=22% Similarity=0.273 Sum_probs=31.4
Q ss_pred EeeecccccCCCCchhhhhhhhcccCccEEEEeccCC--cceeeeecchh
Q 020132 244 VNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVPEK 291 (330)
Q Consensus 244 IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s--e~sIS~vv~~~ 291 (330)
|.+. ..+.||+++++...|+++|++|..+...+. .....|.+...
T Consensus 3 l~i~---~~d~~g~l~~i~~~l~~~~~~I~~~~~~~~~~~~~~~~~v~~~ 49 (70)
T cd04873 3 VEVY---APDRPGLLADITRVLADLGLNIHDARISTTGERALDVFYVTDS 49 (70)
T ss_pred EEEE---eCCCCCHHHHHHHHHHHCCCeEEEEEEeecCCEEEEEEEEECC
Confidence 4455 457899999999999999999976654332 34455555443
No 190
>PRK03670 competence damage-inducible protein A; Provisional
Probab=60.86 E-value=31 Score=32.06 Aligned_cols=70 Identities=14% Similarity=0.208 Sum_probs=45.9
Q ss_pred hHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccC
Q 020132 46 WSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG 125 (330)
Q Consensus 46 ~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrgg 125 (330)
-++..+++.|.+.|++... ..++.| |.+.+.+.++.++. ....+.|++|-+|.+.
T Consensus 20 tN~~~la~~L~~~G~~v~~-----~~iV~D--------d~~~I~~~l~~a~~-~~~DlVIttGGlGpt~----------- 74 (252)
T PRK03670 20 SNSAFIAQKLTEKGYWVRR-----ITTVGD--------DVEEIKSVVLEILS-RKPEVLVISGGLGPTH----------- 74 (252)
T ss_pred hhHHHHHHHHHHCCCEEEE-----EEEcCC--------CHHHHHHHHHHHhh-CCCCEEEECCCccCCC-----------
Confidence 3567889999999987533 223332 23445566766654 1247788888655443
Q ss_pred cchhHHHHHHHHhhc
Q 020132 126 SDFSAAIMGALLRAH 140 (330)
Q Consensus 126 sD~~A~~lA~~l~A~ 140 (330)
.|.|.-.+|++++-+
T Consensus 75 dD~T~eava~a~g~~ 89 (252)
T PRK03670 75 DDVTMLAVAEALGRE 89 (252)
T ss_pred CCchHHHHHHHhCCC
Confidence 399999999999843
No 191
>PRK11589 gcvR glycine cleavage system transcriptional repressor; Provisional
Probab=60.00 E-value=12 Score=33.37 Aligned_cols=63 Identities=13% Similarity=0.161 Sum_probs=42.0
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEecc---C--C-----cceeeeecchh----hHHHHHHHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA---S--S-----EHSVCFAVPEK----EVKAVAEALESKFREA 307 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~---~--s-----e~sIS~vv~~~----d~~~av~~Lh~~f~~~ 307 (330)
..|+++|. ++||+..++-+.|+++||||.-.+.- + + ...+.+-++.. ++.++++.|.+.+..+
T Consensus 96 ~~v~v~G~---DrPGIV~~vT~~la~~~iNI~~L~T~~~~a~~~~~~lf~~~~~v~lP~~~~~~~L~~~l~~l~~eL~vd 172 (190)
T PRK11589 96 VWVQVEVA---DSPHLIERFTALFDSHHMNIAELVSRTQPAEGERPAQLHIQITAHSPASQDAANIEQAFKALCTELNAQ 172 (190)
T ss_pred EEEEEEEC---CCCCHHHHHHHHHHHcCCChhheEEeeecCCCCCcccEEEEEEEEcCCCCCHHHHHHHHHHHHHHhCce
Confidence 57888985 68999999999999999998765421 1 1 23455555543 4555555555555443
No 192
>cd04885 ACT_ThrD-I Tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase). This CD includes each of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase) which catalyzes the committed step in branched chain amino acid biosynthesis in plants and microorganisms, the pyridoxal 5'-phosphate (PLP)-dependent dehydration/deamination of L-threonine (or L-serine) to 2-ketobutyrate (or pyruvate). ThrD-I is a cooperative, feedback-regulated (isoleucine and valine) allosteric enzyme that forms a tetramer and contains four pyridoxal phosphate moieties. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=59.48 E-value=25 Score=25.25 Aligned_cols=50 Identities=16% Similarity=0.251 Sum_probs=34.7
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC---cceeeeecchh---hHHHHHHHHH
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPEK---EVKAVAEALE 301 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s---e~sIS~vv~~~---d~~~av~~Lh 301 (330)
+.++||-+.++.+.+++ +.||..+.|.-+ ...+.+.+.-. +.++.++.|.
T Consensus 5 ipdkPG~l~~~~~~i~~-~~nI~~~~~~~~~~~~~~v~v~ie~~~~~~~~~i~~~L~ 60 (68)
T cd04885 5 FPERPGALKKFLELLGP-PRNITEFHYRNQGGDEARVLVGIQVPDREDLAELKERLE 60 (68)
T ss_pred CCCCCCHHHHHHHHhCC-CCcEEEEEEEcCCCCceEEEEEEEeCCHHHHHHHHHHHH
Confidence 67899999999999999 999998887542 34455555443 4444444443
No 193
>cd00885 cinA Competence-damaged protein. CinA is the first gene in the competence- inducible (cin) operon and is thought to be specifically required at some stage in the process of transformation. This domain is closely related to a domain, found in a variety of proteins involved in biosynthesis of molybdopterin cofactor, where the domain is presumed to bind molybdopterin.
Probab=59.43 E-value=42 Score=29.07 Aligned_cols=70 Identities=20% Similarity=0.214 Sum_probs=46.1
Q ss_pred hhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCccccccc
Q 020132 45 LWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRD 124 (330)
Q Consensus 45 ~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrg 124 (330)
--++..+++.|.+.|++... ..++.+ +.+.+.+.++.+++ ...+.|++|-.+.+
T Consensus 18 d~n~~~l~~~L~~~G~~v~~-----~~~v~D--------d~~~I~~~l~~~~~--~~dlVIttGG~G~t----------- 71 (170)
T cd00885 18 DTNAAFLAKELAELGIEVYR-----VTVVGD--------DEDRIAEALRRASE--RADLVITTGGLGPT----------- 71 (170)
T ss_pred EhHHHHHHHHHHHCCCEEEE-----EEEeCC--------CHHHHHHHHHHHHh--CCCEEEECCCCCCC-----------
Confidence 34567889999999987633 223333 23345566776665 45777887754432
Q ss_pred CcchhHHHHHHHHhhc
Q 020132 125 GSDFSAAIMGALLRAH 140 (330)
Q Consensus 125 gsD~~A~~lA~~l~A~ 140 (330)
..|.+.-.++.+++-+
T Consensus 72 ~~D~t~ea~~~~~~~~ 87 (170)
T cd00885 72 HDDLTREAVAKAFGRP 87 (170)
T ss_pred CCChHHHHHHHHhCCC
Confidence 2499999999999843
No 194
>COG0855 Ppk Polyphosphate kinase [Inorganic ion transport and metabolism]
Probab=59.28 E-value=26 Score=36.86 Aligned_cols=77 Identities=13% Similarity=0.195 Sum_probs=43.8
Q ss_pred HHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcchh--HHHHHH-HHhhceeEEEeecccccccCccchhH-hhhh
Q 020132 90 KRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSDFS--AAIMGA-LLRAHQVTIWTDVDGVYSADPRKVSE-AVIL 165 (330)
Q Consensus 90 ~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD~~--A~~lA~-~l~A~~l~~~tdv~Gv~~~dP~~~~~-a~~i 165 (330)
-...+.|+ ...|-|++|++|.-...+...+-|--.|.. -++++. =+++...-++||+ |++|+||....+ .++.
T Consensus 416 I~WAk~LE--~AGvhVvyG~~glKtHAKm~lVvRrE~~~lrrY~HlGTGNYn~~TAriYTD~-sl~Tad~~i~~Dv~~lF 492 (696)
T COG0855 416 IHWAKRLE--RAGVHVVYGVVGLKTHAKMLLVVRREGGKLRRYVHLGTGNYNPKTARLYTDL-SLLTADPEIGADVTDLF 492 (696)
T ss_pred hHHHHHHH--hCCcEEEecccceeeeeeEEEEEEecCCcEEEEEEecCCCCCccceeeeeec-hhccCCHHHHHHHHHHH
Confidence 33444555 557889999988775554433222211110 011111 1355666799999 799999998766 3344
Q ss_pred hhhh
Q 020132 166 RTLS 169 (330)
Q Consensus 166 ~~is 169 (330)
..||
T Consensus 493 n~lt 496 (696)
T COG0855 493 NFLT 496 (696)
T ss_pred HHhc
Confidence 4443
No 195
>cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=57.01 E-value=26 Score=25.94 Aligned_cols=30 Identities=7% Similarity=0.122 Sum_probs=24.9
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEE
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMI 275 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~I 275 (330)
++.|.+ +++||+++++..+|+.+|++|...
T Consensus 2 ~~ei~~---~Dr~gLfa~i~~~l~~~~l~I~~A 31 (76)
T cd04927 2 LLKLFC---SDRKGLLHDVTEVLYELELTIERV 31 (76)
T ss_pred EEEEEE---CCCCCHHHHHHHHHHHCCCeEEEE
Confidence 455654 478999999999999999999873
No 196
>PRK03673 hypothetical protein; Provisional
Probab=56.55 E-value=35 Score=33.89 Aligned_cols=68 Identities=18% Similarity=0.150 Sum_probs=46.6
Q ss_pred hHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccC
Q 020132 46 WSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG 125 (330)
Q Consensus 46 ~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrgg 125 (330)
-++..+++.|.+.|++.... .++.| |.+...+.++..+. ...+.|++|-+|.+.
T Consensus 21 tN~~~la~~L~~~G~~v~~~-----~~v~D--------~~~~i~~~l~~a~~--~~DlVI~tGGlGpt~----------- 74 (396)
T PRK03673 21 TNAAWLADFFFHQGLPLSRR-----NTVGD--------NLDALVAILRERSQ--HADVLIVNGGLGPTS----------- 74 (396)
T ss_pred hHHHHHHHHHHHCCCEEEEE-----EEcCC--------CHHHHHHHHHHHhc--cCCEEEEcCCCCCCC-----------
Confidence 35778899999999875432 22233 33445566666665 557888888655433
Q ss_pred cchhHHHHHHHHhh
Q 020132 126 SDFSAAIMGALLRA 139 (330)
Q Consensus 126 sD~~A~~lA~~l~A 139 (330)
-|.+.-.+|+++|-
T Consensus 75 dD~t~~avA~a~g~ 88 (396)
T PRK03673 75 DDLSALAAATAAGE 88 (396)
T ss_pred cccHHHHHHHHcCC
Confidence 39999999999994
No 197
>cd04871 ACT_PSP_2 ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_2 CD includes the second of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains
Probab=55.65 E-value=5.1 Score=30.59 Aligned_cols=34 Identities=24% Similarity=0.304 Sum_probs=28.7
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEEecc
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA 278 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~ 278 (330)
+|+++|..+ ..+.++++-+.|+++|+||+-|+|=
T Consensus 1 ivtvlg~~~--~a~~ia~Vs~~lA~~~~NI~~I~~l 34 (84)
T cd04871 1 IVTLLGRPL--TAEQLAAVTRVVADQGLNIDRIRRL 34 (84)
T ss_pred CEEEEcCcC--CHHHHHHHHHHHHHcCCCHHHHHHh
Confidence 478888543 5799999999999999999998874
No 198
>TIGR00177 molyb_syn molybdenum cofactor synthesis domain. The Drosophila protein cinnamon, the Arabidopsis protein cnx1, and rat protein gephyrin each have one domain like MoeA and one like MoaB and Mog. These domains are, however, distantly related to each other, as captured by this model. Gephyrin is unusual in that it seems to be a tubulin-binding neuroprotein involved in the clustering of both blycine receptors and GABA receptors, rather than a protein of molybdenum cofactor biosynthesis.
Probab=54.33 E-value=78 Score=26.40 Aligned_cols=66 Identities=21% Similarity=0.261 Sum_probs=41.4
Q ss_pred hHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccC
Q 020132 46 WSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG 125 (330)
Q Consensus 46 ~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrgg 125 (330)
-++..+.+.|++.|+++..+ .+..+ |.+...+.++++++ ...+.|++|-.+. |.
T Consensus 27 ~n~~~l~~~l~~~G~~v~~~-----~~v~D--------d~~~i~~~l~~~~~--~~DliIttGG~g~-----------g~ 80 (144)
T TIGR00177 27 SNGPLLAALLEEAGFNVSRL-----GIVPD--------DPEEIREILRKAVD--EADVVLTTGGTGV-----------GP 80 (144)
T ss_pred CcHHHHHHHHHHCCCeEEEE-----eecCC--------CHHHHHHHHHHHHh--CCCEEEECCCCCC-----------CC
Confidence 34678899999999875332 22222 23445566776665 4577788774332 23
Q ss_pred cchhHHHHHHHH
Q 020132 126 SDFSAAIMGALL 137 (330)
Q Consensus 126 sD~~A~~lA~~l 137 (330)
.|++...++.+.
T Consensus 81 ~D~t~~ai~~~g 92 (144)
T TIGR00177 81 RDVTPEALEELG 92 (144)
T ss_pred CccHHHHHHHhC
Confidence 488888888765
No 199
>COG4747 ACT domain-containing protein [General function prediction only]
Probab=53.89 E-value=40 Score=27.82 Aligned_cols=56 Identities=18% Similarity=0.316 Sum_probs=40.8
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEEeccC-Ccc-eeeeecchhhHHHHHHHHHHH
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS-SEH-SVCFAVPEKEVKAVAEALESK 303 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~-se~-sIS~vv~~~d~~~av~~Lh~~ 303 (330)
.||+- ..++||-++.+...|+++|||+...+-.. +++ -|..+|++.|. |-++||+.
T Consensus 5 QISvF---lENk~GRL~~~~~~L~eagINiRA~tiAdt~dFGIiRmvV~~~d~--A~~~Lee~ 62 (142)
T COG4747 5 QISVF---LENKPGRLASVANKLKEAGINIRAFTIADTGDFGIIRMVVDRPDE--AHSVLEEA 62 (142)
T ss_pred EEEEE---ecCCcchHHHHHHHHHHcCCceEEEEeccccCcceEEEEcCChHH--HHHHHHHC
Confidence 35554 56789999999999999999999877432 343 35677777765 55667764
No 200
>cd04930 ACT_TH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tyrosine hydroxylases (TH). ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tyrosine hydroxylases (TH). TH catalyses the hydroxylation of L-Tyr to 3,4-dihydroxyphenylalanine, the rate limiting step in the biosynthesis of catecholamines (dopamine, noradrenaline and adrenaline), functioning as hormones and neurotransmitters. The enzyme is not regulated by its amino acid substrate, but instead by phosphorylation at several serine residues located N-terminal of the ACT domain, and by feedback inhibition by catecholamines at the active site. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=52.15 E-value=31 Score=28.07 Aligned_cols=27 Identities=7% Similarity=0.090 Sum_probs=23.8
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEec
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQ 277 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq 277 (330)
+.+.||.+.++++.|+++|||+..|.-
T Consensus 48 l~~~pGsL~~iL~~Fa~~gINLt~IES 74 (115)
T cd04930 48 LKEGFSSLSRILKVFETFEAKIHHLES 74 (115)
T ss_pred eCCCCcHHHHHHHHHHHCCCCEEEEEC
Confidence 356799999999999999999999963
No 201
>cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=50.88 E-value=16 Score=26.71 Aligned_cols=40 Identities=13% Similarity=0.135 Sum_probs=28.5
Q ss_pred ccCCCCchhhhhhhhcccCccEEEEeccCC--cceeeeecch
Q 020132 251 MAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVPE 290 (330)
Q Consensus 251 ~~~~~gv~a~if~~L~~~gI~I~~Isq~~s--e~sIS~vv~~ 290 (330)
+.+.||+++++...|+++|+||....-.+. ..-.+|.|..
T Consensus 8 ~~D~~Gll~~i~~~l~~~~lnI~sa~i~t~~~~~~d~f~v~~ 49 (72)
T cd04926 8 TEDRVGLLSDVTRVFRENGLTVTRAEISTQGDMAVNVFYVTD 49 (72)
T ss_pred ECCccCHHHHHHHHHHHCCcEEEEEEEecCCCeEEEEEEEEC
Confidence 567899999999999999999965432222 3345666643
No 202
>PRK01215 competence damage-inducible protein A; Provisional
Probab=50.72 E-value=57 Score=30.47 Aligned_cols=70 Identities=16% Similarity=0.159 Sum_probs=47.0
Q ss_pred hhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCccccccc
Q 020132 45 LWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRD 124 (330)
Q Consensus 45 ~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrg 124 (330)
--++..+++.|.+.|++.... .++.| |.+.+.+.++.+++ ...+.|++|-.+.+.
T Consensus 22 dtn~~~l~~~L~~~G~~v~~~-----~~v~D--------d~~~I~~~l~~a~~--~~DlVIttGG~g~t~---------- 76 (264)
T PRK01215 22 NTNASWIARRLTYLGYTVRRI-----TVVMD--------DIEEIVSAFREAID--RADVVVSTGGLGPTY---------- 76 (264)
T ss_pred EhhHHHHHHHHHHCCCeEEEE-----EEeCC--------CHHHHHHHHHHHhc--CCCEEEEeCCCcCCh----------
Confidence 345778999999999886432 22333 23445677777765 457888887544332
Q ss_pred CcchhHHHHHHHHhhc
Q 020132 125 GSDFSAAIMGALLRAH 140 (330)
Q Consensus 125 gsD~~A~~lA~~l~A~ 140 (330)
.|.+.-.+|.+++-+
T Consensus 77 -dD~t~eaia~~~g~~ 91 (264)
T PRK01215 77 -DDKTNEGFAKALGVE 91 (264)
T ss_pred -hhhHHHHHHHHhCCC
Confidence 399999999999843
No 203
>PF00994 MoCF_biosynth: Probable molybdopterin binding domain; InterPro: IPR001453 Eukaryotic and prokaryotic molybdoenzymes require a molybdopterin cofactor (MoCF) for their activity. The biosynthesis of this cofactor involves a complex multistep enzymatic pathway. One of the eukaryotic proteins involved in this pathway is the Drosophila protein cinnamon [] which is highly similar to gephyrin, a rat microtubule-associated protein which was thought to anchor the glycine receptor to subsynaptic microtubules. Cinnamon and gephyrin are evolutionary related, in their N-terminal half, to the Escherichia coli MoCF biosynthesis proteins mog/chlG and moaB/chlA2 and, in their C-terminal half, to E. coli moeA/chlE.; GO: 0006777 Mo-molybdopterin cofactor biosynthetic process; PDB: 3TCR_B 1O8O_B 1O8Q_G 1EAV_D 1O8N_C 1UUX_A 1UUY_A 2G2C_A 2G4R_C 3K6A_F ....
Probab=50.60 E-value=63 Score=26.77 Aligned_cols=68 Identities=19% Similarity=0.188 Sum_probs=45.3
Q ss_pred hhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCccccccc
Q 020132 45 LWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRD 124 (330)
Q Consensus 45 ~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrg 124 (330)
--++..+.+.|++.|+..... .++.| |.+...+.++..++ ...+.|++|-.+.+
T Consensus 16 d~n~~~l~~~l~~~G~~v~~~-----~~v~D--------d~~~i~~~l~~~~~--~~D~VittGG~g~~----------- 69 (144)
T PF00994_consen 16 DSNGPFLAALLEELGIEVIRY-----GIVPD--------DPDAIKEALRRALD--RADLVITTGGTGPG----------- 69 (144)
T ss_dssp BHHHHHHHHHHHHTTEEEEEE-----EEEES--------SHHHHHHHHHHHHH--TTSEEEEESSSSSS-----------
T ss_pred EhHHHHHHHHHHHcCCeeeEE-----EEECC--------CHHHHHHHHHhhhc--cCCEEEEcCCcCcc-----------
Confidence 446788999999999965432 23333 34556677777776 56888888854422
Q ss_pred CcchhHHHHHHHHh
Q 020132 125 GSDFSAAIMGALLR 138 (330)
Q Consensus 125 gsD~~A~~lA~~l~ 138 (330)
-.|.+.-.++.+.+
T Consensus 70 ~~D~t~~a~~~~~~ 83 (144)
T PF00994_consen 70 PDDVTPEALAEAGG 83 (144)
T ss_dssp TTCHHHHHHHHHSS
T ss_pred cCCcccHHHHHhcC
Confidence 23888888877765
No 204
>COG0499 SAM1 S-adenosylhomocysteine hydrolase [Coenzyme metabolism]
Probab=47.66 E-value=20 Score=35.21 Aligned_cols=77 Identities=13% Similarity=0.142 Sum_probs=44.4
Q ss_pred HHHHhcCC---ccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhcc-CCCccEEEeeeeecCCCCCcccccccCcch
Q 020132 53 AVVRKNGI---DCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQ-SPSNTIIATGFIASTPDNIPTTLKRDGSDF 128 (330)
Q Consensus 53 ~~L~~~Gi---~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~-~~~~VpVv~G~i~~~~~g~~~~lgrggsD~ 128 (330)
..+.+.|. |+..+|-+-.--..+++||-.+-.+ +.|.+..+. ..|+..||.|| |. +|||
T Consensus 161 ~am~~~G~L~fPai~VNDs~tK~~FDNrYGtgqS~~----DgI~RaTn~liaGK~vVV~GY------G~---vGrG---- 223 (420)
T COG0499 161 RAMEKDGVLKFPAINVNDSVTKSLFDNRYGTGQSLL----DGILRATNVLLAGKNVVVAGY------GW---VGRG---- 223 (420)
T ss_pred HHHHhcCCcccceEeecchhhhcccccccccchhHH----HHHHhhhceeecCceEEEecc------cc---cchH----
Confidence 34555554 5555554432222345555321111 333332221 37899999997 43 6788
Q ss_pred hHHHHHHHHhhceeEEEeecc
Q 020132 129 SAAIMGALLRAHQVTIWTDVD 149 (330)
Q Consensus 129 ~A~~lA~~l~A~~l~~~tdv~ 149 (330)
.+..++.+||+ ++.|+||
T Consensus 224 -~A~~~rg~GA~--ViVtEvD 241 (420)
T COG0499 224 -IAMRLRGMGAR--VIVTEVD 241 (420)
T ss_pred -HHHHhhcCCCe--EEEEecC
Confidence 77888889986 6788886
No 205
>smart00852 MoCF_biosynth Probable molybdopterin binding domain. This domain is found a variety of proteins involved in biosynthesis of molybdopterin cofactor. The domain is presumed to bind molybdopterin. The structure of this domain is known, and it forms an alpha/beta structure. In the known structure of Gephyrin this domain mediates trimerisation.
Probab=47.59 E-value=79 Score=25.84 Aligned_cols=70 Identities=19% Similarity=0.215 Sum_probs=44.7
Q ss_pred chhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccc
Q 020132 44 ELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKR 123 (330)
Q Consensus 44 E~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgr 123 (330)
+..++..+.+.|++.|...... .+..+ |.+...+.++++++ ...+.|++|-.+.
T Consensus 16 ~d~~~~~l~~~l~~~G~~~~~~-----~~v~D--------d~~~I~~~l~~~~~--~~dliittGG~g~----------- 69 (135)
T smart00852 16 YDSNGPALAELLTELGIEVTRY-----VIVPD--------DKEAIKEALREALE--RADLVITTGGTGP----------- 69 (135)
T ss_pred ccCcHHHHHHHHHHCCCeEEEE-----EEeCC--------CHHHHHHHHHHHHh--CCCEEEEcCCCCC-----------
Confidence 3556788999999999875432 22222 33455677777775 4567777774332
Q ss_pred cCcchhHHHHHHHHhh
Q 020132 124 DGSDFSAAIMGALLRA 139 (330)
Q Consensus 124 ggsD~~A~~lA~~l~A 139 (330)
|-.|++-..++..++.
T Consensus 70 g~~D~t~~~l~~~~~~ 85 (135)
T smart00852 70 GPDDVTPEAVAEALGK 85 (135)
T ss_pred CCCcCcHHHHHHHhCC
Confidence 2248888888887763
No 206
>PRK06349 homoserine dehydrogenase; Provisional
Probab=47.55 E-value=26 Score=34.99 Aligned_cols=52 Identities=21% Similarity=0.276 Sum_probs=38.0
Q ss_pred cccCCCCchhhhhhhhcccCccEEEEeccCC---cceeeeecch---hhHHHHHHHHH
Q 020132 250 GMAGVPGTANAIFGAVKDVGANVIMISQASS---EHSVCFAVPE---KEVKAVAEALE 301 (330)
Q Consensus 250 ~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s---e~sIS~vv~~---~d~~~av~~Lh 301 (330)
...+.||+++++-..|++++|++..+.|... ...+.++++. .++.+++..|.
T Consensus 354 ~v~d~pGvLa~I~~~f~~~~vsI~si~q~~~~~~~~~ivivT~~~~e~~l~~~i~~L~ 411 (426)
T PRK06349 354 LVADKPGVLAKIAAIFAENGISIESILQKGAGGEGAEIVIVTHETSEAALRAALAAIE 411 (426)
T ss_pred EecCCcchHHHHHHHHhhcCccEEEEEeccCCCCceeEEEEEEeCCHHHHHHHHHHHh
Confidence 4667899999999999999999999988653 2457777664 44444444443
No 207
>PF02254 TrkA_N: TrkA-N domain; InterPro: IPR003148 The regulator of K+ conductance (RCK) domain is found in many ligand-gated K+ channels, most often attached to the intracellular carboxy terminus. The domain is prevalent among prokaryotic K+ channels, and also found in eukaryotic, high-conductance Ca2+-activated K+ channels (BK channels) [, , ]. Largely involved in redox-linked regulation of potassium channels, the N-terminal part of the RCK domain is predicted to be an active dehydrogenase at least in some cases []. Some have a conserved sequence motif (G-x-G-x-x-G-x(n)-[DE]) for NAD+ binding [], but others do not, reflecting the diversity of ligands for RCK domains. The C-terminal part is less conserved, being absent in some channels, such as the kefC antiporter from Escherichia coli. It is predicted to bind unidentified ligands and to regulate sulphate, sodium and other transporters. The X-ray structure of several RCK domains has been solved [, , ]. It reveals an alpha-beta fold similar to dehydrogenase enzymes. The domain forms a homodimer, producing a cleft between two lobes. It has a composite structure, with an N-terminal (RCK-N), and a C-terminal (RCK-C) subdomain. The RCK-N subdomain forms a Rossmann fold with two alpha helices on one side of a six stranded parallel beta sheet and three alpha helices on the other side. The RCK-C subdomain is an all-beta-strand fold. It forms an extention of the dimer interface and further stabilises the RCK homodimer [, , ]. Ca2+ is a ligand that opens the channel in a concentration-dependent manner. Two Ca2+ ions are located at the base of a cleft between two RCK domains, coordinated by the carboxylate groups of two glutamate residues, and by an aspartate residue [, , ]. RCK domains occur in at least five different contexts: As a single domain on the C terminus of some K+ channels (for example, many prokaryotic K+ channels). As two tandem RCK domains on the C terminus of some transporters that form gating rings (for example, eukaryotic BK channels). The gating ring has an arrangement of eight identical RCK domains, one from each of the four pore-forming subunits and four from the intracellular solution. As two domains, one at the N terminus and another at the C terminus of transporter (for example, the prokaryotic trk system potassium uptake protein A). As a soluble protein (not part of a K+ channel) consisting of two tandem RCK domains. As a soluble protein consisting of a single RCK domain. This entry represents the N-terminal subdomain of RCK.; GO: 0006813 potassium ion transport; PDB: 3L4B_E 1LSS_C 3LLV_A 2FY8_D 2AEF_A 1LNQ_E 3RBX_C 3KXD_A 2AEJ_A 3RBZ_A ....
Probab=45.35 E-value=46 Score=26.04 Aligned_cols=70 Identities=23% Similarity=0.338 Sum_probs=40.4
Q ss_pred eeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCC
Q 020132 38 FVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNI 117 (330)
Q Consensus 38 ~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~ 117 (330)
.++|+|+. ++.++..|.+.+.+.+. ++. |. +.++++.+ .+ ++++.|+..
T Consensus 2 vI~G~g~~--~~~i~~~L~~~~~~vvv--------id~--------d~----~~~~~~~~--~~-~~~i~gd~~------ 50 (116)
T PF02254_consen 2 VIIGYGRI--GREIAEQLKEGGIDVVV--------IDR--------DP----ERVEELRE--EG-VEVIYGDAT------ 50 (116)
T ss_dssp EEES-SHH--HHHHHHHHHHTTSEEEE--------EES--------SH----HHHHHHHH--TT-SEEEES-TT------
T ss_pred EEEcCCHH--HHHHHHHHHhCCCEEEE--------EEC--------Cc----HHHHHHHh--cc-cccccccch------
Confidence 46788887 99999999997754333 222 22 44555554 33 778877621
Q ss_pred cccccccCcchhHHHHHHHHhhceeEEEee
Q 020132 118 PTTLKRDGSDFSAAIMGALLRAHQVTIWTD 147 (330)
Q Consensus 118 ~~~lgrggsD~~A~~lA~~l~A~~l~~~td 147 (330)
|.-...-|..-+|+.+++.|+
T Consensus 51 ---------~~~~l~~a~i~~a~~vv~~~~ 71 (116)
T PF02254_consen 51 ---------DPEVLERAGIEKADAVVILTD 71 (116)
T ss_dssp ---------SHHHHHHTTGGCESEEEEESS
T ss_pred ---------hhhHHhhcCccccCEEEEccC
Confidence 333333344446666766665
No 208
>PRK00549 competence damage-inducible protein A; Provisional
Probab=44.05 E-value=75 Score=31.71 Aligned_cols=70 Identities=24% Similarity=0.221 Sum_probs=46.0
Q ss_pred hhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCccccccc
Q 020132 45 LWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRD 124 (330)
Q Consensus 45 ~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrg 124 (330)
--++..+++.|++.|++... ..++.| |.+.+.+.++..+. ...+.|++|-++.+.
T Consensus 19 DtN~~~L~~~L~~~G~~v~~-----~~~v~D--------d~~~I~~~l~~a~~--~~DlVItTGGlGpt~---------- 73 (414)
T PRK00549 19 NTNAQFLSEKLAELGIDVYH-----QTVVGD--------NPERLLSALEIAEE--RSDLIITTGGLGPTK---------- 73 (414)
T ss_pred EhhHHHHHHHHHHCCCeEEE-----EEEeCC--------CHHHHHHHHHHhcc--CCCEEEECCCCCCCC----------
Confidence 34567889999999987643 223333 23345566665554 457888888655332
Q ss_pred CcchhHHHHHHHHhhc
Q 020132 125 GSDFSAAIMGALLRAH 140 (330)
Q Consensus 125 gsD~~A~~lA~~l~A~ 140 (330)
-|.+.-.+|.+++.+
T Consensus 74 -dD~t~ea~a~~~g~~ 88 (414)
T PRK00549 74 -DDLTKETVAKFLGRE 88 (414)
T ss_pred -CccHHHHHHHHhCCC
Confidence 399999999999854
No 209
>cd04899 ACT_ACR-UUR-like_2 C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains. This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=43.91 E-value=22 Score=25.13 Aligned_cols=32 Identities=13% Similarity=0.280 Sum_probs=25.7
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEEec
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQ 277 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq 277 (330)
+|.+.+ .+.||+++++...|++++++|..+..
T Consensus 2 ~l~v~~---~d~~gll~~i~~~l~~~~~~I~~~~~ 33 (70)
T cd04899 2 VLELTA---LDRPGLLADVTRVLAELGLNIHSAKI 33 (70)
T ss_pred EEEEEE---cCCccHHHHHHHHHHHCCCeEEEEEE
Confidence 455654 47899999999999999999966553
No 210
>PF09413 DUF2007: Domain of unknown function (DUF2007); InterPro: IPR018551 This is a family of proteins with unknown function. ; PDB: 2HFV_A.
Probab=43.82 E-value=35 Score=24.32 Aligned_cols=44 Identities=25% Similarity=0.312 Sum_probs=26.8
Q ss_pred hhhhhhhcccCccEEEEeccCCcc--------eeeeecchhhHHHHHHHHHH
Q 020132 259 NAIFGAVKDVGANVIMISQASSEH--------SVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 259 a~if~~L~~~gI~I~~Isq~~se~--------sIS~vv~~~d~~~av~~Lh~ 302 (330)
..+-..|.++||+...-....+.. -+.+.|+++|.++|.+.|++
T Consensus 13 ~~i~~~L~~~gI~~~v~~~~~~~~~g~~g~~~~~~v~V~~~d~~~A~~il~~ 64 (67)
T PF09413_consen 13 ELIKGLLEENGIPAFVKNEHMSGYAGEPGTGGQVEVYVPEEDYERAREILEE 64 (67)
T ss_dssp HHHHHHHHHTT--EE--S----SS---S--SSSEEEEEEGGGHHHHHHHHHH
T ss_pred HHHHHHHHhCCCcEEEECCccchhhcccCccCceEEEECHHHHHHHHHHHHH
Confidence 345566777777765543322211 18899999999999999976
No 211
>TIGR01127 ilvA_1Cterm threonine dehydratase, medium form. A form of threonine dehydratase with two copies of the C-terminal domain Pfam:PF00585 is described by TIGR01124. This model describes a phylogenetically distinct form with a single copy of pfam00585. This form branches with the catabolic threonine dehydratase of E. coli; many members are designated as catabolic for this reason. However, the catabolic form lacks any pfam00585 domain. Many members of this model are found in species with other Ile biosynthetic enzymes.
Probab=42.68 E-value=60 Score=31.65 Aligned_cols=58 Identities=12% Similarity=0.268 Sum_probs=39.8
Q ss_pred ceeEEeeecccccCCCCchhhhhhhhcccCccEEEEecc-------CCcceeeeecchh---hHHHHHHHH
Q 020132 240 NLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA-------SSEHSVCFAVPEK---EVKAVAEAL 300 (330)
Q Consensus 240 nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~-------~se~sIS~vv~~~---d~~~av~~L 300 (330)
....+.+. +.+.||.++++.+.+++.+.||.-|.+. .....+.+.++-. +.++.++.|
T Consensus 304 r~~~l~v~---l~D~pG~L~~v~~~i~~~~~NI~~i~~~r~~~~~~~~~~~v~v~vet~~~~~~~~i~~~L 371 (380)
T TIGR01127 304 RKVRIETV---LPDRPGALYHLLESIAEARANIVKIDHDRLSKEIPPGFAMVEITLETRGKEHLDEILKIL 371 (380)
T ss_pred CEEEEEEE---eCCCCCHHHHHHHHHhcCCCcEEEEEeeccccCCCCceEEEEEEEEeCCHHHHHHHHHHH
Confidence 34455564 7899999999999999999999887443 1244566666553 333444444
No 212
>PRK07334 threonine dehydratase; Provisional
Probab=42.40 E-value=53 Score=32.43 Aligned_cols=58 Identities=21% Similarity=0.398 Sum_probs=38.9
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccC-------Ccceeeeecchh---hHHHHHHHHHH
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQAS-------SEHSVCFAVPEK---EVKAVAEALES 302 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~-------se~sIS~vv~~~---d~~~av~~Lh~ 302 (330)
+.|.|. ..+++|.+++|.+.|++.++||..+.... ....+.|.+.-. ++.++++.|.+
T Consensus 327 v~l~I~---~~dr~GlL~dI~~~is~~~~nI~~v~~~~~~~~~~~~~~~i~l~i~V~d~~~L~~vi~~Lr~ 394 (403)
T PRK07334 327 ARLRVD---IRDRPGALARVTALIGEAGANIIEVSHQRLFTDLPAKGAELELVIETRDAAHLQEVIAALRA 394 (403)
T ss_pred EEEEEE---eCCCCCHHHHHHHHHhhCCCceEEEEEEecccCCCCCeEEEEEEEEeCCHHHHHHHHHHHHH
Confidence 566665 45789999999999999999999887321 123345445444 44555555544
No 213
>cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=41.16 E-value=62 Score=24.27 Aligned_cols=25 Identities=16% Similarity=0.131 Sum_probs=22.5
Q ss_pred cCCCCchhhhhhhhcccCccEEEEe
Q 020132 252 AGVPGTANAIFGAVKDVGANVIMIS 276 (330)
Q Consensus 252 ~~~~gv~a~if~~L~~~gI~I~~Is 276 (330)
.++||+++++.++|++.|++|.+.-
T Consensus 8 ~DRpGLL~~i~~~l~~~~l~i~~Ak 32 (75)
T cd04896 8 VDQKGLLYDILRTSKDCNIQISYGR 32 (75)
T ss_pred CCcccHHHHHHHHHHHCCeEEEEEE
Confidence 5789999999999999999988754
No 214
>cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=39.58 E-value=28 Score=25.94 Aligned_cols=47 Identities=21% Similarity=0.217 Sum_probs=32.7
Q ss_pred EEeeecccccCCCCchhhhhhhhcccCccEEEEeccCC--cceeeeecchhh
Q 020132 243 LVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVPEKE 292 (330)
Q Consensus 243 ~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s--e~sIS~vv~~~d 292 (330)
+|.|.+ .++||+++++.++|.+.|++|....=++. ..-=.|+|...+
T Consensus 3 viev~a---~DRpGLL~~i~~~l~~~gl~I~~AkIsT~Gerv~DvFyV~d~~ 51 (72)
T cd04895 3 LVKVDS---ARKPGILLEAVQVLTDLDLCITKAYISSDGGWFMDVFHVTDQL 51 (72)
T ss_pred EEEEEE---CCcCCHHHHHHHHHHHCCcEEEEEEEeecCCeEEEEEEEECCC
Confidence 455553 57899999999999999999987543222 233346665554
No 215
>PRK06382 threonine dehydratase; Provisional
Probab=39.37 E-value=75 Score=31.43 Aligned_cols=62 Identities=21% Similarity=0.344 Sum_probs=42.6
Q ss_pred ecceeEEeeecccccCCCCchhhhhhhhcccCccEEEEecc----C---Ccceeeeecchh---hHHHHHHHHHH
Q 020132 238 IDNLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQA----S---SEHSVCFAVPEK---EVKAVAEALES 302 (330)
Q Consensus 238 ~~nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~----~---se~sIS~vv~~~---d~~~av~~Lh~ 302 (330)
.+....+.+. +.+.||.++++.+.+.++++||..+.+. . .+..+.|-++-. +.+++++.|.+
T Consensus 327 ~~~~~rl~v~---v~D~pG~L~~l~~ii~~~~~nI~~v~~~~~~~~~~~~~~~v~i~vet~~~~~~~~v~~~L~~ 398 (406)
T PRK06382 327 LGQLVRIECN---IPDRPGNLYRIANAIASNGGNIYHAEVDNLRKETPPGFQSVTFTVNVRGQDHLDRILNALRE 398 (406)
T ss_pred cCCEEEEEEE---cCCCCCHHHHHHHHHhcCCCcEEEEEEeeccccCCCCcEEEEEEEEeCCHHHHHHHHHHHHH
Confidence 3445666664 8899999999999999999999866653 1 245577777664 33344554433
No 216
>TIGR02667 moaB_proteo molybdenum cofactor biosynthesis protein B, proteobacterial. This model represents the MoaB protein molybdopterin biosynthesis regions in Proteobacteria. This crystallized but incompletely characterized protein is thought to be involved in, though not required for, early steps in molybdopterin biosynthesis. It may bind a molybdopterin precursor. A distinctive conserved motif PCN near the C-terminus helps distinguish this clade from other homologs, including sets of proteins designated MogA.
Probab=38.38 E-value=1.3e+02 Score=25.82 Aligned_cols=71 Identities=20% Similarity=0.306 Sum_probs=44.6
Q ss_pred chhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccc
Q 020132 44 ELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKR 123 (330)
Q Consensus 44 E~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgr 123 (330)
+--++..+++.|++.|++.. ...++.+ |.+...+.++++++.....+.|++|-.+.
T Consensus 20 ~d~n~~~l~~~L~~~G~~v~-----~~~iv~D--------d~~~i~~~l~~~~~~~~~DlVIttGGtg~----------- 75 (163)
T TIGR02667 20 DDTSGQYLVERLTEAGHRLA-----DRAIVKD--------DIYQIRAQVSAWIADPDVQVILITGGTGF----------- 75 (163)
T ss_pred CCCcHHHHHHHHHHCCCeEE-----EEEEcCC--------CHHHHHHHHHHHHhcCCCCEEEECCCcCC-----------
Confidence 45567788999999998643 3333333 33455677777653224578888774332
Q ss_pred cCcchhHHHHHHHHh
Q 020132 124 DGSDFSAAIMGALLR 138 (330)
Q Consensus 124 ggsD~~A~~lA~~l~ 138 (330)
|--|++.-.++..++
T Consensus 76 g~~D~t~eal~~l~~ 90 (163)
T TIGR02667 76 TGRDVTPEALEPLFD 90 (163)
T ss_pred CCCCCcHHHHHHHHC
Confidence 234888888777765
No 217
>COG0462 PrsA Phosphoribosylpyrophosphate synthetase [Nucleotide transport and metabolism / Amino acid transport and metabolism]
Probab=38.05 E-value=57 Score=31.39 Aligned_cols=96 Identities=16% Similarity=0.070 Sum_probs=54.6
Q ss_pred ccceeeeccchhHHHHHHHHHHhcCCccc-cccceeEEEECCCCCCCCCCCchhhHHHHHHhhccC--CCccEEEeeeee
Q 020132 35 FTDFVVGHGELWSAQMLAAVVRKNGIDCK-WMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQS--PSNTIIATGFIA 111 (330)
Q Consensus 35 ~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~-~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~--~~~VpVv~G~i~ 111 (330)
.+|..-..||.+||++++..|...|++-+ .+|...-.+ .+.| +..++.......+.+++... .....|+.++.|
T Consensus 97 RQDk~~~~repIsaklvA~lL~~aG~drv~TvDlH~~qi--qgfF-dipvdnl~a~p~l~~~~~~~~~~~d~vVVSPD~G 173 (314)
T COG0462 97 RQDKAFKPREPISAKLVANLLETAGADRVLTVDLHAPQI--QGFF-DIPVDNLYAAPLLAEYIREKYDLDDPVVVSPDKG 173 (314)
T ss_pred ccCcccCCCCCEeHHHHHHHHHHcCCCeEEEEcCCchhh--cccC-CCccccccchHHHHHHHHHhcCCCCcEEECCCcc
Confidence 34555588999999999999999999632 233322111 1122 12233323334445544421 113556655422
Q ss_pred cCCCCCcccccccCcchhHHHHHHHHhhceeEEEee
Q 020132 112 STPDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTD 147 (330)
Q Consensus 112 ~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~td 147 (330)
+=.-|-.+|..|+++--+|-+.
T Consensus 174 --------------gv~RAr~~A~~L~~~~a~i~K~ 195 (314)
T COG0462 174 --------------GVKRARALADRLGAPLAIIDKR 195 (314)
T ss_pred --------------HHHHHHHHHHHhCCCEEEEEEe
Confidence 2234889999999885555554
No 218
>PRK05788 cobalamin biosynthesis protein CbiG; Validated
Probab=36.15 E-value=24 Score=33.91 Aligned_cols=45 Identities=24% Similarity=0.214 Sum_probs=33.3
Q ss_pred ecCCCCCccc--cc--ccCcchhHHHHHHHHhhceeE-EEeecccccccC
Q 020132 111 ASTPDNIPTT--LK--RDGSDFSAAIMGALLRAHQVT-IWTDVDGVYSAD 155 (330)
Q Consensus 111 ~~~~~g~~~~--lg--rggsD~~A~~lA~~l~A~~l~-~~tdv~Gv~~~d 155 (330)
+.|+.|...+ +| .||+...|-.+|..|||.-++ =.||+.|++.-|
T Consensus 83 vvDe~G~~vIsLLsGH~GGAN~LA~~iA~~lga~pVITTAtd~~g~~avD 132 (315)
T PRK05788 83 VVDEKGKFVISLLSGHHGGANELARDLAKILGAVPVITTATDVNGKAAVD 132 (315)
T ss_pred EEeCCCCEEEEcccCCcccHHHHHHHHHHHhCCEEEEeCCccccCCccHH
Confidence 5567776433 33 688999999999999998643 457888887654
No 219
>cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=35.13 E-value=87 Score=23.01 Aligned_cols=28 Identities=14% Similarity=0.270 Sum_probs=23.7
Q ss_pred EeeecccccCCCCchhhhhhhhcccCccEEE
Q 020132 244 VNVEGTGMAGVPGTANAIFGAVKDVGANVIM 274 (330)
Q Consensus 244 IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~ 274 (330)
|.|. .+++||+++++..+|+.+|+||..
T Consensus 4 I~V~---~~Dr~gLFa~iag~L~~~~LnI~~ 31 (68)
T cd04928 4 ITFA---AGDKPKLLSQLSSLLGDLGLNIAE 31 (68)
T ss_pred EEEE---ECCCcchHHHHHHHHHHCCCceEE
Confidence 4455 347899999999999999999976
No 220
>TIGR00200 cinA_nterm competence/damage-inducible protein CinA N-terminal domain. cinA is a DNA damage- or competence-inducible protein that is polycistronic with recA in a number of species
Probab=33.25 E-value=1.6e+02 Score=29.50 Aligned_cols=68 Identities=16% Similarity=0.167 Sum_probs=45.1
Q ss_pred HHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCc
Q 020132 47 SAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGS 126 (330)
Q Consensus 47 sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggs 126 (330)
++..+++.|++.|++.... .++.| |.+...+.++..++ ...+.|++|-++.+. .
T Consensus 21 N~~~l~~~L~~~G~~v~~~-----~~v~D--------d~~~i~~~l~~a~~--~~DlVIttGGlgpt~-----------d 74 (413)
T TIGR00200 21 NAQWLADFLAHQGLPLSRR-----TTVGD--------NPERLKTIIRIASE--RADVLIFNGGLGPTS-----------D 74 (413)
T ss_pred hHHHHHHHHHHCCCeEEEE-----EEeCC--------CHHHHHHHHHHHhc--CCCEEEEcCCCCCCC-----------c
Confidence 5678899999999875432 22232 23445566666665 457778887554332 3
Q ss_pred chhHHHHHHHHhhc
Q 020132 127 DFSAAIMGALLRAH 140 (330)
Q Consensus 127 D~~A~~lA~~l~A~ 140 (330)
|.+.-.+|.+++-+
T Consensus 75 D~t~eava~~~g~~ 88 (413)
T TIGR00200 75 DLTAETIATAKGEP 88 (413)
T ss_pred ccHHHHHHHHhCCC
Confidence 99999999999843
No 221
>cd00758 MoCF_BD MoCF_BD: molybdenum cofactor (MoCF) binding domain (BD). This domain is found a variety of proteins involved in biosynthesis of molybdopterin cofactor, like MoaB, MogA, and MoeA. The domain is presumed to bind molybdopterin.
Probab=30.36 E-value=2e+02 Score=23.42 Aligned_cols=66 Identities=15% Similarity=0.151 Sum_probs=41.3
Q ss_pred hHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccC
Q 020132 46 WSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDG 125 (330)
Q Consensus 46 ~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrgg 125 (330)
-++..+.+.|++.|.+... ..+..+ |.+...+.++++++ ...+.|++|-.+.+ -
T Consensus 19 ~n~~~l~~~l~~~G~~v~~-----~~~v~D--------d~~~i~~~i~~~~~--~~DlvittGG~g~g-----------~ 72 (133)
T cd00758 19 TNGPALEALLEDLGCEVIY-----AGVVPD--------DADSIRAALIEASR--EADLVLTTGGTGVG-----------R 72 (133)
T ss_pred chHHHHHHHHHHCCCEEEE-----eeecCC--------CHHHHHHHHHHHHh--cCCEEEECCCCCCC-----------C
Confidence 4577889999999976432 122222 33455677777776 45778887743322 2
Q ss_pred cchhHHHHHHHH
Q 020132 126 SDFSAAIMGALL 137 (330)
Q Consensus 126 sD~~A~~lA~~l 137 (330)
.|.+.-.++...
T Consensus 73 ~D~t~~ai~~~g 84 (133)
T cd00758 73 RDVTPEALAELG 84 (133)
T ss_pred CcchHHHHHHhc
Confidence 488877777754
No 222
>PF13511 DUF4124: Domain of unknown function (DUF4124)
Probab=28.54 E-value=64 Score=22.44 Aligned_cols=29 Identities=34% Similarity=0.574 Sum_probs=20.5
Q ss_pred HHHHHHHHhhceeEEEeecccc--cccCccc
Q 020132 130 AAIMGALLRAHQVTIWTDVDGV--YSADPRK 158 (330)
Q Consensus 130 A~~lA~~l~A~~l~~~tdv~Gv--~~~dP~~ 158 (330)
+.+++...-+..+.-|+|.+|. |++.|..
T Consensus 3 ll~l~~~a~aa~vYk~~D~~G~v~ysd~P~~ 33 (60)
T PF13511_consen 3 LLLLAASAAAAEVYKWVDENGVVHYSDTPPP 33 (60)
T ss_pred HHHHhHHHhhccEEEEECCCCCEEECccCCC
Confidence 3444555555689999999996 7777663
No 223
>cd00886 MogA_MoaB MogA_MoaB family. Members of this family are involved in biosynthesis of the molybdenum cofactor (MoCF) an essential cofactor of a diverse group of redox enzymes. MoCF biosynthesis is an evolutionarily conserved pathway present in eubacteria, archaea, and eukaryotes. MoCF contains a tricyclic pyranopterin, termed molybdopterin (MPT). MogA, together with MoeA, is responsible for the metal incorporation into MPT, the third step in MoCF biosynthesis. The plant homolog Cnx1 is a MoeA-MogA fusion protein. The mammalian homolog gephyrin is a MogA-MoeA fusion protein, that plays a critical role in postsynaptic anchoring of inhibitory glycine receptors and major GABAa receptor subtypes. In contrast, MoaB shows high similarity to MogA, but little is known about its physiological role. All well studied members of this family form highly stable trimers.
Probab=28.16 E-value=2.5e+02 Score=23.48 Aligned_cols=68 Identities=22% Similarity=0.270 Sum_probs=40.8
Q ss_pred HHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCc
Q 020132 47 SAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGS 126 (330)
Q Consensus 47 sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggs 126 (330)
++..+.+.|++.|.+... ..+..+ |.+...+.+++.++.....+.|++|-.+.+ .-
T Consensus 21 n~~~l~~~l~~~G~~v~~-----~~~v~D--------d~~~i~~~l~~~~~~~~~DlVittGG~s~g-----------~~ 76 (152)
T cd00886 21 SGPALVELLEEAGHEVVA-----YEIVPD--------DKDEIREALIEWADEDGVDLILTTGGTGLA-----------PR 76 (152)
T ss_pred hHHHHHHHHHHcCCeeee-----EEEcCC--------CHHHHHHHHHHHHhcCCCCEEEECCCcCCC-----------CC
Confidence 466889999999976433 223332 334455666666541134677887743322 23
Q ss_pred chhHHHHHHHHh
Q 020132 127 DFSAAIMGALLR 138 (330)
Q Consensus 127 D~~A~~lA~~l~ 138 (330)
|++...++..++
T Consensus 77 D~t~~al~~~~~ 88 (152)
T cd00886 77 DVTPEATRPLLD 88 (152)
T ss_pred cCcHHHHHHHhC
Confidence 888887777764
No 224
>COG1104 NifS Cysteine sulfinate desulfinase/cysteine desulfurase and related enzymes [Amino acid transport and metabolism]
Probab=28.09 E-value=2.4e+02 Score=28.04 Aligned_cols=94 Identities=11% Similarity=0.149 Sum_probs=63.8
Q ss_pred cccceeeeccchhHHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecC
Q 020132 34 SFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIAST 113 (330)
Q Consensus 34 ~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~ 113 (330)
+-...+.+.=|..+..--..+|+.+|.+++++++..-+. ++. +.+++.+. ++.+.|.-. .+.+
T Consensus 90 ~~~HIIts~iEH~aVl~~~~~Le~~g~~Vtyl~V~~~G~----------v~~----e~L~~al~--~~T~LVSim-~aNn 152 (386)
T COG1104 90 KGKHIITSAIEHPAVLNTCRYLERQGFEVTYLPVDSNGL----------VDL----EQLEEALR--PDTILVSIM-HANN 152 (386)
T ss_pred CCCeEEEcccccHHHHHHHHHHHhcCCeEEEeCCCCCCe----------EcH----HHHHHhcC--CCceEEEEE-eccc
Confidence 345778888899999999999989999999987654322 445 77788886 444444322 2444
Q ss_pred CCCCcccccccCcchhHHHHHHHHhhceeEEEeecccccc
Q 020132 114 PDNIPTTLKRDGSDFSAAIMGALLRAHQVTIWTDVDGVYS 153 (330)
Q Consensus 114 ~~g~~~~lgrggsD~~A~~lA~~l~A~~l~~~tdv~Gv~~ 153 (330)
+-|-+- + -..||+.++...+.|.+|---.+.
T Consensus 153 E~G~IQ-------p--I~ei~~i~k~~~i~fHvDAvQa~G 183 (386)
T COG1104 153 ETGTIQ-------P--IAEIGEICKERGILFHVDAVQAVG 183 (386)
T ss_pred Ceeecc-------c--HHHHHHHHHHcCCeEEEehhhhcC
Confidence 444332 2 567888888888999999433333
No 225
>smart00460 TGc Transglutaminase/protease-like homologues. Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events.
Probab=27.57 E-value=45 Score=23.33 Aligned_cols=25 Identities=28% Similarity=0.484 Sum_probs=20.6
Q ss_pred eccchhHHHHHHHHHHhcCCccccccc
Q 020132 41 GHGELWSAQMLAAVVRKNGIDCKWMDT 67 (330)
Q Consensus 41 ~~GE~~sa~~~~~~L~~~Gi~a~~l~~ 67 (330)
.+.+. |.+++..|+..|||++.+.+
T Consensus 8 ~C~~~--a~l~~~llr~~GIpar~v~g 32 (68)
T smart00460 8 TCGEF--AALFVALLRSLGIPARVVSG 32 (68)
T ss_pred eeHHH--HHHHHHHHHHCCCCeEEEee
Confidence 35566 88999999999999988754
No 226
>COG1778 Low specificity phosphatase (HAD superfamily) [General function prediction only]
Probab=27.28 E-value=16 Score=31.62 Aligned_cols=52 Identities=21% Similarity=0.171 Sum_probs=31.0
Q ss_pred EEeecccccccCccchhHhhhhhhhhhHHhhhhhhcccccccccccceeeecccceEEeeeccc
Q 020132 144 IWTDVDGVYSADPRKVSEAVILRTLSYQEAWEMSYFGANVLHPRTIIPVMRYDIPIVIRNIFNL 207 (330)
Q Consensus 144 ~~tdv~Gv~~~dP~~~~~a~~i~~is~~e~~~l~~~g~~v~~p~a~~~a~~~~i~v~i~~~~~~ 207 (330)
+.+||||++|+ .+++-.-.-+|.. -..+.+--.++..+++||.+-|+.+.+.
T Consensus 11 li~DVDGvLTD-------G~ly~~~~Gee~K-----aFnv~DG~Gik~l~~~Gi~vAIITGr~s 62 (170)
T COG1778 11 LILDVDGVLTD-------GKLYYDENGEEIK-----AFNVRDGHGIKLLLKSGIKVAIITGRDS 62 (170)
T ss_pred EEEeccceeec-------CeEEEcCCCceee-----eeeccCcHHHHHHHHcCCeEEEEeCCCC
Confidence 46899999985 2222221122221 1244444567788888999888877643
No 227
>cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=25.76 E-value=1.8e+02 Score=21.69 Aligned_cols=47 Identities=13% Similarity=0.167 Sum_probs=32.3
Q ss_pred eEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCC--cceeeeecchh
Q 020132 242 ALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS--EHSVCFAVPEK 291 (330)
Q Consensus 242 a~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s--e~sIS~vv~~~ 291 (330)
++|.|.+ ++.||++.++..+|.+.|++|....=++. ...=.|.|...
T Consensus 2 TvveV~~---~DRpGLL~~i~~~l~~~~l~I~~A~I~T~gera~D~FyV~d~ 50 (75)
T cd04897 2 SVVTVQC---RDRPKLLFDVVCTLTDMDYVVFHATIDTDGDDAHQEYYIRHK 50 (75)
T ss_pred EEEEEEe---CCcCcHHHHHHHHHHhCCeEEEEEEEeecCceEEEEEEEEcC
Confidence 4566664 57899999999999999999987653332 12224555444
No 228
>COG0303 MoeA Molybdopterin biosynthesis enzyme [Coenzyme metabolism]
Probab=25.75 E-value=1.9e+02 Score=28.83 Aligned_cols=72 Identities=25% Similarity=0.313 Sum_probs=46.7
Q ss_pred HHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCc
Q 020132 47 SAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGS 126 (330)
Q Consensus 47 sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggs 126 (330)
+...+++.|++.|..... +.+..| |.+...+.+++.++ ...+.|++|-.+ . |..
T Consensus 204 N~~~l~a~l~~~G~e~~~-----~giv~D--------d~~~l~~~i~~a~~--~~DviItsGG~S---------v--G~~ 257 (404)
T COG0303 204 NSYMLAALLERAGGEVVD-----LGIVPD--------DPEALREAIEKALS--EADVIITSGGVS---------V--GDA 257 (404)
T ss_pred CHHHHHHHHHHcCCceee-----ccccCC--------CHHHHHHHHHHhhh--cCCEEEEeCCcc---------C--cch
Confidence 356788899999986433 233322 45566677777776 567888887422 2 345
Q ss_pred chhHHHHHHHHhhceeEEEe
Q 020132 127 DFSAAIMGALLRAHQVTIWT 146 (330)
Q Consensus 127 D~~A~~lA~~l~A~~l~~~t 146 (330)
|++-..+...+| .+.||.
T Consensus 258 D~v~~~l~~~lG--~v~~~g 275 (404)
T COG0303 258 DYVKAALERELG--EVLFHG 275 (404)
T ss_pred HhHHHHHHhcCC--cEEEEe
Confidence 988888877777 566653
No 229
>COG0329 DapA Dihydrodipicolinate synthase/N-acetylneuraminate lyase [Amino acid transport and metabolism / Cell envelope biogenesis, outer membrane]
Probab=25.69 E-value=1.3e+02 Score=28.59 Aligned_cols=80 Identities=16% Similarity=0.116 Sum_probs=45.4
Q ss_pred HHHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCc
Q 020132 47 SAQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGS 126 (330)
Q Consensus 47 sa~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggs 126 (330)
+-+.+.+.|.+.|++...+.+..- .+ .....++-.+.++...+...+.+||+.|- +.+ .|-
T Consensus 26 a~~~lv~~li~~Gv~gi~~~GttG------E~--~~Ls~eEr~~v~~~~v~~~~grvpviaG~-g~~-----~t~----- 86 (299)
T COG0329 26 ALRRLVEFLIAAGVDGLVVLGTTG------ES--PTLTLEERKEVLEAVVEAVGGRVPVIAGV-GSN-----STA----- 86 (299)
T ss_pred HHHHHHHHHHHcCCCEEEECCCCc------cc--hhcCHHHHHHHHHHHHHHHCCCCcEEEec-CCC-----cHH-----
Confidence 356678899999998776654421 11 22333334455555555557899999885 211 110
Q ss_pred ch-hHHHHHHHHhhceeEEE
Q 020132 127 DF-SAAIMGALLRAHQVTIW 145 (330)
Q Consensus 127 D~-~A~~lA~~l~A~~l~~~ 145 (330)
|. --+..|+.+||+.+...
T Consensus 87 eai~lak~a~~~Gad~il~v 106 (299)
T COG0329 87 EAIELAKHAEKLGADGILVV 106 (299)
T ss_pred HHHHHHHHHHhcCCCEEEEe
Confidence 21 13455666677766553
No 230
>COG2150 Predicted regulator of amino acid metabolism, contains ACT domain [General function prediction only]
Probab=25.18 E-value=91 Score=27.07 Aligned_cols=59 Identities=14% Similarity=0.201 Sum_probs=37.4
Q ss_pred eeEEeeecccccCCCCchhhhhhhhcccCccEEEEeccCC----cceeeeecchhhHHHHHHHH
Q 020132 241 LALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQASS----EHSVCFAVPEKEVKAVAEAL 300 (330)
Q Consensus 241 ia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq~~s----e~sIS~vv~~~d~~~av~~L 300 (330)
..+|.+.- .....||+++.+++.++++||+|..+--... +-.+.++.++.-=.+.+..|
T Consensus 93 ~gViei~~-~~~~~pgi~A~V~~~iak~gi~Irqi~~~dpe~~~e~~l~IVte~~iP~~li~el 155 (167)
T COG2150 93 LGVIEIYP-EDARYPGILAGVASLIAKRGISIRQIISEDPELQEEPKLTIVTERPIPGDLIDEL 155 (167)
T ss_pred CeEEEEEe-ccCCCccHHHHHHHHHHHcCceEEEEecCCcccCCCceEEEEEeccCCHHHHHHH
Confidence 33444442 2446799999999999999999988752111 45666666654333344433
No 231
>cd05402 NT_PAP_TUTase Nucleotidyltransferase (NT) domain of poly(A) polymerases and terminal uridylyl transferases. Poly(A) polymerases (PAPs) catalyze mRNA poly(A) tail synthesis, and terminal uridylyl transferases (TUTases) uridylate RNA. PAPs in this subgroup include human PAP alpha, mouse testis-specific cytoplasmic PAP beta, human nuclear PAP gamma, Saccharomyces cerevisiae PAP1, TRF4 and-5, Schizosaccharomyces pombe caffeine-induced death proteins -1, and -14, Caenorhabditis elegans Germ Line Development-2, and Chlamydomonas reinhardtii MUT68. This family also includes human U6 snRNA-specific TUTase1, and Trypanosoma brucei 3'-TUTase-1,-2, and 4. This family belongs to the Pol beta-like NT superfamily. In the majority of enzymes in this superfamily, two carboxylates, Dx[D/E], together with a third more distal carboxylate, coordinate two divalent metal cations involved in a two-metal ion mechanism of nucleotide addition. For the majority of proteins in this family, these carboxyla
Probab=24.70 E-value=96 Score=24.32 Aligned_cols=43 Identities=12% Similarity=0.224 Sum_probs=32.7
Q ss_pred Ccceeeeecch--hhHHHHHHHHHHHHHHHhccCcccccCCCCCC
Q 020132 280 SEHSVCFAVPE--KEVKAVAEALESKFREALNAGRLSQHSSSSWP 322 (330)
Q Consensus 280 se~sIS~vv~~--~d~~~av~~Lh~~f~~~~~~~~i~~~~~~~~~ 322 (330)
|...+++..+. .+..+.++.+.+.+........+..|..+++|
T Consensus 37 SDiDl~i~~~~~~~~~~~~l~~l~~~l~~~~~~~~~~~i~~ArVP 81 (114)
T cd05402 37 SDIDLCLLGPNHRVDREDFLRKLAKLLKKSGEVVEVEPIINARVP 81 (114)
T ss_pred CCeeEEEEeCCCCccHHHHHHHHHHHHHhCCCceeeEEeccCCCC
Confidence 46666666666 47778888888887665556778899999998
No 232
>PTZ00445 p36-lilke protein; Provisional
Probab=24.62 E-value=2.8e+02 Score=25.31 Aligned_cols=27 Identities=22% Similarity=0.188 Sum_probs=22.2
Q ss_pred hHHHHHHHHHHhcCCccccccceeEEE
Q 020132 46 WSAQMLAAVVRKNGIDCKWMDTREVLI 72 (330)
Q Consensus 46 ~sa~~~~~~L~~~Gi~a~~l~~~~~~~ 72 (330)
=++..++..|++.||+++..|-..-++
T Consensus 29 ~~~~~~v~~L~~~GIk~Va~D~DnTlI 55 (219)
T PTZ00445 29 ESADKFVDLLNECGIKVIASDFDLTMI 55 (219)
T ss_pred HHHHHHHHHHHHcCCeEEEecchhhhh
Confidence 358999999999999999988665443
No 233
>PF12122 DUF3582: Protein of unknown function (DUF3582); InterPro: IPR022732 In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold: Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, N-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins. Peptidase families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; N, asparagine; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule. In the case of the asparagine endopeptidases, the nucleophile is asparagine and all are self-processing endopeptidases. In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding. Proteolytic enzymes that exploit serine in their catalytic activity are ubiquitous, being found in viruses, bacteria and eukaryotes []. They include a wide range of peptidase activity, including exopeptidase, endopeptidase, oligopeptidase and omega-peptidase activity. Over 20 families (denoted S1 - S66) of serine protease have been identified, these being grouped into clans on the basis of structural similarity and other functional evidence []. Structures are known for members of the clans and the structures indicate that some appear to be totally unrelated, suggesting different evolutionary origins for the serine peptidases []. Not withstanding their different evolutionary origins, there are similarities in the reaction mechanisms of several peptidases. Chymotrypsin, subtilisin and carboxypeptidase C have a catalytic triad of serine, aspartate and histidine in common: serine acts as a nucleophile, aspartate as an electrophile, and histidine as a base []. The geometric orientations of the catalytic residues are similar between families, despite different protein folds []. The linear arrangements of the catalytic residues commonly reflect clan relationships. For example the catalytic triad in the chymotrypsin clan (PA) is ordered HDS, but is ordered DHS in the subtilisin clan (SB) and SDH in the carboxypeptidase clan (SC) [, ]. This entry represents the N-terminal domain of membrane-bound serine endopeptidases belonging to MEROPS peptidase family S54 (rhomboid-1, clan ST). This domain contains a conserved ASW sequence motif and a single completely conserved residue F that may be functionally important. The tertiary structure of the GlpG protein from Escherichia coli has been determined []. The GlpG protein has six transmembrane domains (other members of the family are predicted to have seven), with the N- and C-terminal ends anchored in the cytoplasm. One transmembrane domain is shorter than the rest, creating an internal, aqueous cavity just below the membrane surface and it is here were proteolysis occurs. There is also a membrane-embedded loop between the first and second transmembrane domains which is postulated to act as a gate controlling substrate access to the active site. No other family of serine peptidases is known to have active site residues within transmembrane domains (although transmembrane active sites are known for aspartic peptidase and metallopeptidases), and the GlpG protein has the type structure for clan ST.; GO: 0004252 serine-type endopeptidase activity, 0016021 integral to membrane; PDB: 3UBB_A 3B45_A 3B44_A 2NRF_A 3TXT_A 2O7L_A 2XTU_A 2IRV_A 2XOW_A 2XTV_A ....
Probab=24.28 E-value=91 Score=24.77 Aligned_cols=51 Identities=16% Similarity=0.302 Sum_probs=33.4
Q ss_pred CCCCchhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHHHH
Q 020132 253 GVPGTANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESKFR 305 (330)
Q Consensus 253 ~~~gv~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~f~ 305 (330)
++|..+..+..-|+..||.+.+-.++.....|.+ .++++.+++...|.. |.
T Consensus 8 ~n~r~AqaF~DYl~sqgI~~~i~~~~~~~~~lwl-~de~~~~~a~~el~~-Fl 58 (101)
T PF12122_consen 8 NNPRAAQAFIDYLASQGIELQIEPEGQGQFALWL-HDEEHLEQAEQELEE-FL 58 (101)
T ss_dssp SSHHHHHHHHHHHHHTT--EEEE-SSSE--EEEE-S-GGGHHHHHHHHHH-HH
T ss_pred CCHHHHHHHHHHHHHCCCeEEEEECCCCceEEEE-eCHHHHHHHHHHHHH-HH
Confidence 4567788889999999999998864433455543 388899988888866 53
No 234
>PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i.e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B ....
Probab=22.57 E-value=47 Score=25.67 Aligned_cols=29 Identities=17% Similarity=0.212 Sum_probs=21.3
Q ss_pred eeccchhHHHHHHHHHHhcCCccccccceeE
Q 020132 40 VGHGELWSAQMLAAVVRKNGIDCKWMDTREV 70 (330)
Q Consensus 40 ~~~GE~~sa~~~~~~L~~~Gi~a~~l~~~~~ 70 (330)
-.|.+. |.++++.|+..||||+.+.+...
T Consensus 52 G~C~~~--a~l~~allr~~Gipar~v~g~~~ 80 (113)
T PF01841_consen 52 GDCEDY--ASLFVALLRALGIPARVVSGYVK 80 (113)
T ss_dssp ESHHHH--HHHHHHHHHHHT--EEEEEEEEE
T ss_pred CccHHH--HHHHHHHHhhCCCceEEEEEEcC
Confidence 446677 88999999999999998865443
No 235
>cd00952 CHBPH_aldolase Trans-o-hydroxybenzylidenepyruvate hydratase-aldolase (HBPHA) and trans-2'-carboxybenzalpyruvate hydratase-aldolase (CBPHA). HBPHA catalyzes HBP to salicyaldehyde and pyruvate. This reaction is part of the degradative pathways for naphthalene and naphthalenesulfonates by bacteria. CBPHA is homologous to HBPHA and catalyzes the cleavage of CBP to 2-carboxylbenzaldehyde and pyruvate during the degradation of phenanthrene. They are member of the DHDPS family of Schiff-base-dependent class I aldolases.
Probab=22.54 E-value=1.8e+02 Score=27.55 Aligned_cols=80 Identities=11% Similarity=-0.018 Sum_probs=47.5
Q ss_pred HHHHHHHHHhcCCccccccceeEEEECCCCCCCCCCCchhhHHHHHHhhccCCCccEEEeeeeecCCCCCcccccccCcc
Q 020132 48 AQMLAAVVRKNGIDCKWMDTREVLIVNPTSSNQVDPDFSESEKRLEKWFSQSPSNTIIATGFIASTPDNIPTTLKRDGSD 127 (330)
Q Consensus 48 a~~~~~~L~~~Gi~a~~l~~~~~~~~~~~~~g~~~~~~~~~~~~i~~~l~~~~~~VpVv~G~i~~~~~g~~~~lgrggsD 127 (330)
-+.+...|.+.|++...+.+..- .+ .....++-.+.++...+...+.+||+.|--+ ..+- |
T Consensus 31 l~~lv~~li~~Gv~Gi~v~GstG------E~--~~Lt~eEr~~v~~~~~~~~~grvpvi~Gv~~------~~t~-----~ 91 (309)
T cd00952 31 TARLVERLIAAGVDGILTMGTFG------EC--ATLTWEEKQAFVATVVETVAGRVPVFVGATT------LNTR-----D 91 (309)
T ss_pred HHHHHHHHHHcCCCEEEECcccc------cc--hhCCHHHHHHHHHHHHHHhCCCCCEEEEecc------CCHH-----H
Confidence 45667788889998776654421 11 2233344445555555555788999988511 1110 2
Q ss_pred h-hHHHHHHHHhhceeEEEe
Q 020132 128 F-SAAIMGALLRAHQVTIWT 146 (330)
Q Consensus 128 ~-~A~~lA~~l~A~~l~~~t 146 (330)
. -.+..|..+||+.+.+..
T Consensus 92 ai~~a~~A~~~Gad~vlv~~ 111 (309)
T cd00952 92 TIARTRALLDLGADGTMLGR 111 (309)
T ss_pred HHHHHHHHHHhCCCEEEECC
Confidence 2 256777888998887654
No 236
>PF09186 DUF1949: Domain of unknown function (DUF1949); InterPro: IPR015269 Members of this entry are a set of functionally uncharacterised hypothetical bacterial proteins. They adopt a ferredoxin-like fold, with a beta-alpha-beta-beta-alpha-beta arrangement []. This entry contains the protein Impact, which is a translational regulator that ensures constant high levels of translation under amino acid starvation. It acts by interacting with Gcn1/Gcn1L1, thereby preventing activation of Gcn2 protein kinases (EIF2AK1 to 4) and subsequent down-regulation of protein synthesis. It is evolutionary conserved from eukaryotes to archaea []. ; PDB: 2CVE_A 1VI7_A.
Probab=22.51 E-value=1.8e+02 Score=19.44 Aligned_cols=45 Identities=18% Similarity=0.264 Sum_probs=37.3
Q ss_pred hhhhhhhhcccCccEEEEeccCCcceeeeecchhhHHHHHHHHHHH
Q 020132 258 ANAIFGAVKDVGANVIMISQASSEHSVCFAVPEKEVKAVAEALESK 303 (330)
Q Consensus 258 ~a~if~~L~~~gI~I~~Isq~~se~sIS~vv~~~d~~~av~~Lh~~ 303 (330)
..++-..|..+++.|.-..++. .+.+.+.|+.++.+...+.|-+.
T Consensus 8 ~~~v~~~l~~~~~~i~~~~y~~-~V~~~v~v~~~~~~~f~~~l~~~ 52 (56)
T PF09186_consen 8 YGKVERLLEQNGIEIVDEDYTD-DVTLTVAVPEEEVEEFKAQLTDL 52 (56)
T ss_dssp HHHHHHHHHHTTTEEEEEEECT-TEEEEEEEECCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCEEEcceecc-eEEEEEEECHHHHHHHHHHHHHH
Confidence 4567778889999999988865 59999999999999888887653
No 237
>PRK06545 prephenate dehydrogenase; Validated
Probab=21.46 E-value=1.3e+02 Score=29.26 Aligned_cols=59 Identities=15% Similarity=0.249 Sum_probs=39.1
Q ss_pred ceeEEeeecccccCCCCchhhhhhhhcccCccEEEEec--cC----CcceeeeecchhhHHHHHHHHHH
Q 020132 240 NLALVNVEGTGMAGVPGTANAIFGAVKDVGANVIMISQ--AS----SEHSVCFAVPEKEVKAVAEALES 302 (330)
Q Consensus 240 nia~IsvvG~~~~~~~gv~a~if~~L~~~gI~I~~Isq--~~----se~sIS~vv~~~d~~~av~~Lh~ 302 (330)
...-+.|. +.+.||.+++++..|++.||||.-|.= +. .-..|+|. ++.+.+++...|.+
T Consensus 289 ~~~~~~v~---v~d~pg~~~~~~~~~~~~~i~i~~~~i~~~~~~~~g~~~~~~~-~~~~~~~~~~~~~~ 353 (359)
T PRK06545 289 SFYDLYVD---VPDEPGVIARVTAILGEEGISIENLRILEAREDIHGVLQISFK-NEEDRERAKALLEE 353 (359)
T ss_pred cceEEEEe---CCCCCCHHHHHHHHHHHcCCCeecceeeeccCCcCceEEEEeC-CHHHHHHHHHHHHh
Confidence 44445554 678999999999999999999875541 00 12345553 44566666666654
No 238
>PF11713 Peptidase_C80: Peptidase C80 family; InterPro: IPR020974 In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold: Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, N-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins. Peptidase families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; N, asparagine; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule. In the case of the asparagine endopeptidases, the nucleophile is asparagine and all are self-processing endopeptidases. In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding. Cysteine peptidases have characteristic molecular topologies, which can be seen not only in their three-dimensional structures, but commonly also in the two-dimensional structures. These are peptidases in which the nucleophile is the sulphydryl group of a cysteine residue. Cysteine proteases are divided into clans (proteins which are evolutionary related), and further sub-divided into families, on the basis of the architecture of their catalytic dyad or triad []. This entry identifies a domain that functions as a cysteine peptidase that belongs to MEROPS peptidase family C80 (RTX self-cleaving toxin, clan CD). This domain is found in bacterial toxins that self-process by a cysteine peptidase mechanism. These include Vibrio cholerae RTX toxin [], and Clostridium difficile toxins A and B []. Some pathogenic bacteria produce unrelated toxins that also require activation and processing, the processing often being autolytic as it is in anthrax lethal factor, tentoxilysin (the tetanus neurotoxin) and bontoxilysin (the botulinum neurotoxin), all of which are metallopeptidases.; PDB: 3GCD_C 3EEB_B 3FZY_A 3PEE_A 3PA8_B 3HO6_A.
Probab=20.70 E-value=75 Score=27.26 Aligned_cols=37 Identities=19% Similarity=0.179 Sum_probs=29.8
Q ss_pred eEEeeecccccCC---CCchhhhhhhhcccCccEEEEecc
Q 020132 242 ALVNVEGTGMAGV---PGTANAIFGAVKDVGANVIMISQA 278 (330)
Q Consensus 242 a~IsvvG~~~~~~---~gv~a~if~~L~~~gI~I~~Isq~ 278 (330)
-.|+++|..|... .++..++...|.++||+.....+.
T Consensus 104 ~~IsLvGC~l~~~~~~~~fa~~f~~~L~~~gi~~~V~A~~ 143 (157)
T PF11713_consen 104 KKISLVGCSLADNNKQESFALQFAQALKKQGINASVSAYT 143 (157)
T ss_dssp SEEEEESSS-S-TTGGGSHHHHHHHHHHHHHHCEEEEEES
T ss_pred CEEEEEEecccCCcccccHHHHHHHHHHhcCCcceEEEEE
Confidence 4788999888776 789999999999999998887753
No 239
>PF11823 DUF3343: Protein of unknown function (DUF3343); InterPro: IPR021778 This family of proteins are functionally uncharacterised. This protein is found in bacteria and archaea. Proteins in this family are typically between 78 to 102 amino acids in length.
Probab=20.25 E-value=1.9e+02 Score=21.08 Aligned_cols=46 Identities=17% Similarity=0.234 Sum_probs=35.7
Q ss_pred hhhhhhhhcccCccEEEEeccC---CcceeeeecchhhHHHHHHHHHHH
Q 020132 258 ANAIFGAVKDVGANVIMISQAS---SEHSVCFAVPEKEVKAVAEALESK 303 (330)
Q Consensus 258 ~a~if~~L~~~gI~I~~Isq~~---se~sIS~vv~~~d~~~av~~Lh~~ 303 (330)
+-+.-+.|.++|++..++.-+. +...+++-++.+|.+.+.+.|.+.
T Consensus 14 a~~~ek~lk~~gi~~~liP~P~~i~~~CG~al~~~~~d~~~i~~~l~~~ 62 (73)
T PF11823_consen 14 AMKAEKLLKKNGIPVRLIPTPREISAGCGLALRFEPEDLEKIKEILEEN 62 (73)
T ss_pred HHHHHHHHHHCCCcEEEeCCChhccCCCCEEEEEChhhHHHHHHHHHHC
Confidence 3355678889999998886322 267899999999999999888763
No 240
>PRK14324 glmM phosphoglucosamine mutase; Provisional
Probab=20.10 E-value=6.5e+02 Score=25.13 Aligned_cols=53 Identities=13% Similarity=0.026 Sum_probs=33.8
Q ss_pred HHHhhhcccccCCCCCccccccceeeeccchhHHHHHHHHHHhcCCccccccc
Q 020132 15 FIRSTYNFLSNVDSGHATESFTDFVVGHGELWSAQMLAAVVRKNGIDCKWMDT 67 (330)
Q Consensus 15 ~i~~~~~~l~~~~~~~~~~~~~~~v~~~GE~~sa~~~~~~L~~~Gi~a~~l~~ 67 (330)
.+..|.+.|.+.++.+...+....++-++--..+.++...|++.|+++..++.
T Consensus 155 ~~~~Y~~~l~~~i~~~~~~~~lkVvvD~~nGa~~~~~~~ll~~lG~~v~~i~~ 207 (446)
T PRK14324 155 VIGRYIVHIKNSFPKDLTLKGLRIVLDTANGAAYKVAPTVFSELGADVIVIND 207 (446)
T ss_pred HHHHHHHHHHHhcCCccCCCCCEEEEECCCchHHHHHHHHHHHcCCeEEEECC
Confidence 34445555555553222223345667766666788888999999998877763
Done!